archetype #,Feature Name,P value (Mann-Whitney),Median Difference,Mean Difference,Significant after Benjamini-Hochberg correction?,Is first bin maximal?
1,GO BLEB ASSEMBLY,3.9926e-07,1.6202,1.3957,1,1
1,GO ANTIGEN PROCESSING AND PRESENTATION OF ENDOGENOUS PEPTIDE ANTIGEN,8.1192e-05,1.5121,1.2888,1,1
1,GO MEMBRANE RAFT ASSEMBLY,7.0571e-06,1.4257,1.5231,1,1
1,GO NEGATIVE REGULATION OF VIRAL ENTRY INTO HOST CELL,2.5122e-07,1.3066,1.1603,1,1
1,GO REGULATION OF T HELPER 2 CELL DIFFERENTIATION,2.8891e-07,1.2317,1.0926,1,1
1,GO ANTIGEN PROCESSING AND PRESENTATION OF ENDOGENOUS ANTIGEN,0.00014418,1.1881,0.98381,1,1
1,GO NEGATIVE REGULATION OF HIPPO SIGNALING,1.9904e-06,1.1139,0.97689,1,1
1,GO REGULATION OF PHOSPHOLIPASE A2 ACTIVITY,1.2366e-07,1.1054,0.98596,1,1
1,GO MODULATION BY SYMBIONT OF ENTRY INTO HOST,3.3202e-07,1.0843,1.0301,1,1
1,GO REGULATION OF TAU PROTEIN KINASE ACTIVITY,0.0006154,1.0756,0.94856,1,1
1,GO T HELPER 2 CELL DIFFERENTIATION,1.6452e-07,1.0692,1.0508,1,1
1,GO POSITIVE REGULATION BY SYMBIONT OF ENTRY INTO HOST,1.5816e-05,1.0649,0.96077,1,1
1,GO POSITIVE REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,6.2985e-07,1.054,0.91261,1,1
1,GO T HELPER 1 CELL DIFFERENTIATION,1.4963e-07,1.0301,0.86747,1,1
1,GO NEUTROPHIL HOMEOSTASIS,1.104e-05,1.0288,0.9251,1,1
1,GO HYALURONAN CATABOLIC PROCESS,1.4674e-06,1.0272,0.98847,1,1
1,GO REGULATION OF PLASMINOGEN ACTIVATION,9.389e-05,1.0145,0.87651,1,1
1,GO REGULATION OF VIRAL ENTRY INTO HOST CELL,8.628e-07,1.0115,0.97766,1,1
1,GO RESPONSE TO INTERFERON ALPHA,2.8077e-06,1.0105,1.0672,1,1
1,GO GLYCOPROTEIN CATABOLIC PROCESS,8.3127e-06,0.98795,0.79839,1,1
1,GO TRAIL ACTIVATED APOPTOTIC SIGNALING PATHWAY,7.889e-07,0.9695,0.92395,1,1
1,GO NEGATIVE REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,0.00032948,0.96203,0.73375,1,1
1,GO ANTIGEN PROCESSING AND PRESENTATION VIA MHC CLASS IB,3.0689e-05,0.9304,0.86227,1,1
1,GO REGULATION OF METANEPHROS DEVELOPMENT,1.6452e-07,0.92007,0.89428,1,1
1,GO NEGATIVE REGULATION OF LEUKOCYTE MEDIATED CYTOTOXICITY,0.00024286,0.90973,0.72951,1,1
1,GO PYRIMIDINE RIBONUCLEOSIDE METABOLIC PROCESS,6.2367e-06,0.90936,0.86293,1,1
1,GO NEGATIVE REGULATION OF INTERLEUKIN 8 PRODUCTION,1.0779e-06,0.892,0.7645,1,1
1,GO POSITIVE REGULATION OF INTERLEUKIN 13 PRODUCTION,1.2454e-05,0.89181,0.75609,1,1
1,GO NEGATIVE REGULATION OF CELL KILLING,0.0001547,0.8802,0.69752,1,1
1,GO MEMBRANE RAFT ORGANIZATION,9.7801e-06,0.87229,0.93217,1,1
1,GO GLOMERULAR EPITHELIAL CELL DEVELOPMENT,2.6902e-06,0.86993,0.78746,1,1
1,GO ENDODERMAL CELL DIFFERENTIATION,2.9301e-06,0.86597,0.86339,1,1
1,GO POSITIVE REGULATION OF T HELPER 1 TYPE IMMUNE RESPONSE,4.5813e-07,0.86061,0.75652,1,1
1,GO RENAL SYSTEM VASCULATURE DEVELOPMENT,3.0264e-07,0.85499,0.84946,1,1
1,GO GLOMERULAR MESANGIUM DEVELOPMENT,3.1904e-06,0.8452,0.71879,1,1
1,GO POSITIVE REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,1.2862e-06,0.83091,0.78294,1,1
1,GO INFLAMMATORY RESPONSE TO WOUNDING,1.5331e-06,0.82817,0.92754,1,1
1,GO REGULATION OF T HELPER 1 TYPE IMMUNE RESPONSE,1.4268e-07,0.82762,0.79249,1,1
1,GO CD40 SIGNALING PATHWAY,1.2971e-07,0.82693,0.77599,1,1
1,GO RESPONSE TO INTERFERON BETA,4.8612e-06,0.81918,0.92985,1,1
1,GO COLLAGEN BIOSYNTHETIC PROCESS,2.9301e-06,0.81777,0.75362,1,1
1,GO POSITIVE REGULATION OF EXTRACELLULAR MATRIX ASSEMBLY,2.6307e-05,0.81615,0.76824,1,1
1,GO NEGATIVE REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,1.5201e-05,0.81582,0.93524,1,1
1,GO NEGATIVE REGULATION OF SINGLE STRANDED VIRAL RNA REPLICATION VIA DOUBLE STRANDED DNA INTERMEDIATE,1.2962e-05,0.80747,0.81432,1,1
1,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN VIA MHC CLASS I,5.0194e-07,0.80446,0.67474,1,1
1,GO HEMIDESMOSOME ASSEMBLY,1.8521e-05,0.80373,0.91387,1,1
1,GO ANTIGEN PROCESSING AND PRESENTATION OF EXOGENOUS PEPTIDE ANTIGEN VIA MHC CLASS I,8.628e-07,0.80137,0.69417,1,1
1,GO ZYMOGEN INHIBITION,1.1237e-07,0.79652,0.84926,1,1
1,GO BONE TRABECULA FORMATION,0.0019282,0.78694,0.66313,1,1
1,GO REGULATION OF EXTRACELLULAR MATRIX ASSEMBLY,0.00057693,0.78408,0.67395,1,1
1,GO POSITIVE REGULATION OF T HELPER CELL DIFFERENTIATION,7.5427e-07,0.78406,0.6651,1,1
1,GO NEGATIVE REGULATION OF T HELPER CELL DIFFERENTIATION,9.8628e-07,0.78229,0.68947,1,1
1,GO PLASMINOGEN ACTIVATION,0.00019753,0.77909,0.59725,1,1
1,GO POSITIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,2.1663e-05,0.77097,0.63158,1,1
1,GO NEGATIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,1.3441e-06,0.77051,0.67479,1,1
1,GO DNA DEAMINATION,8.3127e-06,0.7672,0.6408,1,1
1,GO METANEPHRIC GLOMERULUS DEVELOPMENT,4.1617e-05,0.76685,0.62662,1,1
1,GO NEGATIVE REGULATION OF VIRAL GENOME REPLICATION,3.7145e-05,0.76678,0.68003,1,1
1,GO PYRIMIDINE NUCLEOSIDE CATABOLIC PROCESS,0.00013433,0.76551,0.6038,1,1
1,GO METANEPHRIC NEPHRON EPITHELIUM DEVELOPMENT,2.6902e-06,0.76101,0.71497,1,1
1,GO ENDODERM FORMATION,7.6603e-06,0.76072,0.73679,1,1
1,GO DENDRITIC CELL APOPTOTIC PROCESS,1.0184e-05,0.75393,0.60341,1,1
1,GO HIPPO SIGNALING,5.0683e-06,0.75227,0.62253,1,1
1,GO NEGATIVE REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT,1.9904e-06,0.75166,0.72184,1,1
1,GO INTERLEUKIN 27 MEDIATED SIGNALING PATHWAY,1.1776e-06,0.74902,0.82201,1,1
1,GO NEGATIVE REGULATION OF NITRIC OXIDE METABOLIC PROCESS,5.753e-07,0.74649,0.72725,1,1
1,GO BRANCHING INVOLVED IN SALIVARY GLAND MORPHOGENESIS,2.6307e-05,0.74383,0.65473,1,1
1,GO METANEPHRIC EPITHELIUM DEVELOPMENT,3.3287e-06,0.73881,0.64306,1,1
1,GO WOUND HEALING SPREADING OF EPIDERMAL CELLS,4.6623e-06,0.73765,0.78822,1,1
1,GO LATERAL MESODERM DEVELOPMENT,1.4044e-06,0.73685,0.64083,1,1
1,GO REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,1.4039e-05,0.7297,0.64031,1,1
1,GO POSITIVE REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,2.0829e-07,0.72952,0.64771,1,1
1,GO REGULATION OF APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT,3.5759e-05,0.72759,0.6672,1,1
1,GO CELLULAR RESPONSE TO X RAY,0.00018427,0.72155,0.5304,1,1
1,GO INFLAMMATORY CELL APOPTOTIC PROCESS,4.3763e-07,0.72044,0.71725,1,1
1,GO RESPONSE TO MURAMYL DIPEPTIDE,1.7118e-05,0.71488,0.59951,1,1
1,GO EPIBOLY,4.6623e-06,0.71392,0.71857,1,1
1,GO REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,2.7578e-07,0.71003,0.6839,1,1
1,GO NEGATIVE REGULATION OF VIRAL PROCESS,3.6228e-06,0.7086,0.59955,1,1
1,GO CHAPERONE MEDIATED AUTOPHAGY,0.00072223,0.70781,0.53161,1,1
1,GO TROPHOBLAST CELL MIGRATION,1.0604e-05,0.70407,0.77364,1,1
1,GO CHRONIC INFLAMMATORY RESPONSE,2.3654e-06,0.70342,0.66809,1,1
1,GO NEGATIVE REGULATION OF CELLULAR SENESCENCE,4.1802e-07,0.69716,0.66467,1,1
1,GO POSITIVE REGULATION OF COLLAGEN METABOLIC PROCESS,2.6902e-06,0.69595,0.67264,1,1
1,GO NEGATIVE REGULATION OF VIRAL LIFE CYCLE,9.7801e-06,0.6933,0.62966,1,1
1,GO ANGIOTENSIN ACTIVATED SIGNALING PATHWAY,7.5427e-07,0.69195,0.64889,1,1
1,GO T HELPER 1 TYPE IMMUNE RESPONSE,2.0829e-07,0.69042,0.61433,1,1
1,GO DICHOTOMOUS SUBDIVISION OF AN EPITHELIAL TERMINAL UNIT,0.00013917,0.67972,0.67995,1,1
1,GO MULTI ORGANISM CELLULAR PROCESS,7.0571e-06,0.67857,0.80367,1,1
1,GO RAP PROTEIN SIGNAL TRANSDUCTION,3.0576e-06,0.67808,0.59429,1,1
1,GO XENOBIOTIC CATABOLIC PROCESS,0.00074557,0.67234,0.57467,1,1
1,GO CELL PROLIFERATION INVOLVED IN METANEPHROS DEVELOPMENT,0.00016595,0.67201,0.6678,1,1
1,GO POSITIVE REGULATION OF CHEMOKINE BIOSYNTHETIC PROCESS,9.7346e-05,0.66933,0.62464,1,1
1,GO NEGATIVE REGULATION OF STEM CELL DIFFERENTIATION,9.4334e-07,0.66879,0.67233,1,1
1,GO NEGATIVE REGULATION OF TYROSINE PHOSPHORYLATION OF STAT PROTEIN,9.3916e-06,0.66835,0.61904,1,1
1,GO MUCUS SECRETION,0.00084609,0.66378,0.57868,1,1
1,GO RESPONSE TO INTERLEUKIN 18,0.0037331,0.66078,0.57346,1,1
1,GO NEGATIVE REGULATION OF TYPE I INTERFERON PRODUCTION,4.6623e-06,0.66014,0.50538,1,1
1,GO T CELL EXTRAVASATION,0.00036427,0.65824,0.56867,1,1
1,GO REGULATION OF UNSATURATED FATTY ACID BIOSYNTHETIC PROCESS,9.389e-05,0.65756,0.56895,1,1
1,GO REGULATION OF PINOCYTOSIS,5.2837e-06,0.65699,0.6613,1,1
1,GO REGULATION OF TYPE 2 IMMUNE RESPONSE,7.0571e-06,0.65376,0.62603,1,1
1,GO FIBRINOLYSIS,5.8301e-05,0.65363,0.73087,1,1
1,GO SINGLE STRANDED VIRAL RNA REPLICATION VIA DOUBLE STRANDED DNA INTERMEDIATE,5.9841e-06,0.65247,0.67222,1,1
1,GO GLOMERULAR MESANGIAL CELL PROLIFERATION,1.5201e-05,0.64834,0.68777,1,1
1,GO REGULATION OF PROGRAMMED NECROTIC CELL DEATH,2.5122e-07,0.6482,0.73208,1,1
1,GO T CELL MEDIATED CYTOTOXICITY,5.4121e-05,0.6478,0.55941,1,1
1,GO REGULATION OF RECEPTOR CATABOLIC PROCESS,0.00010092,0.64701,0.51738,1,1
1,GO GAP JUNCTION ASSEMBLY,1.7118e-05,0.64462,0.58393,1,1
1,GO OLIGOSACCHARIDE CATABOLIC PROCESS,0.00013917,0.6445,0.51222,1,1
1,GO PIGMENT GRANULE MATURATION,6.2367e-06,0.64112,0.52246,1,1
1,GO CELL DIFFERENTIATION INVOLVED IN METANEPHROS DEVELOPMENT,3.3132e-05,0.63898,0.53633,1,1
1,GO NEGATIVE REGULATION OF CELL AGING,1.8084e-07,0.62907,0.60635,1,1
1,GO POSITIVE REGULATION BY HOST OF VIRAL PROCESS,2.4692e-06,0.62853,0.60796,1,1
1,GO POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,9.7801e-06,0.62743,0.50568,1,1
1,GO REGULATION OF KERATINOCYTE DIFFERENTIATION,1.8521e-05,0.62346,0.52649,1,1
1,GO NEGATIVE REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,2.1702e-06,0.62295,0.58252,1,1
1,GO NEGATIVE REGULATION OF VIRAL TRANSCRIPTION,1.725e-07,0.62179,0.65187,1,1
1,GO ENDODERM DEVELOPMENT,6.2367e-06,0.61775,0.59546,1,1
1,GO ZYMOGEN ACTIVATION,6.7596e-05,0.6166,0.51418,1,1
1,GO NEGATIVE REGULATION OF PROTEIN AUTOPHOSPHORYLATION,0.0045306,0.61651,0.66628,1,1
1,GO BLOOD VESSEL ENDOTHELIAL CELL PROLIFERATION INVOLVED IN SPROUTING ANGIOGENESIS,0.0001165,0.61622,0.5013,1,1
1,GO REGULATION OF MACROPHAGE DIFFERENTIATION,4.2876e-06,0.61406,0.59821,1,1
1,GO REGULATION OF VIRAL GENOME REPLICATION,4.6623e-06,0.61323,0.51995,1,1
1,GO ACTIVATION OF TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE ACTIVITY,0.010245,0.61236,0.39839,1,1
1,GO CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,2.7578e-07,0.61085,0.57039,1,1
1,GO CELLULAR RESPONSE TO SALT STRESS,2.6307e-05,0.60928,0.56943,1,1
1,GO CARDIAC NEURAL CREST CELL DIFFERENTIATION INVOLVED IN HEART DEVELOPMENT,0.0026572,0.60891,0.63123,1,1
1,GO LEUKOCYTE AGGREGATION,0.00081984,0.6074,0.5151,1,1
1,GO REGULATION OF ISOTYPE SWITCHING,5.2139e-05,0.60729,0.43299,1,1
1,GO CHEMOKINE BIOSYNTHETIC PROCESS,1.7806e-05,0.60628,0.65626,1,1
1,GO BIOLOGICAL PHASE,0.00028792,0.60413,0.59094,1,1
1,GO VASCULOGENESIS,3.4772e-07,0.60346,0.59267,1,1
1,GO TOLL LIKE RECEPTOR 3 SIGNALING PATHWAY,2.5774e-06,0.60224,0.64401,1,1
1,GO TRANSFORMING GROWTH FACTOR BETA1 PRODUCTION,3.9418e-06,0.60153,0.55727,1,1
1,GO REGULATION OF CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT,8.6584e-06,0.59994,0.66284,1,1
1,GO BASEMENT MEMBRANE ORGANIZATION,3.3132e-05,0.59955,0.60472,1,1
1,GO APOPTOTIC CELL CLEARANCE,3.9418e-06,0.59943,0.64989,1,1
1,GO POSITIVE REGULATION OF MONOCYTE DIFFERENTIATION,4.3218e-05,0.59921,0.49325,1,1
1,GO NEGATIVE REGULATION OF NECROTIC CELL DEATH,1.1776e-06,0.59784,0.73496,1,1
1,GO ESTABLISHMENT OF ENDOTHELIAL INTESTINAL BARRIER,0.0030654,0.59725,0.39995,1,1
1,GO CELLULAR RESPONSE TO EXOGENOUS DSRNA,4.8612e-06,0.59637,0.59926,1,1
1,GO POSITIVE REGULATION OF ISOTYPE SWITCHING,8.7323e-05,0.59606,0.44058,1,1
1,GO POSITIVE REGULATION OF ALPHA BETA T CELL ACTIVATION,6.2367e-06,0.5958,0.4279,1,1
1,GO CYTOLYSIS,1.8521e-05,0.59555,0.47077,1,1
1,GO LIVER REGENERATION,3.0576e-06,0.59534,0.5415,1,1
1,GO POSITIVE REGULATION OF VACUOLE ORGANIZATION,1.2454e-05,0.59458,0.5184,1,1
1,GO COLLAGEN METABOLIC PROCESS,1.5201e-05,0.58733,0.54034,1,1
1,GO NUCLEOSIDE CATABOLIC PROCESS,0.00024286,0.58625,0.48282,1,1
1,GO POSITIVE REGULATION OF SPROUTING ANGIOGENESIS,4.1112e-06,0.58625,0.51379,1,1
1,GO CYSTEINE METABOLIC PROCESS,0.00063551,0.58608,0.45339,1,1
1,GO REGULATION OF CELLULAR RESPONSE TO OSMOTIC STRESS,5.2837e-06,0.58529,0.6175,1,1
1,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.00044439,0.58453,0.52447,1,1
1,GO POSITIVE REGULATION OF INTERLEUKIN 2 PRODUCTION,2.0784e-06,0.58278,0.55753,1,1
1,GO POSITIVE REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,6.0198e-07,0.58243,0.56266,1,1
1,GO INTERLEUKIN 1 PRODUCTION,3.0689e-05,0.58224,0.46676,1,1
1,GO NOTOCHORD DEVELOPMENT,5.2837e-06,0.58159,0.63858,1,1
1,GO REGULATION OF VIRAL LIFE CYCLE,2.6902e-06,0.5807,0.51067,1,1
1,GO NEGATIVE REGULATION OF LIPASE ACTIVITY,5.8301e-05,0.57926,0.56169,1,1
1,GO MODULATION BY HOST OF VIRAL PROCESS,6.8936e-07,0.57919,0.5867,1,1
1,GO INTERLEUKIN 35 MEDIATED SIGNALING PATHWAY,5.9841e-06,0.57865,0.60491,1,1
1,GO POSITIVE REGULATION OF PRODUCTION OF MIRNAS INVOLVED IN GENE SILENCING BY MIRNA,9.7346e-05,0.57818,0.64059,1,1
1,GO POSITIVE REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS,6.7596e-05,0.57809,0.55326,1,1
1,GO POSITIVE REGULATION OF PHAGOCYTOSIS ENGULFMENT,6.0504e-05,0.57539,0.61964,1,1
1,GO POSITIVE REGULATION OF VASOCONSTRICTION,1.4044e-06,0.57534,0.47189,1,1
1,GO NEGATIVE REGULATION OF COAGULATION,0.00016023,0.57413,0.54662,1,1
1,GO RIBONUCLEOSIDE CATABOLIC PROCESS,1.104e-05,0.57348,0.62689,1,1
1,GO ENTRY INTO HOST,1.0311e-06,0.57198,0.56994,1,1
1,GO HEME METABOLIC PROCESS,1.4044e-06,0.57183,0.52812,1,1
1,GO REGULATION OF EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,2.4346e-05,0.57123,0.58818,1,1
1,GO REGULATION OF THYMOCYTE APOPTOTIC PROCESS,0.00023468,0.57033,0.49294,1,1
1,GO GLOMERULAR BASEMENT MEMBRANE DEVELOPMENT,0.00081984,0.56741,0.58885,1,1
1,GO GLYCOLIPID CATABOLIC PROCESS,8.4205e-05,0.56622,0.51697,1,1
1,GO POSITIVE REGULATION OF MACROPHAGE ACTIVATION,3.4421e-05,0.56455,0.57084,1,1
1,GO AMYLOID BETA CLEARANCE,3.1888e-05,0.56355,0.44185,1,1
1,GO NEPHRON TUBULE EPITHELIAL CELL DIFFERENTIATION,1.0184e-05,0.5619,0.6594,1,1
1,GO PROTEASOMAL UBIQUITIN INDEPENDENT PROTEIN CATABOLIC PROCESS,5.2837e-06,0.5601,0.54034,1,1
1,GO PYRIMIDINE NUCLEOSIDE METABOLIC PROCESS,3.9418e-06,0.55959,0.50427,1,1
1,GO TOLERANCE INDUCTION,0.00049035,0.55878,0.45802,1,1
1,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY RENIN ANGIOTENSIN,0.00026903,0.55702,0.48826,1,1
1,GO REGULATION OF ANTIGEN PROCESSING AND PRESENTATION,1.104e-05,0.55695,0.52321,1,1
1,GO RESPONSE TO NITROSATIVE STRESS,0.00018427,0.55531,0.43429,1,1
1,GO CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT,2.6307e-05,0.55454,0.49991,1,1
1,GO MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,1.5201e-05,0.55442,0.52659,1,1
1,GO TOLL LIKE RECEPTOR 2 SIGNALING PATHWAY,0.00022676,0.55338,0.52242,1,1
1,GO CELLULAR RESPONSE TO DSRNA,5.9841e-06,0.55324,0.53323,1,1
1,GO TYPE 2 IMMUNE RESPONSE,7.0571e-06,0.5506,0.556,1,1
1,GO REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,7.547e-05,0.55056,0.42506,1,1
1,GO GLYCOSYL COMPOUND CATABOLIC PROCESS,6.2786e-05,0.55054,0.45064,1,1
1,GO BRANCH ELONGATION OF AN EPITHELIUM,0.00072223,0.55036,0.50734,1,1
1,GO MATURATION OF LSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,7.6603e-06,0.54924,0.50633,1,1
1,GO POSITIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE,9.4334e-07,0.54697,0.49811,1,1
1,GO RESPONSE TO X RAY,1.725e-07,0.54625,0.58124,1,1
1,GO REGULATION OF T HELPER CELL DIFFERENTIATION,2.2658e-06,0.54577,0.46327,1,1
1,GO POSITIVE REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,3.1888e-05,0.54548,0.40941,1,1
1,GO NEGATIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,7.547e-05,0.54509,0.52131,1,1
1,GO POSITIVE REGULATION OF INTERLEUKIN 17 PRODUCTION,2.1831e-07,0.54479,0.63326,1,1
1,GO SALIVARY GLAND DEVELOPMENT,0.00023468,0.54391,0.50192,1,1
1,GO ENTRY OF BACTERIUM INTO HOST CELL,0.00018427,0.54357,0.55042,1,1
1,GO POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,5.9841e-06,0.54087,0.50546,1,1
1,GO INTERLEUKIN 13 PRODUCTION,0.00065623,0.54042,0.47741,1,1
1,GO POSITIVE REGULATION OF STEROL TRANSPORT,2.6902e-06,0.5403,0.48195,1,1
1,GO VIRAL GENOME REPLICATION,3.9418e-06,0.53958,0.45233,1,1
1,GO REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,1.0184e-05,0.53905,0.42778,1,1
1,GO NITRIC OXIDE SYNTHASE BIOSYNTHETIC PROCESS,0.00014418,0.53707,0.45003,1,1
1,GO LOW DENSITY LIPOPROTEIN PARTICLE RECEPTOR CATABOLIC PROCESS,6.5149e-05,0.53538,0.49976,1,1
1,GO MODULATION BY HOST OF VIRAL GENOME REPLICATION,7.2111e-07,0.53503,0.58393,1,1
1,GO CELLULAR RESPONSE TO IRON ION,0.00012074,0.53361,0.49443,1,1
1,GO SUBSTRATE ADHESION DEPENDENT CELL SPREADING,4.5813e-07,0.53268,0.52649,1,1
1,GO MATURATION OF SSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,3.7145e-05,0.53245,0.3957,1,1
1,GO COLLAGEN CATABOLIC PROCESS,2.3418e-05,0.53243,0.5421,1,1
1,GO POSITIVE REGULATION OF B CELL MEDIATED IMMUNITY,7.8282e-05,0.5317,0.41552,1,1
1,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY CIRCULATORY RENIN ANGIOTENSIN,0.00041602,0.53142,0.50595,1,1
1,GO REGULATION OF COLLAGEN METABOLIC PROCESS,3.4421e-05,0.53071,0.5597,1,1
1,GO REGULATION OF T CELL APOPTOTIC PROCESS,7.9801e-06,0.52978,0.42911,1,1
1,GO NEGATIVE REGULATION OF DEFENSE RESPONSE TO VIRUS,1.9904e-06,0.52924,0.48881,1,1
1,GO RESPONSE TO TYPE I INTERFERON,9.7346e-05,0.52911,0.6007,1,1
1,GO RETINA VASCULATURE MORPHOGENESIS IN CAMERA TYPE EYE,5.4121e-05,0.5289,0.59621,1,1
1,GO 3 UTR MEDIATED MRNA DESTABILIZATION,2.0829e-07,0.52793,0.52745,1,1
1,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,1.0184e-05,0.52768,0.52038,1,1
1,GO MAMMARY GLAND EPITHELIAL CELL PROLIFERATION,0.00034072,0.52752,0.40181,1,1
1,GO VAGINA DEVELOPMENT,2.7343e-05,0.5274,0.56462,1,1
1,GO RIBOSOMAL LARGE SUBUNIT ASSEMBLY,0.00063551,0.52599,0.35635,1,1
1,GO NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,3.3287e-06,0.5233,0.5873,1,1
1,GO POSITIVE REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,2.0829e-07,0.52267,0.49372,1,1
1,GO NEGATIVE REGULATION OF IMMUNE EFFECTOR PROCESS,2.9301e-06,0.52137,0.47675,1,1
1,GO REGULATION OF AMYLOID BETA CLEARANCE,0.0049174,0.52061,0.36033,1,1
1,GO BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,3.3287e-06,0.51992,0.44348,1,1
1,GO POSITIVE REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION,3.4421e-05,0.51977,0.44153,1,1
1,GO STORE OPERATED CALCIUM ENTRY,6.7596e-05,0.51969,0.38597,1,1
1,GO EXTRACELLULAR MATRIX DISASSEMBLY,2.7343e-05,0.51904,0.51738,1,1
1,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO TELOMERE,0.00027832,0.51714,0.40966,1,1
1,GO RESPONSE TO ANGIOTENSIN,3.17e-07,0.51612,0.49888,1,1
1,GO CELLULAR RESPONSE TO INTERFERON BETA,0.00017186,0.51528,0.4657,1,1
1,GO NEGATIVE REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,0.00010845,0.51455,0.4619,1,1
1,GO RECEPTOR CATABOLIC PROCESS,7.2111e-07,0.51135,0.46481,1,1
1,GO REGULATION OF SYMBIOTIC PROCESS,1.4674e-06,0.50967,0.42182,1,1
1,GO RESPONSE TO INTERFERON GAMMA,2.5308e-05,0.50958,0.48502,1,1
1,GO RESPONSE TO SALT STRESS,1.0184e-05,0.50893,0.38828,1,1
1,GO POSITIVE REGULATION OF PROTEIN IMPORT,1.6729e-06,0.50763,0.468,1,1
1,GO T CELL MEDIATED IMMUNITY,8.6584e-06,0.50749,0.46159,1,1
1,GO REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS,0.00074557,0.50574,0.45416,1,1
1,GO IMMUNOLOGICAL SYNAPSE FORMATION,0.00023468,0.50552,0.48921,1,1
1,GO ELASTIC FIBER ASSEMBLY,0.0073363,0.50279,0.59679,1,1
1,GO POSITIVE REGULATION OF KERATINOCYTE PROLIFERATION,7.547e-05,0.50077,0.49398,1,1
1,GO NEGATIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.00010092,0.50071,0.43046,1,1
1,GO NEGATIVE REGULATION OF PROTEIN MATURATION,9.0221e-07,0.5007,0.62714,1,1
1,GO VENOUS BLOOD VESSEL DEVELOPMENT,0.0021689,0.4997,0.38822,1,1
1,GO REGULATION OF KETONE BIOSYNTHETIC PROCESS,8.7323e-05,0.4983,0.45527,1,1
1,GO POSITIVE REGULATION OF ERAD PATHWAY,2.4692e-06,0.49818,0.42629,1,1
1,GO POSITIVE REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,1.0779e-06,0.49805,0.45909,1,1
1,GO NEGATIVE REGULATION OF VIRAL RELEASE FROM HOST CELL,2.3418e-05,0.49586,0.40976,1,1
1,GO ESTABLISHMENT OF PLANAR POLARITY INVOLVED IN NEURAL TUBE CLOSURE,0.031748,0.49399,0.30596,1,1
1,GO REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,7.013e-05,0.49354,0.36526,1,1
1,GO INTERLEUKIN 1 BETA PRODUCTION,4.4878e-05,0.49344,0.42107,1,1
1,GO POSITIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,0.00079435,0.49327,0.42378,1,1
1,GO NEGATIVE REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,4.3218e-05,0.49314,0.39942,1,1
1,GO TYROSINE PHOSPHORYLATION OF STAT PROTEIN,7.0571e-06,0.49289,0.38754,1,1
1,GO MATURATION OF SSU RRNA,7.013e-05,0.4915,0.37101,1,1
1,GO CAVEOLIN MEDIATED ENDOCYTOSIS,2.1663e-05,0.48967,0.42667,1,1
1,GO RETINAL METABOLIC PROCESS,0.0053338,0.48923,0.35336,1,1
1,GO CELL SUBSTRATE JUNCTION ORGANIZATION,0.00014935,0.4887,0.42715,1,1
1,GO LOW DENSITY LIPOPROTEIN PARTICLE CLEARANCE,6.2985e-07,0.48604,0.54801,1,1
1,GO AORTIC VALVE DEVELOPMENT,0.00026003,0.48593,0.41418,1,1
1,GO PINOCYTOSIS,3.9926e-07,0.48579,0.61613,1,1
1,GO POSITIVE REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.00047456,0.48419,0.45417,1,1
1,GO LOW DENSITY LIPOPROTEIN RECEPTOR PARTICLE METABOLIC PROCESS,1.0184e-05,0.48416,0.48318,1,1
1,GO UDP N ACETYLGLUCOSAMINE METABOLIC PROCESS,5.0226e-05,0.48377,0.38988,1,1
1,GO POSITIVE REGULATION OF METANEPHROS DEVELOPMENT,9.389e-05,0.48321,0.66885,1,1
1,GO REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,4.6597e-05,0.48284,0.35173,1,1
1,GO LONG CHAIN FATTY ACID BIOSYNTHETIC PROCESS,0.00059588,0.48233,0.34521,1,1
1,GO REGULATION OF MYOBLAST FUSION,1.7118e-05,0.48168,0.55024,1,1
1,GO MIDBRAIN DOPAMINERGIC NEURON DIFFERENTIATION,3.3132e-05,0.48084,0.42081,1,1
1,GO REGULATION OF LAMELLIPODIUM MORPHOGENESIS,0.018836,0.48066,0.35725,1,1
1,GO FORMATION OF PRIMARY GERM LAYER,1.8521e-05,0.48051,0.43902,1,1
1,GO PROGESTERONE METABOLIC PROCESS,0.007729,0.48008,0.2296,1,1
1,GO REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO HYPOXIA,4.1802e-07,0.47881,0.41591,1,1
1,GO RRNA PSEUDOURIDINE SYNTHESIS,0.0036303,0.47825,0.30549,1,1
1,GO FATTY ACID BETA OXIDATION USING ACYL COA DEHYDROGENASE,0.00081984,0.47813,0.4044,1,1
1,GO POSITIVE REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,0.0018173,0.47791,0.42846,1,1
1,GO MEMBRANE PROTEIN INTRACELLULAR DOMAIN PROTEOLYSIS,0.00027832,0.47718,0.41691,1,1
1,GO POSITIVE REGULATION OF TELOMERASE RNA LOCALIZATION TO CAJAL BODY,0.00014935,0.47666,0.37023,1,1
1,GO NIK NF KAPPAB SIGNALING,1.6452e-07,0.47654,0.43898,1,1
1,GO C21 STEROID HORMONE BIOSYNTHETIC PROCESS,0.0016129,0.47626,0.3752,1,1
1,GO SKELETAL MUSCLE TISSUE REGENERATION,5.508e-06,0.47622,0.4329,1,1
1,GO MITOTIC NUCLEAR ENVELOPE REASSEMBLY,4.4712e-06,0.47553,0.41563,1,1
1,GO NEGATIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,8.7323e-05,0.47511,0.43263,1,1
1,GO REGULATION OF ACTIN CYTOSKELETON REORGANIZATION,2.1663e-05,0.47505,0.37104,1,1
1,GO NEGATIVE REGULATION OF T CELL APOPTOTIC PROCESS,4.4712e-06,0.47487,0.47393,1,1
1,GO HAIR FOLLICLE MATURATION,0.0010206,0.4746,0.3475,1,1
1,GO ENDONUCLEOLYTIC CLEAVAGE INVOLVED IN RRNA PROCESSING,0.00047456,0.47433,0.39605,1,1
1,GO CYTOKINE METABOLIC PROCESS,4.1112e-06,0.47403,0.40011,1,1
1,GO CARBOHYDRATE DERIVATIVE CATABOLIC PROCESS,1.5201e-05,0.47395,0.35869,1,1
1,GO VIRAL RNA GENOME REPLICATION,7.5427e-07,0.47388,0.44772,1,1
1,GO REGULATION OF TRANSPOSITION,0.0001165,0.47325,0.47218,1,1
1,GO NEGATIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION,2.8077e-06,0.47275,0.49483,1,1
1,GO NEGATIVE REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,0.00098941,0.4724,0.34228,1,1
1,GO SEQUESTERING OF EXTRACELLULAR LIGAND FROM RECEPTOR,0.00047456,0.4719,0.60275,1,1
1,GO BLOOD VESSEL REMODELING,0.00024286,0.47136,0.39561,1,1
1,GO INTERFERON GAMMA MEDIATED SIGNALING PATHWAY,0.0011199,0.4707,0.44371,1,1
1,GO NEGATIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,9.0221e-07,0.46997,0.43709,1,1
1,GO NEGATIVE REGULATION OF MULTI ORGANISM PROCESS,0.00032948,0.46959,0.53804,1,1
1,GO RESPONSE TO INTERLEUKIN 12,5.4977e-07,0.46955,0.43261,1,1
1,GO POSITIVE REGULATION OF ALPHA BETA T CELL PROLIFERATION,0.00090094,0.46929,0.38858,1,1
1,GO POSITIVE REGULATION OF TYROSINE PHOSPHORYLATION OF STAT PROTEIN,0.00030804,0.46889,0.34737,1,1
1,GO RRNA CONTAINING RIBONUCLEOPROTEIN COMPLEX EXPORT FROM NUCLEUS,2.6307e-05,0.46886,0.42364,1,1
1,GO NEGATIVE REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,0.00047456,0.46849,0.37585,1,1
1,GO POSITIVE REGULATION OF G1 S TRANSITION OF MITOTIC CELL CYCLE,3.4772e-07,0.46825,0.44514,1,1
1,GO MOVEMENT IN HOST ENVIRONMENT,7.889e-07,0.46814,0.49432,1,1
1,GO REGULATION OF NITRIC OXIDE BIOSYNTHETIC PROCESS,2.4692e-06,0.46744,0.48672,1,1
1,GO RIBOSOMAL LARGE SUBUNIT BIOGENESIS,7.8282e-05,0.46682,0.40917,1,1
1,GO DEFENSE RESPONSE TO VIRUS,1.2962e-05,0.46678,0.42182,1,1
1,GO REGULATION OF HORMONE METABOLIC PROCESS,4.6597e-05,0.46674,0.42398,1,1
1,GO REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,1.0779e-06,0.46666,0.49681,1,1
1,GO SUBSTRATE DEPENDENT CELL MIGRATION,0.00035231,0.46661,0.37846,1,1
1,GO NEGATIVE REGULATION OF ALPHA BETA T CELL ACTIVATION,3.0689e-05,0.46654,0.40542,1,1
1,GO NEGATIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,1.104e-05,0.4665,0.39772,1,1
1,GO NEGATIVE REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.0030654,0.46592,0.36541,1,1
1,GO REGULATION OF PROTEIN DEUBIQUITINATION,5.7413e-06,0.46552,0.49463,1,1
1,GO HYALURONAN METABOLIC PROCESS,0.00019079,0.4653,0.43524,1,1
1,GO MATURATION OF LSU RRNA,3.1888e-05,0.46526,0.44119,1,1
1,GO REGULATION OF GLOMERULAR FILTRATION,0.0026572,0.46469,0.41319,1,1
1,GO REGULATION OF T CELL CYTOKINE PRODUCTION,3.8583e-05,0.46466,0.45707,1,1
1,GO RESPONSE TO HYPEROXIA,0.00044439,0.4646,0.42674,1,1
1,GO GROWTH PLATE CARTILAGE DEVELOPMENT,6.0504e-05,0.46419,0.41183,1,1
1,GO INTERLEUKIN 8 PRODUCTION,6.7728e-06,0.46405,0.40663,1,1
1,GO DENDRITIC CELL CYTOKINE PRODUCTION,0.0099891,0.46395,0.31686,1,1
1,GO RIG I SIGNALING PATHWAY,1.0779e-06,0.46367,0.43536,1,1
1,GO OUTFLOW TRACT SEPTUM MORPHOGENESIS,0.0010528,0.46351,0.40739,1,1
1,GO CHONDROCYTE DIFFERENTIATION INVOLVED IN ENDOCHONDRAL BONE MORPHOGENESIS,5.0226e-05,0.46346,0.48464,1,1
1,GO MUSCLE CELL FATE COMMITMENT,0.0001547,0.46339,0.47152,1,1
1,GO POSITIVE REGULATION OF VASCULOGENESIS,0.0018173,0.46336,0.38553,1,1
1,GO NUCLEOTIDE SUGAR BIOSYNTHETIC PROCESS,4.1112e-06,0.46315,0.3958,1,1
1,GO POSITIVE REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,7.9801e-06,0.46301,0.65574,1,1
1,GO CELLULAR RESPONSE TO OSMOTIC STRESS,5.2837e-06,0.46233,0.39844,1,1
1,GO COLLAGEN FIBRIL ORGANIZATION,0.0001165,0.46159,0.64582,1,1
1,GO REGULATION OF TRANSLATIONAL TERMINATION,7.6603e-06,0.46056,0.42266,1,1
1,GO REGULATION OF HORMONE BIOSYNTHETIC PROCESS,0.00026003,0.46034,0.45689,1,1
1,GO PYRIMIDINE NUCLEOSIDE BIOSYNTHETIC PROCESS,7.6379e-08,0.45798,0.57132,1,1
1,GO THYMOCYTE APOPTOTIC PROCESS,8.6584e-06,0.45741,0.43501,1,1
1,GO OSTEOBLAST DEVELOPMENT,0.0017641,0.45708,0.36804,1,1
1,GO REGULATION OF CELLULAR AMINO ACID METABOLIC PROCESS,5.0194e-07,0.45701,0.43243,1,1
1,GO POSITIVE REGULATION OF ENDOTHELIAL CELL MIGRATION,5.6174e-05,0.45558,0.4119,1,1
1,GO HYPEROSMOTIC SALINITY RESPONSE,0.00084609,0.4554,0.33115,1,1
1,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN,2.9301e-06,0.45535,0.38867,1,1
1,GO PLATELET DERIVED GROWTH FACTOR RECEPTOR BETA SIGNALING PATHWAY,0.00037661,0.45525,0.36044,1,1
1,GO MEMBRANE PROTEIN PROTEOLYSIS,4.1617e-05,0.45501,0.41578,1,1
1,GO SCF DEPENDENT PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,1.1788e-07,0.45439,0.40471,1,1
1,GO PROTEASOME ASSEMBLY,6.7728e-06,0.45437,0.37866,1,1
1,GO MORPHOGENESIS OF AN EPITHELIAL SHEET,2.0784e-06,0.45382,0.43796,1,1
1,GO POSITIVE REGULATION OF INTERLEUKIN 4 PRODUCTION,0.00012074,0.45343,0.34423,1,1
1,GO LYMPHANGIOGENESIS,2.3418e-05,0.45312,0.43636,1,1
1,GO MESODERMAL CELL DIFFERENTIATION,4.8379e-05,0.4525,0.38028,1,1
1,GO CHAPERONE MEDIATED PROTEIN TRANSPORT,0.02268,0.45146,0.26751,1,1
1,GO INTERLEUKIN 2 PRODUCTION,4.1802e-07,0.45124,0.46555,1,1
1,GO POSITIVE REGULATION OF CYTOKINE BIOSYNTHETIC PROCESS,0.00014935,0.45117,0.42249,1,1
1,GO REGULATION OF MEMBRANE INVAGINATION,0.00041602,0.45081,0.40696,1,1
1,GO REGULATION OF ADAPTIVE IMMUNE RESPONSE,3.9418e-06,0.45052,0.38864,1,1
1,GO BONE TRABECULA MORPHOGENESIS,0.017137,0.45033,0.37198,1,1
1,GO ADAPTIVE IMMUNE RESPONSE BASED ON SOMATIC RECOMBINATION OF IMMUNE RECEPTORS BUILT FROM IMMUNOGLOBULIN SUPERFAMILY DOMAINS,4.2876e-06,0.45007,0.38054,1,1
1,GO PROTEIN LOCALIZATION TO NUCLEOPLASM,0.00025131,0.44966,0.35601,1,1
1,GO REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,2.4346e-05,0.44959,0.42544,1,1
1,GO PORPHYRIN CONTAINING COMPOUND METABOLIC PROCESS,5.508e-06,0.44945,0.41512,1,1
1,GO CELL CELL ADHESION MEDIATED BY INTEGRIN,0.00010845,0.44888,0.58664,1,1
1,GO PRIMARY MIRNA PROCESSING,2.9532e-05,0.44766,0.41171,1,1
1,GO POSITIVE REGULATION OF IMMUNOGLOBULIN PRODUCTION,1.6455e-05,0.44759,0.41263,1,1
1,GO REGULATION OF STEM CELL POPULATION MAINTENANCE,1.3441e-06,0.44643,0.44348,1,1
1,GO PROTEIN LOCALIZATION TO NUCLEAR BODY,0.00021167,0.44599,0.38546,1,1
1,GO MYELOID CELL APOPTOTIC PROCESS,5.0683e-06,0.44554,0.47882,1,1
1,GO REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,1.8521e-05,0.44479,0.57695,1,1
1,GO POSITIVE REGULATION OF CELLULAR EXTRAVASATION,0.0011549,0.44472,0.43802,1,1
1,GO RETINA VASCULATURE DEVELOPMENT IN CAMERA TYPE EYE,2.3654e-06,0.44463,0.498,1,1
1,GO ANTIGEN PROCESSING AND PRESENTATION,2.8077e-06,0.44452,0.38166,1,1
1,GO MODULATION BY HOST OF SYMBIONT PROCESS,1.2308e-06,0.44449,0.40553,1,1
1,GO REGULATION OF GLOMERULUS DEVELOPMENT,0.00038934,0.44432,0.54916,1,1
1,GO POSITIVE REGULATION OF INTERLEUKIN 1 PRODUCTION,0.0012662,0.44414,0.34153,1,1
1,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,6.5149e-05,0.44268,0.40266,1,1
1,GO POSITIVE REGULATION OF T CELL MEDIATED IMMUNITY,2.8418e-05,0.44164,0.42649,1,1
1,GO REGULATION OF SYNCYTIUM FORMATION BY PLASMA MEMBRANE FUSION,7.0571e-06,0.44108,0.5269,1,1
1,GO EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,1.5201e-05,0.43934,0.40627,1,1
1,GO POSITIVE REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,1.1237e-07,0.43909,0.41866,1,1
1,GO NEGATIVE REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,0.00042998,0.43773,0.4073,1,1
1,GO AMINOGLYCAN CATABOLIC PROCESS,5.2139e-05,0.43747,0.45107,1,1
1,GO NEGATIVE REGULATION OF PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,0.0022992,0.4374,0.57632,1,1
1,GO REGULATION OF INTEGRIN MEDIATED SIGNALING PATHWAY,0.00032948,0.4373,0.60872,1,1
1,GO NEGATIVE REGULATION OF NIK NF KAPPAB SIGNALING,5.8301e-05,0.43489,0.37605,1,1
1,GO TYPE I INTERFERON PRODUCTION,1.0604e-05,0.43431,0.34281,1,1
1,GO PROTEIN ACTIVATION CASCADE,7.013e-05,0.43358,0.33543,1,1
1,GO ESTABLISHMENT OF PLANAR POLARITY OF EMBRYONIC EPITHELIUM,0.012508,0.43292,0.34523,1,1
1,GO CELLULAR RESPONSE TO MECHANICAL STIMULUS,1.7118e-05,0.43292,0.47604,1,1
1,GO MACROPHAGE PROLIFERATION,0.0057817,0.43278,0.36432,1,1
1,GO COLLAGEN ACTIVATED SIGNALING PATHWAY,0.0057817,0.43269,0.46344,1,1
1,GO EMBRYONIC VISCEROCRANIUM MORPHOGENESIS,5.6174e-05,0.43259,0.41551,1,1
1,GO REGULATION OF EARLY ENDOSOME TO LATE ENDOSOME TRANSPORT,5.2837e-06,0.43174,0.44988,1,1
1,GO RESPONSE TO FLUID SHEAR STRESS,6.7596e-05,0.43172,0.40725,1,1
1,GO PLASMA LIPOPROTEIN PARTICLE CLEARANCE,2.0784e-06,0.43063,0.41302,1,1
1,GO MYD88 INDEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY,2.5308e-05,0.43051,0.47144,1,1
1,GO PLATELET AGGREGATION,1.4674e-06,0.42999,0.38679,1,1
1,GO POSITIVE REGULATION OF FIBROBLAST MIGRATION,0.030383,0.42824,0.33538,1,1
1,GO POSITIVE REGULATION OF MACROPHAGE MIGRATION,9.8628e-07,0.42778,0.49838,1,1
1,GO POSITIVE REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,1.5816e-05,0.42744,0.35387,1,1
1,GO REGULATION OF EXTRACELLULAR MATRIX DISASSEMBLY,0.00067758,0.42727,0.58237,1,1
1,GO REGULATION OF NECROTIC CELL DEATH,3.6228e-06,0.42704,0.51238,1,1
1,GO RIBOSOME ASSEMBLY,0.00028792,0.42689,0.34493,1,1
1,GO SEMI LUNAR VALVE DEVELOPMENT,0.00072223,0.42641,0.38834,1,1
1,GO POSITIVE REGULATION OF GONAD DEVELOPMENT,0.0057817,0.42612,0.34386,1,1
1,GO BASE CONVERSION OR SUBSTITUTION EDITING,0.00014418,0.42516,0.40423,1,1
1,GO LYMPH VESSEL MORPHOGENESIS,0.00018427,0.42445,0.37107,1,1
1,GO POSITIVE REGULATION OF TYPE 2 IMMUNE RESPONSE,0.00023468,0.42438,0.42738,1,1
1,GO REGULATION OF PROTEIN LOCALIZATION TO CHROMOSOME TELOMERIC REGION,0.00069957,0.4241,0.343,1,1
1,GO NEGATIVE REGULATION OF PRODUCTION OF MIRNAS INVOLVED IN GENE SILENCING BY MIRNA,0.00047456,0.42338,0.38276,1,1
1,GO CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY IN RESPONSE TO VIRUS,7.9801e-06,0.42291,0.39698,1,1
1,GO REGULATION OF ALPHA BETA T CELL ACTIVATION,3.8583e-05,0.42226,0.31022,1,1
1,GO INTESTINAL EPITHELIAL CELL DEVELOPMENT,0.0053338,0.42218,0.30648,1,1
1,GO RIBOSOMAL SMALL SUBUNIT BIOGENESIS,3.4421e-05,0.42213,0.36917,1,1
1,GO NEGATIVE REGULATION OF INTERLEUKIN 2 PRODUCTION,5.9841e-06,0.42121,0.43398,1,1
1,GO POSITIVE REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,0.00040247,0.42118,0.48371,1,1
1,GO REGULATION OF HIPPO SIGNALING,0.001228,0.42085,0.33334,1,1
1,GO L ASCORBIC ACID METABOLIC PROCESS,0.0024367,0.42075,0.34423,1,1
1,GO REGULATION OF PROTEIN K63 LINKED UBIQUITINATION,1.0604e-05,0.42048,0.40325,1,1
1,GO PROTEIN PEPTIDYL PROLYL ISOMERIZATION,1.3441e-06,0.41965,0.37182,1,1
1,GO TETRAPYRROLE BIOSYNTHETIC PROCESS,2.0033e-05,0.41936,0.33316,1,1
1,GO VIRAL LIFE CYCLE,4.3763e-07,0.41928,0.42213,1,1
1,GO POSITIVE REGULATION OF MACROPHAGE CHEMOTAXIS,1.104e-05,0.41924,0.42554,1,1
1,GO RESPONSE TO EPIDERMAL GROWTH FACTOR,1.906e-06,0.41872,0.40747,1,1
1,GO EXTRACELLULAR STRUCTURE ORGANIZATION,7.013e-05,0.41838,0.43811,1,1
1,GO REGULATION OF RIBOSOME BIOGENESIS,1.1493e-05,0.41807,0.47632,1,1
1,GO ENAMEL MINERALIZATION,0.0022992,0.4175,0.39985,1,1
1,GO PEPTIDYL PROLINE MODIFICATION,5.0683e-06,0.41743,0.36083,1,1
1,GO MULTI ORGANISM LOCALIZATION,5.986e-08,0.41721,0.42011,1,1
1,GO TELOMERASE RNA LOCALIZATION,0.00017186,0.41699,0.33483,1,1
1,GO REGULATION OF DEFENSE RESPONSE TO VIRUS,6.0504e-05,0.41699,0.35872,1,1
1,GO KERATAN SULFATE CATABOLIC PROCESS,0.00016595,0.41664,0.55918,1,1
1,GO PURINE NUCLEOSIDE BIOSYNTHETIC PROCESS,5.7413e-06,0.4163,0.5081,1,1
1,GO ALPHA BETA T CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,9.3916e-06,0.41589,0.3775,1,1
1,GO ENDOTHELIAL CELL CHEMOTAXIS,0.0020453,0.41571,0.40457,1,1
1,GO ANIMAL ORGAN REGENERATION,1.7118e-05,0.41553,0.44192,1,1
1,GO HIGH DENSITY LIPOPROTEIN PARTICLE ASSEMBLY,0.00069957,0.41551,0.3804,1,1
1,GO T CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,2.8418e-05,0.41549,0.35012,1,1
1,GO REGULATION OF FIBROBLAST MIGRATION,0.0014299,0.41536,0.36168,1,1
1,GO DETECTION OF BIOTIC STIMULUS,7.013e-05,0.41491,0.419,1,1
1,GO UDP N ACETYLGLUCOSAMINE BIOSYNTHETIC PROCESS,2.2524e-05,0.41479,0.39294,1,1
1,GO PROTEIN LOCALIZATION TO CELL CELL JUNCTION,3.1888e-05,0.41397,0.44134,1,1
1,GO REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,2.3654e-06,0.41376,0.36529,1,1
1,GO NEGATIVE REGULATION OF T CELL DIFFERENTIATION,4.4878e-05,0.41374,0.34508,1,1
1,GO NEGATIVE REGULATION OF CARTILAGE DEVELOPMENT,0.0010859,0.41356,0.41647,1,1
1,GO POSITIVE REGULATION OF VIRAL LIFE CYCLE,4.1802e-07,0.4132,0.40584,1,1
1,GO REGULATION OF STEM CELL DIFFERENTIATION,1.1788e-07,0.41314,0.40165,1,1
1,GO REGULATION OF T CELL MEDIATED IMMUNITY,3.4421e-05,0.41302,0.39102,1,1
1,GO IMMATURE T CELL PROLIFERATION,5.4121e-05,0.41288,0.4502,1,1
1,GO VIRAL TRANSLATION,5.0683e-06,0.41209,0.41362,1,1
1,GO PHOSPHORYLATION OF RNA POLYMERASE II C TERMINAL DOMAIN,2.7343e-05,0.41157,0.32367,1,1
1,GO INTERFERON BETA PRODUCTION,0.00012074,0.41142,0.31503,1,1
1,GO VASCULAR TRANSPORT,0.029068,0.41092,0.44521,1,1
1,GO NEGATIVE REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,0.00017796,0.41075,0.33976,1,1
1,GO REGULATION OF PROTEIN COMPLEX STABILITY,0.0028141,0.41022,0.30102,1,1
1,GO REGULATION OF MONONUCLEAR CELL MIGRATION,2.8418e-05,0.41019,0.36723,1,1
1,GO POSITIVE REGULATION OF PHAGOCYTOSIS,1.4039e-05,0.40945,0.43896,1,1
1,GO PEPTIDE CROSS LINKING,0.00010462,0.40915,0.46253,1,1
1,GO REGULATION OF MRNA BINDING,1.5201e-05,0.40814,0.36707,1,1
1,GO ERBB2 SIGNALING PATHWAY,1.349e-05,0.40799,0.35051,1,1
1,GO GUANOSINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.00025131,0.40715,0.41089,1,1
1,GO POSITIVE REGULATION OF NATURAL KILLER CELL ACTIVATION,0.00023468,0.40708,0.41105,1,1
1,GO MONONUCLEAR CELL DIFFERENTIATION,5.2139e-05,0.40611,0.37476,1,1
1,GO LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,3.4728e-06,0.4053,0.49367,1,1
1,GO CYCLOOXYGENASE PATHWAY,0.02068,0.40521,0.34214,1,1
1,GO EXTRACELLULAR REGULATION OF SIGNAL TRANSDUCTION,0.00017796,0.40504,0.54318,1,1
1,GO REGULATION OF AUTOPHAGOSOME MATURATION,3.0576e-06,0.40446,0.39067,1,1
1,GO INTEGRIN MEDIATED SIGNALING PATHWAY,5.508e-06,0.4044,0.48429,1,1
1,GO REGULATION OF PRODUCTION OF SMALL RNA INVOLVED IN GENE SILENCING BY RNA,9.7346e-05,0.40435,0.3833,1,1
1,GO REGULATION OF MONOCYTE CHEMOTAXIS,0.0001547,0.40416,0.37624,1,1
1,GO I KAPPAB PHOSPHORYLATION,8.4205e-05,0.40407,0.29778,1,1
1,GO REGULATION OF RESPONSE TO OSMOTIC STRESS,2.9532e-05,0.40402,0.44761,1,1
1,GO IRON ION TRANSMEMBRANE TRANSPORT,1.6729e-06,0.40384,0.34478,1,1
1,GO PROGRAMMED NECROTIC CELL DEATH,2.0784e-06,0.40325,0.50713,1,1
1,GO BENZENE CONTAINING COMPOUND METABOLIC PROCESS,0.00016595,0.40267,0.42018,1,1
1,GO NUCLEOTIDE SUGAR METABOLIC PROCESS,5.2837e-06,0.40259,0.36521,1,1
1,GO NEGATIVE REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,0.00010092,0.4013,0.3297,1,1
1,GO NEGATIVE REGULATION OF MONOOXYGENASE ACTIVITY,0.0051916,0.40126,0.37925,1,1
1,GO POSITIVE REGULATION OF VASCULATURE DEVELOPMENT,1.9904e-06,0.40039,0.39782,1,1
1,GO FIBROBLAST MIGRATION,0.00063551,0.40016,0.3504,1,1
1,GO POSITIVE REGULATION OF VIRAL GENOME REPLICATION,6.2985e-07,0.40003,0.35742,1,1
1,GO CELL CELL ADHESION INVOLVED IN GASTRULATION,0.012508,0.39904,0.30553,1,1
1,GO REGULATION OF STEROL TRANSPORT,3.0689e-05,0.39811,0.3285,1,1
1,GO BONE GROWTH,0.00037661,0.39804,0.38928,1,1
1,GO POSITIVE REGULATION OF EPITHELIAL CELL MIGRATION,8.4205e-05,0.39785,0.36744,1,1
1,GO NEGATIVE REGULATION OF BIOMINERALIZATION,0.00028792,0.39779,0.47398,1,1
1,GO ACTIVATION OF NF KAPPAB INDUCING KINASE ACTIVITY,0.00020448,0.39778,0.38012,1,1
1,GO COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE,0.0021062,0.39708,0.38766,1,1
1,GO POSITIVE REGULATION OF CELL MATRIX ADHESION,0.00012074,0.39707,0.45262,1,1
1,GO CD4 POSITIVE ALPHA BETA T CELL CYTOKINE PRODUCTION,0.00036427,0.397,0.41675,1,1
1,GO EMBRYO IMPLANTATION,7.3528e-06,0.3963,0.47112,1,1
1,GO MODULATION OF PROCESS OF OTHER ORGANISM,5.6174e-05,0.39564,0.30342,1,1
1,GO REGULATION OF CELLULAR RESPONSE TO HYPOXIA,1.6729e-06,0.39555,0.42084,1,1
1,GO REGULATION OF HEMATOPOIETIC STEM CELL DIFFERENTIATION,1.2971e-07,0.39552,0.41704,1,1
1,GO ENDONUCLEOLYTIC CLEAVAGE IN ITS1 TO SEPARATE SSU RRNA FROM 5 8S RRNA AND LSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.0017641,0.39525,0.37051,1,1
1,GO REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,8.6584e-06,0.39421,0.39242,1,1
1,GO ISOTYPE SWITCHING TO IGG ISOTYPES,0.0099891,0.39287,0.28247,1,1
1,GO REGULATION OF PROTEIN POLYUBIQUITINATION,0.00016023,0.39208,0.28524,1,1
1,GO HISTONE SERINE PHOSPHORYLATION,8.7323e-05,0.39174,0.39591,1,1
1,GO POSITIVE REGULATION OF MITOPHAGY,0.00067758,0.3914,0.32066,1,1
1,GO REGULATION OF STORE OPERATED CALCIUM ENTRY,0.00055855,0.39137,0.32459,1,1
1,GO T CELL APOPTOTIC PROCESS,2.1702e-06,0.39048,0.3671,1,1
1,GO CERAMIDE CATABOLIC PROCESS,0.00052342,0.38996,0.34096,1,1
1,GO REGULATION OF IMMUNOGLOBULIN PRODUCTION,2.1663e-05,0.38994,0.36368,1,1
1,GO INTERACTION WITH HOST,7.5427e-07,0.38851,0.43045,1,1
1,GO REGULATION OF PROTEIN EXPORT FROM NUCLEUS,2.3654e-06,0.38821,0.39068,1,1
1,GO REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO CHROMOSOME,0.00084609,0.38813,0.31587,1,1
1,GO REGULATION OF PROTEIN IMPORT,1.4039e-05,0.38812,0.37197,1,1
1,GO POSITIVE REGULATION OF PODOSOME ASSEMBLY,0.00018427,0.38781,0.54037,1,1
1,GO POSITIVE REGULATION OF OXIDATIVE STRESS INDUCED CELL DEATH,1.7474e-06,0.38731,0.38453,1,1
1,GO RESPONSE TO ESTROGEN,8.628e-07,0.38605,0.38594,1,1
1,GO POSITIVE REGULATION OF FATTY ACID BETA OXIDATION,0.00029782,0.38585,0.3385,1,1
1,GO REGULATION OF NIK NF KAPPAB SIGNALING,1.7474e-06,0.38534,0.3687,1,1
1,GO MATURATION OF 5 8S RRNA,9.7346e-05,0.38425,0.33464,1,1
1,GO MATURATION OF 5 8S RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.00023468,0.38396,0.31966,1,1
1,GO REGULATION OF PROTEIN MATURATION,1.2308e-06,0.38382,0.38493,1,1
1,GO REGULATION OF GASTRULATION,5.9841e-06,0.38339,0.37265,1,1
1,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR BIOSYNTHETIC PROCESS,0.0031536,0.38332,0.32484,1,1
1,GO NEGATIVE REGULATION OF I KAPPAB KINASE NF KAPPAB SIGNALING,1.4039e-05,0.38263,0.34371,1,1
1,GO INTERLEUKIN 1 MEDIATED SIGNALING PATHWAY,1.0311e-06,0.38246,0.36179,1,1
1,GO REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,0.00072223,0.38224,0.34491,1,1
1,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM,0.0013872,0.38206,0.35524,1,1
1,GO SPROUTING ANGIOGENESIS,1.7806e-05,0.38202,0.34709,1,1
1,GO CYTOPLASMIC TRANSLATION,0.00055855,0.38197,0.30132,1,1
1,GO REGULATION OF DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING,5.508e-06,0.38187,0.3241,1,1
1,GO T CELL DIFFERENTIATION INVOLVED IN IMMUNE RESPONSE,1.1493e-05,0.38186,0.35393,1,1
1,GO NEGATIVE REGULATION OF INTERFERON BETA PRODUCTION,0.0011199,0.3818,0.34614,1,1
1,GO CHONDROITIN SULFATE BIOSYNTHETIC PROCESS,0.00011241,0.38,0.47016,1,1
1,GO POSITIVE REGULATION OF CARDIOCYTE DIFFERENTIATION,0.00023468,0.37959,0.31316,1,1
1,GO BEHAVIORAL RESPONSE TO PAIN,0.001191,0.37959,0.31552,1,1
1,GO REGULATION OF NATURAL KILLER CELL ACTIVATION,6.0504e-05,0.3792,0.39861,1,1
1,GO GLYCOSYL COMPOUND BIOSYNTHETIC PROCESS,1.8958e-07,0.3785,0.50019,1,1
1,GO POSITIVE REGULATION OF MYOTUBE DIFFERENTIATION,1.6455e-05,0.37758,0.42092,1,1
1,GO MEMBRANE INVAGINATION,1.7118e-05,0.3772,0.33591,1,1
1,GO CLEAVAGE INVOLVED IN RRNA PROCESSING,0.0001547,0.37719,0.33031,1,1
1,GO MAMMARY GLAND MORPHOGENESIS,9.7346e-05,0.37681,0.38165,1,1
1,GO PROTEIN TARGETING TO LYSOSOME,0.0014299,0.37643,0.2966,1,1
1,GO MUSCLE FILAMENT SLIDING,4.8379e-05,0.37605,0.33182,1,1
1,GO NEGATIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.0026572,0.37515,0.39304,1,1
1,GO POSITIVE REGULATION OF LAMELLIPODIUM ASSEMBLY,1.1964e-05,0.37484,0.31804,1,1
1,GO REGULATION OF HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION,2.8891e-07,0.37476,0.3705,1,1
1,GO SOMATIC RECOMBINATION OF IMMUNOGLOBULIN GENE SEGMENTS,2.3418e-05,0.37454,0.30615,1,1
1,GO SOMATIC DIVERSIFICATION OF IMMUNOGLOBULINS,2.2524e-05,0.37434,0.29584,1,1
1,GO PYRIMIDINE CONTAINING COMPOUND CATABOLIC PROCESS,2.8418e-05,0.37424,0.32633,1,1
1,GO REGULATION OF SMAD PROTEIN SIGNAL TRANSDUCTION,8.7323e-05,0.37407,0.37158,1,1
1,GO NEGATIVE REGULATION OF IMMUNE RESPONSE,6.0504e-05,0.37282,0.36811,1,1
1,GO REGULATION OF EXOSOMAL SECRETION,0.0054795,0.37219,0.23161,1,1
1,GO POSITIVE REGULATION OF NIK NF KAPPAB SIGNALING,1.104e-05,0.37168,0.33127,1,1
1,GO ENDOTHELIAL CELL APOPTOTIC PROCESS,0.0021062,0.3716,0.31152,1,1
1,GO REGULATION OF LAMELLIPODIUM ORGANIZATION,6.4994e-06,0.3715,0.32597,1,1
1,GO POSITIVE REGULATION OF INTERFERON ALPHA PRODUCTION,0.00041602,0.37108,0.31465,1,1
1,GO POSITIVE REGULATION OF SMOOTHENED SIGNALING PATHWAY,0.0027346,0.37075,0.30499,1,1
1,GO POSITIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.00016023,0.37024,0.32614,1,1
1,GO REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,1.4039e-05,0.36936,0.32904,1,1
1,GO REGULATION OF DEFENSE RESPONSE TO VIRUS BY HOST,0.00074557,0.3692,0.31994,1,1
1,GO CELLULAR RESPONSE TO ARSENIC CONTAINING SUBSTANCE,8.7323e-05,0.36906,0.35067,1,1
1,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,2.2658e-06,0.369,0.31609,1,1
1,GO MRNA TRANSCRIPTION,1.4039e-05,0.36896,0.36621,1,1
1,GO SNRNA PROCESSING,0.00084609,0.36826,0.5597,1,1
1,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION IN RESPONSE TO STRESS,3.3287e-06,0.3678,0.34092,1,1
1,GO NEGATIVE REGULATION OF OSTEOBLAST DIFFERENTIATION,0.00019079,0.36758,0.29975,1,1
1,GO RESPONSE TO MITOCHONDRIAL DEPOLARISATION,0.0001165,0.36751,0.30796,1,1
1,GO REGULATION OF VIRAL TRANSCRIPTION,4.1112e-06,0.36739,0.29188,1,1
1,GO INTERACTION WITH SYMBIONT,1.7806e-05,0.36728,0.31965,1,1
1,GO PULMONARY VALVE DEVELOPMENT,0.0050528,0.367,0.39712,1,1
1,GO POSITIVE REGULATION OF SMAD PROTEIN SIGNAL TRANSDUCTION,0.00067758,0.36672,0.35964,1,1
1,GO INTERLEUKIN 17 PRODUCTION,9.7801e-06,0.36648,0.45344,1,1
1,GO GLIAL CELL ACTIVATION,0.001228,0.36566,0.31018,1,1
1,GO CELLULAR RESPONSE TO HYDROGEN PEROXIDE,5.7413e-06,0.36556,0.32173,1,1
1,GO NCRNA PROCESSING,2.9532e-05,0.36512,0.28483,1,1
1,GO POSITIVE REGULATION OF T CELL PROLIFERATION,4.6597e-05,0.36482,0.33601,1,1
1,GO CYTOPLASMIC TRANSLATIONAL INITIATION,0.00025131,0.36469,0.31166,1,1
1,GO POSITIVE REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,1.9263e-05,0.36452,0.32314,1,1
1,GO REGULATION OF PHAGOCYTOSIS,1.2962e-05,0.36301,0.36829,1,1
1,GO REACTIVE NITROGEN SPECIES METABOLIC PROCESS,1.1964e-05,0.36298,0.3799,1,1
1,GO CHAPERONE MEDIATED PROTEIN FOLDING,0.00054072,0.36294,0.28092,1,1
1,GO IRES DEPENDENT VIRAL TRANSLATIONAL INITIATION,5.7413e-06,0.36285,0.37553,1,1
1,GO NEGATIVE REGULATION OF EXOCYTOSIS,0.0017641,0.36245,0.31144,1,1
1,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO TELOMERE,0.0018173,0.36203,0.27611,1,1
1,GO NATURAL KILLER CELL PROLIFERATION,0.0027346,0.36187,0.36582,1,1
1,GO GROWTH HORMONE RECEPTOR SIGNALING PATHWAY VIA JAK STAT,0.00022676,0.36154,0.51146,1,1
1,GO NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN CONTAINING 2 SIGNALING PATHWAY,0.01282,0.36133,0.36756,1,1
1,GO NEGATIVE REGULATION OF CHONDROCYTE DIFFERENTIATION,0.00087311,0.36122,0.45187,1,1
1,GO PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM,0.0012662,0.36108,0.30771,1,1
1,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION,1.0604e-05,0.36099,0.33041,1,1
1,GO NECROTIC CELL DEATH,5.0683e-06,0.36079,0.44011,1,1
1,GO POSITIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION,0.00016595,0.35978,0.27059,1,1
1,GO POSITIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,8.3127e-06,0.35955,0.3486,1,1
1,GO NEGATIVE REGULATION OF CELL FATE COMMITMENT,0.0051916,0.35916,0.34041,1,1
1,GO LEUKOCYTE APOPTOTIC PROCESS,2.2658e-06,0.35891,0.35473,1,1
1,GO NEGATIVE REGULATION OF CELL SIZE,7.3528e-06,0.35848,0.31998,1,1
1,GO REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,7.013e-05,0.35847,0.27599,1,1
1,GO TRANSLATIONAL TERMINATION,0.00024286,0.35841,0.26613,1,1
1,GO UBIQUITIN DEPENDENT ERAD PATHWAY,8.1192e-05,0.35821,0.27399,1,1
1,GO SKELETAL MUSCLE CELL PROLIFERATION,5.2139e-05,0.35803,0.3933,1,1
1,GO INNATE IMMUNE RESPONSE,2.5308e-05,0.35779,0.27797,1,1
1,GO RESPONSE TO VIRUS,1.0604e-05,0.35752,0.35775,1,1
1,GO RIBOSOMAL SMALL SUBUNIT ASSEMBLY,0.0022992,0.35747,0.30616,1,1
1,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,1.5201e-05,0.35666,0.35833,1,1
1,GO RIBOSOME BIOGENESIS,0.00010462,0.35553,0.29718,1,1
1,GO POSITIVE REGULATION OF CHOLESTEROL EFFLUX,2.6307e-05,0.35514,0.44642,1,1
1,GO EXTRACELLULAR MATRIX ASSEMBLY,0.014138,0.35505,0.37117,1,1
1,GO POSITIVE REGULATION OF LEUKOCYTE CELL CELL ADHESION,6.5149e-05,0.3549,0.26486,1,1
1,GO REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.00014935,0.35415,0.30298,1,1
1,GO REGULATION OF B CELL MEDIATED IMMUNITY,0.00018427,0.35402,0.28895,1,1
1,GO SERTOLI CELL DEVELOPMENT,0.001872,0.35364,0.31632,1,1
1,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.025994,0.35294,0.43775,1,1
1,GO POSITIVE REGULATION OF CELL SUBSTRATE ADHESION,0.00017186,0.35273,0.3849,1,1
1,GO CELLULAR RESPONSE TO OXIDISED LOW DENSITY LIPOPROTEIN PARTICLE STIMULUS,0.013465,0.35247,0.43162,1,1
1,GO CYTOKINETIC PROCESS,3.1904e-06,0.35233,0.32908,1,1
1,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.00010845,0.35188,0.36767,1,1
1,GO FOCAL ADHESION ASSEMBLY,0.00063551,0.35161,0.35611,1,1
1,GO REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.031748,0.35151,0.26121,1,1
1,GO PIGMENT ACCUMULATION,0.00013917,0.35138,0.32497,1,1
1,GO ANAPHASE PROMOTING COMPLEX DEPENDENT CATABOLIC PROCESS,1.6729e-06,0.35119,0.35296,1,1
1,GO POSITIVE REGULATION OF T CELL APOPTOTIC PROCESS,0.001872,0.35089,0.27353,1,1
1,GO HYPOTONIC RESPONSE,0.0012662,0.35069,0.29844,1,1
1,GO B CELL MEDIATED IMMUNITY,2.4346e-05,0.35039,0.3078,1,1
1,GO FOREGUT MORPHOGENESIS,0.00012512,0.35005,0.40004,1,1
1,GO REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,9.0551e-05,0.34959,0.36623,1,1
1,GO ARGININE METABOLIC PROCESS,0.0015189,0.3494,0.32554,1,1
1,GO MONONUCLEAR CELL MIGRATION,0.00019079,0.34928,0.31581,1,1
1,GO MAINTENANCE OF PROTEIN LOCALIZATION IN ORGANELLE,4.4712e-06,0.34904,0.32098,1,1
1,GO NEGATIVE REGULATION OF ERYTHROCYTE DIFFERENTIATION,0.00030804,0.34868,0.34281,1,1
1,GO ERAD PATHWAY,3.8583e-05,0.348,0.25827,1,1
1,GO REGULATION OF RESPONSE TO INTERFERON GAMMA,0.00098941,0.34775,0.33818,1,1
1,GO REGULATION OF VIRAL INDUCED CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,2.8418e-05,0.34748,0.33912,1,1
1,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION,3.5759e-05,0.34673,0.36637,1,1
1,GO MORPHOGENESIS OF AN EPITHELIAL BUD,0.0045306,0.34661,0.37792,1,1
1,GO NEGATIVE REGULATION OF RESPONSE TO BIOTIC STIMULUS,0.00055855,0.34661,0.29049,1,1
1,GO WNT SIGNALING PATHWAY INVOLVED IN MIDBRAIN DOPAMINERGIC NEURON DIFFERENTIATION,0.00016595,0.34579,0.33916,1,1
1,GO REGULATION OF LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,0.00032948,0.34556,0.37092,1,1
1,GO NUCLEOBASE CONTAINING SMALL MOLECULE CATABOLIC PROCESS,0.00036427,0.34517,0.30326,1,1
1,GO CELLULAR RESPONSE TO GROWTH HORMONE STIMULUS,0.00092958,0.34513,0.34231,1,1
1,GO POSITIVE REGULATION OF TYPE I INTERFERON PRODUCTION,3.0689e-05,0.34484,0.27188,1,1
1,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY HORMONE,0.00087311,0.34483,0.29017,1,1
1,GO FIBROBLAST PROLIFERATION,0.00025131,0.34444,0.29509,1,1
1,GO COPPER ION HOMEOSTASIS,7.9801e-06,0.34414,0.47265,1,1
1,GO PROTOPORPHYRINOGEN IX METABOLIC PROCESS,5.4121e-05,0.34374,0.30771,1,1
1,GO NCRNA 3 END PROCESSING,0.0030654,0.34296,0.37691,1,1
1,GO POSITIVE REGULATION OF RESPONSE TO CYTOKINE STIMULUS,0.00055855,0.34235,0.41425,1,1
1,GO NEGATIVE REGULATION OF RESPONSE TO WOUNDING,0.00012074,0.34182,0.30785,1,1
1,GO LENS FIBER CELL DEVELOPMENT,0.0015653,0.34173,0.37575,1,1
1,GO POSITIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,1.349e-05,0.3417,0.36377,1,1
1,GO REGULATION OF LOW DENSITY LIPOPROTEIN PARTICLE CLEARANCE,0.0021062,0.34158,0.35089,1,1
1,GO RRNA METABOLIC PROCESS,0.00013433,0.34139,0.27879,1,1
1,GO RESPONSE TO LAMINAR FLUID SHEAR STRESS,0.02843,0.34117,0.28191,1,1
1,GO REGULATION OF PROTEIN FOLDING,2.2524e-05,0.34102,0.28965,1,1
1,GO DNA DEALKYLATION INVOLVED IN DNA REPAIR,0.00040247,0.34086,0.3235,1,1
1,GO NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,1.9263e-05,0.34062,0.37353,1,1
1,GO RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,0.00037661,0.34004,0.31432,1,1
1,GO APOPTOTIC PROCESS INVOLVED IN MORPHOGENESIS,0.0028957,0.33988,0.31431,1,1
1,GO NEGATIVE REGULATION OF LIPID TRANSPORT,0.00092958,0.33977,0.26611,1,1
1,GO VIRAL GENE EXPRESSION,4.3218e-05,0.33947,0.33929,1,1
1,GO GASTRULATION,2.1663e-05,0.33885,0.32929,1,1
1,GO BASEMENT MEMBRANE ASSEMBLY,0.0019282,0.33884,0.44336,1,1
1,GO RESPONSE TO PROGESTERONE,0.0069616,0.33875,0.28058,1,1
1,GO REGULATION OF CD8 POSITIVE ALPHA BETA T CELL ACTIVATION,0.0025817,0.3385,0.32583,1,1
1,GO BRANCHING INVOLVED IN MAMMARY GLAND DUCT MORPHOGENESIS,0.00020448,0.3383,0.35626,1,1
1,GO REGULATION OF LIPASE ACTIVITY,3.5759e-05,0.3378,0.26345,1,1
1,GO POSITIVE REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.0017123,0.33766,0.33009,1,1
1,GO NEGATIVE REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,2.4692e-06,0.33746,0.30383,1,1
1,GO POSITIVE REGULATION OF TRANSLATION,2.2879e-07,0.33732,0.35442,1,1
1,GO LEFT RIGHT AXIS SPECIFICATION,0.0022992,0.33715,0.37587,1,1
1,GO NEGATIVE REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,9.0551e-05,0.33702,0.45177,1,1
1,GO RESPONSE TO INTERLEUKIN 1,2.5774e-06,0.33695,0.35649,1,1
1,GO BETA CATENIN DESTRUCTION COMPLEX DISASSEMBLY,7.3528e-06,0.33693,0.32782,1,1
1,GO NATURAL KILLER CELL ACTIVATION,2.4346e-05,0.33686,0.31571,1,1
1,GO SMAD PROTEIN COMPLEX ASSEMBLY,9.389e-05,0.33586,0.44759,1,1
1,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,0.0014299,0.3356,0.31629,1,1
1,GO ALPHA BETA T CELL ACTIVATION,0.00013917,0.33552,0.25301,1,1
1,GO REGULATION OF HISTONE PHOSPHORYLATION,0.00034072,0.33543,0.32746,1,1
1,GO POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,6.0504e-05,0.33531,0.39129,1,1
1,GO REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,3.0576e-06,0.33525,0.32394,1,1
1,GO ADAPTIVE IMMUNE RESPONSE,1.1964e-05,0.3351,0.30587,1,1
1,GO MAINTENANCE OF PROTEIN LOCATION IN NUCLEUS,9.3916e-06,0.33454,0.3933,1,1
1,GO REGULATION OF NITRIC OXIDE SYNTHASE ACTIVITY,0.00017186,0.33454,0.27578,1,1
1,GO CORTICAL CYTOSKELETON ORGANIZATION,1.9904e-06,0.3344,0.338,1,1
1,GO LYMPHOCYTE ACTIVATION INVOLVED IN IMMUNE RESPONSE,5.7413e-06,0.33405,0.31729,1,1
1,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS NONSENSE MEDIATED DECAY,0.0023671,0.33323,0.32407,1,1
1,GO CARDIAC MUSCLE CELL MYOBLAST DIFFERENTIATION,0.016339,0.33282,0.34926,1,1
1,GO HEMATOPOIETIC STEM CELL DIFFERENTIATION,1.8958e-07,0.33248,0.35338,1,1
1,GO POSITIVE REGULATION OF IMMUNE EFFECTOR PROCESS,2.0833e-05,0.33242,0.27667,1,1
1,GO POSITIVE REGULATION OF INTERFERON BETA PRODUCTION,0.00032948,0.33193,0.24873,1,1
1,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO CHROMOSOME,0.0016129,0.33184,0.22537,1,1
1,GO KERATAN SULFATE METABOLIC PROCESS,6.2786e-05,0.33159,0.35615,1,1
1,GO NEGATIVE REGULATION OF IMMUNOGLOBULIN PRODUCTION,0.00012074,0.33137,0.38916,1,1
1,GO PROTEIN OXIDATION,0.052669,0.33122,0.29643,1,1
1,GO GOLGI TO VACUOLE TRANSPORT,6.2786e-05,0.33093,0.27386,1,1
1,GO CELL SUBSTRATE ADHESION,4.8379e-05,0.3306,0.35911,1,1
1,GO REGULATION OF RETINOIC ACID RECEPTOR SIGNALING PATHWAY,0.011612,0.33058,0.25663,1,1
1,GO POSITIVE REGULATION OF RNA POLYMERASE II TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,3.8583e-05,0.33054,0.37677,1,1
1,GO CDC42 PROTEIN SIGNAL TRANSDUCTION,0.017137,0.33037,0.23916,1,1
1,GO INTERFERON ALPHA PRODUCTION,0.0015189,0.33031,0.24798,1,1
1,GO TETRAPYRROLE METABOLIC PROCESS,6.0504e-05,0.33019,0.24692,1,1
1,GO PROTEIN TARGETING TO VACUOLE,0.00021909,0.33016,0.25491,1,1
1,GO PYRIMIDINE RIBONUCLEOTIDE METABOLIC PROCESS,5.2139e-05,0.32992,0.29985,1,1
1,GO POSITIVE REGULATION OF INTERLEUKIN 8 PRODUCTION,0.00074557,0.32965,0.29383,1,1
1,GO TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,2.1663e-05,0.32958,0.32372,1,1
1,GO REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,3.1888e-05,0.32926,0.28349,1,1
1,GO POSITIVE REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,0.00023468,0.32914,0.35243,1,1
1,GO RESPONSE TO MANGANESE ION,6.0504e-05,0.32904,0.31022,1,1
1,GO REGULATION OF SECONDARY METABOLITE BIOSYNTHETIC PROCESS,0.009256,0.32862,0.29419,1,1
1,GO POSITIVE REGULATION OF MONOCYTE CHEMOTAXIS,0.0026572,0.32858,0.33947,1,1
1,GO CELLULAR COPPER ION HOMEOSTASIS,2.9532e-05,0.32852,0.51419,1,1
1,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE MEDIATED BY A CHEMICAL SIGNAL,0.00065623,0.32793,0.30866,1,1
1,GO IMMUNE EFFECTOR PROCESS,1.6455e-05,0.3277,0.28404,1,1
1,GO MEDIUM CHAIN FATTY ACID METABOLIC PROCESS,0.0014299,0.32757,0.2605,1,1
1,GO PORE COMPLEX ASSEMBLY,0.00019753,0.32744,0.26788,1,1
1,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.00042998,0.327,0.31046,1,1
1,GO LENS FIBER CELL DIFFERENTIATION,0.00055855,0.32695,0.33105,1,1
1,GO PLATELET MORPHOGENESIS,1.8521e-05,0.32641,0.29071,1,1
1,GO CRANIOFACIAL SUTURE MORPHOGENESIS,0.011047,0.32617,0.3625,1,1
1,GO CHONDROCYTE PROLIFERATION,0.0064317,0.32597,0.39307,1,1
1,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,0.00016023,0.32513,0.34986,1,1
1,GO OSTEOCLAST DEVELOPMENT,7.2754e-05,0.32501,0.37602,1,1
1,GO MITOCHONDRIAL CALCIUM ION TRANSMEMBRANE TRANSPORT,0.00012074,0.32438,0.22687,1,1
1,GO REGULATION OF AUTOPHAGY OF MITOCHONDRION IN RESPONSE TO MITOCHONDRIAL DEPOLARIZATION,0.00092958,0.32436,0.28102,1,1
1,GO LYMPHOCYTE MEDIATED IMMUNITY,3.1888e-05,0.32429,0.29559,1,1
1,GO EPITHELIAL CELL APOPTOTIC PROCESS,0.00069957,0.32418,0.29509,1,1
1,GO SNRNA METABOLIC PROCESS,0.00031859,0.32355,0.44802,1,1
1,GO REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,3.7145e-05,0.32349,0.27818,1,1
1,GO RESPONSE TO HYDROGEN PEROXIDE,0.00016023,0.32328,0.25653,1,1
1,GO MESODERM MORPHOGENESIS,1.7118e-05,0.32325,0.3174,1,1
1,GO LEUKOCYTE MEDIATED CYTOTOXICITY,0.00026903,0.32317,0.25587,1,1
1,GO ESTABLISHMENT OF EPITHELIAL CELL APICAL BASAL POLARITY,0.00098941,0.32292,0.31671,1,1
1,GO RNA 5 END PROCESSING,0.00024286,0.3228,0.28786,1,1
1,GO SPINDLE MIDZONE ASSEMBLY,0.00042998,0.32241,0.28994,1,1
1,GO NEGATIVE REGULATION OF KIDNEY DEVELOPMENT,7.013e-05,0.32222,0.32272,1,1
1,GO POSITIVE REGULATION OF NITRIC OXIDE METABOLIC PROCESS,5.2139e-05,0.32215,0.44586,1,1
1,GO REGULATION OF CELL SUBSTRATE ADHESION,0.0001547,0.32183,0.34225,1,1
1,GO VENTRICULAR CARDIAC MUSCLE CELL DIFFERENTIATION,0.033894,0.32172,0.24435,1,1
1,GO TRANSLATIONAL INITIATION,0.00052342,0.32166,0.28664,1,1
1,GO POSITIVE REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,3.4421e-05,0.32138,0.29595,1,1
1,GO POSITIVE REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,0.0015189,0.32077,0.23886,1,1
1,GO PEPTIDE CATABOLIC PROCESS,0.00050664,0.32074,0.23697,1,1
1,GO 3 PHOSPHOADENOSINE 5 PHOSPHOSULFATE METABOLIC PROCESS,0.0030654,0.32056,0.21989,1,1
1,GO COPPER ION TRANSPORT,4.1617e-05,0.31969,0.32192,1,1
1,GO DEFENSE RESPONSE TO OTHER ORGANISM,3.4421e-05,0.31946,0.26436,1,1
1,GO MAMMARY GLAND DUCT MORPHOGENESIS,9.389e-05,0.3194,0.36691,1,1
1,GO REGULATION OF PODOSOME ASSEMBLY,0.00026003,0.31918,0.42276,1,1
1,GO MONOCYTE CHEMOTAXIS,0.00026003,0.31884,0.34891,1,1
1,GO NEGATIVE REGULATION OF OXIDATIVE STRESS INDUCED NEURON DEATH,9.0551e-05,0.31863,0.30954,1,1
1,GO EXOCRINE SYSTEM DEVELOPMENT,0.0030654,0.31854,0.33091,1,1
1,GO REGULATION OF EPITHELIAL TUBE FORMATION,0.017549,0.31817,0.26501,1,1
1,GO REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,3.3287e-06,0.31788,0.33556,1,1
1,GO VIRAL RELEASE FROM HOST CELL,3.8583e-05,0.31754,0.29322,1,1
1,GO REGENERATION,4.1617e-05,0.3173,0.26388,1,1
1,GO REGULATION OF SECONDARY METABOLIC PROCESS,0.00025131,0.31714,0.38033,1,1
1,GO ENDOPLASMIC RETICULUM MANNOSE TRIMMING,0.00054072,0.3157,0.28188,1,1
1,GO HISTONE PHOSPHORYLATION,4.6597e-05,0.31565,0.27407,1,1
1,GO CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.00024286,0.31539,0.29945,1,1
1,GO POSITIVE REGULATION OF ACTION POTENTIAL,0.0029794,0.31524,0.24854,1,1
1,GO REGULATION OF ENDOTHELIAL CELL MIGRATION,2.9532e-05,0.31482,0.32162,1,1
1,GO POSITIVE REGULATION OF LEUKOCYTE DIFFERENTIATION,5.8301e-05,0.31478,0.26329,1,1
1,GO RECEPTOR BIOSYNTHETIC PROCESS,2.4346e-05,0.31461,0.30158,1,1
1,GO CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.00013433,0.31443,0.30511,1,1
1,GO NCRNA METABOLIC PROCESS,5.8301e-05,0.31443,0.25174,1,1
1,GO CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,2.0033e-05,0.31366,0.31044,1,1
1,GO NEGATIVE REGULATION OF LIPID LOCALIZATION,0.0016129,0.31366,0.22848,1,1
1,GO VESICLE CARGO LOADING,2.1663e-05,0.31358,0.29633,1,1
1,GO POSITIVE REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,0.00040247,0.31352,0.33689,1,1
1,GO REGULATION OF MYOBLAST DIFFERENTIATION,0.0017641,0.31351,0.27097,1,1
1,GO POSITIVE REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.0025817,0.31324,0.28177,1,1
1,GO EXTRINSIC APOPTOTIC SIGNALING PATHWAY,2.0833e-05,0.31274,0.33104,1,1
1,GO SYMBIOTIC PROCESS,2.8891e-07,0.31248,0.28731,1,1
1,GO CELLULAR RESPONSE TO GAMMA RADIATION,0.00047456,0.31232,0.2932,1,1
1,GO RESPONSE TO ARSENIC CONTAINING SUBSTANCE,0.0012662,0.31214,0.27169,1,1
1,GO NEGATIVE REGULATION OF CALCINEURIN MEDIATED SIGNALING,0.0075304,0.31205,0.27038,1,1
1,GO SYNCYTIUM FORMATION,9.389e-05,0.31191,0.31342,1,1
1,GO INTRACELLULAR MRNA LOCALIZATION,2.9532e-05,0.31153,0.38896,1,1
1,GO MRNA TRANSCRIPTION BY RNA POLYMERASE II,0.001228,0.31114,0.25697,1,1
1,GO REGULATION OF IMMUNE EFFECTOR PROCESS,1.7118e-05,0.31034,0.29134,1,1
1,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING,0.0019282,0.30999,0.26357,1,1
1,GO CYTOKINE MEDIATED SIGNALING PATHWAY,2.2524e-05,0.30991,0.34417,1,1
1,GO POSITIVE REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY,0.015574,0.30976,0.30155,1,1
1,GO REGULATION OF RECEPTOR BINDING,0.024846,0.30968,0.29175,1,1
1,GO PYRIMIDINE NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.00059588,0.30968,0.27896,1,1
1,GO NEGATIVE REGULATION OF CHEMOTAXIS,0.0025817,0.30964,0.24008,1,1
1,GO POSITIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY,6.7728e-06,0.30961,0.34701,1,1
1,GO DENDRITIC CELL DIFFERENTIATION,0.019739,0.30939,0.25599,1,1
1,GO POSITIVE REGULATION OF ORGAN GROWTH,2.7343e-05,0.30811,0.33454,1,1
1,GO CELL CELL JUNCTION MAINTENANCE,0.00353,0.30801,0.28563,1,1
1,GO CHONDROCYTE DIFFERENTIATION,0.00034072,0.30746,0.27932,1,1
1,GO REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,1.6729e-06,0.30727,0.28153,1,1
1,GO POSITIVE REGULATION OF PROTEIN AUTOPHOSPHORYLATION,0.0017641,0.30708,0.29187,1,1
1,GO ESTABLISHMENT OF LYMPHOCYTE POLARITY,0.0028957,0.30683,0.30134,1,1
1,GO LIPOPROTEIN LOCALIZATION,0.0027346,0.30655,0.35307,1,1
1,GO REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY,0.00067758,0.30639,0.28696,1,1
1,GO REGULATION OF MICROGLIAL CELL ACTIVATION,0.011904,0.30605,0.26357,1,1
1,GO PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,1.4039e-05,0.30576,0.27989,1,1
1,GO TISSUE REGENERATION,0.00037661,0.30523,0.27292,1,1
1,GO POSITIVE REGULATION OF LIPID STORAGE,2.5308e-05,0.30478,0.38181,1,1
1,GO ASTROCYTE ACTIVATION,0.0066042,0.30474,0.2739,1,1
1,GO REGULATION OF MRNA CATABOLIC PROCESS,6.2985e-07,0.3045,0.27665,1,1
1,GO NEGATIVE REGULATION OF BONE MINERALIZATION,0.015203,0.30418,0.39584,1,1
1,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO VACUOLE,0.00098941,0.304,0.20245,1,1
1,GO REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.00035231,0.30395,0.25098,1,1
1,GO ACTIN FILAMENT SEVERING,0.0022332,0.30394,0.34924,1,1
1,GO CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,4.0073e-05,0.30377,0.30623,1,1
1,GO NUCLEAR PORE ORGANIZATION,0.00011241,0.30376,0.33347,1,1
1,GO POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.009256,0.30363,0.27188,1,1
1,GO VASCULATURE DEVELOPMENT,3.8583e-05,0.30356,0.28461,1,1
1,GO TRNA 5 LEADER REMOVAL,0.00019753,0.3035,0.33214,1,1
1,GO REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,1.9904e-06,0.30344,0.23357,1,1
1,GO POSITIVE REGULATION OF MITOCHONDRIAL CALCIUM ION CONCENTRATION,0.00069957,0.30326,0.34594,1,1
1,GO CYTOKINE PRODUCTION,4.6597e-05,0.30307,0.25563,1,1
1,GO ROSTROCAUDAL NEURAL TUBE PATTERNING,0.0026572,0.30294,0.35738,1,1
1,GO REPLICATIVE SENESCENCE,0.0073363,0.30279,0.36457,1,1
1,GO CELLULAR RESPONSE TO MOLECULE OF BACTERIAL ORIGIN,3.7791e-06,0.30251,0.43386,1,1
1,GO GOLGI TO PLASMA MEMBRANE TRANSPORT,3.4421e-05,0.30227,0.25794,1,1
1,GO REGULATION OF LAMELLIPODIUM ASSEMBLY,1.0311e-06,0.30217,0.31619,1,1
1,GO PIGMENT METABOLIC PROCESS,2.8418e-05,0.30198,0.25685,1,1
1,GO TELOMERE MAINTENANCE VIA RECOMBINATION,0.00069957,0.30179,0.2162,1,1
1,GO CARNITINE METABOLIC PROCESS,0.013465,0.30166,0.2488,1,1
1,GO TROPHOBLAST GIANT CELL DIFFERENTIATION,0.0053338,0.3013,0.22965,1,1
1,GO RECEPTOR SIGNALING PATHWAY VIA STAT,0.00030804,0.30113,0.25674,1,1
1,GO ALPHA BETA T CELL DIFFERENTIATION,0.00035231,0.30084,0.24939,1,1
1,GO MACROPHAGE MIGRATION,4.8612e-06,0.30081,0.35775,1,1
1,GO POSITIVE REGULATION OF DEFENSE RESPONSE TO VIRUS BY HOST,0.0040578,0.30076,0.26845,1,1
1,GO NUCLEOBASE BIOSYNTHETIC PROCESS,0.004408,0.30062,0.23728,1,1
1,GO POSITIVE REGULATION OF DEFENSE RESPONSE,0.00024286,0.30006,0.20834,1,1
1,GO T CELL CYTOKINE PRODUCTION,2.9532e-05,0.29996,0.39267,1,1
1,GO MUSCLE CELL PROLIFERATION,1.2962e-05,0.29994,0.29921,1,1
1,GO URETER DEVELOPMENT,0.0036303,0.29983,0.29817,1,1
1,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,0.00018427,0.29968,0.25199,1,1
1,GO RESPONSE TO CYTOKINE,1.9263e-05,0.29966,0.29208,1,1
1,GO POSITIVE REGULATION OF TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,0.00065623,0.29954,0.24342,1,1
1,GO LEUKOCYTE CELL CELL ADHESION,0.00019079,0.29938,0.23359,1,1
1,GO RRNA MODIFICATION,0.0020453,0.2993,0.21211,1,1
1,GO MITOCHONDRIAL TRANSLATIONAL TERMINATION,0.00098941,0.29927,0.23932,1,1
1,GO CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.00012512,0.29918,0.29352,1,1
1,GO OLIGOPEPTIDE TRANSPORT,0.0029794,0.2991,0.3586,1,1
1,GO REGULATION OF CELL COMMUNICATION BY ELECTRICAL COUPLING,0.0010528,0.29907,0.33454,1,1
1,GO AMINO SUGAR BIOSYNTHETIC PROCESS,0.00095906,0.29838,0.25679,1,1
1,GO INTERLEUKIN 6 MEDIATED SIGNALING PATHWAY,0.0027346,0.29833,0.26917,1,1
1,GO NEGATIVE REGULATION OF CALCIUM MEDIATED SIGNALING,3.8583e-05,0.29831,0.30479,1,1
1,GO RIBONUCLEOSIDE METABOLIC PROCESS,2.8077e-06,0.29831,0.30926,1,1
1,GO NEGATIVE REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.00065623,0.29829,0.25478,1,1
1,GO POSITIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,0.00024286,0.29828,0.22959,1,1
1,GO MYELOID DENDRITIC CELL DIFFERENTIATION,0.0099891,0.29824,0.4015,1,1
1,GO POSITIVE REGULATION OF CELL ADHESION,0.00012074,0.29815,0.28293,1,1
1,GO REGULATION OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE,1.0604e-05,0.29803,0.30704,1,1
1,GO RIBONUCLEOPROTEIN COMPLEX BIOGENESIS,0.00042998,0.29797,0.2276,1,1
1,GO POSITIVE REGULATION OF RESPONSE TO BIOTIC STIMULUS,3.5759e-05,0.29781,0.23693,1,1
1,GO NEGATIVE REGULATION OF GENE SILENCING,7.013e-05,0.29777,0.28742,1,1
1,GO NEGATIVE REGULATION OF MYOBLAST DIFFERENTIATION,0.0026572,0.29765,0.33247,1,1
1,GO REGULATION OF BICELLULAR TIGHT JUNCTION ASSEMBLY,0.0011549,0.29696,0.32403,1,1
1,GO NCRNA EXPORT FROM NUCLEUS,0.00079435,0.2969,0.23221,1,1
1,GO PODOSOME ASSEMBLY,7.013e-05,0.2969,0.38997,1,1
1,GO REGULATION OF KIDNEY DEVELOPMENT,4.1617e-05,0.29644,0.34107,1,1
1,GO CELLULAR RESPONSE TO CORTICOSTEROID STIMULUS,0.0010528,0.29622,0.24838,1,1
1,GO NEGATIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA JAK STAT,0.00026903,0.29619,0.37838,1,1
1,GO ENDOTHELIAL CELL MIGRATION,7.2754e-05,0.29597,0.30658,1,1
1,GO DERMATAN SULFATE PROTEOGLYCAN METABOLIC PROCESS,0.02843,0.29537,0.3781,1,1
1,GO POSITIVE REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,0.00052342,0.2953,0.27673,1,1
1,GO REGULATION OF RESPONSE TO BIOTIC STIMULUS,6.7596e-05,0.29489,0.23356,1,1
1,GO EMBRYONIC HINDLIMB MORPHOGENESIS,0.0047853,0.29484,0.27576,1,1
1,GO NEGATIVE REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,2.5774e-06,0.2948,0.28352,1,1
1,GO SELECTIVE AUTOPHAGY,1.1776e-06,0.29472,0.29955,1,1
1,GO CELLULAR RESPONSE TO VIRUS,8.6584e-06,0.29412,0.31565,1,1
1,GO REGULATION OF CELL AGING,2.4692e-06,0.29407,0.30357,1,1
1,GO SPERM EGG RECOGNITION,6.7596e-05,0.29394,0.24076,1,1
1,GO NEGATIVE REGULATION OF LIPID STORAGE,0.0016129,0.29345,0.31072,1,1
1,GO GLAND MORPHOGENESIS,0.00036427,0.29338,0.3438,1,1
1,GO MEMBRANE LIPID CATABOLIC PROCESS,0.0059384,0.29308,0.1831,1,1
1,GO BLOOD VESSEL MORPHOGENESIS,3.5759e-05,0.29304,0.2898,1,1
1,GO T CELL CHEMOTAXIS,5.4121e-05,0.29304,0.26329,1,1
1,GO ENDOTHELIAL CELL DEVELOPMENT,0.0073363,0.29263,0.21017,1,1
1,GO POSITIVE REGULATION OF ACUTE INFLAMMATORY RESPONSE,0.00030804,0.29181,0.31435,1,1
1,GO POSITIVE REGULATION OF PROTEIN EXPORT FROM NUCLEUS,0.00055855,0.29178,0.30459,1,1
1,GO RESPONSE TO TOPOLOGICALLY INCORRECT PROTEIN,0.0001165,0.29172,0.24372,1,1
1,GO TUMOR NECROSIS FACTOR BIOSYNTHETIC PROCESS,0.00074557,0.29105,0.29146,1,1
1,GO MITOCHONDRIAL TRANSLATION,0.00095906,0.29091,0.22177,1,1
1,GO KETONE BIOSYNTHETIC PROCESS,0.00012512,0.29066,0.25398,1,1
1,GO CARDIAC EPITHELIAL TO MESENCHYMAL TRANSITION,0.037747,0.29056,0.22054,1,1
1,GO LYMPH VESSEL DEVELOPMENT,0.0018173,0.29048,0.3143,1,1
1,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND,0.00049035,0.29039,0.29211,1,1
1,GO MYOBLAST DIFFERENTIATION,7.6603e-06,0.29037,0.32118,1,1
1,GO GOLGI TO PLASMA MEMBRANE PROTEIN TRANSPORT,1.2962e-05,0.29034,0.31038,1,1
1,GO IRON SULFUR CLUSTER ASSEMBLY,0.00026003,0.28993,0.28218,1,1
1,GO MUCOPOLYSACCHARIDE METABOLIC PROCESS,0.00030804,0.28953,0.32322,1,1
1,GO POSITIVE REGULATION OF CELL CELL ADHESION,0.00052342,0.2893,0.21285,1,1
1,GO TOLL LIKE RECEPTOR SIGNALING PATHWAY,1.5201e-05,0.28929,0.30646,1,1
1,GO MYOBLAST MIGRATION,0.0022992,0.28919,0.44014,1,1
1,GO TRACHEA MORPHOGENESIS,0.0010528,0.28909,0.27126,1,1
1,GO PARAXIAL MESODERM DEVELOPMENT,0.00038934,0.28899,0.38686,1,1
1,GO REGULATION OF INNATE IMMUNE RESPONSE,0.00013433,0.28896,0.22138,1,1
1,GO NEGATIVE REGULATION OF EPITHELIAL CELL MIGRATION,0.00045924,0.28892,0.23298,1,1
1,GO REGULATION OF UBIQUITIN PROTEIN LIGASE ACTIVITY,6.2786e-05,0.28882,0.26314,1,1
1,GO T CELL RECEPTOR SIGNALING PATHWAY,8.628e-07,0.28881,0.28488,1,1
1,GO REGULATION OF MIRNA METABOLIC PROCESS,0.0017641,0.28853,0.25921,1,1
1,GO RESPONSE TO DSRNA,6.5149e-05,0.28845,0.3282,1,1
1,GO NEGATIVE REGULATION OF BMP SIGNALING PATHWAY,0.0030654,0.28785,0.28414,1,1
1,GO DEOXYRIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.00028792,0.28779,0.29925,1,1
1,GO MYOBLAST FUSION,0.00017186,0.28771,0.33429,1,1
1,GO SERTOLI CELL DIFFERENTIATION,0.0028957,0.28759,0.25987,1,1
1,GO REGULATION OF LEUKOCYTE PROLIFERATION,0.0015653,0.28755,0.20048,1,1
1,GO RESPONSE TO HEPATOCYTE GROWTH FACTOR,0.001662,0.28736,0.26418,1,1
1,GO REGULATION OF RNA BINDING,9.7801e-06,0.28722,0.28969,1,1
1,GO WOUND HEALING,8.7323e-05,0.28717,0.30468,1,1
1,GO POSITIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION,1.9904e-06,0.28707,0.27274,1,1
1,GO REGULATION OF CHOLESTEROL EFFLUX,0.00013433,0.28691,0.29564,1,1
1,GO POSITIVE REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,4.1802e-07,0.28667,0.30169,1,1
1,GO NEGATIVE REGULATION OF RESPONSE TO REACTIVE OXYGEN SPECIES,0.00029782,0.28584,0.42322,1,1
1,GO CELLULAR RESPONSE TO CHEMICAL STRESS,1.8521e-05,0.28568,0.2464,1,1
1,GO NEGATIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.00042998,0.28566,0.28653,1,1
1,GO MATERNAL PLACENTA DEVELOPMENT,0.00054072,0.28523,0.29039,1,1
1,GO NEGATIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,0.00044439,0.28517,0.24482,1,1
1,GO MACROPHAGE APOPTOTIC PROCESS,0.00014935,0.28445,0.41232,1,1
1,GO SERINE FAMILY AMINO ACID METABOLIC PROCESS,0.00030804,0.28441,0.29813,1,1
1,GO NUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,0.00013917,0.28439,0.30166,1,1
1,GO MYELOID LEUKOCYTE DIFFERENTIATION,2.9532e-05,0.28434,0.22491,1,1
1,GO POSITIVE REGULATION OF RESPONSE TO OXIDATIVE STRESS,3.4728e-06,0.28424,0.3367,1,1
1,GO RNA CATABOLIC PROCESS,7.2111e-07,0.28421,0.26553,1,1
1,GO CELLULAR RESPONSE TO ETHANOL,0.0026572,0.2842,0.2881,1,1
1,GO CELL CELL RECOGNITION,3.9418e-06,0.28408,0.27963,1,1
1,GO POSITIVE REGULATION OF HISTONE DEACETYLATION,0.016339,0.28406,0.20261,1,1
1,GO RETINOIC ACID RECEPTOR SIGNALING PATHWAY,0.0032441,0.28369,0.23735,1,1
1,GO NEGATIVE REGULATION OF RYANODINE SENSITIVE CALCIUM RELEASE CHANNEL ACTIVITY,0.0013054,0.28302,0.2956,1,1
1,GO RESPONSE TO PEPTIDOGLYCAN,0.00069957,0.28287,0.35184,1,1
1,GO NATURAL KILLER CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.00012964,0.28275,0.32583,1,1
1,GO POSITIVE REGULATION OF AUTOPHAGY OF MITOCHONDRION,0.00019753,0.28262,0.25386,1,1
1,GO REGULATION OF CELL MATRIX ADHESION,0.00032948,0.28245,0.32339,1,1
1,GO CARDIAC MUSCLE CELL PROLIFERATION,0.0014299,0.28217,0.26883,1,1
1,GO DECIDUALIZATION,0.017549,0.28206,0.27599,1,1
1,GO REGULATION OF SPROUTING ANGIOGENESIS,1.9263e-05,0.28176,0.34596,1,1
1,GO REGULATION OF LEUKOCYTE MEDIATED CYTOTOXICITY,0.0017641,0.2817,0.24119,1,1
1,GO POSITIVE REGULATION OF LYMPHOCYTE ACTIVATION,3.8583e-05,0.28105,0.24942,1,1
1,GO REGULATION OF LYMPHOCYTE CHEMOTAXIS,0.00049035,0.28092,0.28541,1,1
1,GO SEQUESTERING OF METAL ION,0.00026903,0.28084,0.2613,1,1
1,GO PRODUCTION OF SIRNA INVOLVED IN RNA INTERFERENCE,0.014841,0.28058,0.23468,1,1
1,GO SMOOTH MUSCLE TISSUE DEVELOPMENT,0.033166,0.28057,0.18419,1,1
1,GO PHAGOCYTOSIS,5.508e-06,0.2804,0.32036,1,1
1,GO GLOMERULAR EPITHELIAL CELL DIFFERENTIATION,0.0060989,0.2804,0.33175,1,1
1,GO AMINO SUGAR METABOLIC PROCESS,0.00020448,0.27967,0.23936,1,1
1,GO POSITIVE REGULATION OF IMMUNE RESPONSE,4.3218e-05,0.27951,0.21718,1,1
1,GO CELLULAR RESPONSE TO RETINOIC ACID,0.001228,0.27944,0.25624,1,1
1,GO POSITIVE REGULATION OF EXECUTION PHASE OF APOPTOSIS,2.6307e-05,0.27927,0.377,1,1
1,GO CARDIOBLAST DIFFERENTIATION,0.0064317,0.27899,0.31833,1,1
1,GO NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR SIGNALING PATHWAY,0.00063551,0.27887,0.31931,1,1
1,GO NUCLEOSIDE SALVAGE,0.00081984,0.27852,0.42899,1,1
1,GO REGULATION OF PHOSPHOLIPASE ACTIVITY,8.4205e-05,0.27782,0.26966,1,1
1,GO CHEMOKINE PRODUCTION,0.0020453,0.27751,0.24934,1,1
1,GO REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,1.5816e-05,0.27713,0.27484,1,1
1,GO ESTABLISHMENT OF ENDOTHELIAL BARRIER,0.00059588,0.27711,0.27779,1,1
1,GO MYD88 DEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.013139,0.27702,0.22178,1,1
1,GO NEGATIVE REGULATION OF DNA REPAIR,7.6603e-06,0.27674,0.26988,1,1
1,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS,0.00069957,0.27652,0.26404,1,1
1,GO T CELL ACTIVATION,0.0001547,0.27628,0.21391,1,1
1,GO IMMUNOGLOBULIN PRODUCTION,3.8583e-05,0.27595,0.23898,1,1
1,GO POSITIVE REGULATION OF VIRAL RELEASE FROM HOST CELL,0.0067808,0.27563,0.21094,1,1
1,GO CARTILAGE DEVELOPMENT,0.0017123,0.27548,0.225,1,1
1,GO SMOOTH MUSCLE CELL PROLIFERATION,2.9532e-05,0.27544,0.3342,1,1
1,GO INTERLEUKIN 4 PRODUCTION,0.0067808,0.27542,0.17791,1,1
1,GO POSITIVE REGULATION OF LEUKOCYTE PROLIFERATION,0.00052342,0.27517,0.24391,1,1
1,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS,0.00024286,0.27467,0.24683,1,1
1,GO CELL REDOX HOMEOSTASIS,3.1888e-05,0.27441,0.27871,1,1
1,GO ASTROCYTE DEVELOPMENT,0.00042998,0.27406,0.29919,1,1
1,GO GLYCOSYL COMPOUND METABOLIC PROCESS,4.8379e-05,0.27378,0.21661,1,1
1,GO ACUTE PHASE RESPONSE,0.0060989,0.27373,0.25734,1,1
1,GO POSITIVE REGULATION OF CELL ACTIVATION,8.7323e-05,0.2735,0.23198,1,1
1,GO RESPONSE TO IONIZING RADIATION,3.3287e-06,0.2735,0.27005,1,1
1,GO NEGATIVE REGULATION OF RESPONSE TO CYTOKINE STIMULUS,0.00016595,0.273,0.26527,1,1
1,GO MITOCHONDRIAL PROTEIN PROCESSING,0.0010528,0.27299,0.23474,1,1
1,GO EXTRACELLULAR VESICLE BIOGENESIS,0.0025817,0.27293,0.2131,1,1
1,GO DENDRITIC CELL CHEMOTAXIS,0.0030654,0.27181,0.28109,1,1
1,GO POLARIZED EPITHELIAL CELL DIFFERENTIATION,0.00072223,0.27165,0.24099,1,1
1,GO INNER CELL MASS CELL PROLIFERATION,0.0011199,0.27164,0.34143,1,1
1,GO SULFUR COMPOUND CATABOLIC PROCESS,0.00090094,0.27146,0.32009,1,1
1,GO RESPONSE TO BIOTIC STIMULUS,3.5759e-05,0.2712,0.2397,1,1
1,GO T CELL MIGRATION,0.00072223,0.27115,0.25813,1,1
1,GO MAINTENANCE OF PROTEIN LOCATION,1.2862e-06,0.27113,0.27174,1,1
1,GO NEGATIVE REGULATION OF ACTIVATED T CELL PROLIFERATION,0.016734,0.27104,0.22227,1,1
1,GO MITOTIC CYTOKINETIC PROCESS,3.1888e-05,0.27086,0.28127,1,1
1,GO DICARBOXYLIC ACID BIOSYNTHETIC PROCESS,0.00072223,0.2708,0.31769,1,1
1,GO POSITIVE REGULATION OF T CELL DIFFERENTIATION IN THYMUS,0.0013054,0.27078,0.30401,1,1
1,GO POSITIVE REGULATION OF MONONUCLEAR CELL MIGRATION,0.00069957,0.27069,0.36586,1,1
1,GO PURINE NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,3.4421e-05,0.27044,0.21743,1,1
1,GO REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.001986,0.2703,0.3197,1,1
1,GO TRANSFORMING GROWTH FACTOR BETA PRODUCTION,0.0049174,0.27001,0.2902,1,1
1,GO METANEPHRIC NEPHRON DEVELOPMENT,0.00024286,0.26994,0.27278,1,1
1,GO BETA CATENIN TCF COMPLEX ASSEMBLY,0.0083534,0.26958,0.20729,1,1
1,GO POST TRANSLATIONAL PROTEIN MODIFICATION,0.00032948,0.26924,0.20175,1,1
1,GO NEGATIVE REGULATION OF OSSIFICATION,0.0007696,0.26924,0.21979,1,1
1,GO HEMOGLOBIN METABOLIC PROCESS,0.0053338,0.26889,0.21193,1,1
1,GO LYMPHOCYTE CHEMOTAXIS,5.0226e-05,0.26849,0.28137,1,1
1,GO POSITIVE REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,0.0013872,0.2681,0.20463,1,1
1,GO NEGATIVE REGULATION OF SMOOTHENED SIGNALING PATHWAY,0.0019282,0.268,0.22054,1,1
1,GO NUCLEOBASE METABOLIC PROCESS,0.0018173,0.26754,0.21411,1,1
1,GO NEGATIVE REGULATION OF PHAGOCYTOSIS,0.00098941,0.26751,0.25773,1,1
1,GO EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,0.00011241,0.2674,0.39395,1,1
1,GO NLRP3 INFLAMMASOME COMPLEX ASSEMBLY,0.0042883,0.26706,0.29047,1,1
1,GO I KAPPAB KINASE NF KAPPAB SIGNALING,1.1493e-05,0.26688,0.35378,1,1
1,GO POSITIVE REGULATION OF LAMELLIPODIUM ORGANIZATION,0.0038387,0.26675,0.20169,1,1
1,GO CORONARY VASCULATURE DEVELOPMENT,0.0013457,0.26654,0.26252,1,1
1,GO MEMBRANE DISASSEMBLY,0.0050528,0.26613,0.24921,1,1
1,GO RESPONSE TO OSMOTIC STRESS,0.00079435,0.26552,0.20392,1,1
1,GO KERATINOCYTE MIGRATION,0.001872,0.26548,0.25797,1,1
1,GO POSITIVE REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,0.00014935,0.26537,0.24704,1,1
1,GO CHONDROCYTE DEVELOPMENT,0.0057817,0.26522,0.30449,1,1
1,GO HISTONE H4 DEACETYLATION,0.0049174,0.26479,0.23153,1,1
1,GO POSITIVE REGULATION OF LEUKOCYTE MIGRATION,0.00038934,0.26476,0.25895,1,1
1,GO TRANSLATIONAL ELONGATION,0.00092958,0.2646,0.21184,1,1
1,GO IRON ION HOMEOSTASIS,1.1493e-05,0.26454,0.26054,1,1
1,GO PLASMA MEMBRANE TUBULATION,0.00014418,0.26446,0.29141,1,1
1,GO VIRION ASSEMBLY,1.1964e-05,0.26433,0.22917,1,1
1,GO REGULATION OF LEUKOCYTE DEGRANULATION,0.0045306,0.26425,0.2403,1,1
1,GO TRANSPOSITION,0.025994,0.26409,0.2092,1,1
1,GO REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,0.00084609,0.26387,0.23958,1,1
1,GO NEGATIVE REGULATION OF INTERFERON GAMMA PRODUCTION,0.0038387,0.26372,0.29784,1,1
1,GO REGULATION OF KERATINOCYTE PROLIFERATION,0.0013457,0.26363,0.42808,1,1
1,GO CELLULAR RESPONSE TO INCREASED OXYGEN LEVELS,1.7806e-05,0.26346,0.39003,1,1
1,GO POSITIVE REGULATION OF LIPID LOCALIZATION,2.2524e-05,0.26333,0.24661,1,1
1,GO ENDOCHONDRAL BONE MORPHOGENESIS,0.00025131,0.2633,0.29067,1,1
1,GO RESPONSE TO MOLECULE OF BACTERIAL ORIGIN,1.5201e-05,0.26314,0.32581,1,1
1,GO RESPONSE TO DEXAMETHASONE,0.024846,0.26298,0.16793,1,1
1,GO PRODUCTION OF SMALL RNA INVOLVED IN GENE SILENCING BY RNA,3.1888e-05,0.26294,0.2682,1,1
1,GO CELLULAR KETONE METABOLIC PROCESS,4.0073e-05,0.26289,0.19758,1,1
1,GO ESTABLISHMENT OF EPITHELIAL CELL POLARITY,0.0016129,0.26284,0.25948,1,1
1,GO TROPHECTODERMAL CELL DIFFERENTIATION,0.0019282,0.26264,0.20873,1,1
1,GO REGULATION OF TRANSLATIONAL INITIATION IN RESPONSE TO STRESS,0.00052342,0.26233,0.25426,1,1
1,GO CELLULAR RESPONSE TO REACTIVE OXYGEN SPECIES,2.6307e-05,0.26219,0.24067,1,1
1,GO REGULATION OF PLASMA LIPOPROTEIN PARTICLE LEVELS,0.00034072,0.26192,0.20871,1,1
1,GO NUCLEAR ENVELOPE ORGANIZATION,0.0012662,0.26154,0.21115,1,1
1,GO REGULATION OF MONOOXYGENASE ACTIVITY,0.0010859,0.26151,0.22382,1,1
1,GO RESPONSE TO PARATHYROID HORMONE,0.0041716,0.26132,0.24233,1,1
1,GO NADP METABOLIC PROCESS,0.0099891,0.26127,0.20782,1,1
1,GO MITOCHONDRIAL GENE EXPRESSION,0.0015653,0.2612,0.20556,1,1
1,GO OSTEOBLAST DIFFERENTIATION,0.00059588,0.26112,0.24001,1,1
1,GO POSITIVE REGULATION OF LIPID KINASE ACTIVITY,0.0031536,0.26106,0.20988,1,1
1,GO AUTOPHAGOSOME MATURATION,6.5149e-05,0.26096,0.26182,1,1
1,GO REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,4.8379e-05,0.2609,0.2612,1,1
1,GO STEROL TRANSPORT,0.0011549,0.26086,0.19787,1,1
1,GO POSITIVE REGULATION OF DNA RECOMBINATION,2.3418e-05,0.26079,0.26977,1,1
1,GO CORTICAL ACTIN CYTOSKELETON ORGANIZATION,3.1904e-06,0.26056,0.33024,1,1
1,GO ACTIVATION OF MAPKK ACTIVITY,6.0504e-05,0.26053,0.29347,1,1
1,GO NEGATIVE REGULATION OF MEIOTIC NUCLEAR DIVISION,0.025994,0.2605,0.14916,1,1
1,GO RESPONSE TO WOUNDING,0.00010845,0.26042,0.25377,1,1
1,GO REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,0.0010528,0.25988,0.22792,1,1
1,GO AROMATIC AMINO ACID FAMILY CATABOLIC PROCESS,0.00037661,0.25986,0.23348,1,1
1,GO REGULATION OF GENE SILENCING,2.0784e-06,0.25947,0.25481,1,1
1,GO DNA DEALKYLATION,0.00092958,0.25913,0.24444,1,1
1,GO POSITIVE REGULATION OF VIRAL PROCESS,2.0784e-06,0.25877,0.25293,1,1
1,GO POSITIVE REGULATION OF PHOSPHOLIPID METABOLIC PROCESS,0.00074557,0.25865,0.21432,1,1
1,GO POSITIVE REGULATION OF CALCIUM ION IMPORT,0.0069616,0.25832,0.23541,1,1
1,GO RNA DESTABILIZATION,2.5308e-05,0.25812,0.25818,1,1
1,GO CELLULAR RESPONSE TO OXYGEN RADICAL,0.00092958,0.2581,0.16276,1,1
1,GO REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,8.7323e-05,0.25801,0.24964,1,1
1,GO POSITIVE REGULATION OF CELL CYCLE PHASE TRANSITION,2.4692e-06,0.25786,0.23826,1,1
1,GO POSITIVE REGULATION OF HEART GROWTH,0.00044439,0.25753,0.29185,1,1
1,GO REGULATION OF TOLERANCE INDUCTION,0.026586,0.25752,0.24451,1,1
1,GO GRANULOCYTE MIGRATION,0.00047456,0.2574,0.26925,1,1
1,GO CELL ACTIVATION,6.0504e-05,0.25723,0.22754,1,1
1,GO REGULATION OF RESPONSE TO CYTOKINE STIMULUS,9.0551e-05,0.25674,0.33477,1,1
1,GO LYSOSOMAL PROTEIN CATABOLIC PROCESS,0.0031536,0.25649,0.20109,1,1
1,GO REGULATION OF LIPOPROTEIN PARTICLE CLEARANCE,0.0010528,0.25644,0.26581,1,1
1,GO PROTEIN CATABOLIC PROCESS IN THE VACUOLE,0.0010206,0.25642,0.22591,1,1
1,GO TRNA 5 END PROCESSING,0.00028792,0.25637,0.28881,1,1
1,GO CRISTAE FORMATION,0.015203,0.25634,0.20168,1,1
1,GO CHOLESTEROL EFFLUX,0.00030804,0.25607,0.24302,1,1
1,GO PROTEIN FOLDING,0.00036427,0.25591,0.2084,1,1
1,GO REGULATION OF CELLULAR AMINE METABOLIC PROCESS,7.2754e-05,0.25568,0.24326,1,1
1,GO COMPLEMENT ACTIVATION ALTERNATIVE PATHWAY,0.0017123,0.25553,0.24099,1,1
1,GO REGULATION OF NUCLEASE ACTIVITY,0.0011549,0.25552,0.26642,1,1
1,GO HEPATOCYTE DIFFERENTIATION,0.044685,0.25513,0.24301,1,1
1,GO PYRIMIDINE NUCLEOBASE METABOLIC PROCESS,0.00037661,0.2551,0.27881,1,1
1,GO CELL MATRIX ADHESION,0.00032948,0.25483,0.30045,1,1
1,GO MYELOID DENDRITIC CELL ACTIVATION,0.023205,0.25482,0.32281,1,1
1,GO IMMUNOGLOBULIN PRODUCTION INVOLVED IN IMMUNOGLOBULIN MEDIATED IMMUNE RESPONSE,0.0013872,0.2546,0.20229,1,1
1,GO RRNA TRANSCRIPTION,0.0010859,0.25457,0.23091,1,1
1,GO PROSTATE GLAND DEVELOPMENT,0.00087311,0.25454,0.33258,1,1
1,GO PIGMENT BIOSYNTHETIC PROCESS,4.6597e-05,0.25431,0.22745,1,1
1,GO REGULATION OF IMMUNE RESPONSE,4.8379e-05,0.25381,0.21346,1,1
1,GO NEGATIVE REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,0.001872,0.25378,0.31171,1,1
1,GO COAGULATION,7.8282e-05,0.25352,0.27348,1,1
1,GO PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,6.2786e-05,0.25346,0.25657,1,1
1,GO NEGATIVE REGULATION OF HISTONE ACETYLATION,0.02843,0.25341,0.19188,1,1
1,GO MAINTENANCE OF PROTEIN LOCATION IN CELL,7.0571e-06,0.25329,0.27148,1,1
1,GO REGULATION OF TRANSLATIONAL INITIATION BY EIF2 ALPHA PHOSPHORYLATION,0.0027346,0.25316,0.237,1,1
1,GO REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,4.2876e-06,0.253,0.24813,1,1
1,GO MAMMARY GLAND EPITHELIUM DEVELOPMENT,0.00041602,0.25296,0.26689,1,1
1,GO REGULATION OF LYMPHOCYTE ACTIVATION,0.00012074,0.25286,0.20969,1,1
1,GO CELLULAR NITROGEN COMPOUND CATABOLIC PROCESS,1.6015e-06,0.25279,0.22905,1,1
1,GO POSITIVE REGULATION OF CELL SIZE,0.041967,0.25229,0.22199,1,1
1,GO PYRIMIDINE NUCLEOTIDE BIOSYNTHETIC PROCESS,0.00047456,0.25186,0.21525,1,1
1,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION,2.9532e-05,0.25167,0.24354,1,1
1,GO AUTOPHAGY OF NUCLEUS,0.00072223,0.2516,0.24453,1,1
1,GO REGULATION OF ENDOTHELIAL CELL DEVELOPMENT,0.0012662,0.25097,0.2745,1,1
1,GO REGULATION OF RNA POLYMERASE II TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.00030804,0.25092,0.28924,1,1
1,GO AMYLOID PRECURSOR PROTEIN BIOSYNTHETIC PROCESS,0.046579,0.25089,0.15925,1,1
1,GO POSITIVE REGULATION OF HUMORAL IMMUNE RESPONSE,0.0017123,0.25079,0.24592,1,1
1,GO OLIGOSACCHARIDE LIPID INTERMEDIATE BIOSYNTHETIC PROCESS,0.0020453,0.25077,0.20496,1,1
1,GO KERATAN SULFATE BIOSYNTHETIC PROCESS,0.001986,0.2507,0.24499,1,1
1,GO REGULATION OF HEART GROWTH,0.00052342,0.25055,0.21439,1,1
1,GO ERK1 AND ERK2 CASCADE,4.0073e-05,0.25018,0.23143,1,1
1,GO REGULATION OF CELL ACTIVATION,0.00025131,0.25003,0.19607,1,1
1,GO PLATELET ACTIVATION,0.00028792,0.24983,0.23061,1,1
1,GO NUCLEAR ENVELOPE REASSEMBLY,2.0833e-05,0.24972,0.2529,1,1
1,GO RESPONSE TO INCREASED OXYGEN LEVELS,0.0013457,0.24951,0.27919,1,1
1,GO LYMPHOCYTE MIGRATION,0.00098941,0.24937,0.20427,1,1
1,GO DETERMINATION OF DORSAL VENTRAL ASYMMETRY,0.020205,0.24926,0.23606,1,1
1,GO NUCLEOSIDE METABOLIC PROCESS,1.349e-05,0.24925,0.24856,1,1
1,GO TRNA METHYLATION,0.00021909,0.24895,0.23175,1,1
1,GO REGULATION OF ORGAN GROWTH,5.9841e-06,0.24884,0.28224,1,1
1,GO INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.0037331,0.24872,0.23319,1,1
1,GO NEGATIVE REGULATION OF LEUKOCYTE CHEMOTAXIS,0.014138,0.2485,0.25172,1,1
1,GO REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.00044439,0.24842,0.21623,1,1
1,GO TOXIN TRANSPORT,0.0094949,0.2481,0.15797,1,1
1,GO CELLULAR RESPONSE TO ABIOTIC STIMULUS,5.6174e-05,0.24788,0.20396,1,1
1,GO PYRIMIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,3.3287e-06,0.24788,0.30815,1,1
1,GO REGULATION OF VASCULATURE DEVELOPMENT,3.5759e-05,0.24783,0.28613,1,1
1,GO MITOPHAGY,0.00035231,0.24745,0.2355,1,1
1,GO POSITIVE REGULATION OF INNATE IMMUNE RESPONSE,0.00014935,0.24725,0.20774,1,1
1,GO NEGATIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY,2.8418e-05,0.24713,0.23511,1,1
1,GO REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,0.00055855,0.24698,0.21654,1,1
1,GO TRNA PROCESSING,0.00042998,0.2469,0.18179,1,1
1,GO REGULATION OF LYSOSOMAL LUMEN PH,0.0013457,0.2468,0.25112,1,1
1,GO CELLULAR RESPONSE TO BIOTIC STIMULUS,1.8521e-05,0.24665,0.34812,1,1
1,GO NEGATIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,7.547e-05,0.24627,0.20785,1,1
1,GO NEGATIVE REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,0.0001547,0.24621,0.44,1,1
1,GO LYMPHOCYTE APOPTOTIC PROCESS,0.00021167,0.24615,0.22616,1,1
1,GO REGULATION OF LEUKOCYTE MIGRATION,0.00021909,0.24613,0.24992,1,1
1,GO MIDBODY ABSCISSION,0.00095906,0.24608,0.26348,1,1
1,GO MACROPHAGE CYTOKINE PRODUCTION,0.027188,0.24603,0.35099,1,1
1,GO CELLULAR RESPONSE TO IONIZING RADIATION,0.00069957,0.24586,0.26087,1,1
1,GO SOMATIC DIVERSIFICATION OF IMMUNE RECEPTORS,5.4121e-05,0.24585,0.22762,1,1
1,GO POSITIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS,0.0011549,0.24579,0.17667,1,1
1,GO RESPONSE TO OXYGEN RADICAL,0.00047456,0.24559,0.17801,1,1
1,GO PEPTIDE BIOSYNTHETIC PROCESS,1.7118e-05,0.24559,0.21741,1,1
1,GO NEGATIVE REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,0.0099891,0.24555,0.21671,1,1
1,GO POSITIVE REGULATION OF PROTEIN MATURATION,0.0071468,0.24553,0.21313,1,1
1,GO RESPONSE TO BACTERIUM,0.00010845,0.24518,0.24381,1,1
1,GO REGULATION OF HEMOPOIESIS,1.5201e-05,0.24503,0.21268,1,1
1,GO LIPID IMPORT INTO CELL,0.036164,0.24502,0.19441,1,1
1,GO ACTIVATION OF IMMUNE RESPONSE,3.8583e-05,0.24501,0.19682,1,1
1,GO METANEPHROS DEVELOPMENT,9.7346e-05,0.245,0.24616,1,1
1,GO REGULATION OF DEFENSE RESPONSE,0.00017186,0.24491,0.19959,1,1
1,GO REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE,0.00021909,0.24468,0.19316,1,1
1,GO REGULATION OF MYOTUBE DIFFERENTIATION,0.00025131,0.24459,0.25013,1,1
1,GO LYMPHOCYTE ACTIVATION,0.00014418,0.24458,0.19315,1,1
1,GO RESPONSE TO INTERLEUKIN 7,0.011047,0.24439,0.20184,1,1
1,GO POLYAMINE BIOSYNTHETIC PROCESS,0.010506,0.24435,0.24159,1,1
1,GO POSITIVE REGULATION OF IMMUNE SYSTEM PROCESS,7.8282e-05,0.24394,0.20963,1,1
1,GO AMEBOIDAL TYPE CELL MIGRATION,0.0001165,0.24384,0.24281,1,1
1,GO POSITIVE REGULATION OF GLYCOPROTEIN BIOSYNTHETIC PROCESS,0.00353,0.24367,0.18904,1,1
1,GO MAMMARY GLAND ALVEOLUS DEVELOPMENT,0.0019282,0.24281,0.24966,1,1
1,GO NEGATIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,0.0066042,0.24271,0.25654,1,1
1,GO RESPONSE TO GAMMA RADIATION,3.7145e-05,0.24248,0.24556,1,1
1,GO POSITIVE REGULATION OF PROTEIN DEACETYLATION,0.018836,0.24242,0.1651,1,1
1,GO REGULATION OF LYMPHOCYTE DIFFERENTIATION,0.00052342,0.24174,0.19997,1,1
1,GO HOMOTYPIC CELL CELL ADHESION,0.00038934,0.2417,0.27589,1,1
1,GO RESPONSE TO TESTOSTERONE,8.4205e-05,0.24163,0.26615,1,1
1,GO L GLUTAMATE IMPORT,0.037747,0.24156,0.17912,1,1
1,GO GLUCOSE 6 PHOSPHATE METABOLIC PROCESS,0.00044439,0.24124,0.23592,1,1
1,GO TONGUE MORPHOGENESIS,0.029068,0.24098,0.27712,1,1
1,GO CELL KILLING,0.010773,0.24092,0.14573,1,1
1,GO POSITIVE REGULATION OF PROTEIN KINASE B SIGNALING,0.0013457,0.2409,0.18284,1,1
1,GO REGULATION OF SMOOTHENED SIGNALING PATHWAY,0.0097392,0.24068,0.17891,1,1
1,GO CELLULAR ALDEHYDE METABOLIC PROCESS,0.00020448,0.24023,0.20478,1,1
1,GO NEGATIVE REGULATION OF CELL SUBSTRATE ADHESION,0.0010206,0.24011,0.3314,1,1
1,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE BY P53 CLASS MEDIATOR,0.001872,0.23979,0.25432,1,1
1,GO RETROGRADE VESICLE MEDIATED TRANSPORT GOLGI TO ENDOPLASMIC RETICULUM,1.7806e-05,0.23978,0.22171,1,1
1,GO RESPONSE TO CORTICOSTEROID,0.0010528,0.23978,0.21771,1,1
1,GO TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,0.00019079,0.23965,0.22347,1,1
1,GO AMINOGLYCAN BIOSYNTHETIC PROCESS,0.0039469,0.23946,0.22762,1,1
1,GO ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,2.7343e-05,0.23942,0.20357,1,1
1,GO HISTONE H2B UBIQUITINATION,0.00063551,0.23918,0.21001,1,1
1,GO MITRAL VALVE DEVELOPMENT,0.047551,0.23888,0.28063,1,1
1,GO RHO PROTEIN SIGNAL TRANSDUCTION,0.00027832,0.23884,0.22603,1,1
1,GO PROTEIN LOCALIZATION TO VACUOLE,0.001986,0.23846,0.17115,1,1
1,GO POSITIVE REGULATION OF COAGULATION,0.007729,0.23845,0.25508,1,1
1,GO NEPHRON TUBULE FORMATION,0.026586,0.23827,0.24413,1,1
1,GO POSITIVE REGULATION OF AUTOPHAGY,1.104e-05,0.2382,0.23967,1,1
1,GO RNA 3 END PROCESSING,3.3132e-05,0.23766,0.2125,1,1
1,GO NUCLEAR EXPORT,4.4712e-06,0.23723,0.21894,1,1
1,GO NEURAL TUBE PATTERNING,0.010773,0.23708,0.19163,1,1
1,GO REGULATION OF T CELL ACTIVATION,0.00074557,0.23676,0.18703,1,1
1,GO NEGATIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.0007696,0.23619,0.32206,1,1
1,GO PROTEIN PROCESSING,0.0010206,0.23607,0.19102,1,1
1,GO TISSUE MIGRATION,9.0551e-05,0.23604,0.28409,1,1
1,GO PYRIMIDINE RIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.0057817,0.23515,0.2074,1,1
1,GO POSITIVE REGULATION OF STRESS FIBER ASSEMBLY,0.0016129,0.23508,0.31439,1,1
1,GO NEGATIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY,5.8301e-05,0.23496,0.22249,1,1
1,GO NEGATIVE REGULATION OF ORGAN GROWTH,0.0083534,0.23477,0.15871,1,1
1,GO ACTIN CYTOSKELETON REORGANIZATION,0.0020453,0.23433,0.21793,1,1
1,GO POSITIVE REGULATION OF NITRIC OXIDE SYNTHASE BIOSYNTHETIC PROCESS,0.0060989,0.23395,0.28223,1,1
1,GO POSITIVE REGULATION OF ACTIVATED T CELL PROLIFERATION,0.0045306,0.23387,0.23548,1,1
1,GO POSITIVE REGULATION OF HAIR CYCLE,0.012203,0.23377,0.32412,1,1
1,GO MESODERM DEVELOPMENT,6.0504e-05,0.23369,0.20219,1,1
1,GO LIPID STORAGE,0.00036427,0.23358,0.24103,1,1
1,GO REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,0.031059,0.23255,0.18275,1,1
1,GO T CELL PROLIFERATION,0.0015189,0.23232,0.20009,1,1
1,GO RRNA METHYLATION,0.009256,0.23227,0.15734,1,1
1,GO CELL DEATH IN RESPONSE TO HYDROGEN PEROXIDE,0.0013872,0.23208,0.25568,1,1
1,GO SYNAPTONEMAL COMPLEX ORGANIZATION,0.0041716,0.23201,0.25414,1,1
1,GO ORGANIC CYCLIC COMPOUND CATABOLIC PROCESS,2.6902e-06,0.232,0.20803,1,1
1,GO POSITIVE REGULATION OF UBIQUITIN PROTEIN LIGASE ACTIVITY,0.00057693,0.23168,0.29585,1,1
1,GO NEGATIVE REGULATION OF CELL MATRIX ADHESION,0.00012964,0.23146,0.34363,1,1
1,GO AXIS ELONGATION,0.009256,0.23132,0.25337,1,1
1,GO FC EPSILON RECEPTOR SIGNALING PATHWAY,5.0226e-05,0.2312,0.23804,1,1
1,GO FC RECEPTOR SIGNALING PATHWAY,8.4205e-05,0.23097,0.20017,1,1
1,GO ACTIVATION OF INNATE IMMUNE RESPONSE,2.8418e-05,0.23091,0.23452,1,1
1,GO RNA MODIFICATION,8.4205e-05,0.23061,0.19649,1,1
1,GO REGULATION OF KERATINOCYTE MIGRATION,0.013798,0.23029,0.19251,1,1
1,GO GLOMERULAR EPITHELIUM DEVELOPMENT,0.0010528,0.23028,0.36092,1,1
1,GO NEGATIVE REGULATION OF IMMUNE SYSTEM PROCESS,0.00021909,0.23025,0.22024,1,1
1,GO NEGATIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.0050528,0.23023,0.15979,1,1
1,GO REGULATION OF MRNA 3 END PROCESSING,1.4039e-05,0.23022,0.23193,1,1
1,GO POSITIVE REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS,0.046579,0.23012,0.2835,1,1
1,GO REGULATION OF EPITHELIAL CELL MIGRATION,6.7596e-05,0.2298,0.28467,1,1
1,GO HYPEROSMOTIC RESPONSE,0.004408,0.22955,0.23424,1,1
1,GO POSITIVE REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,0.029068,0.22915,0.1394,1,1
1,GO DE NOVO PROTEIN FOLDING,0.0039469,0.22912,0.17492,1,1
1,GO RESPONSE TO OXIDATIVE STRESS,2.4346e-05,0.22888,0.21948,1,1
1,GO BODY FLUID SECRETION,0.00022676,0.22887,0.21845,1,1
1,GO ENDODERMAL CELL FATE COMMITMENT,0.00031859,0.22824,0.25793,1,1
1,GO CELLULAR IRON ION HOMEOSTASIS,5.0226e-05,0.22821,0.20483,1,1
1,GO NEGATIVE REGULATION OF CELL CYCLE PHASE TRANSITION,1.1964e-05,0.22814,0.2121,1,1
1,GO OSTEOCLAST DIFFERENTIATION,7.013e-05,0.2281,0.20187,1,1
1,GO REGULATION OF PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.00034072,0.22807,0.19955,1,1
1,GO EMBRYONIC CRANIAL SKELETON MORPHOGENESIS,0.00044439,0.22799,0.27463,1,1
1,GO PEPTIDE METABOLIC PROCESS,1.2454e-05,0.22794,0.19902,1,1
1,GO POST GOLGI VESICLE MEDIATED TRANSPORT,1.1493e-05,0.22789,0.23691,1,1
1,GO CARTILAGE DEVELOPMENT INVOLVED IN ENDOCHONDRAL BONE MORPHOGENESIS,0.0050528,0.22766,0.23052,1,1
1,GO POSITIVE REGULATION OF ANIMAL ORGAN MORPHOGENESIS,0.0075304,0.22756,0.23025,1,1
1,GO POSITIVE REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,0.0020453,0.22748,0.21291,1,1
1,GO POSITIVE REGULATION OF PHOSPHOLIPID BIOSYNTHETIC PROCESS,0.0040578,0.22743,0.19344,1,1
1,GO ER ASSOCIATED MISFOLDED PROTEIN CATABOLIC PROCESS,7.2754e-05,0.22728,0.26424,1,1
1,GO POSITIVE REGULATION OF ERK1 AND ERK2 CASCADE,1.0604e-05,0.227,0.24473,1,1
1,GO RNA POLYADENYLATION,0.00022676,0.22693,0.18156,1,1
1,GO TRNA MODIFICATION,0.00072223,0.22664,0.1792,1,1
1,GO BINDING OF SPERM TO ZONA PELLUCIDA,0.00019079,0.22657,0.21338,1,1
1,GO REGULATION OF RECEPTOR LOCALIZATION TO SYNAPSE,0.013465,0.22654,0.1852,1,1
1,GO POSITIVE REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,0.0020453,0.22647,0.21528,1,1
1,GO LEUKOCYTE ACTIVATION INVOLVED IN INFLAMMATORY RESPONSE,0.041093,0.22626,0.20424,1,1
1,GO RUFFLE ORGANIZATION,0.00028792,0.22615,0.18025,1,1
1,GO NEGATIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,0.00021167,0.22599,0.2365,1,1
1,GO NEGATIVE REGULATION OF RESPONSE TO OXIDATIVE STRESS,0.00065623,0.22575,0.20545,1,1
1,GO REGULATION OF MACROPHAGE MIGRATION,2.9532e-05,0.2257,0.27981,1,1
1,GO RESPONSE TO MISFOLDED PROTEIN,0.0021689,0.22541,0.20526,1,1
1,GO FUSION OF SPERM TO EGG PLASMA MEMBRANE INVOLVED IN SINGLE FERTILIZATION,0.036948,0.2252,0.18425,1,1
1,GO REGULATION OF LEUKOCYTE DIFFERENTIATION,0.00044439,0.22509,0.18472,1,1
1,GO STRIATED MUSCLE CELL PROLIFERATION,0.00019753,0.22464,0.27276,1,1
1,GO CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,0.00072223,0.22453,0.30708,1,1
1,GO T HELPER 2 CELL CYTOKINE PRODUCTION,0.014841,0.22432,0.23505,1,1
1,GO CERAMIDE TRANSPORT,0.038561,0.2242,0.21445,1,1
1,GO REGULATION OF CENTRIOLE REPLICATION,0.0046564,0.22419,0.16833,1,1
1,GO MULTIVESICULAR BODY ORGANIZATION,0.00067758,0.22413,0.1829,1,1
1,GO MODULATION BY VIRUS OF HOST CELLULAR PROCESS,0.001986,0.22398,0.21376,1,1
1,GO VESICLE TARGETING TO FROM OR WITHIN GOLGI,0.00010462,0.22367,0.24166,1,1
1,GO REGULATION OF MULTI ORGANISM PROCESS,0.0079323,0.22328,0.19698,1,1
1,GO LEUKOCYTE PROLIFERATION,0.0032441,0.22312,0.169,1,1
1,GO NEGATIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,0.00022676,0.22286,0.23472,1,1
1,GO BONE MORPHOGENESIS,0.0036303,0.22204,0.21887,1,1
1,GO CHYLOMICRON ASSEMBLY,0.0073363,0.22201,0.20547,1,1
1,GO PROTEIN KINASE B SIGNALING,0.00050664,0.22199,0.18497,1,1
1,GO POSITIVE REGULATION OF LYMPHOCYTE MIGRATION,0.0066042,0.2217,0.18764,1,1
1,GO SULFUR AMINO ACID METABOLIC PROCESS,0.0025083,0.22159,0.16038,1,1
1,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE,0.0057817,0.22126,0.16742,1,1
1,GO METANEPHRIC MESENCHYME DEVELOPMENT,0.010245,0.22105,0.26983,1,1
1,GO MACROPHAGE CHEMOTAXIS,6.2786e-05,0.22063,0.33288,1,1
1,GO POSITIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY,0.00013917,0.22058,0.22416,1,1
1,GO MYELOID CELL HOMEOSTASIS,5.4121e-05,0.22051,0.20809,1,1
1,GO POSITIVE REGULATION OF ACTIN FILAMENT POLYMERIZATION,0.00042998,0.21998,0.18048,1,1
1,GO OVULATION,0.036164,0.21987,0.22594,1,1
1,GO POSITIVE REGULATION OF T CELL MIGRATION,0.0013457,0.21975,0.24573,1,1
1,GO POSITIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,0.0099891,0.21963,0.19169,1,1
1,GO CELLULAR RESPONSE TO FLUID SHEAR STRESS,0.0050528,0.21909,0.19526,1,1
1,GO POLYAMINE METABOLIC PROCESS,0.0031536,0.21901,0.22766,1,1
1,GO INNATE IMMUNE RESPONSE ACTIVATING SIGNAL TRANSDUCTION,5.4121e-05,0.21894,0.21876,1,1
1,GO NEGATIVE REGULATION OF WNT SIGNALING PATHWAY,0.0013872,0.21889,0.16791,1,1
1,GO PROTEIN LOCALIZATION TO LYSOSOME,0.02068,0.21887,0.13165,1,1
1,GO POSITIVE REGULATION OF PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.00036427,0.2188,0.23295,1,1
1,GO REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.0097392,0.21856,0.21621,1,1
1,GO POSTTRANSCRIPTIONAL REGULATION OF GENE EXPRESSION,1.3441e-06,0.21853,0.20715,1,1
1,GO MODULATION BY SYMBIONT OF HOST CELLULAR PROCESS,0.00049035,0.21841,0.21952,1,1
1,GO TRANSITION METAL ION HOMEOSTASIS,7.013e-05,0.21821,0.21463,1,1
1,GO REGULATION OF IMMUNE SYSTEM PROCESS,0.00017796,0.21813,0.18378,1,1
1,GO N ACETYLGLUCOSAMINE METABOLIC PROCESS,0.025414,0.2176,0.16326,1,1
1,GO TRNA METABOLIC PROCESS,0.00074557,0.21758,0.17607,1,1
1,GO ERBB SIGNALING PATHWAY,0.00026003,0.21744,0.23781,1,1
1,GO PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,0.015574,0.21699,0.24982,1,1
1,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS EXONUCLEOLYTIC 3 5,0.0094949,0.2168,0.19654,1,1
1,GO INTERFERON GAMMA PRODUCTION,0.00019753,0.21654,0.24949,1,1
1,GO REGULATION OF LIPID LOCALIZATION,0.00044439,0.21649,0.17027,1,1
1,GO REGULATION OF URINE VOLUME,0.00098941,0.21647,0.22207,1,1
1,GO REGULATION OF TRANSLATION IN RESPONSE TO STRESS,0.001662,0.2164,0.19404,1,1
1,GO PLASMA MEMBRANE FUSION,0.036164,0.21637,0.18681,1,1
1,GO RESPONSE TO RETINOIC ACID,0.0007696,0.21608,0.21074,1,1
1,GO NEGATIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE,0.0011199,0.21592,0.21247,1,1
1,GO POSITIVE REGULATION OF TRANSLATIONAL INITIATION,9.7346e-05,0.2159,0.26585,1,1
1,GO REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,0.0018173,0.21588,0.2003,1,1
1,GO CELLULAR RESPONSE TO TOPOLOGICALLY INCORRECT PROTEIN,0.00057693,0.21583,0.19268,1,1
1,GO MITOCHONDRIAL CALCIUM ION HOMEOSTASIS,0.0069616,0.21544,0.17107,1,1
1,GO CYTOPLASMIC SEQUESTERING OF PROTEIN,0.00050664,0.21527,0.20883,1,1
1,GO POSITIVE REGULATION OF PROTEOLYSIS,4.0073e-05,0.21526,0.17854,1,1
1,GO INNER MITOCHONDRIAL MEMBRANE ORGANIZATION,0.015574,0.21516,0.15113,1,1
1,GO VESICLE TARGETING,7.2754e-05,0.21491,0.22302,1,1
1,GO BRANCHING MORPHOGENESIS OF AN EPITHELIAL TUBE,0.0006154,0.21472,0.20847,1,1
1,GO REGULATION OF OXIDATIVE STRESS INDUCED CELL DEATH,0.00030804,0.21456,0.19004,1,1
1,GO REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,0.0033369,0.21425,0.24762,1,1
1,GO RESPONSE TO REACTIVE OXYGEN SPECIES,0.00032948,0.21412,0.1947,1,1
1,GO NEGATIVE REGULATION OF MITOTIC CELL CYCLE,1.7118e-05,0.21408,0.19582,1,1
1,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR,0.00072223,0.21373,0.22192,1,1
1,GO RNA PROCESSING,8.7323e-05,0.21369,0.16966,1,1
1,GO CELLULAR RESPONSE TO NITROGEN STARVATION,0.050569,0.21355,0.23998,1,1
1,GO MRNA TRANSPORT,7.8282e-05,0.21354,0.1901,1,1
1,GO ORGANELLE INHERITANCE,0.00084609,0.21327,0.18272,1,1
1,GO NEGATIVE REGULATION OF LEUKOCYTE DIFFERENTIATION,0.0022332,0.21308,0.17067,1,1
1,GO TERMINATION OF RNA POLYMERASE I TRANSCRIPTION,0.00026003,0.21296,0.22886,1,1
1,GO PROTEIN K63 LINKED UBIQUITINATION,0.00020448,0.21268,0.16655,1,1
1,GO POSITIVE REGULATION OF SEQUESTERING OF CALCIUM ION,0.00353,0.21267,0.22414,1,1
1,GO REGULATION OF PHOSPHOLIPASE C ACTIVITY,0.0042883,0.21238,0.17149,1,1
1,GO NEGATIVE REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.011904,0.21229,0.21386,1,1
1,GO REGULATION OF PROTEIN CATABOLIC PROCESS IN THE VACUOLE,0.024846,0.2118,0.17286,1,1
1,GO CHAPERONE COFACTOR DEPENDENT PROTEIN REFOLDING,0.042857,0.2118,0.11976,1,1
1,GO NEGATIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.0026572,0.21173,0.29046,1,1
1,GO POSITIVE REGULATION OF RECEPTOR RECYCLING,0.0062634,0.21153,0.27922,1,1
1,GO REGULATION OF LYMPHOCYTE MIGRATION,0.0022992,0.2115,0.21223,1,1
1,GO PROTEIN MODIFICATION BY SMALL PROTEIN REMOVAL,5.508e-06,0.21117,0.19448,1,1
1,GO ESTABLISHMENT OF MITOTIC SPINDLE LOCALIZATION,0.0011199,0.21109,0.16033,1,1
1,GO PROTEIN LOCALIZATION TO CELL SURFACE,0.0013457,0.21098,0.14793,1,1
1,GO POSITIVE REGULATION OF EPITHELIAL CELL PROLIFERATION,0.0013457,0.21078,0.20982,1,1
1,GO NEGATIVE REGULATION OF LEUKOCYTE MIGRATION,0.0032441,0.21033,0.20221,1,1
1,GO GLOBAL GENOME NUCLEOTIDE EXCISION REPAIR,2.9301e-06,0.2098,0.22786,1,1
1,GO RIBONUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS,0.00020448,0.20918,0.22549,1,1
1,GO RNA METHYLATION,0.00027832,0.20916,0.19183,1,1
1,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,0.0030654,0.2091,0.17716,1,1
1,GO NUCLEOBASE CONTAINING SMALL MOLECULE INTERCONVERSION,0.0017641,0.20902,0.20132,1,1
1,GO POSITIVE REGULATION OF STEM CELL DIFFERENTIATION,0.052669,0.20883,0.19179,1,1
1,GO SULFUR COMPOUND BIOSYNTHETIC PROCESS,0.0020453,0.20854,0.176,1,1
1,GO REGULATION OF CARDIOCYTE DIFFERENTIATION,0.013465,0.20852,0.16174,1,1
1,GO ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.00081984,0.20827,0.19659,1,1
1,GO REGULATION OF HEART MORPHOGENESIS,0.030383,0.20823,0.24294,1,1
1,GO PYRIMIDINE CONTAINING COMPOUND METABOLIC PROCESS,5.508e-06,0.20805,0.2105,1,1
1,GO NEGATIVE REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY,0.0022332,0.20801,0.19775,1,1
1,GO POSITIVE REGULATION OF LIPASE ACTIVITY,0.00054072,0.20748,0.18107,1,1
1,GO CELLULAR RESPONSE TO OXYGEN LEVELS,0.00012074,0.20696,0.19564,1,1
1,GO POSITIVE REGULATION OF WNT SIGNALING PATHWAY,0.00029782,0.20683,0.1866,1,1
1,GO ENDOSOME ORGANIZATION,0.00038934,0.20655,0.17273,1,1
1,GO RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.00044439,0.20654,0.17895,1,1
1,GO POSITIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,0.0025083,0.20639,0.20065,1,1
1,GO MYELOID CELL DIFFERENTIATION,4.3218e-05,0.20609,0.17783,1,1
1,GO TOOTH MINERALIZATION,0.03245,0.2058,0.21843,1,1
1,GO REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS,0.0036303,0.2057,0.18639,1,1
1,GO CHROMATIN MEDIATED MAINTENANCE OF TRANSCRIPTION,0.0019282,0.20557,0.21352,1,1
1,GO PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,0.047551,0.20552,0.17715,1,1
1,GO MESENCHYMAL TO EPITHELIAL TRANSITION,0.012203,0.20495,0.22614,1,1
1,GO RNA LOCALIZATION,8.4205e-05,0.20488,0.20366,1,1
1,GO POSITIVE REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.00021909,0.2047,0.18128,1,1
1,GO POSITIVE REGULATION OF PROTEIN BINDING,0.00034072,0.20427,0.17861,1,1
1,GO REGULATION OF ERYTHROCYTE DIFFERENTIATION,0.0010206,0.20418,0.21379,1,1
1,GO REGULATION OF DOUBLE STRAND BREAK REPAIR,3.5759e-05,0.20392,0.19086,1,1
1,GO TRNA TRANSPORT,0.0041716,0.20381,0.18781,1,1
1,GO VESICLE BUDDING FROM MEMBRANE,0.0001165,0.20346,0.22031,1,1
1,GO MODULATION BY SYMBIONT OF HOST PROCESS,0.0007696,0.20337,0.18647,1,1
1,GO PROTEIN MATURATION,0.00054072,0.20272,0.14604,1,1
1,GO STRESS FIBER ASSEMBLY,0.0019282,0.20259,0.2182,1,1
1,GO CELLULAR RESPONSE TO ATP,0.0010859,0.20257,0.19442,1,1
1,GO SPLICEOSOMAL SNRNP ASSEMBLY,0.0094949,0.20255,0.14998,1,1
1,GO ESTABLISHMENT OF RNA LOCALIZATION,6.0504e-05,0.20228,0.20034,1,1
1,GO CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,0.00090094,0.20208,0.19098,1,1
1,GO REGULATION OF OSTEOBLAST DIFFERENTIATION,0.0037331,0.20191,0.21281,1,1
1,GO NEGATIVE REGULATION OF HEMOPOIESIS,0.0025083,0.20189,0.15971,1,1
1,GO TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY,0.0016129,0.20144,0.22573,1,1
1,GO REGULATION OF LIPID STORAGE,0.00098941,0.20122,0.23762,1,1
1,GO MITOTIC RECOMBINATION,0.0029794,0.20102,0.20263,1,1
1,GO REGULATION OF RECEPTOR RECYCLING,0.001986,0.2006,0.21529,1,1
1,GO IMMUNE RESPONSE REGULATING SIGNALING PATHWAY,0.00010462,0.2004,0.17371,1,1
1,GO POSITIVE REGULATION OF TISSUE REMODELING,0.0026572,0.20026,0.23064,1,1
1,GO NEGATIVE REGULATION OF STRIATED MUSCLE CELL APOPTOTIC PROCESS,0.013139,0.20023,0.1707,1,1
1,GO TONGUE DEVELOPMENT,0.009256,0.2,0.24937,1,1
1,GO INTRACELLULAR RECEPTOR SIGNALING PATHWAY,0.0010206,0.19982,0.14742,1,1
1,GO PEPTIDYL TYROSINE MODIFICATION,3.3132e-05,0.19935,0.22181,1,1
1,GO MITOTIC CYTOKINESIS,0.0011549,0.19935,0.20166,1,1
1,GO PROTEIN ADP RIBOSYLATION,0.0060989,0.19932,0.17847,1,1
1,GO REGULATION OF MACROPHAGE CHEMOTAXIS,0.0007696,0.19931,0.23034,1,1
1,GO POSITIVE REGULATION OF TELOMERE MAINTENANCE,0.0011199,0.19888,0.14247,1,1
1,GO CELLULAR MACROMOLECULE CATABOLIC PROCESS,1.0311e-06,0.19884,0.16361,1,1
1,GO ESTABLISHMENT OF SPINDLE ORIENTATION,0.00032948,0.19807,0.16933,1,1
1,GO CELLULAR TRANSITION METAL ION HOMEOSTASIS,0.0011549,0.19791,0.17478,1,1
1,GO NEGATIVE REGULATION OF ENDOCYTOSIS,0.0099891,0.19748,0.16287,1,1
1,GO RESPONSE TO STEROID HORMONE,0.00353,0.19721,0.15238,1,1
1,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR SECRETION,0.0071468,0.19713,0.26421,1,1
1,GO RIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,4.8379e-05,0.19683,0.19881,1,1
1,GO TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,1.8251e-06,0.19672,0.19143,1,1
1,GO RNA PHOSPHODIESTER BOND HYDROLYSIS ENDONUCLEOLYTIC,0.0010206,0.19671,0.17792,1,1
1,GO LACTATION,0.0037331,0.1965,0.18953,1,1
1,GO CELL AGING,5.9841e-06,0.19624,0.21193,1,1
1,GO RESPONSE TO OXYGEN LEVELS,0.0023671,0.19603,0.17005,1,1
1,GO HISTONE MRNA METABOLIC PROCESS,0.0042883,0.19596,0.14517,1,1
1,GO POSITIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT,0.0066042,0.19587,0.17961,1,1
1,GO POSITIVE REGULATION OF CELLULAR COMPONENT MOVEMENT,0.0017641,0.19564,0.192,1,1
1,GO NEGATIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.031748,0.19555,0.15768,1,1
1,GO REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,0.00025131,0.19549,0.19861,1,1
1,GO AMIDE BIOSYNTHETIC PROCESS,9.389e-05,0.19521,0.16845,1,1
1,GO TUBE MORPHOGENESIS,0.00044439,0.19429,0.20007,1,1
1,GO RESPIRATORY ELECTRON TRANSPORT CHAIN,0.018398,0.19429,0.14614,1,1
1,GO NEGATIVE REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,0.02268,0.19387,0.14544,1,1
1,GO NEGATIVE REGULATION OF CELL CYCLE PROCESS,1.9263e-05,0.19381,0.17199,1,1
1,GO REGULATION OF RUFFLE ASSEMBLY,0.017969,0.1933,0.12135,1,1
1,GO RNA INTERFERENCE,0.034637,0.19302,0.15537,1,1
1,GO REGULATION OF CHEMOKINE MEDIATED SIGNALING PATHWAY,0.04854,0.19202,0.27113,1,1
1,GO TRANSCRIPTION BY RNA POLYMERASE I,0.0060989,0.19191,0.16988,1,1
1,GO REGULATION OF EXECUTION PHASE OF APOPTOSIS,3.1888e-05,0.19162,0.19082,1,1
1,GO IMMUNE SYSTEM DEVELOPMENT,0.00011241,0.19137,0.15548,1,1
1,GO REGULATION OF MYELOID CELL DIFFERENTIATION,6.0504e-05,0.19026,0.18671,1,1
1,GO DNA TEMPLATED TRANSCRIPTION INITIATION,1.9904e-06,0.18985,0.18348,1,1
1,GO PROTEIN DENEDDYLATION,0.015203,0.18983,0.15017,1,1
1,GO NUCLEAR TRANSPORT,2.2524e-05,0.18981,0.162,1,1
1,GO CIRCULATORY SYSTEM DEVELOPMENT,0.00028792,0.18977,0.19585,1,1
1,GO REGULATION OF HETEROTYPIC CELL CELL ADHESION,0.027188,0.18975,0.18581,1,1
1,GO KERATINOCYTE PROLIFERATION,0.0062634,0.18975,0.33395,1,1
1,GO ORGANIC ACID CATABOLIC PROCESS,0.0099891,0.18956,0.14537,1,1
1,GO SULFUR COMPOUND METABOLIC PROCESS,0.00030804,0.18952,0.16505,1,1
1,GO REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,0.00041602,0.1892,0.24035,1,1
1,GO VACUOLAR ACIDIFICATION,0.0050528,0.18904,0.16947,1,1
1,GO NEGATIVE REGULATION OF INTERLEUKIN 12 PRODUCTION,0.03245,0.18866,0.18126,1,1
1,GO EPITHELIAL TO MESENCHYMAL TRANSITION,0.011326,0.18863,0.17496,1,1
1,GO NUCLEOTIDE EXCISION REPAIR PREINCISION COMPLEX ASSEMBLY,6.7596e-05,0.1883,0.20653,1,1
1,GO CONNECTIVE TISSUE DEVELOPMENT,0.0038387,0.18797,0.1835,1,1
1,GO KIDNEY MESENCHYME DEVELOPMENT,0.029719,0.18741,0.17628,1,1
1,GO REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,0.00019753,0.1872,0.19555,1,1
1,GO MACROMOLECULE CATABOLIC PROCESS,1.1776e-06,0.18718,0.17151,1,1
1,GO REGULATION OF DNA RECOMBINATION,0.00027832,0.18711,0.19847,1,1
1,GO SECONDARY METABOLITE BIOSYNTHETIC PROCESS,0.0083534,0.18702,0.15516,1,1
1,GO REGULATION OF TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,0.00025131,0.18699,0.19125,1,1
1,GO REGULATION OF T CELL CHEMOTAXIS,0.0090226,0.18693,0.20305,1,1
1,GO REGULATION OF T CELL DIFFERENTIATION,0.0036303,0.18681,0.16308,1,1
1,GO CELLULAR RESPONSE TO HEAT,0.00079435,0.18661,0.17683,1,1
1,GO REGULATION OF PROTEIN KINASE A SIGNALING,0.011326,0.1863,0.15933,1,1
1,GO PLACENTA BLOOD VESSEL DEVELOPMENT,0.0071468,0.18616,0.17515,1,1
1,GO NUCLEOTIDE EXCISION REPAIR DNA DUPLEX UNWINDING,6.7728e-06,0.18588,0.22228,1,1
1,GO CHAPERONE MEDIATED PROTEIN COMPLEX ASSEMBLY,0.03939,0.18583,0.15983,1,1
1,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION,0.00021167,0.18551,0.1963,1,1
1,GO CENTRIOLE ASSEMBLY,0.0031536,0.1853,0.13807,1,1
1,GO REGULATION OF OSTEOCLAST DEVELOPMENT,0.00353,0.18519,0.2361,1,1
1,GO PROTEASOMAL PROTEIN CATABOLIC PROCESS,1.5201e-05,0.18498,0.14743,1,1
1,GO PROTEIN HOMOTETRAMERIZATION,0.00027832,0.18497,0.16631,1,1
1,GO CELLULAR AMIDE METABOLIC PROCESS,5.0226e-05,0.18486,0.16166,1,1
1,GO REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,0.00063551,0.18428,0.17359,1,1
1,GO ESCRT COMPLEX DISASSEMBLY,0.044685,0.18403,0.15263,1,1
1,GO MICROTUBULE CYTOSKELETON ORGANIZATION INVOLVED IN MITOSIS,0.0046564,0.18378,0.14717,1,1
1,GO POSITIVE REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,0.00065623,0.18319,0.15843,1,1
1,GO MESENCHYME DEVELOPMENT,0.0022332,0.183,0.18645,1,1
1,GO REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,7.3528e-06,0.18256,0.169,1,1
1,GO MITOTIC NUCLEAR ENVELOPE DISASSEMBLY,0.025414,0.1824,0.21707,1,1
1,GO PROTEIN NEDDYLATION,0.0013457,0.18232,0.18801,1,1
1,GO GOLGI VESICLE BUDDING,0.00049035,0.18208,0.18191,1,1
1,GO LEUKOCYTE DIFFERENTIATION,0.00040247,0.18194,0.16505,1,1
1,GO NEGATIVE REGULATION OF NUCLEAR DIVISION,0.00098941,0.18194,0.16927,1,1
1,GO EMBRYONIC HEART TUBE DEVELOPMENT,1.4609e-05,0.18187,0.22785,1,1
1,GO POSITIVE REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,0.0038387,0.18145,0.17872,1,1
1,GO TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.00044439,0.18081,0.14485,1,1
1,GO CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS,0.0057817,0.18074,0.21567,1,1
1,GO NEGATIVE REGULATION OF CELL DEATH,0.00010845,0.18067,0.15969,1,1
1,GO NEGATIVE REGULATION OF CELL ADHESION,0.013465,0.18052,0.17049,1,1
1,GO APOPTOTIC SIGNALING PATHWAY,0.0016129,0.18031,0.15188,1,1
1,GO ENDOTHELIAL CELL PROLIFERATION,0.0069616,0.18028,0.1636,1,1
1,GO POSITIVE REGULATION OF TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,0.0026572,0.18006,0.16975,1,1
1,GO MORPHOGENESIS OF A POLARIZED EPITHELIUM,3.7145e-05,0.18001,0.20687,1,1
1,GO RNA CAPPING,4.0073e-05,0.17984,0.17955,1,1
1,GO REGULATION OF RESPONSE TO OXIDATIVE STRESS,0.0030654,0.17981,0.15006,1,1
1,GO PROTEIN LOCALIZATION TO NUCLEUS,0.00024286,0.17966,0.15591,1,1
1,GO PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,8.7323e-05,0.1795,0.21587,1,1
1,GO REGULATION OF EMBRYONIC DEVELOPMENT,0.0014738,0.17879,0.1828,1,1
1,GO POSITIVE REGULATION OF CELL AGING,0.038561,0.1785,0.21619,1,1
1,GO REGULATION OF ACTIN FILAMENT ORGANIZATION,0.0013457,0.17841,0.15427,1,1
1,GO FACE DEVELOPMENT,0.0013054,0.17832,0.23535,1,1
1,GO CELLULAR RESPONSE TO LIPID,0.00069957,0.17739,0.17653,1,1
1,GO REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,0.00054072,0.17688,0.13697,1,1
1,GO PROTEIN TARGETING TO MEMBRANE,0.022165,0.17619,0.14915,1,1
1,GO AUTOPHAGOSOME ORGANIZATION,0.00029782,0.17532,0.19285,1,1
1,GO REGULATION OF CELL CYCLE PHASE TRANSITION,0.00018427,0.17497,0.14421,1,1
1,GO HISTONE DEACETYLATION,0.00084609,0.17461,0.12594,1,1
1,GO EMBRYONIC HEART TUBE MORPHOGENESIS,2.9532e-05,0.17459,0.21057,1,1
1,GO RNA PHOSPHODIESTER BOND HYDROLYSIS,0.00042998,0.17438,0.1474,1,1
1,GO REGULATION OF MUSCLE ORGAN DEVELOPMENT,0.0010206,0.17413,0.16944,1,1
1,GO GOLGI VESICLE TRANSPORT,6.0504e-05,0.17379,0.15938,1,1
1,GO PROTEIN TARGETING,0.00072223,0.17315,0.15369,1,1
1,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE,0.00035231,0.17309,0.17913,1,1
1,GO CELLULAR EXTRAVASATION,0.0036303,0.17306,0.18129,1,1
1,GO ATP BIOSYNTHETIC PROCESS,0.012203,0.17266,0.17367,1,1
1,GO MODULATION BY VIRUS OF HOST PROCESS,0.0012662,0.17242,0.17485,1,1
1,GO CYTOPLASMIC SEQUESTERING OF TRANSCRIPTION FACTOR,0.050569,0.17239,0.12843,1,1
1,GO TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,6.2786e-05,0.17205,0.16352,1,1
1,GO REGULATION OF MEGAKARYOCYTE DIFFERENTIATION,0.00020448,0.17203,0.17085,1,1
1,GO NUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS,0.0013457,0.172,0.1457,1,1
1,GO PROTEIN IMPORT,4.6597e-05,0.1717,0.1673,1,1
1,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,0.0050528,0.17154,0.13589,1,1
1,GO STEROL IMPORT,0.0017123,0.17151,0.39713,1,1
1,GO NEURAL TUBE DEVELOPMENT,0.013139,0.17146,0.16419,1,1
1,GO POSITIVE REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,0.001662,0.17106,0.20749,1,1
1,GO ORGANONITROGEN COMPOUND CATABOLIC PROCESS,2.6307e-05,0.17089,0.14946,1,1
1,GO RESPONSE TO KETONE,0.023205,0.17048,0.1118,1,1
1,GO REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.0056288,0.16934,0.1658,1,1
1,GO CELLULAR RESPONSE TO ACID CHEMICAL,0.034637,0.16923,0.1531,1,1
1,GO CYTOSKELETON DEPENDENT CYTOKINESIS,0.0031536,0.16916,0.14135,1,1
1,GO RRNA 3 END PROCESSING,0.0025817,0.16903,0.17091,1,1
1,GO HOMEOSTASIS OF NUMBER OF CELLS WITHIN A TISSUE,0.0011549,0.16866,0.23149,1,1
1,GO EMBRYONIC EYE MORPHOGENESIS,0.050569,0.16865,0.18787,1,1
1,GO MRNA METABOLIC PROCESS,3.0689e-05,0.16862,0.16171,1,1
1,GO INTERMEMBRANE LIPID TRANSFER,0.0028957,0.16847,0.15618,1,1
1,GO NEGATIVE REGULATION OF BLOOD CIRCULATION,0.029068,0.16826,0.2146,1,1
1,GO REGULATION OF NUCLEAR DIVISION,0.001872,0.16809,0.11888,1,1
1,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,0.052669,0.16805,0.13802,1,1
1,GO IMPORT INTO NUCLEUS,0.00021909,0.16798,0.14618,1,1
1,GO RNA POLYMERASE II PREINITIATION COMPLEX ASSEMBLY,0.00025131,0.1677,0.22018,1,1
1,GO REGULATION OF AUTOPHAGY OF MITOCHONDRION,0.00025131,0.16742,0.17059,1,1
1,GO SPINDLE LOCALIZATION,0.00057693,0.16731,0.15215,1,1
1,GO MORPHOGENESIS OF A BRANCHING STRUCTURE,0.0046564,0.16718,0.15797,1,1
1,GO ODONTOGENESIS OF DENTIN CONTAINING TOOTH,0.021165,0.16695,0.1581,1,1
1,GO POSITIVE REGULATION OF LIPID TRANSPORT,0.00029782,0.16683,0.19198,1,1
1,GO REGULATION OF NON MOTILE CILIUM ASSEMBLY,0.0051916,0.16668,0.17152,1,1
1,GO RESPONSE TO UV C,0.0059384,0.16649,0.24093,1,1
1,GO NEUTROPHIL MIGRATION,0.019739,0.16634,0.20815,1,1
1,GO REGULATION OF RESPONSE TO STRESS,0.00021167,0.16626,0.15059,1,1
1,GO POSITIVE REGULATION OF CYTOSKELETON ORGANIZATION,0.0034322,0.1658,0.13977,1,1
1,GO REGULATION OF SPINDLE ORGANIZATION,0.004408,0.1658,0.13995,1,1
1,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR,0.0051916,0.16574,0.13916,1,1
1,GO POSITIVE REGULATION OF INTERFERON GAMMA PRODUCTION,0.0021062,0.16567,0.18735,1,1
1,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,0.017969,0.16565,0.16147,1,1
1,GO COPII COATED VESICLE BUDDING,0.0011199,0.16531,0.18042,1,1
1,GO REGULATION OF ANIMAL ORGAN MORPHOGENESIS,0.00047456,0.16525,0.19027,1,1
1,GO REGULATION OF VACUOLE ORGANIZATION,0.012508,0.16523,0.14233,1,1
1,GO PROTEIN KINASE A SIGNALING,0.00098941,0.16514,0.18856,1,1
1,GO NEGATIVE REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.023205,0.16504,0.14342,1,1
1,GO POSITIVE REGULATION OF CATABOLIC PROCESS,3.5759e-05,0.16465,0.16368,1,1
1,GO REGULATION OF TRANSLATIONAL INITIATION,0.0029794,0.16464,0.13611,1,1
1,GO CANONICAL WNT SIGNALING PATHWAY,0.0045306,0.16417,0.15017,1,1
1,GO CELLULAR COMPONENT DISASSEMBLY,1.6455e-05,0.16397,0.14746,1,1
1,GO LYMPHOCYTE COSTIMULATION,0.0034322,0.16395,0.15024,1,1
1,GO TRANSLESION SYNTHESIS,0.0007696,0.16296,0.16062,1,1
1,GO OSSIFICATION,0.010245,0.16293,0.15834,1,1
1,GO RESPONSE TO HEAT,0.00020448,0.1628,0.18267,1,1
1,GO REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.030383,0.16267,0.11329,1,1
1,GO POSITIVE REGULATION OF BINDING,0.0012662,0.16234,0.14102,1,1
1,GO TELOMERE ORGANIZATION,0.00047456,0.16219,0.14022,1,1
1,GO VACUOLE ORGANIZATION,0.0011199,0.16206,0.12945,1,1
1,GO POSITIVE REGULATION OF PROTEIN CATABOLIC PROCESS,4.1617e-05,0.16175,0.17398,1,1
1,GO RECEPTOR RECYCLING,0.020205,0.16122,0.12322,1,1
1,GO PROTEIN POLYUBIQUITINATION,1.0184e-05,0.161,0.16219,1,1
1,GO SULFUR COMPOUND TRANSPORT,0.0022992,0.16089,0.13313,1,1
1,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE OR POLYSACCHARIDE ANTIGEN VIA MHC CLASS II,0.00079435,0.1608,0.14446,1,1
1,GO THYROID HORMONE METABOLIC PROCESS,0.017137,0.16069,0.14923,1,1
1,GO POSITIVE REGULATION OF CALCIUM MEDIATED SIGNALING,0.018398,0.16049,0.12005,1,1
1,GO HORMONE BIOSYNTHETIC PROCESS,0.018836,0.15931,0.15302,1,1
1,GO REGULATION OF MRNA METABOLIC PROCESS,4.8379e-05,0.15897,0.15164,1,1
1,GO POSITIVE REGULATION OF MAPK CASCADE,0.0013872,0.15896,0.15697,1,1
1,GO POSITIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.0029794,0.15896,0.1415,1,1
1,GO NEGATIVE REGULATION OF MYELOID CELL DIFFERENTIATION,0.00042998,0.15834,0.17673,1,1
1,GO GLIAL CELL APOPTOTIC PROCESS,0.05161,0.15801,0.23768,1,1
1,GO REGULATION OF CELLULAR CATABOLIC PROCESS,4.6623e-06,0.15801,0.16315,1,1
1,GO REGULATION OF MITOPHAGY,0.024288,0.15751,0.17925,1,1
1,GO REGULATION OF LIPID TRANSPORT,0.0019282,0.15735,0.1424,1,1
1,GO ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,0.0045306,0.15703,0.11476,1,1
1,GO POSITIVE REGULATION OF MACROAUTOPHAGY,7.013e-05,0.15693,0.21631,1,1
1,GO REGULATION OF TELOMERE MAINTENANCE,0.0075304,0.1565,0.11965,1,1
1,GO REGULATION OF TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,0.024846,0.1565,0.1148,1,1
1,GO POSITIVE REGULATION OF MUSCLE CELL DIFFERENTIATION,0.012203,0.15616,0.1432,1,1
1,GO CELLULAR PROTEIN CATABOLIC PROCESS,2.8418e-05,0.15603,0.13904,1,1
1,GO VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.0046564,0.15523,0.17671,1,1
1,GO REGULATION OF VASOCONSTRICTION,0.0028957,0.15513,0.20814,1,1
1,GO NEUROMUSCULAR JUNCTION DEVELOPMENT,0.031059,0.15504,0.12782,1,1
1,GO REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS,0.00019079,0.15488,0.1393,1,1
1,GO ASTROCYTE DIFFERENTIATION,0.011612,0.15445,0.15974,1,1
1,GO NUCLEOBASE CONTAINING COMPOUND TRANSPORT,4.0073e-05,0.154,0.14843,1,1
1,GO NEGATIVE REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,0.00012512,0.15364,0.1497,1,1
1,GO MAINTENANCE OF LOCATION,9.0551e-05,0.1534,0.16322,1,1
1,GO POSITIVE REGULATION OF MITOTIC CELL CYCLE,5.0226e-05,0.15305,0.17078,1,1
1,GO ERYTHROCYTE HOMEOSTASIS,0.00017796,0.15291,0.17667,1,1
1,GO PROTEIN LIPID COMPLEX ASSEMBLY,0.013139,0.15267,0.12754,1,1
1,GO NUCLEOTIDE EXCISION REPAIR PREINCISION COMPLEX STABILIZATION,0.0039469,0.15242,0.13091,1,1
1,GO BONE DEVELOPMENT,0.0029794,0.15235,0.17777,1,1
1,GO PROTEIN CATABOLIC PROCESS,4.3218e-05,0.15231,0.13385,1,1
1,GO REPLACEMENT OSSIFICATION,0.025994,0.15222,0.21449,1,1
1,GO RETROGRADE TRANSPORT ENDOSOME TO GOLGI,1.5816e-05,0.15213,0.15624,1,1
1,GO POSITIVE REGULATION OF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY,0.0085714,0.15194,0.20737,1,1
1,GO PYRIMIDINE NUCLEOTIDE METABOLIC PROCESS,0.0073363,0.15168,0.11887,1,1
1,GO RECEPTOR MEDIATED ENDOCYTOSIS,0.0010206,0.15136,0.1577,1,1
1,GO NEGATIVE REGULATION OF RESPONSE TO STIMULUS,0.00098941,0.15101,0.13665,1,1
1,GO POSITIVE REGULATION OF MITOTIC SISTER CHROMATID SEGREGATION,0.031748,0.15088,0.15772,1,1
1,GO CELL CYCLE G2 M PHASE TRANSITION,0.0017123,0.15088,0.11461,1,1
1,GO POSITIVE REGULATION OF LEUKOCYTE CHEMOTAXIS,0.02068,0.15085,0.17911,1,1
1,GO DNA BIOSYNTHETIC PROCESS,2.0784e-06,0.15081,0.16466,1,1
1,GO MEIOTIC SPINDLE ORGANIZATION,0.0051916,0.15039,0.16887,1,1
1,GO TUBE DEVELOPMENT,0.0038387,0.15007,0.15137,1,1
1,GO POSITIVE REGULATION OF CHROMOSOME SEPARATION,0.027188,0.14962,0.15942,1,1
1,GO REGULATION OF T HELPER 17 TYPE IMMUNE RESPONSE,0.001662,0.14949,0.274,1,1
1,GO FORMATION OF EXTRACHROMOSOMAL CIRCULAR DNA,0.023741,0.14916,0.13149,1,1
1,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,0.0040578,0.14901,0.13855,1,1
1,GO REGULATION OF ATTACHMENT OF SPINDLE MICROTUBULES TO KINETOCHORE,0.030383,0.14878,0.1342,1,1
1,GO RNA EXPORT FROM NUCLEUS,0.0051916,0.14871,0.13627,1,1
1,GO POSITIVE REGULATION OF MITOTIC NUCLEAR DIVISION,0.0025083,0.14833,0.15994,1,1
1,GO NON RECOMBINATIONAL REPAIR,0.00021167,0.14777,0.15679,1,1
1,GO REGULATION OF BIOMINERALIZATION,0.049546,0.14774,0.16738,1,1
1,GO REGULATION OF BINDING,0.0050528,0.14765,0.11736,1,1
1,GO POSITIVE REGULATION OF PROTEIN METABOLIC PROCESS,0.00034072,0.14734,0.13433,1,1
1,GO RNA DEPENDENT DNA BIOSYNTHETIC PROCESS,0.00042998,0.14727,0.15282,1,1
1,GO PIGMENT GRANULE ORGANIZATION,0.026586,0.14705,0.19356,1,1
1,GO POSITIVE REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,0.00012074,0.14654,0.14448,1,1
1,GO ENDOPLASMIC RETICULUM TO GOLGI VESICLE MEDIATED TRANSPORT,0.00065623,0.14653,0.13666,1,1
1,GO REGULATION OF PROTEIN BINDING,0.0014299,0.14649,0.14025,1,1
1,GO CELLULAR RESPONSE TO STEROID HORMONE STIMULUS,0.0085714,0.14636,0.12619,1,1
1,GO REGULATION OF CATABOLIC PROCESS,8.3127e-06,0.14626,0.14718,1,1
1,GO REGULATION OF CELL DEATH,0.0007696,0.14611,0.12253,1,1
1,GO DNA TEMPLATED TRANSCRIPTION ELONGATION,0.001228,0.14597,0.12798,1,1
1,GO HOMOLOGOUS CHROMOSOME PAIRING AT MEIOSIS,0.04854,0.14566,0.14632,1,1
1,GO CHROMOSOME LOCALIZATION,0.027803,0.14565,0.11549,1,1
1,GO STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.0069616,0.14544,0.11061,1,1
1,GO DNA DAMAGE RESPONSE DETECTION OF DNA DAMAGE,0.01282,0.1452,0.12295,1,1
1,GO NEURAL TUBE FORMATION,0.013798,0.14497,0.16372,1,1
1,GO NCRNA CATABOLIC PROCESS,0.044685,0.14454,0.1379,1,1
1,GO NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.00087311,0.14452,0.12345,1,1
1,GO HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION,0.00025131,0.1445,0.17725,1,1
1,GO TRANSCYTOSIS,0.033894,0.14396,0.14216,1,1
1,GO CARDIAC SEPTUM DEVELOPMENT,0.0047853,0.14396,0.19645,1,1
1,GO BLASTOCYST GROWTH,0.0083534,0.14348,0.22245,1,1
1,GO REGULATION OF RNA EXPORT FROM NUCLEUS,0.024288,0.14317,0.15704,1,1
1,GO REGULATION OF CELLULAR RESPONSE TO STRESS,0.00057693,0.14298,0.11548,1,1
1,GO RESPONSE TO UV,0.0017641,0.14281,0.13692,1,1
1,GO REGULATION OF PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.00021909,0.14279,0.13806,1,1
1,GO REGULATION OF CENTROSOME DUPLICATION,0.00044439,0.14278,0.17324,1,1
1,GO TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.0075304,0.14268,0.14133,1,1
1,GO SCHWANN CELL DEVELOPMENT,0.024288,0.14254,0.13236,1,1
1,GO UV DAMAGE EXCISION REPAIR,0.052669,0.14225,0.097928,1,1
1,GO ESTABLISHMENT OF TISSUE POLARITY,0.00042998,0.1422,0.18317,1,1
1,GO HEART VALVE DEVELOPMENT,0.022165,0.14185,0.19389,1,1
1,GO POSITIVE REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,0.0012662,0.14083,0.17403,1,1
1,GO NUCLEOBASE CONTAINING SMALL MOLECULE BIOSYNTHETIC PROCESS,0.010773,0.14075,0.13709,1,1
1,GO ORGANIC ACID METABOLIC PROCESS,0.0022332,0.14047,0.11008,1,1
1,GO MITOTIC SPINDLE ORGANIZATION,0.014138,0.14036,0.13203,1,1
1,GO REGULATION OF PROTEIN CATABOLIC PROCESS,5.2139e-05,0.14031,0.13611,1,1
1,GO GENE SILENCING,6.5149e-05,0.14012,0.13875,1,1
1,GO FC RECEPTOR MEDIATED STIMULATORY SIGNALING PATHWAY,0.0045306,0.13997,0.15474,1,1
1,GO SMALL MOLECULE CATABOLIC PROCESS,0.0025817,0.13995,0.12351,1,1
1,GO POSITIVE REGULATION OF CHROMOSOME SEGREGATION,0.05161,0.13963,0.12189,1,1
1,GO POSTREPLICATION REPAIR,0.00063551,0.13961,0.14206,1,1
1,GO CELLULAR RESPONSE TO UV,0.0067808,0.13961,0.12866,1,1
1,GO PROTEIN QUALITY CONTROL FOR MISFOLDED OR INCOMPLETELY SYNTHESIZED PROTEINS,4.0073e-05,0.13859,0.17591,1,1
1,GO INOSITOL LIPID MEDIATED SIGNALING,0.00074557,0.13806,0.17902,1,1
1,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,0.035393,0.13771,0.095157,1,1
1,GO CELLULAR RESPONSE TO RADIATION,0.0016129,0.13765,0.12558,1,1
1,GO RESPONSE TO CHEMOKINE,0.023205,0.13739,0.17569,1,1
1,GO REGULATION OF ACTOMYOSIN STRUCTURE ORGANIZATION,0.010245,0.13688,0.19336,1,1
1,GO PHOSPHATIDYLINOSITOL METABOLIC PROCESS,0.034637,0.13605,0.069149,1,1
1,GO NUCLEUS ORGANIZATION,0.019739,0.13547,0.10785,1,1
1,GO T HELPER 17 TYPE IMMUNE RESPONSE,0.007729,0.13541,0.19393,1,1
1,GO MITOTIC METAPHASE PLATE CONGRESSION,0.017137,0.13522,0.10809,1,1
1,GO ENDOMEMBRANE SYSTEM ORGANIZATION,0.0053338,0.13485,0.089591,1,1
1,GO METAPHASE ANAPHASE TRANSITION OF CELL CYCLE,0.0020453,0.1348,0.18059,1,1
1,GO BODY MORPHOGENESIS,0.038561,0.13442,0.13415,1,1
1,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO ORGANELLE,3.7145e-05,0.13404,0.14585,1,1
1,GO STEM CELL DIFFERENTIATION,0.00014418,0.13358,0.16694,1,1
1,GO NEGATIVE REGULATION OF METAPHASE ANAPHASE TRANSITION OF CELL CYCLE,0.0090226,0.13328,0.16162,1,1
1,GO MESENCHYMAL CELL DIFFERENTIATION,0.021165,0.13301,0.15418,1,1
1,GO HOMEOSTASIS OF NUMBER OF CELLS,0.00052342,0.13283,0.13973,1,1
1,GO ANATOMICAL STRUCTURE FORMATION INVOLVED IN MORPHOGENESIS,0.0023671,0.13261,0.14533,1,1
1,GO REGULATION OF ACTIN FILAMENT BASED PROCESS,0.001228,0.13258,0.14901,1,1
1,GO VIRAL BUDDING,0.0013872,0.13218,0.16172,1,1
1,GO REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.015953,0.13196,0.097798,1,1
1,GO NUCLEOTIDE EXCISION REPAIR,0.00026003,0.13195,0.13512,1,1
1,GO CELLULAR HORMONE METABOLIC PROCESS,0.01282,0.13191,0.12295,1,1
1,GO NEGATIVE REGULATION OF CELL CYCLE,0.0025083,0.13123,0.098971,1,1
1,GO REGULATION OF CHEMOTAXIS,0.017969,0.13062,0.11933,1,1
1,GO GENITALIA DEVELOPMENT,0.025414,0.13028,0.098901,1,1
1,GO NUCLEOTIDE EXCISION REPAIR DNA DAMAGE RECOGNITION,0.0037331,0.13023,0.14715,1,1
1,GO POSITIVE REGULATION OF INTRACELLULAR TRANSPORT,0.00074557,0.13002,0.1283,1,1
1,GO RNA PHOSPHODIESTER BOND HYDROLYSIS EXONUCLEOLYTIC,0.013798,0.1297,0.092286,1,1
1,GO MRNA 3 END PROCESSING,0.0030654,0.12957,0.13614,1,1
1,GO CELL CYCLE PHASE TRANSITION,0.00087311,0.12952,0.1097,1,1
1,GO MAINTENANCE OF LOCATION IN CELL,0.00031859,0.12923,0.15068,1,1
1,GO UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS VIA THE MULTIVESICULAR BODY SORTING PATHWAY,0.00087311,0.12876,0.12337,1,1
1,GO NEGATIVE REGULATION OF CELLULAR COMPONENT MOVEMENT,0.025994,0.12869,0.12267,1,1
1,GO REGULATION OF OXIDOREDUCTASE ACTIVITY,0.0046564,0.12865,0.13428,1,1
1,GO REGULATION OF SENSORY PERCEPTION,0.041093,0.12846,0.11738,1,1
1,GO NEGATIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY,0.012203,0.12816,0.097961,1,1
1,GO RECEPTOR METABOLIC PROCESS,0.0038387,0.12743,0.12521,1,1
1,GO METAPHASE PLATE CONGRESSION,0.015203,0.1273,0.11905,1,1
1,GO REGULATION OF OSTEOCLAST DIFFERENTIATION,0.013798,0.12646,0.11062,1,1
1,GO POSITIVE REGULATION OF MITOCHONDRIAL FISSION,0.029719,0.1261,0.18239,1,1
1,GO ORGAN GROWTH,0.0031536,0.12521,0.16762,1,1
1,GO REGULATION OF WNT SIGNALING PATHWAY,0.019739,0.12488,0.12086,1,1
1,GO PROTEIN MONOUBIQUITINATION,0.0045306,0.12407,0.091485,1,1
1,GO REGULATION OF DNA CATABOLIC PROCESS,0.00052342,0.124,0.21988,1,1
1,GO REGULATION OF MITOTIC CELL CYCLE,0.001228,0.12391,0.11067,1,1
1,GO CYTOKINESIS,0.0090226,0.12373,0.10505,1,1
1,GO APOPTOTIC PROCESS,0.00079435,0.1235,0.11336,1,1
1,GO TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.0030654,0.12241,0.13441,1,1
1,GO PROCESS UTILIZING AUTOPHAGIC MECHANISM,0.00025131,0.12222,0.11303,1,1
1,GO REGULATION OF ERAD PATHWAY,0.0083534,0.12215,0.1213,1,1
1,GO MORPHOGENESIS OF EMBRYONIC EPITHELIUM,0.018836,0.1221,0.13221,1,1
1,GO NUCLEIC ACID PHOSPHODIESTER BOND HYDROLYSIS,0.00022676,0.12208,0.11276,1,1
1,GO NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.0019282,0.12207,0.16077,1,1
1,GO ACTIN FILAMENT ORGANIZATION,0.041093,0.12171,0.096139,1,1
1,GO CELL CYCLE G1 S PHASE TRANSITION,0.0049174,0.12098,0.11163,1,1
1,GO REGULATION OF HISTONE UBIQUITINATION,0.0081404,0.11871,0.14013,1,1
1,GO CELL DIVISION,0.012508,0.11853,0.091467,1,1
1,GO MITOTIC G2 M TRANSITION CHECKPOINT,0.042857,0.11822,0.12083,1,1
1,GO REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,0.00030804,0.11775,0.12763,1,1
1,GO CELLULAR SENESCENCE,0.0029794,0.11703,0.12509,1,1
1,GO NUCLEOTIDE EXCISION REPAIR DNA INCISION,0.0073363,0.11682,0.11664,1,1
1,GO TISSUE MORPHOGENESIS,0.001662,0.11597,0.15024,1,1
1,GO REGULATION OF CHROMOSOME SEPARATION,0.0049174,0.11547,0.16403,1,1
1,GO AUTOPHAGY OF MITOCHONDRION,0.00084609,0.11502,0.1375,1,1
1,GO REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.0087944,0.1146,0.10431,1,1
1,GO METANEPHRIC NEPHRON MORPHOGENESIS,0.041093,0.11358,0.14163,1,1
1,GO ACTIN POLYMERIZATION OR DEPOLYMERIZATION,0.0036303,0.11335,0.11658,1,1
1,GO NEGATIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS,0.0047853,0.11332,0.10566,1,1
1,GO REGULATION OF DNA REPLICATION,0.012508,0.11296,0.094317,1,1
1,GO REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,0.0001165,0.11294,0.12809,1,1
1,GO REGULATION OF AUTOPHAGY,0.0010528,0.11277,0.11173,1,1
1,GO MEMBRANE ORGANIZATION,0.013139,0.11274,0.082158,1,1
1,GO REGULATION OF ACTIN FILAMENT LENGTH,0.017137,0.11223,0.097598,1,1
1,GO POSITIVE REGULATION OF CENTROSOME CYCLE,0.041093,0.11204,0.11507,1,1
1,GO ORGANELLE FISSION,0.02843,0.11178,0.076591,1,1
1,GO ORGANONITROGEN COMPOUND BIOSYNTHETIC PROCESS,0.00054072,0.11155,0.103,1,1
1,GO FEMALE GAMETE GENERATION,0.01282,0.11153,0.081845,1,1
1,GO APOPTOTIC DNA FRAGMENTATION,0.0064317,0.11115,0.094958,1,1
1,GO POSITIVE REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,0.00055855,0.1109,0.15421,1,1
1,GO ESTROGEN METABOLIC PROCESS,0.02166,0.11086,0.14754,1,1
1,GO MIRNA MEDIATED INHIBITION OF TRANSLATION,0.043763,0.11009,0.13576,1,1
1,GO HEART GROWTH,0.043763,0.10984,0.1187,1,1
1,GO IN UTERO EMBRYONIC DEVELOPMENT,0.0020453,0.10974,0.10906,1,1
1,GO REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,0.022165,0.10911,0.1106,1,1
1,GO MODIFICATION DEPENDENT MACROMOLECULE CATABOLIC PROCESS,0.00011241,0.10894,0.118,1,1
1,GO INTRA S DNA DAMAGE CHECKPOINT,0.010506,0.10883,0.12597,1,1
1,GO MRNA EXPORT FROM NUCLEUS,0.010506,0.10851,0.11208,1,1
1,GO NEGATIVE REGULATION OF PROTEIN CATABOLIC PROCESS,0.00353,0.10794,0.091252,1,1
1,GO REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.00063551,0.1076,0.12054,1,1
1,GO CELLULAR RESPONSE TO DNA DAMAGE STIMULUS,0.00012074,0.10751,0.10516,1,1
1,GO MACROAUTOPHAGY,7.547e-05,0.10746,0.13176,1,1
1,GO REGULATION OF CELL CYCLE PROCESS,0.0018173,0.10742,0.096355,1,1
1,GO PROTEIN LOCALIZATION TO ORGANELLE,7.013e-05,0.10712,0.10474,1,1
1,GO POSITIVE REGULATION OF PROTEIN DEPHOSPHORYLATION,0.013465,0.10624,0.14125,1,1
1,GO MITOTIC CELL CYCLE CHECKPOINT,0.0021689,0.10542,0.11328,1,1
1,GO RESPONSE TO ABIOTIC STIMULUS,0.017549,0.1053,0.083644,1,1
1,GO SPINDLE ORGANIZATION,0.046579,0.10392,0.088331,1,1
1,GO NEGATIVE REGULATION OF PROTEIN KINASE B SIGNALING,0.016734,0.10354,0.13362,1,1
1,GO REGULATION OF DNA REPAIR,0.011612,0.10232,0.091418,1,1
1,GO NEGATIVE REGULATION OF BINDING,0.038561,0.10135,0.078448,1,1
1,GO DNA TEMPLATED TRANSCRIPTION TERMINATION,0.014486,0.10134,0.12466,1,1
1,GO RNA SURVEILLANCE,0.00353,0.10112,0.16302,1,1
1,GO MITOTIC CELL CYCLE,0.00353,0.10003,0.098733,1,1
1,GO PROTEIN CONTAINING COMPLEX SUBUNIT ORGANIZATION,0.0018173,0.099729,0.072648,1,1
1,GO PEPTIDYL THREONINE MODIFICATION,0.027803,0.09936,0.087252,1,1
1,GO EMBRYONIC MORPHOGENESIS,0.034637,0.098714,0.094361,1,1
1,GO POSITIVE REGULATION OF JUN KINASE ACTIVITY,0.035393,0.098571,0.090304,1,1
1,GO PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION,0.00045924,0.098195,0.091999,1,1
1,GO POSITIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,0.035393,0.09817,0.082267,1,1
1,GO PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.00026903,0.098126,0.094432,1,1
1,GO RUFFLE ASSEMBLY,0.015203,0.096832,0.11848,1,1
1,GO REGULATION OF ATPASE ACTIVITY,0.0062634,0.096651,0.096257,1,1
1,GO ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY,0.029068,0.095725,0.084299,1,1
1,GO CHROMOSOME SEPARATION,0.017137,0.095352,0.12818,1,1
1,GO OUTFLOW TRACT MORPHOGENESIS,0.049546,0.093943,0.1875,1,1
1,GO REGULATION OF DNA METABOLIC PROCESS,0.00035231,0.093265,0.10591,1,1
1,GO POSITIVE REGULATION OF ORGANELLE ORGANIZATION,0.009256,0.093032,0.07966,1,1
1,GO NEGATIVE REGULATION OF DNA METABOLIC PROCESS,0.0014299,0.092091,0.13185,1,1
1,GO CELL CYCLE PROCESS,0.011612,0.092088,0.07622,1,1
1,GO ORGANELLE DISASSEMBLY,0.0014738,0.091245,0.11025,1,1
1,GO REGULATION OF ANATOMICAL STRUCTURE MORPHOGENESIS,0.031059,0.0906,0.085434,1,1
1,GO DNA METABOLIC PROCESS,0.00063551,0.090204,0.095756,1,1
1,GO REGULATION OF CENTROSOME CYCLE,0.0042883,0.089521,0.12041,1,1
1,GO ATTACHMENT OF SPINDLE MICROTUBULES TO KINETOCHORE,0.042857,0.088474,0.11477,1,1
1,GO TUBE FORMATION,0.029719,0.08837,0.11836,1,1
1,GO NEGATIVE REGULATION OF CHROMOSOME SEGREGATION,0.041967,0.088203,0.11796,1,1
1,GO PEPTIDYL AMINO ACID MODIFICATION,0.0064317,0.08754,0.071453,1,1
1,GO RESPONSE TO PEPTIDE,0.026586,0.087436,0.072104,1,1
1,GO REGULATION OF CELL CYCLE,0.015574,0.086329,0.066633,1,1
1,GO INTRACELLULAR PROTEIN TRANSPORT,0.00047456,0.085755,0.085941,1,1
1,GO SNRNA TRANSCRIPTION,0.0042883,0.085252,0.099109,1,1
1,GO DNA INTEGRITY CHECKPOINT,0.050569,0.084952,0.079297,1,1
1,GO CELL CELL SIGNALING BY WNT,0.047551,0.084622,0.094761,1,1
1,GO CELLULAR PROTEIN CONTAINING COMPLEX ASSEMBLY,0.017549,0.083705,0.053928,1,1
1,GO PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.015953,0.083256,0.067405,1,1
1,GO POSITIVE REGULATION OF DNA METABOLIC PROCESS,0.00035231,0.082616,0.10252,1,1
1,GO NON CANONICAL WNT SIGNALING PATHWAY,0.011904,0.081474,0.12437,1,1
1,GO HEART DEVELOPMENT,0.021165,0.080762,0.11303,1,1
1,GO MITOTIC NUCLEAR DIVISION,0.010245,0.078081,0.096371,1,1
1,GO REGULATION OF GENE EXPRESSION EPIGENETIC,0.050569,0.077702,0.080763,1,1
1,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO MEMBRANE,0.035393,0.077628,0.081701,1,1
1,GO POSITIVE REGULATION OF CELL CYCLE PROCESS,0.031748,0.077543,0.066286,1,1
1,GO CELL CYCLE,0.018398,0.077,0.063208,1,1
1,GO PROTEIN LOCALIZATION TO CHROMOSOME,0.025994,0.075168,0.11064,1,1
1,GO CELL CYCLE CHECKPOINT,0.016339,0.075122,0.079891,1,1
1,GO CHROMOSOME SEGREGATION,0.038561,0.074881,0.082981,1,1
1,GO DOUBLE STRAND BREAK REPAIR,0.0069616,0.074853,0.10312,1,1
1,GO DNA MODIFICATION,0.017549,0.074223,0.088602,1,1
1,GO CHROMOSOME CONDENSATION,0.009256,0.074131,0.12035,1,1
1,GO RESPONSE TO PEPTIDE HORMONE,0.046579,0.073238,0.061459,1,1
1,GO DNA SYNTHESIS INVOLVED IN DNA REPAIR,0.02843,0.070309,0.083239,1,1
1,GO TRANSCRIPTION BY RNA POLYMERASE III,0.016734,0.070249,0.083786,1,1
1,GO INTRACELLULAR TRANSPORT,0.0054795,0.069634,0.064029,1,1
1,GO MITOTIC SISTER CHROMATID SEGREGATION,0.045624,0.069617,0.083828,1,1
1,GO NUCLEAR CHROMOSOME SEGREGATION,0.047551,0.067762,0.074774,1,1
1,GO REGULATION OF CHROMOSOME SEGREGATION,0.026586,0.065553,0.10756,1,1
1,GO DNA CATABOLIC PROCESS ENDONUCLEOLYTIC,0.036948,0.063781,0.065656,1,1
1,GO DNA RECOMBINATION,0.02268,0.059759,0.095868,1,1
1,GO NEGATIVE REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS,0.027803,0.059605,0.059179,1,1
1,GO POSITIVE REGULATION OF DEPHOSPHORYLATION,0.035393,0.059512,0.10784,1,1
1,GO REGULATION OF CYTOSKELETON ORGANIZATION,0.033894,0.059151,0.076623,1,1
1,GO SUPRAMOLECULAR FIBER ORGANIZATION,0.036164,0.058854,0.098284,1,1
1,GO DNA REPAIR,0.0060989,0.058216,0.084605,1,1
2,GO REGULATION OF POSTSYNAPTIC SPECIALIZATION ASSEMBLY,3.6228e-06,0.94756,0.94014,1,1
2,GO POSTSYNAPTIC SPECIALIZATION ASSEMBLY,2.9301e-06,0.91031,0.81499,1,1
2,GO POSITIVE REGULATION OF SYNAPTIC PLASTICITY,1.071e-07,0.80365,0.80566,1,1
2,GO REGULATION OF POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR INTERNALIZATION,1.0311e-06,0.79422,0.73973,1,1
2,GO REGULATION OF SYNAPTIC VESICLE FUSION TO PRESYNAPTIC ACTIVE ZONE MEMBRANE,6.8936e-07,0.7916,0.92578,1,1
2,GO RESPONSE TO HISTAMINE,2.2658e-06,0.74477,0.72042,1,1
2,GO RESPONSE TO L GLUTAMATE,4.2876e-06,0.69465,0.60666,1,1
2,GO SYNAPSE MATURATION,1.4674e-06,0.68545,0.7436,1,1
2,GO SECRETORY GRANULE LOCALIZATION,2.0033e-05,0.65007,0.54422,1,1
2,GO REGULATION OF EXCITATORY SYNAPSE ASSEMBLY,2.8418e-05,0.62605,0.56859,1,1
2,GO COMPLEMENT ACTIVATION LECTIN PATHWAY,1.2454e-05,0.61639,0.52145,1,1
2,GO PYRAMIDAL NEURON DIFFERENTIATION,3.3132e-05,0.60719,0.59391,1,1
2,GO TYPE B PANCREATIC CELL APOPTOTIC PROCESS,4.0073e-05,0.59411,0.55227,1,1
2,GO REGULATION OF SYNAPSE MATURATION,7.2754e-05,0.57877,0.59374,1,1
2,GO DENSE CORE GRANULE TRANSPORT,0.00041602,0.57831,0.51559,1,1
2,GO GAMMA AMINOBUTYRIC ACID SIGNALING PATHWAY,4.1112e-06,0.57691,0.53241,1,1
2,GO BRANCHING MORPHOGENESIS OF A NERVE,4.6623e-06,0.5716,0.67473,1,1
2,GO NEGATIVE REGULATION OF NEUROTRANSMITTER TRANSPORT,8.6584e-06,0.5636,0.52821,1,1
2,GO SYNAPTIC VESICLE MATURATION,1.5816e-05,0.56314,0.55209,1,1
2,GO POSITIVE REGULATION OF GONAD DEVELOPMENT,2.2524e-05,0.55993,0.47787,1,1
2,GO OPIOID RECEPTOR SIGNALING PATHWAY,1.906e-06,0.54883,0.56841,1,1
2,GO PARASYMPATHETIC NERVOUS SYSTEM DEVELOPMENT,0.013465,0.5278,0.27946,1,1
2,GO POSTSYNAPTIC SPECIALIZATION ORGANIZATION,4.1617e-05,0.52422,0.50849,1,1
2,GO TELENCEPHALON GLIAL CELL MIGRATION,3.1888e-05,0.52089,0.44522,1,1
2,GO REGULATION OF AMPA RECEPTOR ACTIVITY,0.00026003,0.51822,0.43648,1,1
2,GO REGULATION OF SHORT TERM NEURONAL SYNAPTIC PLASTICITY,3.8583e-05,0.51426,0.60361,1,1
2,GO RIBOSOMAL LARGE SUBUNIT ASSEMBLY,0.00029782,0.51233,0.39413,1,1
2,GO MODIFICATION OF POSTSYNAPTIC STRUCTURE,3.1904e-06,0.50604,0.55189,1,1
2,GO CORPUS CALLOSUM DEVELOPMENT,1.2366e-07,0.50581,0.55815,1,1
2,GO POSTSYNAPSE ASSEMBLY,2.2524e-05,0.50478,0.5522,1,1
2,GO FORMATION OF CYTOPLASMIC TRANSLATION INITIATION COMPLEX,0.001662,0.49835,0.41138,1,1
2,GO NEURON CELLULAR HOMEOSTASIS,1.5331e-06,0.49745,0.49407,1,1
2,GO SUCKLING BEHAVIOR,2.6902e-06,0.49306,0.46816,1,1
2,GO PLASMA MEMBRANE REPAIR,6.0198e-07,0.49163,0.5509,1,1
2,GO MESENCHYMAL TO EPITHELIAL TRANSITION,0.00019753,0.4888,0.39291,1,1
2,GO REGULATION OF MODIFICATION OF SYNAPTIC STRUCTURE,5.2837e-06,0.48509,0.42077,1,1
2,GO UV PROTECTION,3.0576e-06,0.48315,0.47018,1,1
2,GO REGULATION OF GUANYLATE CYCLASE ACTIVITY,0.0026572,0.48243,0.39301,1,1
2,GO OXYGEN TRANSPORT,0.007729,0.48098,0.47859,1,1
2,GO ADULT HEART DEVELOPMENT,2.9532e-05,0.46765,0.43997,1,1
2,GO GLYCINE TRANSPORT,0.010245,0.46638,0.32803,1,1
2,GO POSITIVE REGULATION OF DENDRITIC SPINE MORPHOGENESIS,1.1964e-05,0.46059,0.47156,1,1
2,GO CELLULAR RESPONSE TO BRAIN DERIVED NEUROTROPHIC FACTOR STIMULUS,7.547e-05,0.45958,0.48595,1,1
2,GO PROTEIN LOCALIZATION TO AXON,0.0037331,0.45649,0.45228,1,1
2,GO TELENCEPHALON REGIONALIZATION,0.0066042,0.45498,0.35935,1,1
2,GO CRANIAL NERVE STRUCTURAL ORGANIZATION,0.0047853,0.45378,0.36699,1,1
2,GO MODIFICATION OF SYNAPTIC STRUCTURE,3.3287e-06,0.45296,0.44,1,1
2,GO MATURATION OF LSU RRNA,0.00014935,0.4519,0.37323,1,1
2,GO POSITIVE REGULATION OF NEURON MIGRATION,0.00072223,0.45108,0.37243,1,1
2,GO RIBOSOME ASSEMBLY,0.00032948,0.44701,0.35206,1,1
2,GO EXCITATORY SYNAPSE ASSEMBLY,3.3132e-05,0.44645,0.43335,1,1
2,GO NEGATIVE REGULATION OF LYASE ACTIVITY,2.3418e-05,0.44561,0.41876,1,1
2,GO PEPTIDYL SERINE DEPHOSPHORYLATION,1.5816e-05,0.44531,0.41464,1,1
2,GO MODIFICATION OF POSTSYNAPTIC ACTIN CYTOSKELETON,0.00026003,0.44497,0.40363,1,1
2,GO SYNAPTIC MEMBRANE ADHESION,0.00038934,0.44341,0.47686,1,1
2,GO CYTOPLASMIC TRANSLATIONAL INITIATION,0.00013433,0.44103,0.35656,1,1
2,GO TRICARBOXYLIC ACID METABOLIC PROCESS,7.8282e-05,0.44058,0.41204,1,1
2,GO ENDONUCLEOLYTIC CLEAVAGE INVOLVED IN RRNA PROCESSING,0.0019282,0.43622,0.29455,1,1
2,GO CENTRAL NERVOUS SYSTEM PROJECTION NEURON AXONOGENESIS,3.7145e-05,0.43405,0.49431,1,1
2,GO CYCLIC NUCLEOTIDE CATABOLIC PROCESS,5.2139e-05,0.43229,0.44291,1,1
2,GO POSITIVE REGULATION OF CYTOPLASMIC TRANSLATION,0.02068,0.42852,0.26809,1,1
2,GO REGULATION OF GONAD DEVELOPMENT,0.00090094,0.42822,0.27321,1,1
2,GO POSITIVE REGULATION OF NEUROBLAST PROLIFERATION,1.4039e-05,0.42626,0.40752,1,1
2,GO RIBOSOMAL LARGE SUBUNIT BIOGENESIS,0.00036427,0.41768,0.35519,1,1
2,GO PURINE NUCLEOBASE BIOSYNTHETIC PROCESS,0.00052342,0.41701,0.41583,1,1
2,GO IMP METABOLIC PROCESS,9.0551e-05,0.41481,0.41783,1,1
2,GO CGMP METABOLIC PROCESS,0.00045924,0.41082,0.36304,1,1
2,GO CARDIAC VENTRICLE FORMATION,0.00040247,0.41063,0.57213,1,1
2,GO NETRIN ACTIVATED SIGNALING PATHWAY,0.00044439,0.40928,0.41246,1,1
2,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO TELOMERE,0.00034072,0.40609,0.35238,1,1
2,GO RESPONSE TO ELECTRICAL STIMULUS,9.0551e-05,0.40382,0.32816,1,1
2,GO VITAMIN CATABOLIC PROCESS,0.01282,0.40346,0.31243,1,1
2,GO L GLUTAMATE TRANSMEMBRANE TRANSPORT,8.3127e-06,0.4005,0.35991,1,1
2,GO COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE,0.0062634,0.3971,0.36548,1,1
2,GO REGULATION OF CGMP MEDIATED SIGNALING,0.013139,0.39707,0.27753,1,1
2,GO ATRIAL CARDIAC MUSCLE CELL TO AV NODE CELL SIGNALING,2.3418e-05,0.39682,0.38372,1,1
2,GO NEUROMUSCULAR SYNAPTIC TRANSMISSION,6.5149e-05,0.39636,0.43113,1,1
2,GO ELASTIC FIBER ASSEMBLY,0.00045924,0.39581,0.47755,1,1
2,GO ENDONUCLEOLYTIC CLEAVAGE IN ITS1 TO SEPARATE SSU RRNA FROM 5 8S RRNA AND LSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.0059384,0.39443,0.26069,1,1
2,GO MYOBLAST PROLIFERATION,4.6623e-06,0.39425,0.4101,1,1
2,GO SIALYLATION,0.0013457,0.39342,0.40768,1,1
2,GO REGULATION OF INOSITOL PHOSPHATE BIOSYNTHETIC PROCESS,2.2524e-05,0.3916,0.34173,1,1
2,GO CARDIAC CHAMBER FORMATION,0.00041602,0.39111,0.51814,1,1
2,GO CARDIAC RIGHT VENTRICLE MORPHOGENESIS,0.0057817,0.38824,0.30976,1,1
2,GO INNERVATION,0.00052342,0.38703,0.39486,1,1
2,GO FACIAL NERVE MORPHOGENESIS,0.0066042,0.38467,0.35033,1,1
2,GO NEUROTRANSMITTER RECEPTOR INTERNALIZATION,0.00031859,0.38363,0.34614,1,1
2,GO NEGATIVE CHEMOTAXIS,0.00012512,0.38309,0.34246,1,1
2,GO VENTRICULAR CARDIAC MUSCLE CELL DIFFERENTIATION,0.0057817,0.38233,0.2726,1,1
2,GO REGULATION OF COLLAGEN METABOLIC PROCESS,0.0027346,0.38146,0.25967,1,1
2,GO POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR INTERNALIZATION,0.00019753,0.38097,0.35262,1,1
2,GO CYTOPLASMIC TRANSLATION,0.00049035,0.38017,0.35101,1,1
2,GO VESICLE FUSION TO PLASMA MEMBRANE,7.9801e-06,0.37741,0.47846,1,1
2,GO OUTFLOW TRACT SEPTUM MORPHOGENESIS,0.0069616,0.37522,0.29253,1,1
2,GO PROTEIN DNA COMPLEX DISASSEMBLY,0.001228,0.37444,0.36944,1,1
2,GO HEART VALVE FORMATION,0.00037661,0.37386,0.39291,1,1
2,GO AV NODE CELL TO BUNDLE OF HIS CELL COMMUNICATION,0.00045924,0.36967,0.38396,1,1
2,GO MATURATION OF LSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.00018427,0.36937,0.37404,1,1
2,GO G PROTEIN COUPLED GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.00012964,0.36873,0.41623,1,1
2,GO CHEMOSENSORY BEHAVIOR,0.0020453,0.36777,0.26236,1,1
2,GO DENTATE GYRUS DEVELOPMENT,7.8282e-05,0.36694,0.51687,1,1
2,GO VENOUS BLOOD VESSEL DEVELOPMENT,0.009256,0.36495,0.27525,1,1
2,GO REGULATION OF VESICLE FUSION,4.4878e-05,0.36279,0.4105,1,1
2,GO CHONDROCYTE DIFFERENTIATION INVOLVED IN ENDOCHONDRAL BONE MORPHOGENESIS,0.0036303,0.35922,0.25656,1,1
2,GO PROTEIN TRIMERIZATION,0.00022676,0.3573,0.36141,1,1
2,GO G PROTEIN COUPLED PURINERGIC RECEPTOR SIGNALING PATHWAY,0.033166,0.35692,0.22823,1,1
2,GO MODULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL,7.013e-05,0.3558,0.41317,1,1
2,GO L GLUTAMATE IMPORT,0.00045924,0.35529,0.29567,1,1
2,GO CENTRAL NERVOUS SYSTEM NEURON AXONOGENESIS,0.00014418,0.3552,0.31646,1,1
2,GO ADAPTATION OF SIGNALING PATHWAY,0.0014299,0.35044,0.24031,1,1
2,GO NEGATIVE REGULATION OF ADENYLATE CYCLASE ACTIVITY,0.0001547,0.34932,0.33442,1,1
2,GO RIBOSOMAL SMALL SUBUNIT ASSEMBLY,0.00065623,0.34881,0.3587,1,1
2,GO POSITIVE REGULATION OF CALCIUM ION DEPENDENT EXOCYTOSIS,0.00090094,0.34876,0.44965,1,1
2,GO CELL CELL SIGNALING INVOLVED IN CARDIAC CONDUCTION,2.5774e-06,0.34625,0.39766,1,1
2,GO RIBOSOMAL SMALL SUBUNIT BIOGENESIS,0.00022676,0.34618,0.32216,1,1
2,GO ADULT FEEDING BEHAVIOR,0.00065623,0.34356,0.22249,1,1
2,GO NEGATIVE REGULATION OF KERATINOCYTE PROLIFERATION,0.021165,0.34351,0.2709,1,1
2,GO DORSAL VENTRAL AXIS SPECIFICATION,0.0022992,0.34218,0.3393,1,1
2,GO G PROTEIN COUPLED RECEPTOR INTERNALIZATION,0.00067758,0.34121,0.27606,1,1
2,GO TRANSLATIONAL INITIATION,0.0010528,0.3411,0.3039,1,1
2,GO REGULATION OF CYTOPLASMIC TRANSLATION,1.7806e-05,0.34055,0.31045,1,1
2,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM,0.0083534,0.33889,0.32249,1,1
2,GO REGULATION OF ODONTOGENESIS OF DENTIN CONTAINING TOOTH,0.03939,0.33738,0.25131,1,1
2,GO REGULATION OF TRANSLATIONAL FIDELITY,0.0010859,0.33694,0.25895,1,1
2,GO GAS TRANSPORT,0.0066042,0.33673,0.37192,1,1
2,GO LAYER FORMATION IN CEREBRAL CORTEX,0.0017641,0.33651,0.28969,1,1
2,GO PURINE NUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,0.0015189,0.33579,0.29889,1,1
2,GO NEGATIVE REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.00031859,0.32762,0.38047,1,1
2,GO TELOMERASE RNA LOCALIZATION,0.00013917,0.32701,0.32189,1,1
2,GO CHEMICAL SYNAPTIC TRANSMISSION POSTSYNAPTIC,1.0604e-05,0.32643,0.36839,1,1
2,GO REGULATION OF NEURON MIGRATION,0.00036427,0.32467,0.28077,1,1
2,GO SYNAPTIC TRANSMISSION GABAERGIC,2.6307e-05,0.32293,0.28974,1,1
2,GO LOCOMOTORY EXPLORATION BEHAVIOR,0.0067808,0.32231,0.3593,1,1
2,GO SYNAPTIC VESICLE PRIMING,3.0689e-05,0.32128,0.41314,1,1
2,GO CELL PROLIFERATION IN FOREBRAIN,0.027803,0.32032,0.19312,1,1
2,GO NEUROTRANSMITTER REUPTAKE,0.00029782,0.31881,0.30582,1,1
2,GO CALCIUM DEPENDENT CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES,0.00090094,0.31727,0.30085,1,1
2,GO BASIC AMINO ACID TRANSMEMBRANE TRANSPORT,0.027803,0.317,0.2786,1,1
2,GO PURINE CONTAINING COMPOUND SALVAGE,0.0023671,0.31699,0.27417,1,1
2,GO REGULATION OF POSTSYNAPTIC MEMBRANE POTENTIAL,4.1617e-05,0.31621,0.33865,1,1
2,GO POSITIVE REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,0.00016023,0.31598,0.29368,1,1
2,GO GLYCOLYTIC PROCESS THROUGH FRUCTOSE 6 PHOSPHATE,0.00079435,0.31522,0.36813,1,1
2,GO MATURATION OF 5 8S RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.00087311,0.31486,0.26049,1,1
2,GO AORTA DEVELOPMENT,0.0016129,0.31397,0.20113,1,1
2,GO MATURATION OF SSU RRNA,0.00045924,0.31375,0.29689,1,1
2,GO PREPULSE INHIBITION,0.011047,0.31329,0.33627,1,1
2,GO REGULATION OF ADENYLATE CYCLASE ACTIVITY,1.4609e-05,0.3125,0.37367,1,1
2,GO NEURON PROJECTION ORGANIZATION,3.1904e-06,0.31218,0.30704,1,1
2,GO REGULATION OF PROTEIN LOCALIZATION TO CHROMOSOME TELOMERIC REGION,0.00059588,0.31056,0.29615,1,1
2,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS NONSENSE MEDIATED DECAY,0.0047853,0.31015,0.32372,1,1
2,GO NEGATIVE REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.00047456,0.3101,0.30501,1,1
2,GO REGULATION OF DELAYED RECTIFIER POTASSIUM CHANNEL ACTIVITY,0.00081984,0.30788,0.31239,1,1
2,GO REGULATION OF NEURON PROJECTION ARBORIZATION,0.041967,0.30776,0.23304,1,1
2,GO RRNA PSEUDOURIDINE SYNTHESIS,0.011904,0.30728,0.28329,1,1
2,GO HYDROGEN PEROXIDE CATABOLIC PROCESS,0.00042998,0.30492,0.26796,1,1
2,GO PROTEIN LOCALIZATION TO NUCLEAR BODY,0.0021689,0.30332,0.24321,1,1
2,GO SEMAPHORIN PLEXIN SIGNALING PATHWAY,0.0037331,0.30275,0.20971,1,1
2,GO MUSCLE CELL CELLULAR HOMEOSTASIS,0.00069957,0.30273,0.3116,1,1
2,GO REGULATION OF METANEPHROS DEVELOPMENT,0.037747,0.30237,0.18672,1,1
2,GO POSITIVE REGULATION OF TELOMERASE RNA LOCALIZATION TO CAJAL BODY,0.00019753,0.2983,0.34389,1,1
2,GO PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM,0.0047853,0.29787,0.27686,1,1
2,GO DIVALENT METAL ION EXPORT,0.00059588,0.29766,0.39797,1,1
2,GO REGULATION OF LYASE ACTIVITY,3.0689e-05,0.29634,0.26996,1,1
2,GO MEMBRANE DEPOLARIZATION DURING CARDIAC MUSCLE CELL ACTION POTENTIAL,4.4878e-05,0.2951,0.38378,1,1
2,GO AEROBIC ELECTRON TRANSPORT CHAIN,0.0021062,0.29468,0.22458,1,1
2,GO MATURATION OF 5 8S RRNA,0.0017641,0.29439,0.24399,1,1
2,GO REGULATION OF NEUROTRANSMITTER UPTAKE,0.041967,0.29417,0.18102,1,1
2,GO MATING BEHAVIOR,0.0025817,0.29386,0.21672,1,1
2,GO POSITIVE REGULATION OF CATECHOLAMINE SECRETION,0.0010206,0.29365,0.4059,1,1
2,GO PURINE NUCLEOSIDE BIOSYNTHETIC PROCESS,0.0079323,0.29304,0.18715,1,1
2,GO MITOCHONDRIAL TRANSCRIPTION,0.0038387,0.29273,0.25142,1,1
2,GO PEPTIDYL ARGININE N METHYLATION,0.00010462,0.29234,0.31636,1,1
2,GO PHASIC SMOOTH MUSCLE CONTRACTION,0.0075304,0.29187,0.24686,1,1
2,GO CLEAVAGE INVOLVED IN RRNA PROCESSING,0.0026572,0.29084,0.22203,1,1
2,GO SA NODE CELL TO ATRIAL CARDIAC MUSCLE CELL COMMUNICATION,0.0036303,0.29063,0.33102,1,1
2,GO REGULATION OF RYANODINE SENSITIVE CALCIUM RELEASE CHANNEL ACTIVITY,0.0010528,0.29002,0.23738,1,1
2,GO NAD METABOLIC PROCESS,0.0028957,0.28961,0.2362,1,1
2,GO POSITIVE REGULATION OF LYASE ACTIVITY,0.0025083,0.28931,0.23327,1,1
2,GO L SERINE METABOLIC PROCESS,0.011904,0.28863,0.29792,1,1
2,GO POSTSYNAPTIC MODULATION OF CHEMICAL SYNAPTIC TRANSMISSION,0.0071468,0.28737,0.21499,1,1
2,GO REGULATION OF SYNAPTIC VESICLE EXOCYTOSIS,4.2876e-06,0.28722,0.38318,1,1
2,GO POSITIVE REGULATION OF MRNA 3 END PROCESSING,9.7346e-05,0.28657,0.21378,1,1
2,GO MATURATION OF SSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.00072223,0.28487,0.2813,1,1
2,GO TRNA WOBBLE BASE MODIFICATION,0.0010206,0.28381,0.22364,1,1
2,GO CELL MIGRATION INVOLVED IN HEART DEVELOPMENT,0.015203,0.2822,0.25272,1,1
2,GO REGULATION OF POSTSYNAPSE ORGANIZATION,1.9263e-05,0.2812,0.29651,1,1
2,GO RIBOSOME BIOGENESIS,0.00057693,0.27931,0.25228,1,1
2,GO CEREBRAL CORTEX RADIALLY ORIENTED CELL MIGRATION,9.389e-05,0.27784,0.31439,1,1
2,GO VOCALIZATION BEHAVIOR,0.030383,0.27735,0.35457,1,1
2,GO NEGATIVE REGULATION OF RECEPTOR INTERNALIZATION,0.029068,0.27701,0.172,1,1
2,GO FORMATION OF TRANSLATION PREINITIATION COMPLEX,0.00025131,0.27665,0.31857,1,1
2,GO REGULATION OF MRNA BINDING,0.00026003,0.27398,0.297,1,1
2,GO PEPTIDYL HISTIDINE MODIFICATION,0.00063551,0.27295,0.21766,1,1
2,GO MESODERMAL CELL FATE SPECIFICATION,0.041093,0.27198,0.18829,1,1
2,GO NEGATIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA JAK STAT,0.004408,0.27146,0.1994,1,1
2,GO POSITIVE REGULATION OF SEQUESTERING OF CALCIUM ION,0.0015653,0.27089,0.28208,1,1
2,GO POSITIVE REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,0.00054072,0.27016,0.23454,1,1
2,GO STRESS GRANULE ASSEMBLY,1.1493e-05,0.2701,0.24164,1,1
2,GO PROTEIN TARGETING TO MEMBRANE,0.0021689,0.26871,0.22891,1,1
2,GO PROTEIN LOCALIZATION TO NUCLEOPLASM,0.00353,0.26731,0.20427,1,1
2,GO EXTRACELLULAR MATRIX ASSEMBLY,0.0011199,0.26595,0.24764,1,1
2,GO BONE GROWTH,0.009256,0.2629,0.2313,1,1
2,GO GTP METABOLIC PROCESS,0.0021689,0.26286,0.23585,1,1
2,GO NEURON REMODELING,0.0010528,0.2624,0.29998,1,1
2,GO HYPOTONIC RESPONSE,0.025994,0.26188,0.17492,1,1
2,GO DNA DEALKYLATION INVOLVED IN DNA REPAIR,0.013139,0.26177,0.20083,1,1
2,GO REGULATION OF SYNAPSE STRUCTURE OR ACTIVITY,4.0073e-05,0.26171,0.23927,1,1
2,GO LEARNING,3.5759e-05,0.26107,0.2771,1,1
2,GO REGULATION OF FEMALE GONAD DEVELOPMENT,0.016734,0.26084,0.2363,1,1
2,GO NEGATIVE REGULATION OF CALCINEURIN MEDIATED SIGNALING,0.0042883,0.26079,0.20316,1,1
2,GO MITOCHONDRION DISTRIBUTION,0.00014935,0.26009,0.25265,1,1
2,GO REGULATION OF DIGESTIVE SYSTEM PROCESS,0.00014935,0.25989,0.19652,1,1
2,GO TRANSLATIONAL ELONGATION,0.00038934,0.25826,0.22275,1,1
2,GO POSITIVE REGULATION OF ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,0.0039469,0.25823,0.2013,1,1
2,GO RRNA MODIFICATION,0.007729,0.2571,0.21839,1,1
2,GO RRNA METABOLIC PROCESS,0.00084609,0.25574,0.22872,1,1
2,GO SOMITE ROSTRAL CAUDAL AXIS SPECIFICATION,0.00087311,0.25477,0.26261,1,1
2,GO REPRODUCTIVE BEHAVIOR,0.0018173,0.25446,0.24261,1,1
2,GO CELL JUNCTION DISASSEMBLY,0.0013054,0.25444,0.25289,1,1
2,GO POSITIVE REGULATION OF TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,9.0551e-05,0.25444,0.25267,1,1
2,GO VIRAL TRANSLATION,0.0013054,0.25369,0.28863,1,1
2,GO POSITIVE REGULATION OF DENDRITIC SPINE DEVELOPMENT,0.00019753,0.25151,0.27618,1,1
2,GO CELL PROLIFERATION IN HINDBRAIN,0.013798,0.25024,0.23231,1,1
2,GO MITOCHONDRION LOCALIZATION,3.4421e-05,0.24872,0.21481,1,1
2,GO ALDEHYDE BIOSYNTHETIC PROCESS,0.029068,0.24711,0.20917,1,1
2,GO PSEUDOURIDINE SYNTHESIS,0.015574,0.2463,0.21943,1,1
2,GO POSITIVE REGULATION OF ORGAN GROWTH,0.0022332,0.24555,0.21421,1,1
2,GO RETINOIC ACID RECEPTOR SIGNALING PATHWAY,0.0066042,0.24493,0.19261,1,1
2,GO RRNA CONTAINING RIBONUCLEOPROTEIN COMPLEX EXPORT FROM NUCLEUS,0.0022332,0.24364,0.23682,1,1
2,GO NEGATIVE REGULATION OF SODIUM ION TRANSPORT,0.0047853,0.24321,0.20474,1,1
2,GO NOREPINEPHRINE TRANSPORT,0.0021689,0.24248,0.20411,1,1
2,GO NEURON PROJECTION EXTENSION INVOLVED IN NEURON PROJECTION GUIDANCE,0.0059384,0.24118,0.17636,1,1
2,GO REGULATION OF NUCLEAR CELL CYCLE DNA REPLICATION,0.00079435,0.23776,0.19158,1,1
2,GO INHIBITORY SYNAPSE ASSEMBLY,0.001228,0.23725,0.42057,1,1
2,GO DETECTION OF TEMPERATURE STIMULUS INVOLVED IN SENSORY PERCEPTION,0.037747,0.23697,0.22179,1,1
2,GO ASSOCIATIVE LEARNING,5.2139e-05,0.23591,0.24356,1,1
2,GO ONE CARBON COMPOUND TRANSPORT,0.020205,0.23556,0.15196,1,1
2,GO NEGATIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.0060989,0.23513,0.18145,1,1
2,GO REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.00026903,0.23406,0.20807,1,1
2,GO FOREBRAIN REGIONALIZATION,0.016339,0.23337,0.24722,1,1
2,GO POSITIVE REGULATION OF MESENCHYMAL CELL PROLIFERATION,0.025994,0.23302,0.20211,1,1
2,GO RIBONUCLEOPROTEIN COMPLEX BIOGENESIS,0.00026903,0.23286,0.2258,1,1
2,GO SERINE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.037747,0.23278,0.22524,1,1
2,GO GAMMA AMINOBUTYRIC ACID TRANSPORT,0.0094949,0.23246,0.20721,1,1
2,GO POLYOL TRANSPORT,0.0079323,0.23114,0.18719,1,1
2,GO TRNA WOBBLE URIDINE MODIFICATION,0.0039469,0.2296,0.2025,1,1
2,GO SNORNA 3 END PROCESSING,0.00098941,0.22817,0.34461,1,1
2,GO TRNA MODIFICATION,0.00019079,0.22811,0.22381,1,1
2,GO RRNA TRANSCRIPTION,0.00054072,0.22764,0.21113,1,1
2,GO EXPLORATION BEHAVIOR,0.0081404,0.22547,0.28578,1,1
2,GO REGULATION OF CYCLASE ACTIVITY,6.2786e-05,0.22515,0.25885,1,1
2,GO NEGATIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT,0.00019753,0.22483,0.2524,1,1
2,GO VIRAL GENE EXPRESSION,0.011904,0.22434,0.20572,1,1
2,GO LATERAL VENTRICLE DEVELOPMENT,0.0083534,0.22406,0.22513,1,1
2,GO MITOCHONDRIAL TRANSLATIONAL TERMINATION,0.0028141,0.22387,0.20694,1,1
2,GO TRNA METHYLATION,0.0022992,0.22314,0.17565,1,1
2,GO NEGATIVE REGULATION OF NEUROTRANSMITTER SECRETION,0.0057817,0.22244,0.24928,1,1
2,GO SYNAPSE ORGANIZATION,9.0551e-05,0.22201,0.22157,1,1
2,GO POSTSYNAPSE ORGANIZATION,7.8282e-05,0.22101,0.24513,1,1
2,GO N ACETYLGLUCOSAMINE METABOLIC PROCESS,0.0031536,0.22073,0.17238,1,1
2,GO REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO CHROMOSOME,0.0033369,0.22015,0.19904,1,1
2,GO MITOCHONDRIAL ELECTRON TRANSPORT NADH TO UBIQUINONE,0.0026572,0.21849,0.17044,1,1
2,GO NUCLEOLAR LARGE RRNA TRANSCRIPTION BY RNA POLYMERASE I,8.7323e-05,0.21784,0.23145,1,1
2,GO AROMATIC AMINO ACID TRANSPORT,0.004408,0.21751,0.34059,1,1
2,GO CELLULAR RESPONSE TO PH,0.00013433,0.21743,0.2188,1,1
2,GO NUCLEOBASE BIOSYNTHETIC PROCESS,0.0028141,0.21551,0.28893,1,1
2,GO PURINE CONTAINING COMPOUND CATABOLIC PROCESS,0.00087311,0.21531,0.21643,1,1
2,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL APOPTOTIC PROCESS,0.00024286,0.21398,0.23165,1,1
2,GO ATP SYNTHESIS COUPLED ELECTRON TRANSPORT,0.0083534,0.21394,0.15885,1,1
2,GO REGULATION OF STORE OPERATED CALCIUM ENTRY,0.011612,0.21373,0.23113,1,1
2,GO REGULATION OF SYNAPTIC VESICLE RECYCLING,0.023205,0.21365,0.20936,1,1
2,GO CARTILAGE DEVELOPMENT INVOLVED IN ENDOCHONDRAL BONE MORPHOGENESIS,0.0097392,0.21356,0.18451,1,1
2,GO REGULATION OF RNA BINDING,0.00035231,0.21323,0.24793,1,1
2,GO TUBULIN DEACETYLATION,0.014841,0.2129,0.1902,1,1
2,GO INTRASPECIES INTERACTION BETWEEN ORGANISMS,0.017969,0.21275,0.19516,1,1
2,GO SPLICEOSOMAL SNRNP ASSEMBLY,0.00045924,0.21256,0.19071,1,1
2,GO PROTEIN TARGETING TO MITOCHONDRION,0.0006154,0.21208,0.1453,1,1
2,GO POSITIVE REGULATION OF VOLTAGE GATED POTASSIUM CHANNEL ACTIVITY,0.033894,0.21116,0.18694,1,1
2,GO POSITIVE REGULATION OF SYNAPSE ASSEMBLY,0.0045306,0.21,0.19261,1,1
2,GO REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.0015189,0.20967,0.16934,1,1
2,GO PYRIMIDINE NUCLEOTIDE BIOSYNTHETIC PROCESS,0.0075304,0.20888,0.1496,1,1
2,GO POSITIVE REGULATION OF CARDIAC MUSCLE CELL DIFFERENTIATION,0.0024367,0.20799,0.17967,1,1
2,GO SYNAPTIC TRANSMISSION CHOLINERGIC,0.045624,0.20758,0.15517,1,1
2,GO OXIDATIVE PHOSPHORYLATION,0.0031536,0.20716,0.16271,1,1
2,GO DEOXYRIBOSE PHOSPHATE BIOSYNTHETIC PROCESS,0.010506,0.20713,0.17369,1,1
2,GO REGULATION OF SYNAPSE ASSEMBLY,0.00087311,0.20663,0.2178,1,1
2,GO POSITIVE REGULATION OF HEART GROWTH,0.0071468,0.20653,0.178,1,1
2,GO PROTEIN IMPORT INTO MITOCHONDRIAL MATRIX,0.00035231,0.20626,0.23644,1,1
2,GO POSITIVE REGULATION OF MITOCHONDRIAL TRANSLATION,0.00059588,0.20539,0.29311,1,1
2,GO URONIC ACID METABOLIC PROCESS,0.00055855,0.20522,0.1716,1,1
2,GO POSITIVE REGULATION OF DENDRITE MORPHOGENESIS,0.00044439,0.20471,0.21521,1,1
2,GO SODIUM INDEPENDENT ORGANIC ANION TRANSPORT,0.0046564,0.20437,0.16281,1,1
2,GO REGULATION OF CARDIAC MUSCLE CONTRACTION BY REGULATION OF THE RELEASE OF SEQUESTERED CALCIUM ION,0.016734,0.20408,0.20365,1,1
2,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO TELOMERE,0.0017641,0.20349,0.19653,1,1
2,GO TELOMERIC LOOP DISASSEMBLY,0.001191,0.20346,0.2066,1,1
2,GO AMINO ACID TRANSMEMBRANE TRANSPORT,6.0504e-05,0.2032,0.21928,1,1
2,GO REGULATION OF TUBULIN DEACETYLATION,0.027188,0.20276,0.20538,1,1
2,GO RIBONUCLEOPROTEIN COMPLEX SUBUNIT ORGANIZATION,0.00012074,0.20188,0.20711,1,1
2,GO CRANIAL NERVE MORPHOGENESIS,0.033894,0.20162,0.20302,1,1
2,GO TRANSLATIONAL TERMINATION,0.0039469,0.20079,0.19092,1,1
2,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO CHROMOSOME,0.0034322,0.20069,0.15221,1,1
2,GO FEAR RESPONSE,0.0097392,0.19857,0.16602,1,1
2,GO NEUROMUSCULAR PROCESS CONTROLLING BALANCE,0.00050664,0.19822,0.19569,1,1
2,GO NCRNA PROCESSING,0.0012662,0.19782,0.18397,1,1
2,GO SNORNA METABOLIC PROCESS,0.0031536,0.1972,0.30796,1,1
2,GO INNER MITOCHONDRIAL MEMBRANE ORGANIZATION,0.0049174,0.19691,0.19162,1,1
2,GO HISTONE ARGININE METHYLATION,0.00067758,0.1969,0.2115,1,1
2,GO IRON COORDINATION ENTITY TRANSPORT,0.0062634,0.19677,0.19911,1,1
2,GO AMINO ACID IMPORT,0.0041716,0.19661,0.18047,1,1
2,GO POSITIVE REGULATION OF MRNA PROCESSING,2.6902e-06,0.19536,0.20291,1,1
2,GO L ALPHA AMINO ACID TRANSMEMBRANE TRANSPORT,0.00028792,0.19524,0.23795,1,1
2,GO NLS BEARING PROTEIN IMPORT INTO NUCLEUS,0.014841,0.19511,0.13259,1,1
2,GO MITOCHONDRIAL RNA METABOLIC PROCESS,0.0060989,0.19511,0.20831,1,1
2,GO RESPONSE TO PROSTAGLANDIN E,0.052669,0.1941,0.096069,1,1
2,GO AEROBIC RESPIRATION,0.0016129,0.1938,0.17211,1,1
2,GO RNA POLYADENYLATION,0.00042998,0.19367,0.14716,1,1
2,GO CELLULAR ANION HOMEOSTASIS,0.044685,0.19324,0.18555,1,1
2,GO FORMATION OF EXTRACHROMOSOMAL CIRCULAR DNA,0.017969,0.1928,0.15027,1,1
2,GO MRNA MODIFICATION,0.0007696,0.19273,0.23559,1,1
2,GO NEGATIVE REGULATION OF CATION CHANNEL ACTIVITY,0.0018173,0.19214,0.17905,1,1
2,GO DENDRITE SELF AVOIDANCE,0.041967,0.19194,0.1856,1,1
2,GO POSITIVE REGULATION OF LONG TERM SYNAPTIC POTENTIATION,0.001191,0.19124,0.22808,1,1
2,GO PLASMA MEMBRANE TUBULATION,0.011326,0.19059,0.15792,1,1
2,GO REGULATION OF DENDRITE DEVELOPMENT,0.00012074,0.19017,0.20882,1,1
2,GO RESPIRATORY GASEOUS EXCHANGE BY RESPIRATORY SYSTEM,0.0006154,0.18942,0.15551,1,1
2,GO PROTEIN NITROSYLATION,0.020205,0.18795,0.19961,1,1
2,GO MEMBRANE DISASSEMBLY,0.026586,0.1872,0.12351,1,1
2,GO REGULATION OF TRANSLATIONAL ELONGATION,0.0028141,0.18641,0.16102,1,1
2,GO NEGATIVE REGULATION OF CIRCADIAN RHYTHM,0.0039469,0.18635,0.20534,1,1
2,GO CRISTAE FORMATION,0.010773,0.18633,0.19498,1,1
2,GO NADH DEHYDROGENASE COMPLEX ASSEMBLY,0.001228,0.18625,0.18231,1,1
2,GO RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL BY ENDOPLASMIC RETICULUM,0.011047,0.18468,0.17127,1,1
2,GO MITOCHONDRIAL CALCIUM ION TRANSMEMBRANE TRANSPORT,0.0069616,0.18464,0.14181,1,1
2,GO FOREBRAIN CELL MIGRATION,0.00049035,0.18415,0.23235,1,1
2,GO POSITIVE REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,0.0016129,0.18413,0.17665,1,1
2,GO NEGATIVE REGULATION OF BEHAVIOR,0.0056288,0.18358,0.23025,1,1
2,GO CALCIUM ION IMPORT INTO CYTOSOL,0.024846,0.18345,0.22184,1,1
2,GO POSITIVE REGULATION OF CREB TRANSCRIPTION FACTOR ACTIVITY,0.045624,0.18289,0.16825,1,1
2,GO PEPTIDYL ARGININE METHYLATION,0.00032948,0.18283,0.21665,1,1
2,GO REGULATION OF CATION CHANNEL ACTIVITY,0.00026003,0.18249,0.2041,1,1
2,GO CYCLIC NUCLEOTIDE METABOLIC PROCESS,0.001191,0.18234,0.20343,1,1
2,GO BLOOD COAGULATION INTRINSIC PATHWAY,0.0049174,0.18212,0.1579,1,1
2,GO REGULATION OF OXIDATIVE PHOSPHORYLATION,0.007729,0.18164,0.17887,1,1
2,GO REGULATION OF CELLULAR RESPONSE TO HEAT,0.0007696,0.17987,0.13438,1,1
2,GO REGULATION OF PROTEIN KINASE A SIGNALING,0.0022992,0.17916,0.17914,1,1
2,GO POSITIVE REGULATION OF GLYCOLYTIC PROCESS,0.014841,0.17909,0.14522,1,1
2,GO RESPIRATORY ELECTRON TRANSPORT CHAIN,0.01282,0.17876,0.14442,1,1
2,GO SMOOTH MUSCLE CELL APOPTOTIC PROCESS,7.547e-05,0.17796,0.2271,1,1
2,GO PYRUVATE METABOLIC PROCESS,0.0045306,0.17695,0.12067,1,1
2,GO NEGATIVE REGULATION OF CALCIUM MEDIATED SIGNALING,0.0075304,0.17618,0.15109,1,1
2,GO CARDIAC LEFT VENTRICLE MORPHOGENESIS,0.0034322,0.17482,0.21853,1,1
2,GO SARCOPLASMIC RETICULUM CALCIUM ION TRANSPORT,0.0028957,0.17417,0.18703,1,1
2,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERASE,0.0023671,0.17411,0.13803,1,1
2,GO CELLULAR RESPIRATION,0.0041716,0.17387,0.14646,1,1
2,GO MITOCHONDRIAL RESPIRATORY CHAIN COMPLEX ASSEMBLY,0.0073363,0.17338,0.14406,1,1
2,GO POSITIVE REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,0.010245,0.17319,0.13409,1,1
2,GO HISTONE MRNA METABOLIC PROCESS,0.00027832,0.17269,0.15609,1,1
2,GO EXCRETION,0.0056288,0.17257,0.13673,1,1
2,GO REGULATION OF NERVOUS SYSTEM PROCESS,0.0010859,0.17212,0.20056,1,1
2,GO CELLULAR RESPONSE TO HEAT,0.0013457,0.17064,0.12044,1,1
2,GO L AMINO ACID TRANSPORT,0.00063551,0.17017,0.19111,1,1
2,GO CELLULAR RESPONSE TO NITRIC OXIDE,0.0067808,0.17,0.1241,1,1
2,GO REGULATION OF SYNAPTIC TRANSMISSION GABAERGIC,0.00353,0.16997,0.15308,1,1
2,GO REGULATION OF TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,0.00023468,0.16976,0.15496,1,1
2,GO POSITIVE REGULATION OF SODIUM ION TRANSPORT,0.0013457,0.16916,0.2218,1,1
2,GO HISTONE H3 K9 DEMETHYLATION,0.0083534,0.16904,0.19259,1,1
2,GO TRNA PROCESSING,0.00090094,0.16875,0.17937,1,1
2,GO NEGATIVE REGULATION OF LIPID CATABOLIC PROCESS,0.036948,0.16846,0.17184,1,1
2,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS,0.010506,0.16785,0.18837,1,1
2,GO HIPPOCAMPUS DEVELOPMENT,0.0054795,0.16721,0.20077,1,1
2,GO REGULATION OF SYNAPTIC VESICLE ENDOCYTOSIS,0.0064317,0.16709,0.21801,1,1
2,GO REGULATION OF SPINDLE CHECKPOINT,0.00092958,0.1669,0.14928,1,1
2,GO GUANOSINE CONTAINING COMPOUND METABOLIC PROCESS,0.0041716,0.16648,0.13209,1,1
2,GO RRNA METHYLATION,0.0081404,0.16645,0.18496,1,1
2,GO FOLIC ACID METABOLIC PROCESS,0.041967,0.16632,0.17031,1,1
2,GO CARBOHYDRATE PHOSPHORYLATION,0.012203,0.16623,0.14042,1,1
2,GO STRIATUM DEVELOPMENT,0.016339,0.16617,0.18751,1,1
2,GO POSITIVE REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL,0.0079323,0.16511,0.13868,1,1
2,GO MITOCHONDRIAL PROTEIN PROCESSING,0.01282,0.16366,0.17074,1,1
2,GO CYTOPLASMIC SEQUESTERING OF TRANSCRIPTION FACTOR,0.041093,0.16341,0.1333,1,1
2,GO CARDIAC CONDUCTION,0.010773,0.16145,0.15299,1,1
2,GO NEGATIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.010506,0.16121,0.17084,1,1
2,GO POTASSIUM ION IMPORT ACROSS PLASMA MEMBRANE,0.0059384,0.16057,0.19391,1,1
2,GO IRES DEPENDENT VIRAL TRANSLATIONAL INITIATION,0.011047,0.1597,0.20058,1,1
2,GO INORGANIC ION IMPORT ACROSS PLASMA MEMBRANE,0.0029794,0.15835,0.14723,1,1
2,GO MITOTIC DNA REPLICATION CHECKPOINT,0.010506,0.15666,0.14296,1,1
2,GO MICROTUBULE NUCLEATION BY MICROTUBULE ORGANIZING CENTER,0.046579,0.15659,0.12563,1,1
2,GO NEGATIVE REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,0.033894,0.15562,0.12154,1,1
2,GO NEGATIVE REGULATION OF PEPTIDE HORMONE SECRETION,0.029068,0.15409,0.1588,1,1
2,GO THYROID GLAND DEVELOPMENT,0.022165,0.15356,0.18117,1,1
2,GO TELOMERE MAINTENANCE VIA RECOMBINATION,0.012203,0.15294,0.16955,1,1
2,GO IMPORT INTO CELL,0.00031859,0.15268,0.16949,1,1
2,GO MRNA METHYLATION,0.01282,0.15177,0.19339,1,1
2,GO RESPONSE TO OXYGEN GLUCOSE DEPRIVATION,0.011326,0.15121,0.21752,1,1
2,GO REGULATION OF CARDIAC CONDUCTION,0.024846,0.15042,0.12439,1,1
2,GO RNA SURVEILLANCE,0.033894,0.1503,0.12882,1,1
2,GO REGULATION OF ENDOCYTIC RECYCLING,0.02268,0.14991,0.1987,1,1
2,GO SYNAPSE ASSEMBLY,0.012203,0.1488,0.16867,1,1
2,GO NEGATIVE REGULATION OF CAMP MEDIATED SIGNALING,0.044685,0.1478,0.14767,1,1
2,GO NCRNA METABOLIC PROCESS,0.0029794,0.14765,0.15371,1,1
2,GO POSITIVE REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.017137,0.14759,0.15602,1,1
2,GO REGULATION OF NUCLEOTIDE BIOSYNTHETIC PROCESS,0.041093,0.1475,0.12282,1,1
2,GO REGULATION OF TRANSLATIONAL INITIATION,0.00069957,0.1464,0.12066,1,1
2,GO POSITIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,0.015574,0.14537,0.10928,1,1
2,GO NEGATIVE REGULATION OF FAT CELL DIFFERENTIATION,0.035393,0.14524,0.11023,1,1
2,GO POSITIVE REGULATION OF CARBOHYDRATE METABOLIC PROCESS,0.007729,0.14423,0.10342,1,1
2,GO PROTEIN TARGETING,0.007729,0.14409,0.10904,1,1
2,GO TRICARBOXYLIC ACID CYCLE,0.0064317,0.14323,0.14307,1,1
2,GO TELOMERE MAINTENANCE IN RESPONSE TO DNA DAMAGE,0.00026003,0.14301,0.15939,1,1
2,GO POSITIVE REGULATION OF MRNA SPLICING VIA SPLICEOSOME,7.013e-05,0.14268,0.18832,1,1
2,GO PEPTIDE BIOSYNTHETIC PROCESS,0.0054795,0.14261,0.13749,1,1
2,GO CYTOPLASMIC SEQUESTERING OF PROTEIN,0.0053338,0.13936,0.16664,1,1
2,GO PROTEIN HETEROOLIGOMERIZATION,0.0020453,0.13918,0.15842,1,1
2,GO RNA CATABOLIC PROCESS,0.012203,0.13892,0.11055,1,1
2,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS EXONUCLEOLYTIC 3 5,0.03939,0.13858,0.17548,1,1
2,GO SYNAPTIC VESICLE RECYCLING,0.029719,0.13856,0.14167,1,1
2,GO NEGATIVE REGULATION OF ENDOCYTOSIS,0.041093,0.13814,0.09988,1,1
2,GO REPLICATION FORK PROCESSING,0.0040578,0.13801,0.13472,1,1
2,GO REGULATION OF MITOCHONDRIAL FISSION,0.03245,0.13664,0.1133,1,1
2,GO TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.0042883,0.13658,0.11355,1,1
2,GO REGULATION OF TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,0.0011549,0.13652,0.13207,1,1
2,GO REGULATION OF MRNA POLYADENYLATION,0.0014738,0.13645,0.12815,1,1
2,GO REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT,0.0026572,0.13362,0.13974,1,1
2,GO ARTERY DEVELOPMENT,0.049546,0.13343,0.062324,1,1
2,GO REGULATION OF CELL CYCLE ARREST,0.011047,0.13304,0.088991,1,1
2,GO RNA METHYLATION,0.0039469,0.1329,0.13947,1,1
2,GO DNA REPLICATION CHECKPOINT,0.0041716,0.13282,0.1289,1,1
2,GO REGULATION OF CALCIUM ION DEPENDENT EXOCYTOSIS,0.01282,0.13277,0.23479,1,1
2,GO NEUROMUSCULAR PROCESS,0.0060989,0.13239,0.14602,1,1
2,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION,0.0016129,0.1315,0.11326,1,1
2,GO AMINO ACID TRANSPORT,0.00016595,0.13054,0.1682,1,1
2,GO POSITIVE REGULATION OF TRANSLATION,0.0090226,0.13023,0.11092,1,1
2,GO CELLULAR PROTEIN COMPLEX DISASSEMBLY,0.0010206,0.12938,0.11393,1,1
2,GO COCHLEA DEVELOPMENT,0.0085714,0.12808,0.14509,1,1
2,GO RESPONSE TO AMPHETAMINE,0.045624,0.1275,0.13089,1,1
2,GO REGULATION OF TRANSCRIPTION OF NUCLEOLAR LARGE RRNA BY RNA POLYMERASE I,0.01282,0.12653,0.14995,1,1
2,GO METENCEPHALON DEVELOPMENT,0.0054795,0.12488,0.16011,1,1
2,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO MEMBRANE,0.0056288,0.12485,0.12084,1,1
2,GO TRNA TRANSPORT,0.007729,0.12413,0.1308,1,1
2,GO NUCLEOTIDE PHOSPHORYLATION,0.0047853,0.12371,0.12014,1,1
2,GO ATP METABOLIC PROCESS,0.0024367,0.12365,0.10989,1,1
2,GO NEGATIVE REGULATION OF CALCIUM ION TRANSPORT,0.02268,0.12358,0.10602,1,1
2,GO REGULATION OF MRNA PROCESSING,0.001228,0.12321,0.10397,1,1
2,GO PROTEOGLYCAN METABOLIC PROCESS,0.041093,0.12291,0.091021,1,1
2,GO BASE EXCISION REPAIR,0.017549,0.12253,0.087776,1,1
2,GO GLUTAMINE METABOLIC PROCESS,0.0031536,0.12242,0.15681,1,1
2,GO SODIUM ION TRANSMEMBRANE TRANSPORT,0.02843,0.12167,0.10248,1,1
2,GO REGULATION OF TRANSCRIPTION BY RNA POLYMERASE III,0.0039469,0.12166,0.10347,1,1
2,GO REGULATION OF PROTEIN TARGETING TO MEMBRANE,0.029719,0.12095,0.11361,1,1
2,GO REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,0.0075304,0.12071,0.11613,1,1
2,GO REGULATION OF CATION TRANSMEMBRANE TRANSPORT,0.011904,0.11981,0.10207,1,1
2,GO REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,0.0075304,0.11938,0.12948,1,1
2,GO POSITIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION,0.042857,0.11906,0.073813,1,1
2,GO REGULATION OF RNA POLYMERASE II TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.03939,0.11847,0.11502,1,1
2,GO AMIDE BIOSYNTHETIC PROCESS,0.0087944,0.11847,0.11837,1,1
2,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.0050528,0.11797,0.10938,1,1
2,GO NCRNA EXPORT FROM NUCLEUS,0.033166,0.11753,0.11239,1,1
2,GO POSITIVE REGULATION OF CATION CHANNEL ACTIVITY,0.036164,0.11708,0.11111,1,1
2,GO NUCLEOBASE CONTAINING SMALL MOLECULE INTERCONVERSION,0.024846,0.11601,0.12444,1,1
2,GO REGULATION OF MORPHOGENESIS OF A BRANCHING STRUCTURE,0.041967,0.11561,0.11825,1,1
2,GO PROTEIN LOCALIZATION TO MITOCHONDRION,0.007729,0.11555,0.076652,1,1
2,GO PROTEIN TETRAMERIZATION,0.00059588,0.11506,0.13276,1,1
2,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,0.0099891,0.11483,0.10236,1,1
2,GO REGULATION OF REGULATED SECRETORY PATHWAY,0.0013054,0.1146,0.172,1,1
2,GO NCRNA 3 END PROCESSING,0.01282,0.11383,0.095253,1,1
2,GO POSITIVE REGULATION OF DIGESTIVE SYSTEM PROCESS,0.015574,0.11325,0.13457,1,1
2,GO CELLULAR GLUCOSE HOMEOSTASIS,0.0047853,0.11257,0.11194,1,1
2,GO MUSCLE ORGAN MORPHOGENESIS,0.031059,0.11238,0.095715,1,1
2,GO POSITIVE REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,0.029068,0.11227,0.098242,1,1
2,GO EPHRIN RECEPTOR SIGNALING PATHWAY,0.033166,0.1119,0.10784,1,1
2,GO REGULATION OF RNA EXPORT FROM NUCLEUS,0.022165,0.11169,0.12288,1,1
2,GO CELLULAR RESPONSE TO DRUG,0.0085714,0.11156,0.12578,1,1
2,GO REGULATION OF NUCLEOTIDE METABOLIC PROCESS,0.016734,0.11143,0.084827,1,1
2,GO POSITIVE REGULATION OF CELLULAR CARBOHYDRATE METABOLIC PROCESS,0.033166,0.1105,0.076747,1,1
2,GO TELENCEPHALON DEVELOPMENT,0.0028141,0.11012,0.13391,1,1
2,GO SPERMATID NUCLEUS DIFFERENTIATION,0.036948,0.10884,0.10272,1,1
2,GO CALCIUM ION TRANSMEMBRANE TRANSPORT,0.0094949,0.10875,0.096243,1,1
2,GO NUCLEOBASE CONTAINING SMALL MOLECULE BIOSYNTHETIC PROCESS,0.009256,0.1067,0.12313,1,1
2,GO RNA 3 END PROCESSING,0.0064317,0.10664,0.082163,1,1
2,GO DNA TEMPLATED TRANSCRIPTION ELONGATION,0.0050528,0.10659,0.091621,1,1
2,GO MRNA 3 END PROCESSING,0.0075304,0.10424,0.078822,1,1
2,GO NEGATIVE REGULATION OF HISTONE METHYLATION,0.018398,0.10337,0.13184,1,1
2,GO G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY COUPLED TO CYCLIC NUCLEOTIDE SECOND MESSENGER,0.016734,0.1032,0.091181,1,1
2,GO POSITIVE REGULATION OF TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,0.02843,0.10275,0.079815,1,1
2,GO POTASSIUM ION TRANSPORT,0.035393,0.10273,0.1169,1,1
2,GO REGULATION OF SYSTEM PROCESS,0.016734,0.10271,0.089714,1,1
2,GO REGULATION OF CELL CYCLE CHECKPOINT,0.0037331,0.10232,0.09644,1,1
2,GO LEUKOCYTE TETHERING OR ROLLING,0.009256,0.1022,0.12556,1,1
2,GO TELOMERE ORGANIZATION,0.0059384,0.1018,0.092471,1,1
2,GO N TERMINAL PROTEIN AMINO ACID MODIFICATION,0.047551,0.10107,0.0937,1,1
2,GO REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.024846,0.10018,0.11791,1,1
2,GO NUCLEOTIDE EXCISION REPAIR DNA DAMAGE RECOGNITION,0.024288,0.099497,0.10904,1,1
2,GO MRNA METABOLIC PROCESS,0.0014299,0.099475,0.10604,1,1
2,GO ENERGY DERIVATION BY OXIDATION OF ORGANIC COMPOUNDS,0.024846,0.097809,0.086502,1,1
2,GO DNA TEMPLATED TRANSCRIPTION TERMINATION,0.004408,0.096457,0.12148,1,1
2,GO RNA PROCESSING,0.00044439,0.096204,0.11772,1,1
2,GO TERMINATION OF RNA POLYMERASE II TRANSCRIPTION,0.001986,0.096203,0.10604,1,1
2,GO INTERSTRAND CROSS LINK REPAIR,0.0028141,0.095757,0.09109,1,1
2,GO NUCLEOTIDE EXCISION REPAIR DNA INCISION,0.044685,0.095589,0.080866,1,1
2,GO RNA SPLICING VIA ENDONUCLEOLYTIC CLEAVAGE AND LIGATION,0.02268,0.093868,0.12209,1,1
2,GO NCRNA TRANSCRIPTION,0.0025083,0.093842,0.09324,1,1
2,GO MONOSACCHARIDE BIOSYNTHETIC PROCESS,0.024846,0.091317,0.082704,1,1
2,GO TRANSCRIPTION BY RNA POLYMERASE III,0.0094949,0.090542,0.090551,1,1
2,GO PHOSPHATE ION TRANSPORT,0.02166,0.089491,0.090965,1,1
2,GO DNA DEPENDENT DNA REPLICATION,0.020205,0.089143,0.079149,1,1
2,GO REGULATION OF CALCIUM ION TRANSPORT,0.029068,0.08883,0.090382,1,1
2,GO POSITIVE REGULATION OF GENE EXPRESSION EPIGENETIC,0.037747,0.087362,0.086978,1,1
2,GO RNA SPLICING VIA TRANSESTERIFICATION REACTIONS,0.0012662,0.08686,0.10335,1,1
2,GO PALLIUM DEVELOPMENT,0.011612,0.086703,0.12236,1,1
2,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE,0.025994,0.082868,0.082697,1,1
2,GO PROTEIN HETEROTETRAMERIZATION,0.0050528,0.082708,0.13026,1,1
2,GO MRNA PROCESSING,0.0010859,0.07968,0.091229,1,1
2,GO TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,0.016339,0.07527,0.067584,1,1
2,GO RNA SPLICING,0.0023671,0.072933,0.085108,1,1
2,GO CELL SURFACE RECEPTOR SIGNALING PATHWAY INVOLVED IN CELL CELL SIGNALING,0.036164,0.061913,0.066182,1,1
2,GO NEGATIVE REGULATION OF DNA METABOLIC PROCESS,0.037747,0.053063,0.05135,1,1
2,GO CARDIAC VENTRICLE MORPHOGENESIS,0.036164,0.048604,0.11244,1,1
3,GO ANTIGEN PROCESSING AND PRESENTATION OF ENDOGENOUS PEPTIDE ANTIGEN,0.00024286,1.6395,1.2343,1,1
3,GO ANTIGEN PROCESSING AND PRESENTATION OF ENDOGENOUS ANTIGEN,0.00025131,1.3107,0.98562,1,1
3,GO REGULATION OF DENDRITIC CELL DIFFERENTIATION,7.5427e-07,1.2926,1.2254,1,1
3,GO CYTIDINE TO URIDINE EDITING,2.3418e-05,0.87532,0.75995,1,1
3,GO ANTIGEN PROCESSING AND PRESENTATION VIA MHC CLASS IB,0.00087311,0.87266,0.68576,1,1
3,GO NERVOUS SYSTEM PROCESS INVOLVED IN REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,3.5759e-05,0.8674,0.72023,1,1
3,GO MATURE B CELL DIFFERENTIATION INVOLVED IN IMMUNE RESPONSE,9.0179e-06,0.84588,0.65533,1,1
3,GO TOLERANCE INDUCTION,1.0604e-05,0.79848,0.72928,1,1
3,GO BRANCHING INVOLVED IN LABYRINTHINE LAYER MORPHOGENESIS,3.1904e-06,0.77816,0.80166,1,1
3,GO MUCUS SECRETION,0.0001165,0.76818,0.64236,1,1
3,GO PROGESTERONE METABOLIC PROCESS,2.5308e-05,0.76646,0.89138,1,1
3,GO GLYCOSIDE METABOLIC PROCESS,0.00034072,0.76369,0.8256,1,1
3,GO POSITIVE REGULATION OF T CELL MEDIATED CYTOTOXICITY,0.00087311,0.75446,0.53117,1,1
3,GO POSITIVE REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,3.3287e-06,0.75103,0.66387,1,1
3,GO HISTAMINE SECRETION,2.6322e-07,0.72977,0.76558,1,1
3,GO LIPID DROPLET FORMATION,1.9904e-06,0.72109,0.717,1,1
3,GO EOSINOPHIL CHEMOTAXIS,3.7145e-05,0.70833,0.52409,1,1
3,GO REGULATION OF PLASMINOGEN ACTIVATION,0.0028957,0.67893,0.44564,1,1
3,GO SIGNALING RECEPTOR LIGAND PRECURSOR PROCESSING,0.00045924,0.67161,0.55164,1,1
3,GO REGULATION OF T CELL MEDIATED CYTOTOXICITY,0.00040247,0.65651,0.51015,1,1
3,GO RESPONSE TO TYPE I INTERFERON,1.5816e-05,0.6564,0.61199,1,1
3,GO NEGATIVE REGULATION OF VIRAL GENOME REPLICATION,9.389e-05,0.65203,0.49497,1,1
3,GO FATTY ACID DERIVATIVE CATABOLIC PROCESS,3.3287e-06,0.6518,0.60856,1,1
3,GO HISTAMINE TRANSPORT,6.0198e-07,0.64859,0.70122,1,1
3,GO ACTIN FILAMENT NETWORK FORMATION,0.00032948,0.64318,0.49791,1,1
3,GO NEGATIVE REGULATION OF MYOTUBE DIFFERENTIATION,5.4272e-08,0.64091,0.6443,1,1
3,GO NEGATIVE REGULATION OF GLYCOLYTIC PROCESS,0.00025131,0.63787,0.51859,1,1
3,GO RESPONSE TO IMMOBILIZATION STRESS,7.2111e-07,0.63728,0.54152,1,1
3,GO EOSINOPHIL MIGRATION,5.2139e-05,0.635,0.50112,1,1
3,GO LIPID DIGESTION,5.7413e-06,0.6329,0.65297,1,1
3,GO INTESTINAL LIPID ABSORPTION,1.0779e-06,0.63284,0.72986,1,1
3,GO DENDRITIC CELL DIFFERENTIATION,8.6584e-06,0.62672,0.53198,1,1
3,GO REGULATION OF VITAMIN METABOLIC PROCESS,2.1663e-05,0.62499,0.60286,1,1
3,GO GERMINAL CENTER FORMATION,6.5149e-05,0.62464,0.50613,1,1
3,GO T CELL MEDIATED CYTOTOXICITY,0.00044439,0.6241,0.46851,1,1
3,GO CALCIUM INDEPENDENT CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES,1.6455e-05,0.61712,0.60264,1,1
3,GO REGULATION OF LIPOPROTEIN METABOLIC PROCESS,5.4121e-05,0.61535,0.46017,1,1
3,GO MATURE B CELL DIFFERENTIATION,3.1888e-05,0.61012,0.44787,1,1
3,GO RENAL ABSORPTION,1.4039e-05,0.60893,0.6637,1,1
3,GO INTESTINAL ABSORPTION,3.6563e-08,0.60799,0.7016,1,1
3,GO POSITIVE REGULATION OF HORMONE METABOLIC PROCESS,0.00090094,0.6077,0.49668,1,1
3,GO POSITIVE REGULATION OF CELL MATURATION,5.7413e-06,0.60589,0.56994,1,1
3,GO SEROTONIN METABOLIC PROCESS,2.7343e-05,0.60488,0.59991,1,1
3,GO REGULATION OF TOLERANCE INDUCTION,2.9532e-05,0.60097,0.59853,1,1
3,GO PRIMARY AMINO COMPOUND METABOLIC PROCESS,2.5774e-06,0.60002,0.59075,1,1
3,GO INTERFERON GAMMA MEDIATED SIGNALING PATHWAY,2.9532e-05,0.59911,0.54725,1,1
3,GO SPHINGOMYELIN METABOLIC PROCESS,3.3202e-07,0.59359,0.55486,1,1
3,GO ORGAN OR TISSUE SPECIFIC IMMUNE RESPONSE,1.2962e-05,0.5878,0.47106,1,1
3,GO NEGATIVE REGULATION OF HUMORAL IMMUNE RESPONSE,5.4121e-05,0.58767,0.57658,1,1
3,GO TOLL LIKE RECEPTOR 2 SIGNALING PATHWAY,0.00014935,0.58478,0.59576,1,1
3,GO NEGATIVE REGULATION OF MUSCLE ADAPTATION,0.0013457,0.58407,0.55109,1,1
3,GO DETECTION OF EXTERNAL BIOTIC STIMULUS,2.2524e-05,0.58031,0.56023,1,1
3,GO NEGATIVE REGULATION OF B CELL APOPTOTIC PROCESS,9.7801e-06,0.5764,0.54905,1,1
3,GO TERTIARY ALCOHOL METABOLIC PROCESS,0.00069957,0.57526,0.61019,1,1
3,GO DETECTION OF OTHER ORGANISM,1.0604e-05,0.57053,0.58636,1,1
3,GO LEYDIG CELL DIFFERENTIATION,0.00010462,0.56517,0.54152,1,1
3,GO QUINONE METABOLIC PROCESS,6.0504e-05,0.56322,0.64371,1,1
3,GO RESPONSE TO NITROSATIVE STRESS,1.7118e-05,0.5629,0.53522,1,1
3,GO ADHESION OF SYMBIONT TO HOST,0.00022676,0.56022,0.46356,1,1
3,GO ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.00022676,0.55884,0.49921,1,1
3,GO REGULATION OF CD8 POSITIVE ALPHA BETA T CELL ACTIVATION,3.0689e-05,0.55526,0.50585,1,1
3,GO GROWTH HORMONE RECEPTOR SIGNALING PATHWAY VIA JAK STAT,2.0833e-05,0.55286,0.5271,1,1
3,GO NEGATIVE REGULATION OF RECEPTOR BINDING,0.0001547,0.54408,0.52954,1,1
3,GO O GLYCAN PROCESSING,7.2111e-07,0.54305,0.52944,1,1
3,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY RENIN ANGIOTENSIN,0.00084609,0.54259,0.59125,1,1
3,GO NEGATIVE REGULATION OF B CELL MEDIATED IMMUNITY,1.104e-05,0.54053,0.62316,1,1
3,GO TOXIN METABOLIC PROCESS,2.0784e-06,0.53844,0.52619,1,1
3,GO REGULATION OF SUPEROXIDE ANION GENERATION,0.00013433,0.53687,0.50055,1,1
3,GO NEGATIVE REGULATION OF VIRAL LIFE CYCLE,0.00032948,0.53607,0.38023,1,1
3,GO NEGATIVE REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,8.7323e-05,0.53324,0.48941,1,1
3,GO POSITIVE REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,1.9904e-06,0.53172,0.5471,1,1
3,GO KETONE CATABOLIC PROCESS,0.00011241,0.53151,0.47323,1,1
3,GO NEGATIVE REGULATION OF PLATELET ACTIVATION,0.00028792,0.53068,0.40979,1,1
3,GO NEGATIVE REGULATION OF ANOIKIS,4.6597e-05,0.52772,0.64403,1,1
3,GO MONOCYTE CHEMOTACTIC PROTEIN 1 PRODUCTION,0.011612,0.52689,0.30699,1,1
3,GO REGULATION OF PLATELET AGGREGATION,0.00012512,0.52634,0.44624,1,1
3,GO AMMONIUM ION METABOLIC PROCESS,1.2454e-05,0.52345,0.51454,1,1
3,GO CERAMIDE CATABOLIC PROCESS,0.0045306,0.51734,0.39034,1,1
3,GO NEGATIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,0.00021909,0.51501,0.39108,1,1
3,GO RESPONSE TO EPINEPHRINE,0.0025817,0.51035,0.35664,1,1
3,GO POSITIVE REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,8.7323e-05,0.50897,0.40789,1,1
3,GO REGULATION OF KETONE BIOSYNTHETIC PROCESS,0.0022332,0.50882,0.38007,1,1
3,GO POSITIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.0001165,0.50847,0.43982,1,1
3,GO NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,7.0571e-06,0.50785,0.51253,1,1
3,GO CHEMOKINE C X C MOTIF LIGAND 2 PRODUCTION,7.013e-05,0.50746,0.46987,1,1
3,GO NEGATIVE REGULATION OF TISSUE REMODELING,1.2454e-05,0.50249,0.48074,1,1
3,GO RETINAL METABOLIC PROCESS,0.00026903,0.50162,0.57734,1,1
3,GO NOTCH SIGNALING INVOLVED IN HEART DEVELOPMENT,0.00010462,0.49794,0.45921,1,1
3,GO RESPONSE TO COLD,5.9841e-06,0.49588,0.42409,1,1
3,GO NEGATIVE REGULATION OF MULTICELLULAR ORGANISM GROWTH,0.0022992,0.49544,0.36968,1,1
3,GO RESPONSE TO INTERLEUKIN 18,0.0022332,0.49506,0.45426,1,1
3,GO EXTRACELLULAR MATRIX CONSTITUENT SECRETION,0.00032948,0.4949,0.53046,1,1
3,GO REGULATION OF WATER LOSS VIA SKIN,3.3132e-05,0.49381,0.46694,1,1
3,GO MYD88 DEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY,4.6623e-06,0.48662,0.42753,1,1
3,GO CATECHOLAMINE BIOSYNTHETIC PROCESS,0.00014935,0.48639,0.50168,1,1
3,GO POSITIVE REGULATION OF ALPHA BETA T CELL PROLIFERATION,0.00031859,0.48408,0.36877,1,1
3,GO NEGATIVE REGULATION OF ANION TRANSMEMBRANE TRANSPORT,0.00014418,0.48394,0.43873,1,1
3,GO EPITHELIAL CELL MORPHOGENESIS,0.00025131,0.47659,0.40172,1,1
3,GO REGULATION OF B CELL APOPTOTIC PROCESS,2.8418e-05,0.4758,0.44633,1,1
3,GO NEGATIVE REGULATION OF VIRAL PROCESS,0.00023468,0.4749,0.34177,1,1
3,GO REGULATION OF GLOMERULUS DEVELOPMENT,0.00069957,0.47287,0.45078,1,1
3,GO MEMBRANE LIPID CATABOLIC PROCESS,3.5759e-05,0.4714,0.45476,1,1
3,GO LABYRINTHINE LAYER MORPHOGENESIS,0.00057693,0.47018,0.4776,1,1
3,GO SECONDARY METABOLIC PROCESS,6.7596e-05,0.46942,0.43603,1,1
3,GO DETECTION OF MOLECULE OF BACTERIAL ORIGIN,0.00055855,0.46618,0.42183,1,1
3,GO REGULATION OF METALLOPEPTIDASE ACTIVITY,0.0031536,0.46573,0.34936,1,1
3,GO NEGATIVE REGULATION OF BONE REMODELING,2.1663e-05,0.46518,0.49516,1,1
3,GO REGULATION OF PLATELET ACTIVATION,1.4039e-05,0.46359,0.41499,1,1
3,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY CIRCULATORY RENIN ANGIOTENSIN,0.0010528,0.46193,0.46487,1,1
3,GO AMINE BIOSYNTHETIC PROCESS,1.3605e-07,0.46157,0.47968,1,1
3,GO L PHENYLALANINE METABOLIC PROCESS,3.7145e-05,0.4614,0.6391,1,1
3,GO REGULATION OF INTEGRIN ACTIVATION,2.1702e-06,0.45984,0.48183,1,1
3,GO NEGATIVE REGULATION OF INNATE IMMUNE RESPONSE,0.00031859,0.45942,0.37456,1,1
3,GO REGULATION OF NEURON MATURATION,4.1112e-06,0.45856,0.43617,1,1
3,GO FRUCTOSE METABOLIC PROCESS,0.0024367,0.4567,0.49806,1,1
3,GO RESPONSE TO REDOX STATE,5.0683e-06,0.4565,0.42445,1,1
3,GO REGULATION OF BONE REMODELING,4.2876e-06,0.4563,0.44374,1,1
3,GO NEGATIVE REGULATION OF REGULATED SECRETORY PATHWAY,2.0833e-05,0.45616,0.40425,1,1
3,GO CELL DIFFERENTIATION INVOLVED IN EMBRYONIC PLACENTA DEVELOPMENT,2.1663e-05,0.45455,0.50848,1,1
3,GO ATF6 MEDIATED UNFOLDED PROTEIN RESPONSE,0.0001547,0.45412,0.5093,1,1
3,GO NUCLEOTIDE SUGAR TRANSMEMBRANE TRANSPORT,1.6455e-05,0.45388,0.50209,1,1
3,GO REGULATION OF ANOIKIS,0.00010462,0.45357,0.49197,1,1
3,GO NEGATIVE REGULATION OF LIPID BIOSYNTHETIC PROCESS,2.9532e-05,0.45325,0.36132,1,1
3,GO POSITIVE REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.00014418,0.45175,0.39616,1,1
3,GO RESPONSE TO STEROL DEPLETION,3.3287e-06,0.44979,0.50004,1,1
3,GO RESPONSE TO DIETARY EXCESS,0.00014418,0.44928,0.41616,1,1
3,GO ZYMOGEN ACTIVATION,0.00019079,0.44914,0.39656,1,1
3,GO RENAL SYSTEM PROCESS INVOLVED IN REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.00059588,0.44804,0.36996,1,1
3,GO TOLL LIKE RECEPTOR 3 SIGNALING PATHWAY,0.0010206,0.44773,0.3429,1,1
3,GO MICROVILLUS ORGANIZATION,0.00019753,0.44611,0.38749,1,1
3,GO LONG CHAIN FATTY ACID CATABOLIC PROCESS,0.00026903,0.44608,0.51779,1,1
3,GO HEPATOCYTE APOPTOTIC PROCESS,0.0012662,0.4457,0.47213,1,1
3,GO BASE CONVERSION OR SUBSTITUTION EDITING,3.7145e-05,0.4452,0.42901,1,1
3,GO PHAGOLYSOSOME ASSEMBLY,4.4712e-06,0.44519,0.45778,1,1
3,GO REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,1.9904e-06,0.4441,0.46047,1,1
3,GO MACROPHAGE ACTIVATION INVOLVED IN IMMUNE RESPONSE,6.2786e-05,0.44309,0.44317,1,1
3,GO BONE RESORPTION,1.8251e-06,0.44246,0.44254,1,1
3,GO REGULATION OF ACROSOME REACTION,0.0010206,0.44121,0.40828,1,1
3,GO CELLULAR RESPONSE TO GROWTH HORMONE STIMULUS,8.3127e-06,0.44076,0.47936,1,1
3,GO IMMUNOLOGICAL SYNAPSE FORMATION,0.013798,0.43999,0.32229,1,1
3,GO RESPONSE TO STIMULUS INVOLVED IN REGULATION OF MUSCLE ADAPTATION,7.547e-05,0.43938,0.45171,1,1
3,GO NEUROTRANSMITTER BIOSYNTHETIC PROCESS,0.0033369,0.43937,0.3515,1,1
3,GO NEGATIVE REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,0.00087311,0.43885,0.36367,1,1
3,GO REGULATION OF TISSUE REMODELING,3.9418e-06,0.43875,0.39641,1,1
3,GO SIGNAL PEPTIDE PROCESSING,5.2139e-05,0.43827,0.41736,1,1
3,GO GALACTOSE METABOLIC PROCESS,0.001662,0.4369,0.45424,1,1
3,GO MAINTENANCE OF GASTROINTESTINAL EPITHELIUM,3.8583e-05,0.43678,0.40439,1,1
3,GO ALPHA BETA T CELL PROLIFERATION,2.6307e-05,0.43613,0.39232,1,1
3,GO REGULATION OF PROTEIN COMPLEX STABILITY,1.4039e-05,0.43454,0.39546,1,1
3,GO CELLULAR RESPONSE TO COPPER ION,0.004408,0.43409,0.55022,1,1
3,GO PARTURITION,0.0037331,0.43332,0.30792,1,1
3,GO POSITIVE REGULATION OF CELL MATRIX ADHESION,0.00047456,0.43277,0.36445,1,1
3,GO POSITIVE REGULATION OF OSTEOBLAST PROLIFERATION,2.1663e-05,0.43262,0.4469,1,1
3,GO REGULATORY T CELL DIFFERENTIATION,0.00019079,0.43202,0.36969,1,1
3,GO IMMUNOGLOBULIN SECRETION,5.6174e-05,0.4306,0.3827,1,1
3,GO NEGATIVE REGULATION OF INTERLEUKIN 1 PRODUCTION,6.5149e-05,0.4304,0.46867,1,1
3,GO POSITIVE REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,2.9532e-05,0.43023,0.39753,1,1
3,GO REGULATION OF CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS,0.0011199,0.42959,0.31217,1,1
3,GO LIVER MORPHOGENESIS,7.8282e-05,0.42898,0.40022,1,1
3,GO CELL ADHESION MEDIATED BY INTEGRIN,6.0504e-05,0.4289,0.38955,1,1
3,GO ACTIN FILAMENT SEVERING,0.0015189,0.42814,0.37536,1,1
3,GO PLASMINOGEN ACTIVATION,0.0013054,0.42654,0.4091,1,1
3,GO POSITIVE REGULATION OF FERTILIZATION,0.0013457,0.42406,0.32864,1,1
3,GO NEUROTRANSMITTER METABOLIC PROCESS,2.0833e-05,0.42364,0.39734,1,1
3,GO INTRACELLULAR STEROL TRANSPORT,7.0571e-06,0.42364,0.39636,1,1
3,GO POSITIVE REGULATION OF HETEROTYPIC CELL CELL ADHESION,0.010245,0.42357,0.33641,1,1
3,GO REGULATION OF VIRAL GENOME REPLICATION,0.00031859,0.42207,0.30007,1,1
3,GO REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,1.4044e-06,0.41896,0.47841,1,1
3,GO B CELL APOPTOTIC PROCESS,2.6902e-06,0.41876,0.44159,1,1
3,GO REGULATION OF CHOLESTEROL ESTERIFICATION,0.00063551,0.41822,0.45735,1,1
3,GO CELLULAR DEFENSE RESPONSE,1.9904e-06,0.41768,0.42557,1,1
3,GO MUSCLE ATROPHY,0.0010859,0.41647,0.32484,1,1
3,GO NEGATIVE REGULATION OF INTERLEUKIN 1 BETA PRODUCTION,9.0551e-05,0.41596,0.43354,1,1
3,GO CELLULAR RESPONSE TO PURINE CONTAINING COMPOUND,0.0056288,0.41593,0.36462,1,1
3,GO POSITIVE REGULATION OF NEUTROPHIL MIGRATION,0.00030804,0.41464,0.31632,1,1
3,GO REGULATION OF OSTEOCLAST DEVELOPMENT,2.0833e-05,0.41406,0.43307,1,1
3,GO REGULATION OF T CELL CYTOKINE PRODUCTION,0.001228,0.41176,0.29283,1,1
3,GO T CELL MEDIATED IMMUNITY,0.00027832,0.41129,0.31105,1,1
3,GO PROTEIN DEMANNOSYLATION,6.0504e-05,0.41112,0.3994,1,1
3,GO PLASMA MEMBRANE PHOSPHOLIPID SCRAMBLING,6.2786e-05,0.41045,0.40771,1,1
3,GO VITAMIN D METABOLIC PROCESS,1.6455e-05,0.41001,0.3978,1,1
3,GO POSITIVE REGULATION OF T CELL MEDIATED IMMUNITY,0.0013054,0.40728,0.31466,1,1
3,GO BARBED END ACTIN FILAMENT CAPPING,0.00020448,0.40717,0.42964,1,1
3,GO INOSITOL TRISPHOSPHATE METABOLIC PROCESS,0.00052342,0.40716,0.39898,1,1
3,GO REGULATION OF TRANSMISSION OF NERVE IMPULSE,0.00084609,0.40573,0.37751,1,1
3,GO FOAM CELL DIFFERENTIATION,0.00012512,0.40448,0.3095,1,1
3,GO POSITIVE REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,0.00353,0.40342,0.30877,1,1
3,GO NEGATIVE REGULATION OF T CELL MEDIATED IMMUNITY,5.0226e-05,0.40314,0.34233,1,1
3,GO REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,0.00019079,0.40249,0.36185,1,1
3,GO ACTIVATION OF ADENYLATE CYCLASE ACTIVITY,0.00030804,0.40242,0.27953,1,1
3,GO REGULATION OF SPHINGOLIPID BIOSYNTHETIC PROCESS,5.7413e-06,0.40206,0.36594,1,1
3,GO STEROID ESTERIFICATION,0.00028792,0.40201,0.44248,1,1
3,GO NATURAL KILLER CELL MEDIATED IMMUNITY,2.8418e-05,0.40164,0.34707,1,1
3,GO LUNG CELL DIFFERENTIATION,0.00012964,0.40107,0.48516,1,1
3,GO NEGATIVE REGULATION OF ALPHA BETA T CELL PROLIFERATION,0.001986,0.3998,0.415,1,1
3,GO MITOCHONDRIAL DEPOLARIZATION,8.6584e-06,0.39919,0.38599,1,1
3,GO MYD88 INDEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY,5.6174e-05,0.39901,0.36721,1,1
3,GO IMMUNOLOGICAL MEMORY PROCESS,6.0504e-05,0.39885,0.38348,1,1
3,GO VITAMIN D BIOSYNTHETIC PROCESS,0.00011241,0.39883,0.38594,1,1
3,GO REGULATION OF DEVELOPMENT HETEROCHRONIC,0.0027346,0.39844,0.39987,1,1
3,GO PROSTANOID METABOLIC PROCESS,0.00036427,0.39715,0.41218,1,1
3,GO REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,4.4878e-05,0.39655,0.35278,1,1
3,GO POSITIVE REGULATION OF ASTROCYTE DIFFERENTIATION,0.011612,0.39619,0.34872,1,1
3,GO REGULATION OF VIRAL LIFE CYCLE,0.00021167,0.39616,0.29339,1,1
3,GO POSITIVE REGULATION OF WOUND HEALING,3.4421e-05,0.39602,0.37055,1,1
3,GO DIGESTION,7.889e-07,0.39593,0.3712,1,1
3,GO REGULATION OF PROTEIN GLYCOSYLATION,4.3218e-05,0.3955,0.49612,1,1
3,GO REGULATION OF T CELL MEDIATED IMMUNITY,0.00067758,0.39438,0.29028,1,1
3,GO INSEMINATION,0.00038934,0.39401,0.36693,1,1
3,GO REGULATION OF ASPARTIC TYPE PEPTIDASE ACTIVITY,0.00092958,0.39378,0.47311,1,1
3,GO TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY,0.00022676,0.39346,0.31452,1,1
3,GO RESPONSE TO THYROID HORMONE,0.0018173,0.39334,0.26873,1,1
3,GO RESPONSE TO INTERFERON GAMMA,0.00032948,0.39285,0.31992,1,1
3,GO RESPONSE TO LITHIUM ION,1.4674e-06,0.39243,0.51347,1,1
3,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,5.9841e-06,0.39231,0.41743,1,1
3,GO DIGESTIVE SYSTEM PROCESS,6.8936e-07,0.39141,0.34897,1,1
3,GO INNER EAR AUDITORY RECEPTOR CELL DIFFERENTIATION,1.6455e-05,0.39121,0.37349,1,1
3,GO CD8 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.00081984,0.39069,0.45478,1,1
3,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.0013872,0.3894,0.32031,1,1
3,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.00081984,0.38709,0.2602,1,1
3,GO BILE ACID AND BILE SALT TRANSPORT,0.00012512,0.38681,0.58946,1,1
3,GO RESPONSE TO COPPER ION,0.00017796,0.38601,0.52715,1,1
3,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY HORMONE,0.0018173,0.3855,0.41416,1,1
3,GO ANOIKIS,2.0833e-05,0.38393,0.39349,1,1
3,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,8.1192e-05,0.38254,0.28698,1,1
3,GO NEGATIVE REGULATION OF EXOCYTOSIS,0.00018427,0.38238,0.32261,1,1
3,GO BRANCHED CHAIN AMINO ACID TRANSPORT,0.0069616,0.38197,0.4271,1,1
3,GO ACTIVATION OF NF KAPPAB INDUCING KINASE ACTIVITY,0.00016023,0.38134,0.36364,1,1
3,GO DEFENSE RESPONSE TO VIRUS,0.00017186,0.38114,0.27926,1,1
3,GO CD8 POSITIVE ALPHA BETA T CELL ACTIVATION,3.5759e-05,0.38112,0.42995,1,1
3,GO REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,7.547e-05,0.38098,0.33108,1,1
3,GO NEGATIVE REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.0022992,0.38048,0.3271,1,1
3,GO SUPEROXIDE ANION GENERATION,9.389e-05,0.37997,0.39988,1,1
3,GO POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.0039469,0.37898,0.32624,1,1
3,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,0.00025131,0.37869,0.31157,1,1
3,GO REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,4.2876e-06,0.37814,0.36341,1,1
3,GO POSITIVE REGULATION OF CELL KILLING,6.2786e-05,0.37695,0.34194,1,1
3,GO AROMATIC AMINO ACID FAMILY METABOLIC PROCESS,3.7145e-05,0.37683,0.32027,1,1
3,GO POSITIVE REGULATION OF CALCINEURIN MEDIATED SIGNALING,0.00017186,0.3757,0.34279,1,1
3,GO ACUTE PHASE RESPONSE,0.00021167,0.37529,0.32725,1,1
3,GO NEGATIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,0.0025083,0.37501,0.26456,1,1
3,GO RESPONSE TO MAGNESIUM ION,9.7346e-05,0.37406,0.44349,1,1
3,GO PHOSPHATIDYLCHOLINE BIOSYNTHETIC PROCESS,3.7791e-06,0.37397,0.34945,1,1
3,GO REGULATION OF BICELLULAR TIGHT JUNCTION ASSEMBLY,2.7343e-05,0.37373,0.42972,1,1
3,GO REGULATION OF VASCULOGENESIS,0.0011549,0.37368,0.36563,1,1
3,GO HYDROGEN PEROXIDE BIOSYNTHETIC PROCESS,0.0020453,0.37284,0.29401,1,1
3,GO REGULATION OF LAMELLIPODIUM MORPHOGENESIS,0.0030654,0.37254,0.4588,1,1
3,GO CORTICOSTEROID HORMONE SECRETION,0.0033369,0.37233,0.33497,1,1
3,GO CYCLOOXYGENASE PATHWAY,0.0020453,0.372,0.44842,1,1
3,GO REGULATION OF LEUKOCYTE DEGRANULATION,0.00035231,0.37067,0.2925,1,1
3,GO REGULATION OF SUPEROXIDE METABOLIC PROCESS,0.00030804,0.37066,0.33769,1,1
3,GO NEGATIVE REGULATION OF IMMUNE RESPONSE,0.00026003,0.37055,0.29114,1,1
3,GO NEGATIVE REGULATION OF CYTOKINE BIOSYNTHETIC PROCESS,4.3218e-05,0.36972,0.41666,1,1
3,GO NEGATIVE REGULATION OF B CELL ACTIVATION,1.2962e-05,0.36967,0.34072,1,1
3,GO POSITIVE REGULATION OF TRANSFORMING GROWTH FACTOR BETA PRODUCTION,0.00050664,0.36963,0.2913,1,1
3,GO PROTEIN O LINKED GLYCOSYLATION,4.4712e-06,0.36949,0.35196,1,1
3,GO VASODILATION,0.00087311,0.36921,0.37171,1,1
3,GO GLYCOSYLCERAMIDE METABOLIC PROCESS,8.1192e-05,0.36893,0.39497,1,1
3,GO TISSUE REMODELING,9.0179e-06,0.36757,0.32564,1,1
3,GO POSITIVE REGULATION OF RESPONSE TO CYTOKINE STIMULUS,2.4346e-05,0.36748,0.34456,1,1
3,GO POSITIVE REGULATION OF B CELL PROLIFERATION,4.0073e-05,0.36738,0.33572,1,1
3,GO MOVEMENT IN HOST ENVIRONMENT,0.00042998,0.36725,0.24301,1,1
3,GO REGULATION OF HORMONE METABOLIC PROCESS,0.0030654,0.36696,0.30704,1,1
3,GO CARBOHYDRATE DERIVATIVE TRANSPORT,8.628e-07,0.36681,0.37198,1,1
3,GO POSITIVE REGULATION OF RESPONSE TO WOUNDING,0.00020448,0.36623,0.29299,1,1
3,GO NEGATIVE REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS,0.001662,0.3658,0.28283,1,1
3,GO REGULATION OF LIGASE ACTIVITY,0.00067758,0.36499,0.2583,1,1
3,GO CELLULAR RESPONSE TO LOW DENSITY LIPOPROTEIN PARTICLE STIMULUS,0.00016595,0.3648,0.34301,1,1
3,GO POSITIVE REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,5.0226e-05,0.36475,0.29758,1,1
3,GO LIPID TRANSLOCATION,1.349e-05,0.36472,0.31147,1,1
3,GO CELL MIGRATION INVOLVED IN GASTRULATION,0.0014738,0.36363,0.37241,1,1
3,GO REGULATION OF ICOSANOID SECRETION,1.0779e-06,0.36362,0.41412,1,1
3,GO CELLULAR RESPONSE TO DEXAMETHASONE STIMULUS,0.00081984,0.36353,0.28463,1,1
3,GO LEUKOCYTE MEDIATED CYTOTOXICITY,9.389e-05,0.36257,0.28969,1,1
3,GO POSITIVE REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,0.00081984,0.36177,0.36524,1,1
3,GO CELLULAR RESPONSE TO THYROID HORMONE STIMULUS,0.0059384,0.36123,0.27541,1,1
3,GO CELLULAR RESPONSE TO CADMIUM ION,0.0023671,0.36122,0.39804,1,1
3,GO PHOSPHATIDYLSERINE METABOLIC PROCESS,4.0073e-05,0.3603,0.29965,1,1
3,GO RESPONSE TO INTERLEUKIN 2,2.5308e-05,0.35966,0.31278,1,1
3,GO SERINE PHOSPHORYLATION OF STAT PROTEIN,0.00050664,0.35926,0.33338,1,1
3,GO EPOXYGENASE P450 PATHWAY,0.014138,0.3591,0.2668,1,1
3,GO REGULATION OF DEFENSE RESPONSE TO VIRUS BY HOST,0.00032948,0.35869,0.31403,1,1
3,GO REGULATION OF COAGULATION,0.00055855,0.35867,0.30451,1,1
3,GO VIRAL GENOME REPLICATION,0.00030804,0.35831,0.25823,1,1
3,GO REGULATION OF EXOSOMAL SECRETION,2.9532e-05,0.35826,0.31466,1,1
3,GO ENDOTHELIAL CELL CHEMOTAXIS,0.00069957,0.35821,0.31966,1,1
3,GO REGULATION OF TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY,0.00098941,0.35807,0.32382,1,1
3,GO LEUKOTRIENE METABOLIC PROCESS,0.00010092,0.3575,0.33037,1,1
3,GO B CELL MEDIATED IMMUNITY,0.00018427,0.35743,0.25721,1,1
3,GO STEROL HOMEOSTASIS,2.7343e-05,0.3557,0.35036,1,1
3,GO POSITIVE REGULATION OF NATURAL KILLER CELL ACTIVATION,0.0020453,0.35548,0.2561,1,1
3,GO LYMPHOCYTE MEDIATED IMMUNITY,6.7596e-05,0.35533,0.26445,1,1
3,GO REGULATION OF ADAPTIVE IMMUNE RESPONSE,0.00028792,0.35468,0.2632,1,1
3,GO REGULATION OF STEROID METABOLIC PROCESS,1.7118e-05,0.35395,0.30964,1,1
3,GO POSITIVE REGULATION OF VIRAL RELEASE FROM HOST CELL,0.00027832,0.35385,0.30706,1,1
3,GO NEGATIVE REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,0.00036427,0.35331,0.36353,1,1
3,GO POSITIVE REGULATION OF CAMP MEDIATED SIGNALING,0.0045306,0.35294,0.27115,1,1
3,GO BONE REMODELING,1.4039e-05,0.35275,0.35981,1,1
3,GO PEPTIDYL TYROSINE AUTOPHOSPHORYLATION,9.7801e-06,0.35265,0.32522,1,1
3,GO REGULATION OF NEUTROPHIL CHEMOTAXIS,2.6307e-05,0.35249,0.31485,1,1
3,GO REGULATION OF HOMOTYPIC CELL CELL ADHESION,0.00095906,0.35146,0.3264,1,1
3,GO POSITIVE REGULATION OF NATURAL KILLER CELL MEDIATED CYTOTOXICITY,0.00084609,0.35144,0.23651,1,1
3,GO SHORT CHAIN FATTY ACID METABOLIC PROCESS,0.0025817,0.35141,0.29223,1,1
3,GO ANTIBACTERIAL HUMORAL RESPONSE,2.1663e-05,0.35128,0.36331,1,1
3,GO ACUTE INFLAMMATORY RESPONSE,2.8418e-05,0.35102,0.35243,1,1
3,GO PARAXIAL MESODERM MORPHOGENESIS,0.0090226,0.35012,0.33217,1,1
3,GO REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,4.1617e-05,0.34987,0.2783,1,1
3,GO NEGATIVE REGULATION OF RESPONSE TO BIOTIC STIMULUS,0.00052342,0.34981,0.2866,1,1
3,GO PHOSPHOLIPID EFFLUX,0.00045924,0.34937,0.36905,1,1
3,GO RESPONSE TO WATER,0.0071468,0.34868,0.27654,1,1
3,GO B CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.00012964,0.34805,0.24475,1,1
3,GO NATURAL KILLER CELL PROLIFERATION,0.0022332,0.34763,0.3229,1,1
3,GO MAGNESIUM ION TRANSPORT,0.00026003,0.34741,0.29631,1,1
3,GO FUCOSE METABOLIC PROCESS,0.0094949,0.34715,0.30354,1,1
3,GO PHAGOSOME ACIDIFICATION,2.2658e-06,0.34703,0.36183,1,1
3,GO POSITIVE REGULATION OF GRANULOCYTE CHEMOTAXIS,0.00014935,0.34699,0.28741,1,1
3,GO REGULATION OF B CELL RECEPTOR SIGNALING PATHWAY,0.0021062,0.34688,0.2956,1,1
3,GO CELLULAR RESPONSE TO LIPOPROTEIN PARTICLE STIMULUS,7.013e-05,0.3465,0.32734,1,1
3,GO POSITIVE REGULATION OF BLOOD PRESSURE,0.00024286,0.34617,0.27581,1,1
3,GO ESTABLISHMENT OF ENDOTHELIAL INTESTINAL BARRIER,0.00026003,0.34614,0.40431,1,1
3,GO NEGATIVE REGULATION OF GLIAL CELL PROLIFERATION,0.031059,0.34606,0.26855,1,1
3,GO AMINO SUGAR CATABOLIC PROCESS,5.4121e-05,0.34592,0.3575,1,1
3,GO REGULATION OF LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,0.0007696,0.34576,0.28094,1,1
3,GO SPHINGOSINE BIOSYNTHETIC PROCESS,0.016339,0.3456,0.26467,1,1
3,GO CELLULAR RESPONSE TO STEROL DEPLETION,1.349e-05,0.34546,0.40103,1,1
3,GO LYTIC VACUOLE ORGANIZATION,5.2533e-07,0.34517,0.35566,1,1
3,GO LOW DENSITY LIPOPROTEIN PARTICLE REMODELING,0.0010859,0.34516,0.2987,1,1
3,GO LIPID DROPLET ORGANIZATION,2.0033e-05,0.34421,0.30384,1,1
3,GO ICOSANOID METABOLIC PROCESS,3.6228e-06,0.34403,0.38241,1,1
3,GO REGULATION OF B CELL MEDIATED IMMUNITY,0.00067758,0.34369,0.23134,1,1
3,GO NEGATIVE REGULATION OF LIPID METABOLIC PROCESS,1.8521e-05,0.34319,0.26498,1,1
3,GO CELLULAR ALDEHYDE METABOLIC PROCESS,0.0026572,0.34252,0.30948,1,1
3,GO MYOBLAST FUSION,0.0010528,0.34153,0.2522,1,1
3,GO SMOOTH MUSCLE CELL MIGRATION,0.0015653,0.3414,0.2759,1,1
3,GO NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR SIGNALING PATHWAY,5.8301e-05,0.34121,0.28416,1,1
3,GO POSITIVE REGULATION OF INTERFERON ALPHA PRODUCTION,8.7323e-05,0.34116,0.35339,1,1
3,GO REGULATION OF FERTILIZATION,0.00012074,0.34114,0.34535,1,1
3,GO POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,0.00027832,0.34043,0.28524,1,1
3,GO REGULATION OF EPIDERMAL CELL DIFFERENTIATION,2.7343e-05,0.33995,0.36072,1,1
3,GO REGULATION OF B CELL PROLIFERATION,1.5816e-05,0.3398,0.33406,1,1
3,GO RESPONSE TO ARSENIC CONTAINING SUBSTANCE,0.00023468,0.33934,0.34983,1,1
3,GO REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,0.00016023,0.3389,0.24658,1,1
3,GO CELLULAR RESPONSE TO REACTIVE NITROGEN SPECIES,1.5201e-05,0.33854,0.30825,1,1
3,GO NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN CONTAINING 2 SIGNALING PATHWAY,0.0085714,0.3385,0.25001,1,1
3,GO REGULATION OF STEROID BIOSYNTHETIC PROCESS,2.6307e-05,0.33837,0.30346,1,1
3,GO LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,2.5308e-05,0.33835,0.26401,1,1
3,GO STEROL METABOLIC PROCESS,1.104e-05,0.33812,0.2955,1,1
3,GO POSITIVE REGULATION OF I KAPPAB KINASE NF KAPPAB SIGNALING,2.5308e-05,0.33803,0.27927,1,1
3,GO REGULATION OF GLIAL CELL PROLIFERATION,0.0020453,0.33756,0.24011,1,1
3,GO RESPONSE TO MINERALOCORTICOID,3.7145e-05,0.33744,0.31368,1,1
3,GO LEPTIN MEDIATED SIGNALING PATHWAY,0.019283,0.33698,0.19975,1,1
3,GO ARACHIDONIC ACID METABOLIC PROCESS,5.508e-06,0.33605,0.35005,1,1
3,GO KERATINIZATION,1.1493e-05,0.33601,0.30051,1,1
3,GO POSITIVE REGULATION OF GLYCOPROTEIN BIOSYNTHETIC PROCESS,0.0013457,0.33575,0.37461,1,1
3,GO POSITIVE REGULATION OF KERATINOCYTE DIFFERENTIATION,0.0012662,0.33567,0.38671,1,1
3,GO CELLULAR RESPONSE TO MECHANICAL STIMULUS,0.0001547,0.33538,0.33403,1,1
3,GO NEGATIVE REGULATION OF STEROID METABOLIC PROCESS,0.00023468,0.3352,0.30473,1,1
3,GO STEROID BIOSYNTHETIC PROCESS,1.0184e-05,0.33492,0.29541,1,1
3,GO GLYCOSPHINGOLIPID METABOLIC PROCESS,7.8282e-05,0.33484,0.30915,1,1
3,GO C21 STEROID HORMONE METABOLIC PROCESS,0.001662,0.33463,0.36439,1,1
3,GO PHENOL CONTAINING COMPOUND BIOSYNTHETIC PROCESS,1.5816e-05,0.3343,0.31177,1,1
3,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CONTRACTION,0.015574,0.33429,0.29543,1,1
3,GO DORSAL AORTA DEVELOPMENT,0.0039469,0.33426,0.25999,1,1
3,GO AROMATIC AMINO ACID FAMILY CATABOLIC PROCESS,0.0057817,0.33394,0.32211,1,1
3,GO REGULATION OF CELL KILLING,9.389e-05,0.33388,0.30888,1,1
3,GO ETHER METABOLIC PROCESS,0.0046564,0.33312,0.21333,1,1
3,GO PRODUCTION OF SIRNA INVOLVED IN RNA INTERFERENCE,0.0038387,0.33278,0.25164,1,1
3,GO NEGATIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE,1.5816e-05,0.33182,0.33864,1,1
3,GO CORNIFICATION,1.2454e-05,0.33161,0.34097,1,1
3,GO REGULATION OF DEFENSE RESPONSE TO VIRUS,0.00013917,0.33118,0.25072,1,1
3,GO HEPATOCYTE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,1.5201e-05,0.33114,0.45224,1,1
3,GO TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,1.7118e-05,0.33039,0.28802,1,1
3,GO CELL KILLING,9.7801e-06,0.33,0.27109,1,1
3,GO CELLULAR RESPONSE TO FATTY ACID,0.00022676,0.32995,0.31588,1,1
3,GO SNARE COMPLEX ASSEMBLY,0.0011199,0.32886,0.25052,1,1
3,GO RESPONSE TO PEPTIDOGLYCAN,0.0012662,0.32883,0.24195,1,1
3,GO REGULATION OF MEMBRANE LIPID DISTRIBUTION,1.1493e-05,0.32844,0.29839,1,1
3,GO REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.0025083,0.32792,0.23287,1,1
3,GO REGULATION OF LEUKOCYTE MEDIATED CYTOTOXICITY,0.00044439,0.32786,0.30036,1,1
3,GO POSITIVE REGULATION OF LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,0.0049174,0.32759,0.22882,1,1
3,GO INNATE IMMUNE RESPONSE,4.8379e-05,0.32685,0.25081,1,1
3,GO NEGATIVE REGULATION OF LEUKOCYTE CELL CELL ADHESION,7.2754e-05,0.32679,0.27124,1,1
3,GO NEGATIVE REGULATION OF T CELL PROLIFERATION,2.0033e-05,0.32667,0.31082,1,1
3,GO KETONE BIOSYNTHETIC PROCESS,0.00065623,0.32632,0.28695,1,1
3,GO DETECTION OF CHEMICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF TASTE,3.5759e-05,0.32616,0.25187,1,1
3,GO FATTY ACID BETA OXIDATION USING ACYL COA OXIDASE,0.00353,0.32588,0.34461,1,1
3,GO IMMUNE EFFECTOR PROCESS,5.2139e-05,0.32569,0.24549,1,1
3,GO METHIONINE METABOLIC PROCESS,1.2454e-05,0.32564,0.33214,1,1
3,GO NEGATIVE REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,9.389e-05,0.32557,0.31646,1,1
3,GO HYPOTHALAMUS DEVELOPMENT,0.00087311,0.32554,0.28684,1,1
3,GO RESPONSE TO INTERLEUKIN 15,0.0059384,0.32537,0.25476,1,1
3,GO APICAL JUNCTION ASSEMBLY,2.9301e-06,0.32437,0.39234,1,1
3,GO POSITIVE REGULATION OF T CELL CYTOKINE PRODUCTION,0.00087311,0.32376,0.25727,1,1
3,GO RESPONSE TO CADMIUM ION,0.0016129,0.32369,0.27752,1,1
3,GO REGULATION OF PROSTAGLANDIN SECRETION,0.00010092,0.32356,0.35153,1,1
3,GO NONRIBOSOMAL PEPTIDE BIOSYNTHETIC PROCESS,6.7596e-05,0.32342,0.3875,1,1
3,GO TYPE I INTERFERON PRODUCTION,0.00012074,0.32338,0.25064,1,1
3,GO POSITIVE REGULATION OF OXIDATIVE STRESS INDUCED CELL DEATH,0.00069957,0.32336,0.24007,1,1
3,GO POSITIVE REGULATION OF TISSUE REMODELING,6.0504e-05,0.32325,0.35928,1,1
3,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.0015189,0.32214,0.25001,1,1
3,GO DEFENSE RESPONSE TO GRAM POSITIVE BACTERIUM,0.00016595,0.3217,0.25493,1,1
3,GO STEROID METABOLIC PROCESS,3.9418e-06,0.32163,0.31732,1,1
3,GO TRNA CATABOLIC PROCESS,0.0053338,0.32152,0.34666,1,1
3,GO REGULATION OF WOUND HEALING,0.00024286,0.32088,0.27559,1,1
3,GO RESPONSE TO CORTICOSTERONE,0.00047456,0.32029,0.31689,1,1
3,GO REGULATION OF NEUTROPHIL MIGRATION,7.013e-05,0.32024,0.32603,1,1
3,GO EPITHELIAL CELL FATE COMMITMENT,0.017137,0.32022,0.25621,1,1
3,GO PLATELET DEGRANULATION,0.001872,0.31951,0.22382,1,1
3,GO NEGATIVE REGULATION OF CHEMOKINE PRODUCTION,0.0037331,0.31927,0.31453,1,1
3,GO DEFENSE RESPONSE TO OTHER ORGANISM,3.1888e-05,0.31897,0.24238,1,1
3,GO MEDIUM CHAIN FATTY ACID METABOLIC PROCESS,0.00041602,0.31829,0.33492,1,1
3,GO OLIGOPEPTIDE TRANSPORT,0.00057693,0.31817,0.37536,1,1
3,GO VERY LOW DENSITY LIPOPROTEIN PARTICLE ASSEMBLY,5.6174e-05,0.31794,0.40739,1,1
3,GO ACTIVATION OF JANUS KINASE ACTIVITY,0.00022676,0.31775,0.37691,1,1
3,GO NEGATIVE REGULATION OF LEUKOCYTE DIFFERENTIATION,0.00013433,0.31756,0.23613,1,1
3,GO NEGATIVE REGULATION OF NOTCH SIGNALING PATHWAY,0.00018427,0.31755,0.35825,1,1
3,GO RETINOL METABOLIC PROCESS,0.00017796,0.31713,0.40605,1,1
3,GO RESPONSE TO VIRUS,0.0001547,0.31712,0.24111,1,1
3,GO NEGATIVE REGULATION OF LIPID TRANSPORT,0.00023468,0.31651,0.33232,1,1
3,GO FUSION OF SPERM TO EGG PLASMA MEMBRANE INVOLVED IN SINGLE FERTILIZATION,0.0036303,0.31636,0.2808,1,1
3,GO CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.00050664,0.31629,0.22896,1,1
3,GO POSITIVE REGULATION OF NOTCH SIGNALING PATHWAY,4.8379e-05,0.31617,0.30426,1,1
3,GO POSITIVE REGULATION OF CELL SUBSTRATE ADHESION,0.0094949,0.31579,0.17911,1,1
3,GO CELLULAR RESPONSE TO PROSTAGLANDIN STIMULUS,0.0062634,0.31546,0.29769,1,1
3,GO ADRENAL GLAND DEVELOPMENT,6.7596e-05,0.31537,0.42877,1,1
3,GO RESPONSE TO GROWTH HORMONE,5.0683e-06,0.31526,0.37199,1,1
3,GO NEGATIVE REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.00027832,0.31477,0.30305,1,1
3,GO PROTEIN DEGLYCOSYLATION,0.00023468,0.31471,0.3541,1,1
3,GO REGULATION OF FC RECEPTOR MEDIATED STIMULATORY SIGNALING PATHWAY,0.014486,0.31431,0.27403,1,1
3,GO UBIQUINONE METABOLIC PROCESS,9.7801e-06,0.31423,0.32759,1,1
3,GO GDP METABOLIC PROCESS,0.0028141,0.31419,0.28492,1,1
3,GO KERATINOCYTE DEVELOPMENT,0.011326,0.31414,0.28955,1,1
3,GO NEGATIVE REGULATION OF LIPID LOCALIZATION,3.0689e-05,0.3137,0.32067,1,1
3,GO POSITIVE REGULATION OF EPIDERMAL CELL DIFFERENTIATION,0.0006154,0.31323,0.33648,1,1
3,GO POSITIVE REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,0.00017186,0.31307,0.24263,1,1
3,GO CYTOKINE MEDIATED SIGNALING PATHWAY,3.5759e-05,0.31267,0.25644,1,1
3,GO LEUKOCYTE MEDIATED IMMUNITY,5.8301e-05,0.31236,0.25356,1,1
3,GO MAINTENANCE OF BLOOD BRAIN BARRIER,2.6307e-05,0.31186,0.35905,1,1
3,GO LABYRINTHINE LAYER DEVELOPMENT,0.00059588,0.31161,0.28178,1,1
3,GO NEUROTRANSMITTER CATABOLIC PROCESS,0.0022332,0.31143,0.30952,1,1
3,GO REGULATION OF ACTIN NUCLEATION,4.4878e-05,0.31106,0.33076,1,1
3,GO PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,3.1888e-05,0.31103,0.25607,1,1
3,GO REGULATION OF KERATINOCYTE DIFFERENTIATION,0.0056288,0.3107,0.24677,1,1
3,GO RESPONSE TO XENOBIOTIC STIMULUS,0.00023468,0.31067,0.30302,1,1
3,GO REGULATION OF ACUTE INFLAMMATORY RESPONSE,0.00028792,0.30991,0.279,1,1
3,GO TOLL LIKE RECEPTOR SIGNALING PATHWAY,3.5759e-05,0.30983,0.27617,1,1
3,GO POSITIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,0.0007696,0.3092,0.2129,1,1
3,GO NEGATIVE REGULATION OF MYELOID CELL APOPTOTIC PROCESS,0.00038934,0.30832,0.31387,1,1
3,GO CELLULAR RESPONSE TO OXIDISED LOW DENSITY LIPOPROTEIN PARTICLE STIMULUS,0.0016129,0.30828,0.28362,1,1
3,GO HETEROTYPIC CELL CELL ADHESION,0.0028957,0.30815,0.21288,1,1
3,GO GLYCOSYLATION,9.0179e-06,0.30808,0.30143,1,1
3,GO NEGATIVE REGULATION OF BLOOD PRESSURE,0.001986,0.30802,0.22887,1,1
3,GO B CELL PROLIFERATION,2.7343e-05,0.30786,0.26434,1,1
3,GO POSITIVE REGULATION OF CALCIUM ION IMPORT,0.01282,0.3078,0.17792,1,1
3,GO CELLULAR RESPONSE TO CORTICOSTEROID STIMULUS,0.012203,0.30768,0.20139,1,1
3,GO REGULATION OF FIBRINOLYSIS,0.0054795,0.30762,0.33473,1,1
3,GO REGULATION OF B CELL ACTIVATION,4.6597e-05,0.30747,0.24926,1,1
3,GO REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION,0.0028141,0.30662,0.21738,1,1
3,GO POSITIVE REGULATION OF TYPE I INTERFERON PRODUCTION,7.013e-05,0.30526,0.24386,1,1
3,GO PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,7.3528e-06,0.30469,0.29282,1,1
3,GO T CELL CYTOKINE PRODUCTION,0.0022992,0.3045,0.2246,1,1
3,GO NEGATIVE REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,1.104e-05,0.3044,0.34043,1,1
3,GO I KAPPAB KINASE NF KAPPAB SIGNALING,7.547e-05,0.30427,0.22777,1,1
3,GO LIPID LOCALIZATION,1.1964e-05,0.30354,0.26777,1,1
3,GO RESPONSE TO DEXAMETHASONE,0.00079435,0.30327,0.24423,1,1
3,GO PHOSPHATIDYLCHOLINE METABOLIC PROCESS,1.9904e-06,0.30322,0.30491,1,1
3,GO REGULATION OF ANION TRANSMEMBRANE TRANSPORT,0.00026003,0.30315,0.39472,1,1
3,GO REGULATION OF PERK MEDIATED UNFOLDED PROTEIN RESPONSE,0.0015189,0.30275,0.29325,1,1
3,GO REGULATION OF RESPONSE TO BIOTIC STIMULUS,1.4609e-05,0.30203,0.25682,1,1
3,GO B CELL HOMEOSTASIS,0.00012512,0.3019,0.27624,1,1
3,GO RESPONSE TO CAFFEINE,0.00098941,0.30171,0.25938,1,1
3,GO POSITIVE REGULATION OF CELL SIZE,5.0226e-05,0.30155,0.37243,1,1
3,GO ENDOTHELIAL CELL APOPTOTIC PROCESS,0.024288,0.30123,0.16362,1,1
3,GO POSITIVE REGULATION OF BONE RESORPTION,0.00069957,0.30108,0.37873,1,1
3,GO REGULATION OF SYMBIOTIC PROCESS,0.00034072,0.30104,0.21493,1,1
3,GO CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,8.4205e-05,0.30069,0.24789,1,1
3,GO INTERLEUKIN 1 PRODUCTION,0.00067758,0.30043,0.22968,1,1
3,GO POSITIVE REGULATION OF FATTY ACID OXIDATION,0.010773,0.30029,0.24804,1,1
3,GO TRANSFORMING GROWTH FACTOR BETA PRODUCTION,0.0001165,0.29997,0.27393,1,1
3,GO REGULATION OF LEUKOCYTE PROLIFERATION,0.00024286,0.29991,0.24405,1,1
3,GO MYELOID LEUKOCYTE MEDIATED IMMUNITY,7.8282e-05,0.29979,0.26372,1,1
3,GO REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,1.7118e-05,0.29979,0.30237,1,1
3,GO NEGATIVE REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,0.00029782,0.29977,0.3554,1,1
3,GO POLY N ACETYLLACTOSAMINE METABOLIC PROCESS,0.00030804,0.29966,0.34201,1,1
3,GO RESPONSE TO TUMOR NECROSIS FACTOR,5.4121e-05,0.29962,0.24915,1,1
3,GO NEGATIVE REGULATION OF LYMPHOCYTE ACTIVATION,0.00023468,0.29937,0.24092,1,1
3,GO KERATAN SULFATE METABOLIC PROCESS,0.0014299,0.29919,0.23475,1,1
3,GO BILE ACID METABOLIC PROCESS,1.2962e-05,0.29912,0.36752,1,1
3,GO DIET INDUCED THERMOGENESIS,0.00084609,0.29902,0.25733,1,1
3,GO MEGAKARYOCYTE DEVELOPMENT,0.00065623,0.29885,0.3265,1,1
3,GO POSITIVE REGULATION OF ORGANIC ACID TRANSPORT,2.2524e-05,0.29869,0.35969,1,1
3,GO PROTEIN CATABOLIC PROCESS IN THE VACUOLE,0.00045924,0.29835,0.34341,1,1
3,GO REGULATION OF IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE,0.00038934,0.29833,0.2985,1,1
3,GO POSITIVE REGULATION OF NITRIC OXIDE METABOLIC PROCESS,0.00084609,0.2979,0.25473,1,1
3,GO FUCOSYLATION,0.0014299,0.29784,0.29319,1,1
3,GO REGULATION OF HETEROTYPIC CELL CELL ADHESION,0.007729,0.29746,0.30248,1,1
3,GO CELLULAR RESPONSE TO LITHIUM ION,0.00019079,0.29689,0.31744,1,1
3,GO LYMPHOCYTE ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.00027832,0.29671,0.21697,1,1
3,GO OPTIC NERVE DEVELOPMENT,0.00059588,0.29647,0.34262,1,1
3,GO REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.00014935,0.29637,0.25699,1,1
3,GO CELLULAR RESPONSE TO TESTOSTERONE STIMULUS,0.019739,0.29633,0.30331,1,1
3,GO POSITIVE REGULATION OF LEUKOCYTE DEGRANULATION,0.00035231,0.29627,0.2995,1,1
3,GO REGULATION OF IMMUNE EFFECTOR PROCESS,0.00020448,0.29613,0.2205,1,1
3,GO NEGATIVE REGULATION OF MAP KINASE ACTIVITY,0.00021167,0.29608,0.27955,1,1
3,GO POSITIVE REGULATION OF GLUTAMATE SECRETION,0.0083534,0.29605,0.30211,1,1
3,GO REGULATION OF RECEPTOR BINDING,0.021165,0.29593,0.23574,1,1
3,GO INTERLEUKIN 8 PRODUCTION,0.00019753,0.29592,0.26778,1,1
3,GO NATURAL KILLER CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.0001547,0.2959,0.25377,1,1
3,GO NEGATIVE REGULATION OF ANION TRANSPORT,0.0036303,0.29575,0.19621,1,1
3,GO POSITIVE REGULATION OF LEUKOCYTE PROLIFERATION,0.00036427,0.29574,0.23735,1,1
3,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION,0.00038934,0.29573,0.22196,1,1
3,GO POSITIVE REGULATION OF DEFENSE RESPONSE,1.7118e-05,0.29563,0.24397,1,1
3,GO RESPONSE TO HEPATOCYTE GROWTH FACTOR,0.0030654,0.29533,0.29901,1,1
3,GO NEGATIVE REGULATION OF B CELL PROLIFERATION,4.3218e-05,0.29522,0.32142,1,1
3,GO WATER HOMEOSTASIS,9.0551e-05,0.29514,0.28476,1,1
3,GO NEGATIVE REGULATION OF LEUKOCYTE PROLIFERATION,9.7346e-05,0.29511,0.27845,1,1
3,GO INTERLEUKIN 13 PRODUCTION,0.010245,0.29497,0.24328,1,1
3,GO RESPONSE TO FORSKOLIN,0.015574,0.29453,0.25998,1,1
3,GO POSITIVE REGULATION OF GLIAL CELL PROLIFERATION,0.00081984,0.29432,0.29433,1,1
3,GO RADIAL GLIAL CELL DIFFERENTIATION,0.0064317,0.29429,0.30418,1,1
3,GO POSITIVE REGULATION OF ALPHA BETA T CELL ACTIVATION,0.0025083,0.2941,0.18881,1,1
3,GO OSTEOBLAST PROLIFERATION,0.00067758,0.29337,0.2758,1,1
3,GO MYELOID LEUKOCYTE ACTIVATION,0.00010092,0.29333,0.24228,1,1
3,GO ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.00028792,0.29318,0.27891,1,1
3,GO GASTRULATION WITH MOUTH FORMING SECOND,0.00042998,0.29231,0.27334,1,1
3,GO POSITIVE REGULATION OF INTERLEUKIN 8 PRODUCTION,1.5201e-05,0.29225,0.33362,1,1
3,GO POSITIVE REGULATION OF RESPONSE TO OXIDATIVE STRESS,0.00063551,0.29157,0.20246,1,1
3,GO INTERLEUKIN 6 PRODUCTION,6.2786e-05,0.29113,0.23322,1,1
3,GO T CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.00081984,0.29082,0.21406,1,1
3,GO REGULATION OF RESPIRATORY BURST,5.6174e-05,0.29029,0.36841,1,1
3,GO BUNDLE OF HIS CELL TO PURKINJE MYOCYTE COMMUNICATION,0.050569,0.29028,0.29435,1,1
3,GO POSITIVE REGULATION OF RENAL SODIUM EXCRETION,0.015203,0.29027,0.27576,1,1
3,GO ICOSANOID BIOSYNTHETIC PROCESS,0.00010462,0.28982,0.2866,1,1
3,GO NEGATIVE REGULATION OF PEPTIDASE ACTIVITY,0.00010092,0.28979,0.24148,1,1
3,GO DEFENSE RESPONSE TO BACTERIUM,5.2837e-06,0.28973,0.26559,1,1
3,GO POSITIVE REGULATION OF DEFENSE RESPONSE TO VIRUS BY HOST,0.00034072,0.28939,0.31218,1,1
3,GO PHOSPHATIDYLSERINE ACYL CHAIN REMODELING,0.001662,0.28903,0.24262,1,1
3,GO REGULATION OF PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,3.4421e-05,0.28863,0.24407,1,1
3,GO AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.00092958,0.2885,0.21859,1,1
3,GO GOLGI TO ENDOSOME TRANSPORT,0.0010528,0.28833,0.27154,1,1
3,GO REGULATION OF NECROTIC CELL DEATH,0.00045924,0.28827,0.28187,1,1
3,GO BILE ACID BIOSYNTHETIC PROCESS,0.00021167,0.28812,0.29061,1,1
3,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION,0.00081984,0.2874,0.32901,1,1
3,GO INTERLEUKIN 10 PRODUCTION,6.7596e-05,0.28714,0.25964,1,1
3,GO OLIGODENDROCYTE DEVELOPMENT,0.00045924,0.2869,0.24666,1,1
3,GO ADAPTIVE IMMUNE RESPONSE,0.00012964,0.28652,0.25281,1,1
3,GO POSITIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,0.0031536,0.28612,0.24594,1,1
3,GO POSITIVE REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.0032441,0.28607,0.2371,1,1
3,GO POSITIVE REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION,0.0016129,0.28594,0.26547,1,1
3,GO EXTRACELLULAR VESICLE BIOGENESIS,1.349e-05,0.28579,0.27147,1,1
3,GO NEGATIVE REGULATION OF LIPID STORAGE,0.00031859,0.28538,0.27237,1,1
3,GO NEGATIVE REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,0.013465,0.28528,0.21539,1,1
3,GO LUNG EPITHELIUM DEVELOPMENT,0.0033369,0.28475,0.26958,1,1
3,GO REGULATION OF CARDIAC MUSCLE CELL ACTION POTENTIAL,0.00055855,0.2847,0.3151,1,1
3,GO DEFENSE RESPONSE,3.5759e-05,0.28421,0.22849,1,1
3,GO TRANSPOSITION,0.0037331,0.28405,0.28174,1,1
3,GO HUMORAL IMMUNE RESPONSE MEDIATED BY CIRCULATING IMMUNOGLOBULIN,0.00042998,0.28386,0.30234,1,1
3,GO REGULATION OF CHOLESTEROL METABOLIC PROCESS,0.00020448,0.28375,0.2318,1,1
3,GO NEGATIVE REGULATION OF T CELL DIFFERENTIATION,0.0041716,0.28358,0.19044,1,1
3,GO CELLULAR RESPONSE TO EPINEPHRINE STIMULUS,0.013465,0.28354,0.27389,1,1
3,GO POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.00020448,0.28335,0.29415,1,1
3,GO PROSTAGLANDIN TRANSPORT,0.00072223,0.28315,0.33169,1,1
3,GO NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.0017123,0.28297,0.26506,1,1
3,GO RESPIRATORY BURST,0.00030804,0.28287,0.26463,1,1
3,GO REGULATION OF INNATE IMMUNE RESPONSE,1.6455e-05,0.28257,0.25766,1,1
3,GO POLYOL TRANSPORT,0.0010206,0.28253,0.32142,1,1
3,GO PROTEIN N LINKED GLYCOSYLATION,0.00012512,0.28218,0.25491,1,1
3,GO ALPHA LINOLENIC ACID METABOLIC PROCESS,0.00052342,0.28212,0.24575,1,1
3,GO MONOACYLGLYCEROL METABOLIC PROCESS,0.0054795,0.282,0.31182,1,1
3,GO POSITIVE REGULATION OF INFLAMMATORY RESPONSE,9.7346e-05,0.28196,0.26689,1,1
3,GO MAMMARY GLAND ALVEOLUS DEVELOPMENT,0.0017123,0.28153,0.24423,1,1
3,GO CELLULAR RESPONSE TO ALCOHOL,0.00072223,0.28123,0.19004,1,1
3,GO LIPOSACCHARIDE METABOLIC PROCESS,0.00034072,0.28096,0.25466,1,1
3,GO CELL CELL JUNCTION ORGANIZATION,6.7596e-05,0.28093,0.24778,1,1
3,GO POSITIVE REGULATION OF PROTEIN KINASE B SIGNALING,0.00016595,0.28084,0.20679,1,1
3,GO ZINC ION HOMEOSTASIS,0.0094949,0.28069,0.30538,1,1
3,GO RESPONSE TO TUMOR CELL,0.00021909,0.28051,0.33345,1,1
3,GO FATTY ACID DERIVATIVE METABOLIC PROCESS,4.4712e-06,0.28051,0.31735,1,1
3,GO POSITIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY,0.00020448,0.28041,0.22262,1,1
3,GO METHIONINE BIOSYNTHETIC PROCESS,0.00010845,0.27992,0.37228,1,1
3,GO PEPTIDYL ASPARAGINE MODIFICATION,0.0017641,0.27973,0.24242,1,1
3,GO CELL CELL JUNCTION ASSEMBLY,1.4039e-05,0.27968,0.27359,1,1
3,GO PHOSPHATIDYLETHANOLAMINE ACYL CHAIN REMODELING,4.3218e-05,0.27967,0.28943,1,1
3,GO STEROL BIOSYNTHETIC PROCESS,1.8521e-05,0.27962,0.28753,1,1
3,GO CELLULAR RESPONSE TO STARVATION,1.104e-05,0.27942,0.2516,1,1
3,GO MAST CELL MEDIATED IMMUNITY,0.00055855,0.2792,0.2472,1,1
3,GO REGULATION OF ORGANIC ACID TRANSPORT,7.547e-05,0.27909,0.29449,1,1
3,GO REVERSE CHOLESTEROL TRANSPORT,0.0017641,0.27903,0.40699,1,1
3,GO HAIR CELL DIFFERENTIATION,8.4205e-05,0.27896,0.25498,1,1
3,GO REGULATION OF MYOTUBE DIFFERENTIATION,3.4421e-05,0.27888,0.26064,1,1
3,GO CHEMOKINE PRODUCTION,0.00081984,0.27842,0.20519,1,1
3,GO NEGATIVE REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,0.0025083,0.27811,0.20271,1,1
3,GO ORGANIC HYDROXY COMPOUND TRANSPORT,1.5201e-05,0.27786,0.24801,1,1
3,GO REGULATION OF HEPATOCYTE PROLIFERATION,0.0027346,0.27785,0.32305,1,1
3,GO AMELOGENESIS,0.0066042,0.27758,0.23001,1,1
3,GO BONE CELL DEVELOPMENT,0.00023468,0.27722,0.23874,1,1
3,GO REGULATION OF RESPONSE TO CYTOKINE STIMULUS,2.2524e-05,0.27721,0.26558,1,1
3,GO PRODUCTION OF MOLECULAR MEDIATOR INVOLVED IN INFLAMMATORY RESPONSE,0.00010845,0.27697,0.28521,1,1
3,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,0.010506,0.27685,0.16803,1,1
3,GO ORGANIC HYDROXY COMPOUND BIOSYNTHETIC PROCESS,4.4712e-06,0.27672,0.25751,1,1
3,GO STEROL TRANSPORT,3.5759e-05,0.27647,0.27844,1,1
3,GO CELLULAR MODIFIED AMINO ACID BIOSYNTHETIC PROCESS,0.0021062,0.2764,0.22344,1,1
3,GO ER NUCLEUS SIGNALING PATHWAY,0.00055855,0.27607,0.27206,1,1
3,GO CERAMIDE BIOSYNTHETIC PROCESS,4.1617e-05,0.27585,0.2423,1,1
3,GO NEGATIVE REGULATION OF CELL ACTIVATION,0.00034072,0.27532,0.20431,1,1
3,GO AMINE METABOLIC PROCESS,3.0576e-06,0.27516,0.2811,1,1
3,GO RESPONSE TO INTERLEUKIN 6,0.00090094,0.27506,0.26455,1,1
3,GO POLYAMINE BIOSYNTHETIC PROCESS,0.00049035,0.2749,0.28774,1,1
3,GO LEUKOCYTE PROLIFERATION,0.00016595,0.27484,0.21589,1,1
3,GO REGULATION OF ALPHA BETA T CELL ACTIVATION,0.00087311,0.27478,0.19159,1,1
3,GO MONOCARBOXYLIC ACID CATABOLIC PROCESS,0.00019753,0.27476,0.23073,1,1
3,GO ENDOPLASMIC RETICULUM TO CYTOSOL TRANSPORT,0.00017796,0.27453,0.25224,1,1
3,GO RESPONSE TO LAMINAR FLUID SHEAR STRESS,0.0066042,0.27447,0.30604,1,1
3,GO PHOSPHOLIPID HOMEOSTASIS,0.0097392,0.2744,0.24124,1,1
3,GO GLYCEROL ETHER METABOLIC PROCESS,0.013139,0.27439,0.16684,1,1
3,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,0.00021167,0.27416,0.23041,1,1
3,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,0.015953,0.27353,0.26742,1,1
3,GO VACUOLAR ACIDIFICATION,7.6603e-06,0.27274,0.34698,1,1
3,GO RESPONSE TO BIOTIC STIMULUS,7.2754e-05,0.27261,0.20707,1,1
3,GO LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,0.0083534,0.27254,0.21956,1,1
3,GO EMBRYONIC PLACENTA DEVELOPMENT,0.00084609,0.27246,0.24325,1,1
3,GO RESPONSE TO FATTY ACID,0.0010206,0.27234,0.21429,1,1
3,GO RESPONSE TO ACIDIC PH,0.011047,0.27204,0.24437,1,1
3,GO PHOSPHOLIPID TRANSPORT,2.9532e-05,0.27184,0.23705,1,1
3,GO TISSUE HOMEOSTASIS,9.7801e-06,0.27171,0.23018,1,1
3,GO ORGANOPHOSPHATE ESTER TRANSPORT,1.3441e-06,0.27153,0.26085,1,1
3,GO DETERMINATION OF ADULT LIFESPAN,0.00034072,0.27149,0.27997,1,1
3,GO PHYSIOLOGICAL CARDIAC MUSCLE HYPERTROPHY,0.0051916,0.27144,0.22637,1,1
3,GO REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,1.8521e-05,0.27076,0.30674,1,1
3,GO NEGATIVE REGULATION OF LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,0.00072223,0.27059,0.31432,1,1
3,GO ENDOCRINE PROCESS,0.00059588,0.27055,0.24712,1,1
3,GO POSITIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,0.00022676,0.27011,0.21971,1,1
3,GO DIOL METABOLIC PROCESS,0.00024286,0.26943,0.32323,1,1
3,GO CELLULAR BIOGENIC AMINE METABOLIC PROCESS,1.7474e-06,0.26941,0.32184,1,1
3,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.00087311,0.26872,0.20286,1,1
3,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE MEDIATED BY A CHEMICAL SIGNAL,0.0024367,0.26871,0.31729,1,1
3,GO LIPID STORAGE,0.00057693,0.26833,0.24455,1,1
3,GO HORMONE CATABOLIC PROCESS,0.0030654,0.26823,0.36512,1,1
3,GO RESPONSE TO FOLLICLE STIMULATING HORMONE,0.00090094,0.26778,0.25027,1,1
3,GO LYMPHOID PROGENITOR CELL DIFFERENTIATION,0.0094949,0.26776,0.23367,1,1
3,GO ANTIMICROBIAL HUMORAL RESPONSE,5.0226e-05,0.26765,0.24143,1,1
3,GO NEGATIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION,0.0032441,0.2676,0.19055,1,1
3,GO UNSATURATED FATTY ACID METABOLIC PROCESS,7.9801e-06,0.26757,0.32993,1,1
3,GO REGULATION OF B CELL DIFFERENTIATION,0.0006154,0.26741,0.25506,1,1
3,GO RESPONSE TO NUTRIENT,0.0037331,0.26733,0.16281,1,1
3,GO EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.0011199,0.26726,0.20272,1,1
3,GO INTERLEUKIN 4 PRODUCTION,0.0050528,0.26702,0.2063,1,1
3,GO DRUG METABOLIC PROCESS,0.00021909,0.26696,0.33012,1,1
3,GO REGULATION OF LIPID BIOSYNTHETIC PROCESS,1.5816e-05,0.26685,0.26139,1,1
3,GO B CELL RECEPTOR SIGNALING PATHWAY,5.0226e-05,0.26674,0.32827,1,1
3,GO NEGATIVE REGULATION OF GLUCOSE IMPORT,0.052669,0.26655,0.16884,1,1
3,GO CYTOPLASM ORGANIZATION,0.00025131,0.26633,0.30009,1,1
3,GO POSITIVE REGULATION OF B CELL ACTIVATION,0.00038934,0.26609,0.21429,1,1
3,GO POSITIVE REGULATION OF COLD INDUCED THERMOGENESIS,6.2367e-06,0.26603,0.25807,1,1
3,GO POSITIVE REGULATION OF INTERLEUKIN 10 PRODUCTION,7.013e-05,0.26602,0.24781,1,1
3,GO INTRACELLULAR LIPID TRANSPORT,0.00013917,0.26573,0.25653,1,1
3,GO REGULATION OF MUSCLE ADAPTATION,0.00092958,0.26558,0.17741,1,1
3,GO REGULATION OF LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,0.0039469,0.26547,0.30568,1,1
3,GO REGULATION OF FATTY ACID TRANSPORT,5.2837e-06,0.26531,0.3893,1,1
3,GO EPIDERMAL CELL DIFFERENTIATION,1.2962e-05,0.26522,0.26365,1,1
3,GO ENDOCARDIUM DEVELOPMENT,0.02268,0.26505,0.22569,1,1
3,GO MYELOID DENDRITIC CELL DIFFERENTIATION,0.0051916,0.26484,0.2578,1,1
3,GO POSITIVE REGULATION OF ACTIN NUCLEATION,0.0051916,0.2647,0.22004,1,1
3,GO REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,0.00023468,0.2646,0.22596,1,1
3,GO POSITIVE REGULATION OF CHEMOKINE PRODUCTION,0.00067758,0.26449,0.22985,1,1
3,GO REGULATION OF ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.0064317,0.26432,0.24836,1,1
3,GO NEGATIVE REGULATION OF CELL CELL ADHESION,0.00017186,0.26415,0.24687,1,1
3,GO POSITIVE REGULATION OF AMYLOID BETA FORMATION,0.0036303,0.26392,0.22308,1,1
3,GO KERATINOCYTE DIFFERENTIATION,3.1888e-05,0.26325,0.26222,1,1
3,GO NEGATIVE REGULATION OF HEMOPOIESIS,0.0001165,0.26322,0.22375,1,1
3,GO MEMBRANE LIPID METABOLIC PROCESS,2.9532e-05,0.2631,0.26391,1,1
3,GO INTERLEUKIN 12 PRODUCTION,9.7801e-06,0.26287,0.30003,1,1
3,GO ISOPRENOID BIOSYNTHETIC PROCESS,0.00036427,0.26286,0.32271,1,1
3,GO TRANSFERRIN TRANSPORT,2.0784e-06,0.26283,0.33676,1,1
3,GO REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,0.00024286,0.26271,0.25071,1,1
3,GO LATE ENDOSOME TO VACUOLE TRANSPORT VIA MULTIVESICULAR BODY SORTING PATHWAY,0.00022676,0.26238,0.25109,1,1
3,GO MULTICELLULAR ORGANISMAL HOMEOSTASIS,5.0683e-06,0.26216,0.21535,1,1
3,GO POSITIVE REGULATION OF ANION TRANSPORT,0.00019753,0.26211,0.30151,1,1
3,GO LIPOPROTEIN CATABOLIC PROCESS,0.001872,0.26204,0.23717,1,1
3,GO AMYLOID BETA METABOLIC PROCESS,0.001662,0.26197,0.20738,1,1
3,GO CELLULAR RESPONSE TO STEROL,0.00040247,0.26162,0.28997,1,1
3,GO REGULATION OF RESPONSE TO INTERFERON GAMMA,0.00040247,0.26133,0.26896,1,1
3,GO DENDRITIC CELL MIGRATION,0.010506,0.26118,0.17431,1,1
3,GO SECRETION BY TISSUE,0.0006154,0.26114,0.23717,1,1
3,GO PLASMA MEMBRANE FUSION,0.0026572,0.26113,0.2528,1,1
3,GO FAT SOLUBLE VITAMIN BIOSYNTHETIC PROCESS,0.0090226,0.26105,0.21988,1,1
3,GO MAST CELL ACTIVATION,0.00013433,0.26093,0.26069,1,1
3,GO NEGATIVE REGULATION OF ACTIN FILAMENT DEPOLYMERIZATION,0.00016023,0.26085,0.26123,1,1
3,GO DISACCHARIDE METABOLIC PROCESS,0.00087311,0.26068,0.34604,1,1
3,GO CELLULAR RESPONSE TO EXTERNAL STIMULUS,6.5149e-05,0.26031,0.22381,1,1
3,GO MYELOID LEUKOCYTE MIGRATION,0.00021167,0.26021,0.20236,1,1
3,GO REGULATION OF ASTROCYTE DIFFERENTIATION,0.034637,0.25891,0.17194,1,1
3,GO LYMPHOCYTE MIGRATION,0.00049035,0.25889,0.19667,1,1
3,GO FATTY ACID CATABOLIC PROCESS,0.00018427,0.25881,0.24149,1,1
3,GO POSITIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,1.4609e-05,0.25855,0.26208,1,1
3,GO GAMMA DELTA T CELL DIFFERENTIATION,0.033166,0.25803,0.29254,1,1
3,GO REGULATION OF THE FORCE OF HEART CONTRACTION,0.004408,0.25773,0.19755,1,1
3,GO RESPONSE TO PROTOZOAN,0.0040578,0.25771,0.17515,1,1
3,GO POSITIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.0021062,0.25733,0.1756,1,1
3,GO PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,0.00027832,0.2573,0.18911,1,1
3,GO NEGATIVE REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT,0.049546,0.2573,0.18243,1,1
3,GO REGULATION OF SULFUR METABOLIC PROCESS,0.043763,0.25729,0.18022,1,1
3,GO PROTEIN IMPORT INTO PEROXISOME MATRIX,0.00050664,0.25711,0.25201,1,1
3,GO HORMONE METABOLIC PROCESS,0.00063551,0.25697,0.2624,1,1
3,GO REGULATION OF CELL CELL ADHESION,0.00017796,0.25681,0.21196,1,1
3,GO PLACENTA BLOOD VESSEL DEVELOPMENT,0.011612,0.25647,0.18211,1,1
3,GO RESPONSE TO GONADOTROPIN,0.0006154,0.25639,0.24027,1,1
3,GO SPHINGOLIPID METABOLIC PROCESS,1.5816e-05,0.25635,0.27323,1,1
3,GO NEGATIVE REGULATION OF IMMUNE SYSTEM PROCESS,0.00036427,0.25597,0.19098,1,1
3,GO POSITIVE REGULATION OF CELL CELL ADHESION,0.00025131,0.25593,0.20411,1,1
3,GO VASCULAR WOUND HEALING,0.011047,0.25579,0.31486,1,1
3,GO ORGANELLE MEMBRANE FUSION,0.00052342,0.25565,0.20748,1,1
3,GO POSITIVE REGULATION OF RESPONSE TO BIOTIC STIMULUS,1.9263e-05,0.25558,0.25386,1,1
3,GO INFLAMMATORY RESPONSE,9.389e-05,0.25514,0.20799,1,1
3,GO PRIMARY ALCOHOL METABOLIC PROCESS,0.00021909,0.25487,0.3222,1,1
3,GO PERK MEDIATED UNFOLDED PROTEIN RESPONSE,0.011326,0.25458,0.23365,1,1
3,GO PIRNA METABOLIC PROCESS,0.001662,0.25452,0.29653,1,1
3,GO MUSCLE HYPERTROPHY,0.00014935,0.25427,0.21602,1,1
3,GO CELLULAR RESPONSE TO ALKALOID,2.4346e-05,0.25383,0.25528,1,1
3,GO CELLULAR RESPONSE TO INORGANIC SUBSTANCE,6.4994e-06,0.25374,0.23957,1,1
3,GO ANDROGEN METABOLIC PROCESS,0.00035231,0.25349,0.37269,1,1
3,GO POSITIVE REGULATION OF HORMONE SECRETION,5.8301e-05,0.25324,0.23988,1,1
3,GO ALANINE TRANSPORT,0.017137,0.2531,0.24917,1,1
3,GO MONOCYTE CHEMOTAXIS,0.0029794,0.25294,0.20052,1,1
3,GO VESICLE TARGETING TO FROM OR WITHIN GOLGI,0.00013917,0.25267,0.23306,1,1
3,GO CELLULAR KETONE METABOLIC PROCESS,0.00027832,0.25262,0.22715,1,1
3,GO VITAMIN CATABOLIC PROCESS,0.025414,0.25246,0.26996,1,1
3,GO CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,6.2786e-05,0.25239,0.23547,1,1
3,GO ACETYL COA BIOSYNTHETIC PROCESS,0.017549,0.25215,0.21587,1,1
3,GO NEGATIVE REGULATION OF TRANSCRIPTION BY COMPETITIVE PROMOTER BINDING,0.043763,0.25215,0.1736,1,1
3,GO RESPONSE TO CYTOKINE,0.00017186,0.25125,0.19623,1,1
3,GO CERAMIDE METABOLIC PROCESS,5.0226e-05,0.25095,0.25704,1,1
3,GO EXOCYTOSIS,0.00013433,0.25079,0.19475,1,1
3,GO SPHINGOID METABOLIC PROCESS,0.001191,0.25071,0.26846,1,1
3,GO INTERLEUKIN 6 MEDIATED SIGNALING PATHWAY,0.0028141,0.25001,0.26054,1,1
3,GO NOTCH SIGNALING PATHWAY,0.00038934,0.24999,0.19403,1,1
3,GO REGULATION OF RESPONSE TO WOUNDING,0.0018173,0.24996,0.20767,1,1
3,GO ORGANIC HYDROXY COMPOUND METABOLIC PROCESS,4.4712e-06,0.24994,0.24998,1,1
3,GO LEUKOCYTE MIGRATION,0.00017796,0.24985,0.21966,1,1
3,GO VESICLE BUDDING FROM MEMBRANE,0.00067758,0.24972,0.20289,1,1
3,GO CARBOHYDRATE TRANSPORT,4.2876e-06,0.24963,0.26196,1,1
3,GO POSITIVE REGULATION OF RUFFLE ASSEMBLY,0.010506,0.24943,0.22941,1,1
3,GO FATTY ACID DERIVATIVE TRANSPORT,0.00019079,0.24941,0.26581,1,1
3,GO RESPONSE TO BACTERIUM,0.00021167,0.24938,0.19851,1,1
3,GO POSITIVE REGULATION OF INTERFERON BETA PRODUCTION,0.00041602,0.24915,0.25366,1,1
3,GO POSITIVE REGULATION OF B CELL DIFFERENTIATION,0.029068,0.24904,0.17844,1,1
3,GO POSITIVE REGULATION OF GLUCONEOGENESIS,0.0021062,0.24897,0.38317,1,1
3,GO POSITIVE REGULATION OF T CELL PROLIFERATION,0.0014299,0.2486,0.2002,1,1
3,GO REGULATION OF GLUCOSE METABOLIC PROCESS,4.4712e-06,0.24856,0.25476,1,1
3,GO POSITIVE REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.00017186,0.24843,0.25067,1,1
3,GO MEMBRANE FISSION,0.009256,0.2483,0.22039,1,1
3,GO CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.0015189,0.24822,0.18008,1,1
3,GO REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,0.0026572,0.24808,0.23341,1,1
3,GO REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY,0.0041716,0.24806,0.191,1,1
3,GO EPITHELIAL STRUCTURE MAINTENANCE,0.00029782,0.24803,0.23481,1,1
3,GO MEMBRANE FUSION,0.00012964,0.248,0.20454,1,1
3,GO REGULATION OF BILE ACID METABOLIC PROCESS,0.0056288,0.24771,0.33926,1,1
3,GO REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,0.00032948,0.24766,0.25716,1,1
3,GO CELLULAR RESPONSE TO CHOLESTEROL,0.0087944,0.24738,0.25147,1,1
3,GO T CELL PROLIFERATION,0.00040247,0.2473,0.20922,1,1
3,GO REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.0010859,0.24708,0.24586,1,1
3,GO LATE ENDOSOME TO VACUOLE TRANSPORT,0.00021909,0.24701,0.22225,1,1
3,GO REGULATION OF T CELL MIGRATION,0.01282,0.247,0.19021,1,1
3,GO REGULATION OF NOTCH SIGNALING PATHWAY,0.00038934,0.24687,0.23046,1,1
3,GO POSITIVE REGULATION OF PEPTIDE HORMONE SECRETION,7.013e-05,0.24686,0.23382,1,1
3,GO REGULATION OF RESPONSE TO TUMOR CELL,0.0054795,0.24682,0.21491,1,1
3,GO POSITIVE REGULATION OF PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,2.1663e-05,0.2468,0.24287,1,1
3,GO REGULATION OF CELLULAR CARBOHYDRATE METABOLIC PROCESS,3.0689e-05,0.24676,0.23131,1,1
3,GO REGULATION OF DEFENSE RESPONSE,4.4878e-05,0.24663,0.20879,1,1
3,GO VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,0.0036303,0.24639,0.2779,1,1
3,GO POSITIVE REGULATION OF BLOOD VESSEL DIAMETER,0.0039469,0.2463,0.22437,1,1
3,GO ENTEROENDOCRINE CELL DIFFERENTIATION,0.02843,0.24622,0.1695,1,1
3,GO PRO B CELL DIFFERENTIATION,0.024846,0.24615,0.18492,1,1
3,GO T CELL MIGRATION,0.0083534,0.2457,0.17551,1,1
3,GO COAGULATION,0.0014738,0.2457,0.16487,1,1
3,GO INNATE IMMUNE RESPONSE ACTIVATING SIGNAL TRANSDUCTION,1.2962e-05,0.24557,0.2568,1,1
3,GO NADP METABOLIC PROCESS,0.0012662,0.24528,0.2864,1,1
3,GO REGULATION OF DEFENSE RESPONSE TO BACTERIUM,0.0025083,0.24495,0.2964,1,1
3,GO PROTEIN LOCALIZATION TO CELL CELL JUNCTION,0.0013457,0.24492,0.28957,1,1
3,GO NEGATIVE REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,0.025994,0.24488,0.14972,1,1
3,GO POSITIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY,4.3218e-05,0.2443,0.21926,1,1
3,GO PHOSPHOLIPID CATABOLIC PROCESS,7.013e-05,0.24428,0.32489,1,1
3,GO POSITIVE REGULATION OF PROTEIN AUTOPHOSPHORYLATION,0.017137,0.24419,0.15243,1,1
3,GO POSITIVE REGULATION OF CELL ADHESION,0.00065623,0.24407,0.19026,1,1
3,GO CELLULAR RESPONSE TO KETONE,0.00032948,0.24372,0.22529,1,1
3,GO TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,0.00038934,0.24364,0.19302,1,1
3,GO CELLULAR CARBOHYDRATE BIOSYNTHETIC PROCESS,3.4421e-05,0.24362,0.23511,1,1
3,GO CAMP BIOSYNTHETIC PROCESS,0.036164,0.24342,0.18959,1,1
3,GO RESPONSE TO PROGESTERONE,0.0017641,0.24299,0.21966,1,1
3,GO REGULATION OF ACTION POTENTIAL,0.0026572,0.24255,0.21297,1,1
3,GO POSITIVE REGULATION OF IMMUNE EFFECTOR PROCESS,0.00063551,0.2425,0.19193,1,1
3,GO NEGATIVE REGULATION OF INTERLEUKIN 6 PRODUCTION,0.00029782,0.24249,0.21176,1,1
3,GO LIPOPROTEIN METABOLIC PROCESS,0.00010462,0.24245,0.21366,1,1
3,GO MONOVALENT INORGANIC CATION HOMEOSTASIS,2.4346e-05,0.24191,0.21303,1,1
3,GO RENAL SYSTEM PROCESS,0.0007696,0.2419,0.19242,1,1
3,GO DIOL BIOSYNTHETIC PROCESS,0.00079435,0.24142,0.33474,1,1
3,GO SYNCYTIUM FORMATION,0.0022992,0.2413,0.18161,1,1
3,GO REGULATION OF MUSCLE HYPERTROPHY,0.0031536,0.24079,0.18416,1,1
3,GO AUTOPHAGY OF NUCLEUS,0.0045306,0.24038,0.22071,1,1
3,GO POSITIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS,3.0689e-05,0.24028,0.2175,1,1
3,GO CYTOKINE PRODUCTION,0.00010462,0.24024,0.21474,1,1
3,GO INTERLEUKIN 1 BETA PRODUCTION,0.0010528,0.23977,0.22186,1,1
3,GO EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.0010859,0.23952,0.1888,1,1
3,GO POSITIVE REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.00052342,0.2395,0.24417,1,1
3,GO LEUKOCYTE CELL CELL ADHESION,0.00027832,0.23941,0.20194,1,1
3,GO PANCREATIC JUICE SECRETION,0.016734,0.23926,0.17971,1,1
3,GO REGULATION OF BODY FLUID LEVELS,0.00045924,0.23899,0.17687,1,1
3,GO POSITIVE REGULATION OF LEUKOCYTE CELL CELL ADHESION,0.00098941,0.23886,0.18622,1,1
3,GO MUSCLE ADAPTATION,0.00028792,0.2386,0.1912,1,1
3,GO DEFENSE RESPONSE TO GRAM NEGATIVE BACTERIUM,0.00018427,0.23853,0.2191,1,1
3,GO GLIAL CELL PROLIFERATION,0.0067808,0.23849,0.19431,1,1
3,GO CELLULAR RESPONSE TO CALCIUM ION,0.00072223,0.23833,0.22777,1,1
3,GO POSITIVE REGULATION OF TYROSINE PHOSPHORYLATION OF STAT PROTEIN,0.0011199,0.23809,0.21069,1,1
3,GO PANCREAS DEVELOPMENT,0.0056288,0.23777,0.18027,1,1
3,GO POSITIVE CHEMOTAXIS,0.0056288,0.23755,0.15515,1,1
3,GO EATING BEHAVIOR,0.00018427,0.23753,0.22129,1,1
3,GO VESICLE TARGETING,0.00069957,0.23752,0.21247,1,1
3,GO GLYCOPROTEIN BIOSYNTHETIC PROCESS,8.1192e-05,0.23741,0.22396,1,1
3,GO T HELPER CELL LINEAGE COMMITMENT,0.0017123,0.23727,0.19625,1,1
3,GO MUSCLE HYPERTROPHY IN RESPONSE TO STRESS,0.042857,0.23701,0.16497,1,1
3,GO AMMONIUM TRANSPORT,0.010773,0.23701,0.18848,1,1
3,GO POSITIVE REGULATION OF IMMUNE RESPONSE,0.00027832,0.23694,0.1832,1,1
3,GO ALCOHOL METABOLIC PROCESS,2.1663e-05,0.23674,0.24621,1,1
3,GO RESPONSE TO STARVATION,1.9263e-05,0.23661,0.2331,1,1
3,GO POLYSACCHARIDE METABOLIC PROCESS,7.547e-05,0.23647,0.21818,1,1
3,GO VITAMIN BIOSYNTHETIC PROCESS,0.0028141,0.23645,0.2265,1,1
3,GO EPITHELIAL CELL APOPTOTIC PROCESS,0.00090094,0.23641,0.20141,1,1
3,GO PIGMENTATION,0.00047456,0.23614,0.16212,1,1
3,GO POSITIVE REGULATION OF ACTIN FILAMENT POLYMERIZATION,0.00041602,0.23605,0.18383,1,1
3,GO PROTEIN PROCESSING,9.0551e-05,0.2355,0.2436,1,1
3,GO SPLEEN DEVELOPMENT,0.00032948,0.23534,0.21907,1,1
3,GO NEGATIVE REGULATION OF PROTEOLYSIS,0.00030804,0.23527,0.192,1,1
3,GO NEGATIVE REGULATION OF MEIOTIC NUCLEAR DIVISION,0.011904,0.23525,0.267,1,1
3,GO INTERFERON ALPHA PRODUCTION,0.00022676,0.23524,0.23132,1,1
3,GO PROTEIN CONTAINING COMPLEX REMODELING,0.0031536,0.23523,0.2384,1,1
3,GO B CELL ACTIVATION,7.547e-05,0.23521,0.19978,1,1
3,GO HEMATOPOIETIC STEM CELL PROLIFERATION,0.00038934,0.23516,0.23765,1,1
3,GO ALPHA BETA T CELL ACTIVATION,0.00016595,0.23513,0.22083,1,1
3,GO LEUKOCYTE CHEMOTAXIS,0.00030804,0.2351,0.19386,1,1
3,GO REGULATION OF BLOOD PRESSURE,0.00019079,0.23477,0.18416,1,1
3,GO POSITIVE REGULATION OF HEART RATE,0.0041716,0.2347,0.25951,1,1
3,GO ALCOHOL BIOSYNTHETIC PROCESS,0.00012512,0.23467,0.22218,1,1
3,GO UNSATURATED FATTY ACID BIOSYNTHETIC PROCESS,0.007729,0.23433,0.17568,1,1
3,GO NEGATIVE REGULATION OF INFLAMMATORY RESPONSE,0.00042998,0.2343,0.19299,1,1
3,GO AMINOGLYCAN BIOSYNTHETIC PROCESS,0.0081404,0.23425,0.15789,1,1
3,GO CELL CHEMOTAXIS,0.00017796,0.23395,0.20247,1,1
3,GO OLIGOSACCHARIDE BIOSYNTHETIC PROCESS,0.0056288,0.23362,0.24531,1,1
3,GO REGULATION OF ENDOTHELIAL CELL DEVELOPMENT,0.00047456,0.23332,0.27095,1,1
3,GO REGULATION OF IMMUNE RESPONSE,0.00044439,0.23331,0.17212,1,1
3,GO POSITIVE REGULATION OF INTERLEUKIN 6 PRODUCTION,0.00074557,0.2333,0.22749,1,1
3,GO SODIUM ION HOMEOSTASIS,0.00019079,0.23288,0.21026,1,1
3,GO NEGATIVE REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.015574,0.23271,0.19618,1,1
3,GO POSITIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS,0.014486,0.23237,0.20797,1,1
3,GO EPIDERMIS DEVELOPMENT,0.0001165,0.23201,0.20431,1,1
3,GO RESPONSE TO METAL ION,7.6603e-06,0.232,0.22546,1,1
3,GO ER OVERLOAD RESPONSE,0.0073363,0.23187,0.23076,1,1
3,GO AMYLOID FIBRIL FORMATION,0.012508,0.23181,0.19601,1,1
3,GO POSITIVE REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,0.0059384,0.23181,0.21049,1,1
3,GO GRANULOCYTE MIGRATION,0.00054072,0.23178,0.18978,1,1
3,GO NEGATIVE REGULATION OF DEFENSE RESPONSE,0.00037661,0.23145,0.2229,1,1
3,GO CELL ACTIVATION,0.00022676,0.23137,0.18274,1,1
3,GO PURINE NUCLEOTIDE TRANSPORT,5.8301e-05,0.23133,0.23758,1,1
3,GO POSITIVE REGULATION OF MYELOID CELL DIFFERENTIATION,2.7343e-05,0.23115,0.24694,1,1
3,GO PH REDUCTION,5.0226e-05,0.23106,0.23731,1,1
3,GO VITAMIN METABOLIC PROCESS,0.0041716,0.2309,0.20639,1,1
3,GO INDOLE CONTAINING COMPOUND METABOLIC PROCESS,0.00042998,0.2309,0.25709,1,1
3,GO CELLULAR RESPONSE TO FOLLICLE STIMULATING HORMONE STIMULUS,0.0025083,0.23088,0.27798,1,1
3,GO CELLULAR RESPONSE TO EXTRACELLULAR STIMULUS,0.00024286,0.23071,0.18546,1,1
3,GO REGULATION OF GRANULOCYTE CHEMOTAXIS,0.00014935,0.23033,0.20027,1,1
3,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,0.00059588,0.23006,0.19138,1,1
3,GO REGULATION OF LEUKOCYTE DIFFERENTIATION,0.00017796,0.23001,0.17558,1,1
3,GO REGULATION OF RETROGRADE PROTEIN TRANSPORT ER TO CYTOSOL,0.00069957,0.22998,0.19077,1,1
3,GO REGULATION OF NIK NF KAPPAB SIGNALING,0.0023671,0.22974,0.13323,1,1
3,GO GLYCEROPHOSPHOLIPID CATABOLIC PROCESS,0.00098941,0.22949,0.2565,1,1
3,GO GOLGI VESICLE BUDDING,0.00011241,0.22943,0.2189,1,1
3,GO REGULATION OF HORMONE SECRETION,0.00012964,0.22919,0.19435,1,1
3,GO REGULATION OF PEPTIDE SECRETION,1.349e-05,0.22915,0.20418,1,1
3,GO ACTIVATION OF IMMUNE RESPONSE,0.00017796,0.22914,0.18604,1,1
3,GO PEPTIDE SECRETION,3.8583e-05,0.22899,0.20095,1,1
3,GO POSITIVE REGULATION OF FIBROBLAST PROLIFERATION,0.042857,0.22897,0.15233,1,1
3,GO MANNOSYLATION,4.1617e-05,0.22889,0.2562,1,1
3,GO NEUTRAL AMINO ACID TRANSPORT,0.015574,0.22889,0.24139,1,1
3,GO NUCLEOTIDE TRANSPORT,2.5308e-05,0.22835,0.23531,1,1
3,GO POSITIVE REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,0.0013457,0.22814,0.18798,1,1
3,GO POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO STRESS,0.009256,0.22812,0.23404,1,1
3,GO ENDOPLASMIC RETICULUM CALCIUM ION HOMEOSTASIS,0.00065623,0.22804,0.23691,1,1
3,GO MHC CLASS II BIOSYNTHETIC PROCESS,0.0054795,0.22803,0.20114,1,1
3,GO REGULATION OF PEPTIDASE ACTIVITY,7.8282e-05,0.22794,0.22706,1,1
3,GO CELLULAR RESPONSE TO BIOTIC STIMULUS,0.00019753,0.22788,0.18732,1,1
3,GO REGULATION OF INFLAMMATORY RESPONSE,0.00021909,0.22781,0.19455,1,1
3,GO POSITIVE REGULATION OF NIK NF KAPPAB SIGNALING,0.0017641,0.22779,0.15972,1,1
3,GO POSITIVE REGULATION OF T CELL MIGRATION,0.017137,0.22743,0.15466,1,1
3,GO CYTOKINE SECRETION,9.7346e-05,0.22741,0.22284,1,1
3,GO GLANDULAR EPITHELIAL CELL DIFFERENTIATION,0.035393,0.22729,0.15588,1,1
3,GO HORMONE TRANSPORT,6.5149e-05,0.22704,0.21142,1,1
3,GO LIPID HOMEOSTASIS,0.00019753,0.22697,0.23681,1,1
3,GO LINOLEIC ACID METABOLIC PROCESS,0.017549,0.22686,0.26584,1,1
3,GO REGULATION OF MAST CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.0062634,0.22644,0.23809,1,1
3,GO LYMPHOCYTE COSTIMULATION,0.00038934,0.22641,0.20352,1,1
3,GO REGULATION OF CELLULAR PH,8.6584e-06,0.22619,0.22024,1,1
3,GO SKIN DEVELOPMENT,0.00021167,0.22608,0.19588,1,1
3,GO CHLORIDE ION HOMEOSTASIS,0.01282,0.22601,0.17702,1,1
3,GO NEGATIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,5.2139e-05,0.22582,0.19887,1,1
3,GO REGULATION OF RUFFLE ASSEMBLY,0.0034322,0.2258,0.20442,1,1
3,GO RESPONSE TO CORTICOSTEROID,0.00074557,0.22543,0.18879,1,1
3,GO ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC PROCESS,9.389e-05,0.22532,0.20037,1,1
3,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,3.0576e-06,0.22502,0.21994,1,1
3,GO RESPONSE TO PH,0.0087944,0.22501,0.16675,1,1
3,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY,5.7413e-06,0.22495,0.20707,1,1
3,GO REGULATION OF EPITHELIAL CELL DIFFERENTIATION,0.00079435,0.22479,0.1907,1,1
3,GO ISOPRENOID METABOLIC PROCESS,0.00072223,0.22467,0.22708,1,1
3,GO ARACHIDONIC ACID SECRETION,0.00036427,0.22466,0.24421,1,1
3,GO POSITIVE REGULATION OF LYMPHOCYTE ACTIVATION,0.00081984,0.22458,0.17221,1,1
3,GO IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE,0.00090094,0.22381,0.2266,1,1
3,GO POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.044685,0.22362,0.09939,1,1
3,GO REGULATION OF GLIAL CELL APOPTOTIC PROCESS,0.041093,0.22351,0.20873,1,1
3,GO INSULIN SECRETION,0.00012964,0.2234,0.19603,1,1
3,GO REGULATION OF LIPID TRANSPORT,0.00019079,0.22338,0.23814,1,1
3,GO DETOXIFICATION,0.043763,0.2232,0.16924,1,1
3,GO POSITIVE REGULATION OF INNATE IMMUNE RESPONSE,2.2524e-05,0.22315,0.23302,1,1
3,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,0.007729,0.22304,0.1784,1,1
3,GO RESPONSE TO CALCIUM ION,0.00049035,0.22276,0.19532,1,1
3,GO REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,0.0037331,0.22274,0.15853,1,1
3,GO REGULATION OF PEPTIDE HORMONE SECRETION,0.00012964,0.22272,0.19979,1,1
3,GO REGULATION OF PLASMA LIPOPROTEIN PARTICLE LEVELS,0.0027346,0.22266,0.17147,1,1
3,GO MUSCLE CELL MIGRATION,0.010245,0.22236,0.17112,1,1
3,GO FC EPSILON RECEPTOR SIGNALING PATHWAY,7.2754e-05,0.22231,0.19826,1,1
3,GO POSITIVE REGULATION OF FATTY ACID TRANSPORT,0.00013433,0.2223,0.32641,1,1
3,GO POSITIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION,0.0022332,0.22227,0.14901,1,1
3,GO ASPARTATE FAMILY AMINO ACID METABOLIC PROCESS,0.0028141,0.22209,0.20343,1,1
3,GO POSITIVE REGULATION OF PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,0.018398,0.22207,0.18165,1,1
3,GO POSITIVE REGULATION OF ATP METABOLIC PROCESS,0.010773,0.22191,0.1423,1,1
3,GO RESPONSE TO KETONE,0.00045924,0.22161,0.17426,1,1
3,GO CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.0019282,0.22148,0.17994,1,1
3,GO RESPONSE TO ALCOHOL,0.00016595,0.22136,0.17171,1,1
3,GO LYMPHOCYTE HOMEOSTASIS,0.00044439,0.22113,0.20093,1,1
3,GO REGULATION OF GLUCONEOGENESIS,2.0833e-05,0.221,0.27056,1,1
3,GO PHAGOSOME MATURATION,0.00017186,0.22091,0.26968,1,1
3,GO REGULATION OF NUCLEASE ACTIVITY,0.0024367,0.22077,0.18203,1,1
3,GO FATTY ACID TRANSMEMBRANE TRANSPORT,0.019283,0.22074,0.19181,1,1
3,GO STRIATED MUSCLE CELL APOPTOTIC PROCESS,0.00098941,0.22028,0.22452,1,1
3,GO REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,0.0016129,0.21963,0.16286,1,1
3,GO REGULATION OF APOPTOTIC SIGNALING PATHWAY,0.0001547,0.2196,0.17876,1,1
3,GO APOPTOTIC SIGNALING PATHWAY,0.00019079,0.21958,0.17318,1,1
3,GO ACTIN NUCLEATION,2.5308e-05,0.21947,0.23036,1,1
3,GO WOUND HEALING,0.0040578,0.21933,0.14803,1,1
3,GO CELL CELL ADHESION INVOLVED IN GASTRULATION,0.020205,0.21911,0.22166,1,1
3,GO CARBOHYDRATE DERIVATIVE BIOSYNTHETIC PROCESS,0.00016595,0.21881,0.17887,1,1
3,GO ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.00040247,0.21861,0.17431,1,1
3,GO FATTY ACID BIOSYNTHETIC PROCESS,0.00037661,0.21835,0.2136,1,1
3,GO POLYSACCHARIDE BIOSYNTHETIC PROCESS,5.0226e-05,0.21821,0.23297,1,1
3,GO CELLULAR LIPID CATABOLIC PROCESS,4.0073e-05,0.21799,0.25351,1,1
3,GO IMMUNE RESPONSE REGULATING SIGNALING PATHWAY,8.1192e-05,0.21787,0.18518,1,1
3,GO PTERIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.010773,0.21778,0.25537,1,1
3,GO NEGATIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,0.0051916,0.21771,0.18409,1,1
3,GO EPITHELIAL CELL DIFFERENTIATION,0.0001547,0.21655,0.1924,1,1
3,GO POSITIVE REGULATION OF INTERLEUKIN 12 PRODUCTION,0.00055855,0.21613,0.23858,1,1
3,GO CELLULAR HORMONE METABOLIC PROCESS,0.0017123,0.21597,0.24788,1,1
3,GO LAMELLIPODIUM MORPHOGENESIS,0.015203,0.21591,0.2183,1,1
3,GO KERATAN SULFATE BIOSYNTHETIC PROCESS,0.0064317,0.21585,0.16594,1,1
3,GO T CELL DIFFERENTIATION INVOLVED IN IMMUNE RESPONSE,0.0036303,0.21564,0.1681,1,1
3,GO POSITIVE REGULATION OF BLOOD CIRCULATION,0.00069957,0.21524,0.18979,1,1
3,GO REGULATION OF CELL CELL ADHESION MEDIATED BY CADHERIN,0.0041716,0.21521,0.28741,1,1
3,GO POSITIVE REGULATION OF LEUKOCYTE DIFFERENTIATION,0.0013457,0.21506,0.15058,1,1
3,GO RESPONSE TO INORGANIC SUBSTANCE,1.1493e-05,0.21503,0.18155,1,1
3,GO LIPID EXPORT FROM CELL,0.0062634,0.21499,0.24272,1,1
3,GO MEMBRANE LIPID BIOSYNTHETIC PROCESS,0.00036427,0.21469,0.19224,1,1
3,GO B CELL DIFFERENTIATION,2.9532e-05,0.21419,0.2117,1,1
3,GO CELLULAR RESPONSE TO MOLECULE OF BACTERIAL ORIGIN,0.00095906,0.21382,0.17481,1,1
3,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION,0.00013433,0.21378,0.18346,1,1
3,GO T CELL ACTIVATION,0.00030804,0.21355,0.18402,1,1
3,GO GRANULOCYTE CHEMOTAXIS,0.001228,0.21318,0.15562,1,1
3,GO ASPARTATE FAMILY AMINO ACID CATABOLIC PROCESS,0.011904,0.21297,0.20464,1,1
3,GO ADIPOSE TISSUE DEVELOPMENT,0.00084609,0.21276,0.19245,1,1
3,GO CIRCADIAN REGULATION OF GENE EXPRESSION,8.7323e-05,0.21253,0.219,1,1
3,GO TRANSITION METAL ION HOMEOSTASIS,0.0049174,0.21253,0.15599,1,1
3,GO REGULATION OF CELL ACTIVATION,0.0015189,0.2125,0.15126,1,1
3,GO RESPONSE TO MACROPHAGE COLONY STIMULATING FACTOR,0.011612,0.21244,0.22221,1,1
3,GO REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,0.0075304,0.2122,0.12902,1,1
3,GO NEGATIVE REGULATION OF NUCLEOTIDE METABOLIC PROCESS,0.018398,0.21204,0.21824,1,1
3,GO REGULATION OF MAST CELL ACTIVATION,0.009256,0.2118,0.17633,1,1
3,GO LIPID BIOSYNTHETIC PROCESS,5.6174e-05,0.21175,0.19691,1,1
3,GO WHITE FAT CELL DIFFERENTIATION,0.0007696,0.21165,0.22203,1,1
3,GO RDNA HETEROCHROMATIN ASSEMBLY,0.00013433,0.21161,0.22758,1,1
3,GO REGULATION OF HORMONE LEVELS,4.4878e-05,0.21148,0.22221,1,1
3,GO RNA INTERFERENCE,0.037747,0.21131,0.1313,1,1
3,GO PROTEIN LOCALIZATION TO ENDOSOME,0.018836,0.21121,0.17889,1,1
3,GO NEGATIVE REGULATION OF MUSCLE HYPERTROPHY,0.036164,0.21104,0.18559,1,1
3,GO CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY IN RESPONSE TO VIRUS,0.00095906,0.21087,0.21504,1,1
3,GO IMMUNOGLOBULIN PRODUCTION INVOLVED IN IMMUNOGLOBULIN MEDIATED IMMUNE RESPONSE,0.0025083,0.21072,0.14805,1,1
3,GO RESPONSE TO DSRNA,0.001662,0.2106,0.15611,1,1
3,GO REGULATION OF HUMORAL IMMUNE RESPONSE,0.0030654,0.21044,0.20899,1,1
3,GO POSITIVE REGULATION OF CELL ACTIVATION,0.0014299,0.21016,0.15678,1,1
3,GO REGULATION OF ENDOCRINE PROCESS,0.00081984,0.21006,0.2261,1,1
3,GO TERPENOID METABOLIC PROCESS,0.0027346,0.21002,0.20525,1,1
3,GO REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,0.012508,0.20965,0.17706,1,1
3,GO CELLULAR RESPONSE TO CHEMICAL STRESS,0.00057693,0.20933,0.17024,1,1
3,GO TRANSCYTOSIS,0.0028957,0.20923,0.23264,1,1
3,GO REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.0037331,0.20899,0.18277,1,1
3,GO REGULATION OF LYSOSOMAL LUMEN PH,0.0006154,0.20897,0.30742,1,1
3,GO ADAPTIVE THERMOGENESIS,5.9841e-06,0.20858,0.2185,1,1
3,GO PROSTAGLANDIN SECRETION,0.0064317,0.2082,0.23396,1,1
3,GO RESPONSE TO STEROL,0.0034322,0.20799,0.20339,1,1
3,GO REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.040234,0.20793,0.13291,1,1
3,GO VACUOLE ORGANIZATION,5.9841e-06,0.20791,0.23127,1,1
3,GO PROTEIN AUTOPROCESSING,0.0039469,0.20787,0.27894,1,1
3,GO PHENOL CONTAINING COMPOUND METABOLIC PROCESS,0.00045924,0.20773,0.18491,1,1
3,GO NEUTROPHIL MIGRATION,0.00026003,0.2077,0.18865,1,1
3,GO LIPID OXIDATION,0.0024367,0.20755,0.17658,1,1
3,GO CARBOHYDRATE HOMEOSTASIS,0.00021167,0.20742,0.1869,1,1
3,GO MYELOID LEUKOCYTE CYTOKINE PRODUCTION,0.010245,0.20709,0.14822,1,1
3,GO REGULATION OF CELL ADHESION,0.0013872,0.20709,0.16452,1,1
3,GO RESPONSE TO OSMOTIC STRESS,0.0022332,0.20696,0.18836,1,1
3,GO POSITIVE REGULATION OF IMMUNE SYSTEM PROCESS,0.00020448,0.20684,0.17241,1,1
3,GO PLATELET MORPHOGENESIS,0.0033369,0.20679,0.18889,1,1
3,GO GLYCEROLIPID CATABOLIC PROCESS,0.00090094,0.20662,0.23413,1,1
3,GO GLUTAMATE METABOLIC PROCESS,0.0047853,0.20649,0.17537,1,1
3,GO REGULATION OF GLUCAN BIOSYNTHETIC PROCESS,0.0038387,0.20639,0.15148,1,1
3,GO NEGATIVE REGULATION OF SMALL MOLECULE METABOLIC PROCESS,0.0017641,0.20618,0.15782,1,1
3,GO NECROTIC CELL DEATH,0.00044439,0.20613,0.26175,1,1
3,GO LONG CHAIN FATTY ACID METABOLIC PROCESS,0.00084609,0.20591,0.20795,1,1
3,GO REGULATION OF CARBOHYDRATE BIOSYNTHETIC PROCESS,9.0179e-06,0.20578,0.21691,1,1
3,GO ACTIVATION OF INNATE IMMUNE RESPONSE,3.0689e-05,0.20567,0.23659,1,1
3,GO POSITIVE REGULATION OF KIDNEY DEVELOPMENT,0.017137,0.20564,0.18046,1,1
3,GO LEUKOCYTE DIFFERENTIATION,0.00017186,0.20544,0.16659,1,1
3,GO CELLULAR CARBOHYDRATE METABOLIC PROCESS,0.00018427,0.20542,0.18288,1,1
3,GO ORGANELLE FUSION,0.00069957,0.2054,0.16914,1,1
3,GO CHOLESTEROL STORAGE,0.0021062,0.2054,0.23223,1,1
3,GO PEPTIDE HORMONE SECRETION,9.389e-05,0.20529,0.20057,1,1
3,GO REGULATION OF RESPONSE TO EXTERNAL STIMULUS,0.00028792,0.20504,0.16391,1,1
3,GO REGULATION OF PROTEIN AUTOPHOSPHORYLATION,0.012203,0.20492,0.15427,1,1
3,GO SPHINGOLIPID BIOSYNTHETIC PROCESS,0.00019753,0.2049,0.19778,1,1
3,GO CELL CELL ADHESION,0.0028957,0.20398,0.14422,1,1
3,GO REGULATION OF EPIDERMIS DEVELOPMENT,0.0010206,0.20395,0.20368,1,1
3,GO REGULATION OF LYMPHOCYTE ACTIVATION,0.00092958,0.20353,0.16357,1,1
3,GO REGULATION OF T CELL ACTIVATION,0.00063551,0.20341,0.17419,1,1
3,GO NEUTRAL LIPID CATABOLIC PROCESS,0.0027346,0.20322,0.22181,1,1
3,GO RESPONSE TO MECHANICAL STIMULUS,0.00021909,0.20285,0.19068,1,1
3,GO GLYCOPROTEIN METABOLIC PROCESS,0.00049035,0.20271,0.18996,1,1
3,GO LYMPHOCYTE ACTIVATION,0.00063551,0.2026,0.15218,1,1
3,GO XENOBIOTIC TRANSPORT,0.0062634,0.20258,0.26434,1,1
3,GO NEGATIVE REGULATION OF MUSCLE CELL DIFFERENTIATION,0.00016595,0.20238,0.25977,1,1
3,GO FC RECEPTOR SIGNALING PATHWAY,0.00038934,0.20236,0.1533,1,1
3,GO REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.017137,0.20232,0.11388,1,1
3,GO REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,0.0057817,0.20222,0.17869,1,1
3,GO REGULATION OF LIPID STORAGE,0.0047853,0.20219,0.17073,1,1
3,GO ACTIN FILAMENT DEPOLYMERIZATION,0.00050664,0.20211,0.19293,1,1
3,GO TUMOR NECROSIS FACTOR BIOSYNTHETIC PROCESS,0.0079323,0.20182,0.14756,1,1
3,GO PROTEIN AUTO ADP RIBOSYLATION,0.010773,0.20166,0.27262,1,1
3,GO REGULATION OF LYMPHOCYTE DIFFERENTIATION,0.001872,0.20163,0.13651,1,1
3,GO PHOSPHATIDYLETHANOLAMINE BIOSYNTHETIC PROCESS,0.00031859,0.20157,0.20156,1,1
3,GO REGULATION OF KILLING OF CELLS OF OTHER ORGANISM,0.023741,0.20154,0.1882,1,1
3,GO REGULATION OF CHOLESTEROL BIOSYNTHETIC PROCESS,0.00098941,0.20121,0.18956,1,1
3,GO REGULATION OF ENDOTHELIAL CELL MIGRATION,0.0075304,0.20117,0.14872,1,1
3,GO PHOSPHATIDYLCHOLINE ACYL CHAIN REMODELING,4.3218e-05,0.20093,0.23447,1,1
3,GO REGULATION OF PH,3.3132e-05,0.20089,0.20737,1,1
3,GO PROTEIN MATURATION,0.00030804,0.20084,0.19,1,1
3,GO PLATELET ACTIVATION,0.00084609,0.20081,0.17774,1,1
3,GO SECRETION,0.00013917,0.20073,0.17061,1,1
3,GO COPII COATED VESICLE BUDDING,0.00022676,0.20059,0.20349,1,1
3,GO MULTI MULTICELLULAR ORGANISM PROCESS,0.0038387,0.20059,0.15918,1,1
3,GO HEPATICOBILIARY SYSTEM DEVELOPMENT,0.00054072,0.20017,0.17405,1,1
3,GO GPI ANCHOR METABOLIC PROCESS,0.0023671,0.20011,0.21017,1,1
3,GO PHOSPHATIDYLETHANOLAMINE METABOLIC PROCESS,2.1663e-05,0.2001,0.25242,1,1
3,GO MACROMOLECULE DEPALMITOYLATION,0.00081984,0.20005,0.2293,1,1
3,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY,0.0057817,0.19971,0.19128,1,1
3,GO POSITIVE REGULATION OF COAGULATION,0.0069616,0.19971,0.20608,1,1
3,GO CELLULAR RESPONSE TO HYDROGEN PEROXIDE,0.00098941,0.19868,0.18662,1,1
3,GO BRANCHING INVOLVED IN BLOOD VESSEL MORPHOGENESIS,0.0046564,0.19849,0.23199,1,1
3,GO CELLULAR RESPONSE TO INCREASED OXYGEN LEVELS,0.0017641,0.19801,0.22129,1,1
3,GO PROTEIN ADP RIBOSYLATION,0.017549,0.19776,0.1531,1,1
3,GO POSITIVE REGULATION OF EPIDERMIS DEVELOPMENT,0.02068,0.19742,0.17762,1,1
3,GO NCRNA CATABOLIC PROCESS,0.0094949,0.19712,0.13853,1,1
3,GO LONG CHAIN FATTY ACID TRANSPORT,0.00065623,0.197,0.19034,1,1
3,GO NEGATIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,0.0026572,0.19687,0.14729,1,1
3,GO REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,0.00092958,0.19686,0.17358,1,1
3,GO FAT SOLUBLE VITAMIN METABOLIC PROCESS,0.010506,0.19662,0.19227,1,1
3,GO POSTTRANSLATIONAL PROTEIN TARGETING TO ENDOPLASMIC RETICULUM MEMBRANE,0.0017123,0.19656,0.19694,1,1
3,GO POSITIVE REGULATION OF ATP BIOSYNTHETIC PROCESS,0.013798,0.19654,0.28607,1,1
3,GO CELLULAR MONOVALENT INORGANIC CATION HOMEOSTASIS,4.1617e-05,0.19652,0.19168,1,1
3,GO NEGATIVE REGULATION OF ERK1 AND ERK2 CASCADE,0.025994,0.19651,0.13366,1,1
3,GO REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.00095906,0.19646,0.17355,1,1
3,GO ENDOCYTIC RECYCLING,0.0051916,0.19645,0.1348,1,1
3,GO DIGESTIVE SYSTEM DEVELOPMENT,0.004408,0.19639,0.14653,1,1
3,GO CELLULAR TRANSITION METAL ION HOMEOSTASIS,0.011612,0.19622,0.14634,1,1
3,GO RESPONSE TO INSULIN,9.0551e-05,0.19606,0.17459,1,1
3,GO REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,2.6307e-05,0.19601,0.20422,1,1
3,GO EPITHELIUM DEVELOPMENT,0.00047456,0.19595,0.13952,1,1
3,GO IMIDAZOLE CONTAINING COMPOUND METABOLIC PROCESS,0.017969,0.1959,0.19393,1,1
3,GO POSITIVE REGULATION OF LAMELLIPODIUM ORGANIZATION,0.0045306,0.19581,0.14939,1,1
3,GO REGULATION OF LIPID LOCALIZATION,0.0010206,0.19577,0.19941,1,1
3,GO T CELL DIFFERENTIATION,0.00027832,0.19552,0.15885,1,1
3,GO REGULATION OF LIPOPROTEIN LIPASE ACTIVITY,0.047551,0.19543,0.13084,1,1
3,GO FATTY ACID METABOLIC PROCESS,0.00018427,0.19533,0.22094,1,1
3,GO REGULATION OF CHROMATIN ASSEMBLY,0.00087311,0.19502,0.15769,1,1
3,GO VESICLE ORGANIZATION,0.00050664,0.1947,0.16802,1,1
3,GO ENGULFMENT OF APOPTOTIC CELL,0.023741,0.19453,0.13275,1,1
3,GO POSITIVE REGULATION OF MUSCLE HYPERTROPHY,0.019283,0.19445,0.12637,1,1
3,GO LIPID METABOLIC PROCESS,0.00013433,0.19435,0.1885,1,1
3,GO REGULATION OF RENAL SYSTEM PROCESS,0.016734,0.19404,0.19042,1,1
3,GO REGULATION OF TUBE SIZE,0.0036303,0.19401,0.1569,1,1
3,GO REGULATION OF ERBB SIGNALING PATHWAY,0.0019282,0.19398,0.17748,1,1
3,GO REPLICATIVE SENESCENCE,0.022165,0.1939,0.20209,1,1
3,GO REGULATION OF INSULIN SECRETION,0.00044439,0.19343,0.17268,1,1
3,GO KILLING OF CELLS IN OTHER ORGANISM INVOLVED IN SYMBIOTIC INTERACTION,0.0053338,0.19329,0.14835,1,1
3,GO CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,0.0027346,0.19297,0.19099,1,1
3,GO POSITIVE REGULATION OF LIPID BIOSYNTHETIC PROCESS,0.0038387,0.1929,0.16677,1,1
3,GO DENDRITIC CELL CHEMOTAXIS,0.05161,0.19287,0.126,1,1
3,GO REGULATION OF APPETITE,0.013798,0.19264,0.12015,1,1
3,GO SEQUESTERING OF CALCIUM ION,0.0016129,0.19223,0.15949,1,1
3,GO REGULATION OF T CELL DIFFERENTIATION,0.001662,0.19218,0.13496,1,1
3,GO REGULATION OF HEMOPOIESIS,0.00023468,0.19211,0.15101,1,1
3,GO REGULATION OF TRANSLATION IN RESPONSE TO STRESS,0.016734,0.19167,0.15024,1,1
3,GO LABYRINTHINE LAYER BLOOD VESSEL DEVELOPMENT,0.033894,0.19155,0.14312,1,1
3,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION,0.0059384,0.19153,0.19484,1,1
3,GO NEGATIVE REGULATION OF HYDROLASE ACTIVITY,0.00022676,0.19139,0.16329,1,1
3,GO REGULATION OF SMALL MOLECULE METABOLIC PROCESS,0.00021167,0.19134,0.17351,1,1
3,GO RESPONSE TO MOLECULE OF BACTERIAL ORIGIN,0.0022332,0.19117,0.15625,1,1
3,GO REGULATION OF FATTY ACID OXIDATION,0.033894,0.19103,0.15228,1,1
3,GO T CELL RECEPTOR SIGNALING PATHWAY,0.0022992,0.19102,0.14803,1,1
3,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,0.0015189,0.19101,0.1626,1,1
3,GO NEGATIVE REGULATION OF ERBB SIGNALING PATHWAY,0.00054072,0.19098,0.18032,1,1
3,GO HUMORAL IMMUNE RESPONSE,3.1888e-05,0.1906,0.21609,1,1
3,GO POSITIVE REGULATION OF INSULIN SECRETION,0.00042998,0.19057,0.19238,1,1
3,GO ALPHA BETA T CELL DIFFERENTIATION,0.00079435,0.19049,0.1898,1,1
3,GO DETERMINATION OF DORSAL VENTRAL ASYMMETRY,0.014841,0.18993,0.17592,1,1
3,GO PROTEIN KINASE B SIGNALING,0.0049174,0.18988,0.12776,1,1
3,GO REGULATION OF IMMUNE SYSTEM PROCESS,0.00057693,0.18967,0.1523,1,1
3,GO NEGATIVE REGULATION OF ASTROCYTE DIFFERENTIATION,0.044685,0.18964,0.14659,1,1
3,GO REGULATION OF DENDRITE EXTENSION,0.0099891,0.18959,0.31561,1,1
3,GO POSITIVE REGULATION OF FAT CELL DIFFERENTIATION,0.0067808,0.18945,0.18972,1,1
3,GO FATTY ACID DERIVATIVE BIOSYNTHETIC PROCESS,0.00041602,0.18911,0.22046,1,1
3,GO REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY,0.015574,0.18897,0.17342,1,1
3,GO EXECUTION PHASE OF APOPTOSIS,7.5427e-07,0.18892,0.2151,1,1
3,GO SENSORY PERCEPTION OF TASTE,0.0018173,0.18888,0.15332,1,1
3,GO SUPEROXIDE METABOLIC PROCESS,0.00063551,0.18886,0.22225,1,1
3,GO MUSCLE CELL APOPTOTIC PROCESS,0.0013872,0.18878,0.1728,1,1
3,GO LONG CHAIN FATTY ACYL COA METABOLIC PROCESS,0.0033369,0.18861,0.24468,1,1
3,GO RESPONSE TO MUSCLE INACTIVITY,0.042857,0.1886,0.17997,1,1
3,GO POSITIVE REGULATION OF HEMOPOIESIS,0.00040247,0.18847,0.16942,1,1
3,GO CELLULAR LIPID METABOLIC PROCESS,0.00012074,0.18835,0.1897,1,1
3,GO VASCULAR ENDOTHELIAL GROWTH FACTOR SIGNALING PATHWAY,0.014486,0.18814,0.18732,1,1
3,GO DEVELOPMENTAL PIGMENTATION,0.0028957,0.18792,0.14372,1,1
3,GO CELLULAR RESPONSE TO NITROGEN STARVATION,0.0031536,0.18785,0.23331,1,1
3,GO POSITIVE REGULATION OF SECRETION,3.3132e-05,0.18772,0.2019,1,1
3,GO POSITIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION,0.0026572,0.18771,0.18064,1,1
3,GO GLYCOLIPID BIOSYNTHETIC PROCESS,0.0062634,0.18759,0.16671,1,1
3,GO EPITHELIAL CELL DEVELOPMENT,0.0060989,0.18754,0.13574,1,1
3,GO REGULATION OF LIPID METABOLIC PROCESS,0.00040247,0.18701,0.16645,1,1
3,GO LEUKOCYTE HOMEOSTASIS,0.0056288,0.18695,0.1429,1,1
3,GO GAMMA DELTA T CELL ACTIVATION,0.017969,0.18667,0.23137,1,1
3,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,3.7145e-05,0.18666,0.17834,1,1
3,GO CALCIUM ION TRANSMEMBRANE IMPORT INTO CYTOSOL,0.0036303,0.18632,0.13407,1,1
3,GO NEGATIVE REGULATION OF INTERLEUKIN 12 PRODUCTION,0.014486,0.18623,0.1864,1,1
3,GO MYOTUBE DIFFERENTIATION,0.00092958,0.18617,0.17545,1,1
3,GO MYELOID LEUKOCYTE DIFFERENTIATION,0.0028141,0.18606,0.14252,1,1
3,GO LYMPHOCYTE APOPTOTIC PROCESS,0.0013457,0.186,0.21178,1,1
3,GO IRON ION TRANSPORT,6.5149e-05,0.18597,0.23923,1,1
3,GO REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.0025817,0.18554,0.15663,1,1
3,GO PHOSPHOLIPASE C ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,6.7596e-05,0.18551,0.22746,1,1
3,GO PROTEIN LIPID COMPLEX SUBUNIT ORGANIZATION,0.00045924,0.18551,0.22392,1,1
3,GO POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.02843,0.18546,0.10521,1,1
3,GO NEUROEPITHELIAL CELL DIFFERENTIATION,0.001986,0.18476,0.26563,1,1
3,GO GLUCOSE METABOLIC PROCESS,3.5759e-05,0.18474,0.217,1,1
3,GO CARBOHYDRATE DERIVATIVE METABOLIC PROCESS,0.00065623,0.18469,0.15857,1,1
3,GO GOLGI RIBBON FORMATION,0.0066042,0.18462,0.18817,1,1
3,GO PHOSPHOLIPID METABOLIC PROCESS,6.0504e-05,0.18452,0.16889,1,1
3,GO POSITIVE REGULATION OF RECEPTOR INTERNALIZATION,0.0059384,0.18435,0.17842,1,1
3,GO ACID SECRETION,0.0036303,0.18391,0.15574,1,1
3,GO MYELOID DENDRITIC CELL ACTIVATION,0.0097392,0.18384,0.17747,1,1
3,GO CHLORIDE TRANSPORT,0.0007696,0.18369,0.14822,1,1
3,GO REGULATION OF MEMBRANE DEPOLARIZATION,0.0054795,0.18354,0.1566,1,1
3,GO PROTEIN O LINKED MANNOSYLATION,0.0099891,0.18338,0.18869,1,1
3,GO POSITIVE REGULATION OF MITOCHONDRION ORGANIZATION,0.00031859,0.18306,0.13828,1,1
3,GO FIBROBLAST PROLIFERATION,0.03245,0.18291,0.119,1,1
3,GO REGULATION OF CARBOHYDRATE METABOLIC PROCESS,0.00026003,0.1828,0.16989,1,1
3,GO RESPONSE TO WOUNDING,0.009256,0.18272,0.12674,1,1
3,GO CARBOHYDRATE METABOLIC PROCESS,0.00057693,0.18254,0.17491,1,1
3,GO ESTABLISHMENT OF EPITHELIAL CELL POLARITY,0.033166,0.18251,0.16588,1,1
3,GO OXIDATION REDUCTION PROCESS,0.00042998,0.18239,0.18325,1,1
3,GO REGULATION OF CALCIUM ION DEPENDENT EXOCYTOSIS,0.0032441,0.18236,0.25299,1,1
3,GO ENDOTHELIAL CELL MIGRATION,0.0090226,0.18232,0.14555,1,1
3,GO RENAL TUBULE DEVELOPMENT,0.018398,0.1823,0.11516,1,1
3,GO POSITIVE REGULATION OF PEPTIDE SECRETION,1.104e-05,0.18209,0.21102,1,1
3,GO PROTON TRANSMEMBRANE TRANSPORT,2.0033e-05,0.18201,0.21251,1,1
3,GO LONG CHAIN FATTY ACYL COA BIOSYNTHETIC PROCESS,0.0020453,0.18165,0.24001,1,1
3,GO POSITIVE REGULATION OF EXOCYTOSIS,0.00038934,0.1815,0.20025,1,1
3,GO LYMPHOCYTE DIFFERENTIATION,0.00042998,0.18132,0.1416,1,1
3,GO CELLULAR RESPONSE TO GAMMA RADIATION,0.025994,0.18127,0.13162,1,1
3,GO NEUTROPHIL CHEMOTAXIS,0.0006154,0.18074,0.14617,1,1
3,GO RESPONSE TO LIPID,0.0019282,0.18072,0.13629,1,1
3,GO TEMPERATURE HOMEOSTASIS,0.00012074,0.18064,0.17615,1,1
3,GO POSITIVE REGULATION OF OSTEOCLAST DIFFERENTIATION,0.013139,0.18026,0.15585,1,1
3,GO RESPONSE TO CHEMOKINE,0.00057693,0.17992,0.15247,1,1
3,GO POSITIVE REGULATION OF PROTEIN BINDING,0.0045306,0.17979,0.16241,1,1
3,GO CHEMICAL HOMEOSTASIS,6.5149e-05,0.17955,0.16593,1,1
3,GO MECHANORECEPTOR DIFFERENTIATION,0.00037661,0.17938,0.18278,1,1
3,GO VESICLE MEDIATED TRANSPORT BETWEEN ENDOSOMAL COMPARTMENTS,0.0017123,0.17932,0.17246,1,1
3,GO CELLULAR RESPONSE TO INSULIN STIMULUS,0.0001547,0.17929,0.16133,1,1
3,GO RESPONSE TO EXTRACELLULAR STIMULUS,0.00012512,0.17925,0.17168,1,1
3,GO CALCIUM ION REGULATED EXOCYTOSIS,0.0025083,0.17918,0.26506,1,1
3,GO ENDOCRINE PANCREAS DEVELOPMENT,0.0075304,0.17903,0.1749,1,1
3,GO NEGATIVE REGULATION OF MEIOTIC CELL CYCLE,0.0062634,0.17878,0.20415,1,1
3,GO POSITIVE REGULATION OF CYTOKINE SECRETION,0.00022676,0.1786,0.19323,1,1
3,GO PROTEIN DESTABILIZATION,0.00027832,0.17843,0.17514,1,1
3,GO EPITHELIAL TUBE BRANCHING INVOLVED IN LUNG MORPHOGENESIS,0.043763,0.17812,0.15911,1,1
3,GO ORGANELLE INHERITANCE,0.0013457,0.17796,0.15578,1,1
3,GO DIVALENT INORGANIC CATION HOMEOSTASIS,0.00059588,0.17784,0.1329,1,1
3,GO RESPONSE TO PROSTAGLANDIN,0.014138,0.17783,0.1966,1,1
3,GO POLYOL BIOSYNTHETIC PROCESS,0.0013457,0.17782,0.20834,1,1
3,GO MYELOID CELL DIFFERENTIATION,0.00024286,0.17776,0.14826,1,1
3,GO NEGATIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS,0.0045306,0.17742,0.14315,1,1
3,GO REGULATION OF PHOSPHOLIPID BIOSYNTHETIC PROCESS,0.0081404,0.17736,0.19928,1,1
3,GO RESPONSE TO STEROID HORMONE,0.0014738,0.17733,0.15115,1,1
3,GO REGULATION OF SODIUM ION TRANSPORT,0.019283,0.17722,0.14101,1,1
3,GO GLOMERULUS DEVELOPMENT,0.0066042,0.17713,0.17927,1,1
3,GO INTERFERON GAMMA PRODUCTION,0.01282,0.17698,0.12533,1,1
3,GO LIPID CATABOLIC PROCESS,9.7346e-05,0.17659,0.20999,1,1
3,GO NEGATIVE REGULATION OF CELL ADHESION,0.0040578,0.17574,0.15219,1,1
3,GO REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,0.00022676,0.1756,0.14778,1,1
3,GO CELLULAR RESPONSE TO GONADOTROPIN STIMULUS,0.0083534,0.17553,0.19074,1,1
3,GO RESPONSE TO REACTIVE OXYGEN SPECIES,0.00023468,0.17522,0.15209,1,1
3,GO MONOSACCHARIDE METABOLIC PROCESS,0.00030804,0.17502,0.21932,1,1
3,GO POSITIVE REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,0.00067758,0.17501,0.14034,1,1
3,GO CELLULAR RESPONSE TO REACTIVE OXYGEN SPECIES,0.00057693,0.17468,0.1582,1,1
3,GO NEGATIVE REGULATION OF OSSIFICATION,0.018836,0.1746,0.13301,1,1
3,GO RECEPTOR SIGNALING PATHWAY VIA STAT,0.00040247,0.17425,0.17689,1,1
3,GO ORGANIC ANION TRANSPORT,0.00017186,0.17416,0.18387,1,1
3,GO CELLULAR PROTEIN CONTAINING COMPLEX LOCALIZATION,0.0049174,0.17389,0.17142,1,1
3,GO METAL ION HOMEOSTASIS,0.00029782,0.17349,0.13988,1,1
3,GO REGULATION OF ANION TRANSPORT,0.00063551,0.17344,0.22227,1,1
3,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,0.00050664,0.17302,0.17858,1,1
3,GO RESPONSE TO MONOSACCHARIDE,0.0018173,0.17273,0.14015,1,1
3,GO REGULATION OF BONE DEVELOPMENT,0.01282,0.17225,0.13938,1,1
3,GO IMMUNE SYSTEM DEVELOPMENT,0.00018427,0.17198,0.13508,1,1
3,GO POSITIVE REGULATION OF INTERLEUKIN 1 PRODUCTION,0.010245,0.1718,0.16842,1,1
3,GO RESPONSE TO ETHER,0.0019282,0.17168,0.18319,1,1
3,GO NEUTRAL LIPID METABOLIC PROCESS,0.0069616,0.17167,0.14803,1,1
3,GO OOCYTE DIFFERENTIATION,0.0010528,0.1715,0.15532,1,1
3,GO REGULATION OF LEUKOCYTE MIGRATION,0.0051916,0.17141,0.13711,1,1
3,GO GLUTAMINE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.022165,0.17085,0.24674,1,1
3,GO INORGANIC ION IMPORT ACROSS PLASMA MEMBRANE,0.02166,0.17083,0.1219,1,1
3,GO ANION TRANSMEMBRANE TRANSPORT,0.00069957,0.17079,0.15543,1,1
3,GO DETECTION OF STIMULUS,5.2139e-05,0.17072,0.1403,1,1
3,GO REGULATION OF FATTY ACID METABOLIC PROCESS,0.0071468,0.17053,0.16458,1,1
3,GO REGULATION OF SECRETION,0.00019753,0.17039,0.15572,1,1
3,GO FATTY ACID TRANSPORT,0.0015653,0.16959,0.18967,1,1
3,GO CYTOSOLIC CALCIUM ION TRANSPORT,0.0060989,0.16955,0.1183,1,1
3,GO CELLULAR PIGMENTATION,0.0010528,0.16927,0.17475,1,1
3,GO POSITIVE REGULATION OF LIPID TRANSPORT,0.0007696,0.16913,0.18671,1,1
3,GO PROTEIN LOCALIZATION TO GOLGI APPARATUS,0.0016129,0.16868,0.15642,1,1
3,GO RESPONSE TO CARBOHYDRATE,0.0018173,0.16858,0.1393,1,1
3,GO REGULATION OF LYMPHOCYTE MIGRATION,0.016339,0.16725,0.14853,1,1
3,GO MONONUCLEAR CELL MIGRATION,0.015574,0.16722,0.12318,1,1
3,GO WATER SOLUBLE VITAMIN METABOLIC PROCESS,0.03939,0.16719,0.16174,1,1
3,GO PHOSPHOLIPID BIOSYNTHETIC PROCESS,5.0226e-05,0.16716,0.18241,1,1
3,GO INORGANIC ANION TRANSPORT,0.00041602,0.16693,0.14316,1,1
3,GO TYROSINE PHOSPHORYLATION OF STAT PROTEIN,0.009256,0.16693,0.13047,1,1
3,GO REGULATION OF EPITHELIAL CELL MIGRATION,0.0045306,0.16666,0.14929,1,1
3,GO RESPONSE TO OXIDATIVE STRESS,0.0010206,0.16658,0.14099,1,1
3,GO POSITIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,0.00079435,0.16656,0.13474,1,1
3,GO REGULATION OF PROTEOLYSIS,0.00050664,0.16654,0.15323,1,1
3,GO GLYCEROLIPID METABOLIC PROCESS,0.00026903,0.16649,0.15519,1,1
3,GO BIOLOGICAL ADHESION,0.013798,0.16627,0.10982,1,1
3,GO MONOCARBOXYLIC ACID TRANSPORT,0.00055855,0.16621,0.2052,1,1
3,GO T HELPER 17 TYPE IMMUNE RESPONSE,0.0025083,0.16616,0.17727,1,1
3,GO PROTEOLYSIS,0.00016595,0.16613,0.14075,1,1
3,GO TRIGLYCERIDE METABOLIC PROCESS,0.01282,0.16613,0.13625,1,1
3,GO AGING,0.00084609,0.16607,0.12825,1,1
3,GO REGULATION OF RESPONSE TO STRESS,0.0010206,0.166,0.12574,1,1
3,GO RHO PROTEIN SIGNAL TRANSDUCTION,0.024846,0.16557,0.10393,1,1
3,GO RESPONSE TO DRUG,0.0015653,0.16528,0.14794,1,1
3,GO CARBOHYDRATE TRANSMEMBRANE TRANSPORT,0.0057817,0.16519,0.16562,1,1
3,GO PROTEIN K48 LINKED UBIQUITINATION,0.00034072,0.16513,0.13986,1,1
3,GO CIRCULATORY SYSTEM PROCESS,0.001228,0.16462,0.12796,1,1
3,GO PHOSPHORYLATED CARBOHYDRATE DEPHOSPHORYLATION,0.001228,0.16462,0.22921,1,1
3,GO ANION TRANSPORT,0.00014935,0.1646,0.16899,1,1
3,GO NEGATIVE REGULATION OF GTPASE ACTIVITY,0.00087311,0.16412,0.14964,1,1
3,GO ION HOMEOSTASIS,0.00037661,0.16357,0.14258,1,1
3,GO NEGATIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,0.00092958,0.16291,0.17417,1,1
3,GO FATTY ACID BETA OXIDATION,0.019283,0.16289,0.15803,1,1
3,GO CELLULAR RESPONSE TO PEPTIDE HORMONE STIMULUS,0.00049035,0.16257,0.13983,1,1
3,GO POSITIVE REGULATION OF INTERFERON GAMMA PRODUCTION,0.020205,0.16251,0.1512,1,1
3,GO REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,0.0040578,0.16244,0.12903,1,1
3,GO REGULATION OF LIPID CATABOLIC PROCESS,0.0047853,0.1623,0.13072,1,1
3,GO REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,0.014841,0.16219,0.13846,1,1
3,GO ACTIVATED T CELL PROLIFERATION,0.013465,0.16198,0.14938,1,1
3,GO RUFFLE ORGANIZATION,0.00092958,0.1617,0.1898,1,1
3,GO COPULATION,0.031748,0.16167,0.15776,1,1
3,GO ORGANELLE DISASSEMBLY,0.00025131,0.16154,0.16541,1,1
3,GO REGULATION OF ACTOMYOSIN STRUCTURE ORGANIZATION,0.026586,0.16152,0.097956,1,1
3,GO CELLULAR RESPONSE TO LIPID,0.0069616,0.16152,0.1183,1,1
3,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,0.0013054,0.16143,0.16704,1,1
3,GO POSITIVE REGULATION OF FATTY ACID METABOLIC PROCESS,0.050569,0.16138,0.11691,1,1
3,GO REGULATION OF ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY,0.0025817,0.16135,0.20168,1,1
3,GO POSITIVE REGULATION OF OXIDOREDUCTASE ACTIVITY,0.01282,0.16089,0.16924,1,1
3,GO REGULATION OF GLUCOSE IMPORT,0.0049174,0.16078,0.15916,1,1
3,GO REGULATION OF T HELPER 17 TYPE IMMUNE RESPONSE,0.031059,0.1605,0.1251,1,1
3,GO MANGANESE ION TRANSPORT,0.0049174,0.16036,0.17666,1,1
3,GO NEGATIVE REGULATION OF STEROL TRANSPORT,0.0041716,0.16032,0.37934,1,1
3,GO FATTY ACYL COA BIOSYNTHETIC PROCESS,0.041093,0.16024,0.12703,1,1
3,GO PHOSPHATIDYLINOSITOL BIOSYNTHETIC PROCESS,0.0010528,0.16009,0.13141,1,1
3,GO VASCULAR PROCESS IN CIRCULATORY SYSTEM,0.0007696,0.15968,0.17696,1,1
3,GO PEROXISOMAL MEMBRANE TRANSPORT,0.0013872,0.15967,0.18375,1,1
3,GO NEGATIVE REGULATION OF MAPK CASCADE,0.012508,0.15963,0.13304,1,1
3,GO EPITHELIAL CELL PROLIFERATION,0.0099891,0.15958,0.11497,1,1
3,GO MULTIVESICULAR BODY ORGANIZATION,0.0011199,0.15957,0.1496,1,1
3,GO REGULATION OF CELL MATURATION,0.0033369,0.15932,0.15568,1,1
3,GO LIPOPROTEIN BIOSYNTHETIC PROCESS,0.0029794,0.15931,0.12713,1,1
3,GO REGULATION OF ACTIVIN RECEPTOR SIGNALING PATHWAY,0.049546,0.15916,0.10638,1,1
3,GO LUNG MORPHOGENESIS,0.049546,0.15909,0.11403,1,1
3,GO S ADENOSYLMETHIONINE METABOLIC PROCESS,0.031748,0.15902,0.14477,1,1
3,GO VERY LONG CHAIN FATTY ACID METABOLIC PROCESS,0.0010859,0.15891,0.16536,1,1
3,GO TRANSLESION SYNTHESIS,0.0018173,0.15881,0.13166,1,1
3,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR SECRETION,0.0069616,0.15864,0.15704,1,1
3,GO GLYCEROLIPID BIOSYNTHETIC PROCESS,0.00025131,0.15835,0.16104,1,1
3,GO THIOESTER BIOSYNTHETIC PROCESS,0.013139,0.15822,0.16198,1,1
3,GO ESTABLISHMENT OR MAINTENANCE OF TRANSMEMBRANE ELECTROCHEMICAL GRADIENT,0.011612,0.15748,0.16774,1,1
3,GO MYELOID CELL DEVELOPMENT,0.001662,0.15727,0.13774,1,1
3,GO MULTICELLULAR ORGANISM AGING,0.0026572,0.15704,0.15143,1,1
3,GO INTERMEDIATE FILAMENT BASED PROCESS,0.016734,0.15647,0.15353,1,1
3,GO NUCLEAR TRANSCRIBED MRNA POLY A TAIL SHORTENING,0.0017123,0.15647,0.14063,1,1
3,GO RESPONSE TO OXYGEN CONTAINING COMPOUND,0.00052342,0.15591,0.13086,1,1
3,GO ORGANOPHOSPHATE BIOSYNTHETIC PROCESS,0.0032441,0.15582,0.12714,1,1
3,GO REGULATION OF LEUKOCYTE CHEMOTAXIS,0.0018173,0.15581,0.14117,1,1
3,GO ORGANIC HYDROXY COMPOUND CATABOLIC PROCESS,8.4205e-05,0.15567,0.21459,1,1
3,GO GLIAL CELL APOPTOTIC PROCESS,0.042857,0.15566,0.17859,1,1
3,GO PREASSEMBLY OF GPI ANCHOR IN ER MEMBRANE,0.001872,0.15555,0.19249,1,1
3,GO EPIDERMAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.0075304,0.15551,0.14124,1,1
3,GO REGULATION OF CELL MATRIX ADHESION,0.0083534,0.15536,0.16938,1,1
3,GO POSITIVE REGULATION OF ERBB SIGNALING PATHWAY,0.013139,0.15459,0.14253,1,1
3,GO MULTIVESICULAR BODY SORTING PATHWAY,0.0014738,0.15452,0.15547,1,1
3,GO CARBOHYDRATE BIOSYNTHETIC PROCESS,0.00022676,0.1544,0.17001,1,1
3,GO REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION,0.0025083,0.15419,0.11511,1,1
3,GO RESPONSE TO HYDROGEN PEROXIDE,0.00065623,0.15403,0.15945,1,1
3,GO REGULATION OF RESPONSE TO OXIDATIVE STRESS,0.015203,0.15401,0.10712,1,1
3,GO ENDOPLASMIC RETICULUM TO GOLGI VESICLE MEDIATED TRANSPORT,0.00090094,0.15361,0.16272,1,1
3,GO INTESTINAL EPITHELIAL CELL DIFFERENTIATION,0.011612,0.1536,0.16063,1,1
3,GO REGULATION OF PEPTIDE TRANSPORT,4.8379e-05,0.15356,0.14764,1,1
3,GO RESPONSE TO ALKALOID,0.0036303,0.15332,0.14391,1,1
3,GO INSULIN RECEPTOR SIGNALING PATHWAY,0.00072223,0.15329,0.14077,1,1
3,GO PEROXISOME ORGANIZATION,0.0030654,0.15318,0.17428,1,1
3,GO LYSOSOME LOCALIZATION,0.0042883,0.15311,0.14139,1,1
3,GO SENSORY PERCEPTION OF BITTER TASTE,0.00049035,0.15287,0.15087,1,1
3,GO COLUMNAR CUBOIDAL EPITHELIAL CELL DIFFERENTIATION,0.0099891,0.15252,0.14938,1,1
3,GO POSITIVE REGULATION OF LYMPHOCYTE MIGRATION,0.025414,0.15249,0.12804,1,1
3,GO NEGATIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS,0.0051916,0.15193,0.16016,1,1
3,GO REGULATION OF MAP KINASE ACTIVITY,0.0022332,0.15156,0.13838,1,1
3,GO NEGATIVE REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY,0.017549,0.15153,0.1496,1,1
3,GO POSITIVE REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.0049174,0.15151,0.21357,1,1
3,GO GLAND DEVELOPMENT,0.0013872,0.15138,0.12833,1,1
3,GO RESPONSE TO ANTIBIOTIC,0.0010528,0.15138,0.17859,1,1
3,GO REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.0037331,0.15123,0.14063,1,1
3,GO CALCIUM ION IMPORT,0.021165,0.15116,0.10811,1,1
3,GO HOMEOSTATIC PROCESS,8.4205e-05,0.15108,0.13588,1,1
3,GO SIGNAL RELEASE,0.001872,0.15085,0.13286,1,1
3,GO NEGATIVE REGULATION OF COLD INDUCED THERMOGENESIS,0.013465,0.1507,0.14948,1,1
3,GO POSITIVE REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT,0.0040578,0.15068,0.13672,1,1
3,GO REGULATION OF NEUROINFLAMMATORY RESPONSE,0.04854,0.15047,0.11433,1,1
3,GO MONOCARBOXYLIC ACID BIOSYNTHETIC PROCESS,0.0014299,0.15039,0.16302,1,1
3,GO POSITIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,0.00353,0.15033,0.13372,1,1
3,GO INORGANIC ANION TRANSMEMBRANE TRANSPORT,0.00045924,0.15027,0.15063,1,1
3,GO MORPHOGENESIS OF A BRANCHING STRUCTURE,0.049546,0.14991,0.08666,1,1
3,GO ENDOSOME ORGANIZATION,0.00035231,0.14987,0.17368,1,1
3,GO NEGATIVE REGULATION OF CATALYTIC ACTIVITY,0.001986,0.14964,0.12585,1,1
3,GO ACTIN FILAMENT BASED TRANSPORT,0.014138,0.14962,0.20978,1,1
3,GO PSEUDOPODIUM ORGANIZATION,0.049546,0.1492,0.22122,1,1
3,GO ACROSOME REACTION,0.020205,0.14917,0.18068,1,1
3,GO REGULATION OF MEIOTIC CELL CYCLE,0.001872,0.14872,0.12648,1,1
3,GO GLYCEROPHOSPHOLIPID METABOLIC PROCESS,0.00012964,0.14871,0.16072,1,1
3,GO POLYOL CATABOLIC PROCESS,0.0033369,0.14865,0.15323,1,1
3,GO CELL MOTILITY,0.019739,0.1486,0.090384,1,1
3,GO POSITIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.00030804,0.14843,0.18117,1,1
3,GO RESPONSE TO ACID CHEMICAL,0.0056288,0.14832,0.11618,1,1
3,GO CELLULAR RESPONSE TO ORGANIC CYCLIC COMPOUND,0.0022332,0.14831,0.11477,1,1
3,GO RESPONSE TO ORGANIC CYCLIC COMPOUND,0.0013872,0.14815,0.1199,1,1
3,GO BIOMINERALIZATION,0.0087944,0.14814,0.13121,1,1
3,GO REGULATION OF CELL POPULATION PROLIFERATION,0.0016129,0.1481,0.11907,1,1
3,GO POSITIVE REGULATION OF CELL POPULATION PROLIFERATION,0.0051916,0.14802,0.11394,1,1
3,GO PEROXISOMAL TRANSPORT,0.0030654,0.14796,0.1839,1,1
3,GO PROTEIN LOCALIZATION TO PLASMA MEMBRANE,0.024288,0.14777,0.10896,1,1
3,GO ENDOMEMBRANE SYSTEM ORGANIZATION,0.0013457,0.14763,0.12307,1,1
3,GO HIGH DENSITY LIPOPROTEIN PARTICLE REMODELING,0.015953,0.14749,0.22845,1,1
3,GO POSITIVE REGULATION OF PROTEIN TARGETING TO MITOCHONDRION,0.0024367,0.14746,0.13337,1,1
3,GO POSITIVE REGULATION OF GLIOGENESIS,0.033166,0.14696,0.11288,1,1
3,GO VIRAL BUDDING VIA HOST ESCRT COMPLEX,0.00054072,0.14673,0.19309,1,1
3,GO STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.0087944,0.14657,0.10954,1,1
3,GO RESPONSE TO HORMONE,0.00079435,0.14653,0.13967,1,1
3,GO ORGANIC ACID BIOSYNTHETIC PROCESS,0.0019282,0.14623,0.17313,1,1
3,GO ORGANIC ACID CATABOLIC PROCESS,0.0073363,0.14612,0.16725,1,1
3,GO AUTOPHAGY OF MITOCHONDRION,0.00090094,0.14608,0.16716,1,1
3,GO MODULATION OF PROCESS OF OTHER ORGANISM,0.014841,0.14566,0.075161,1,1
3,GO NEGATIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY,0.0017123,0.14559,0.12047,1,1
3,GO CELL MATURATION,0.00017186,0.14547,0.14975,1,1
3,GO POSITIVE REGULATION OF LEUKOCYTE MIGRATION,0.017969,0.1453,0.1127,1,1
3,GO CELLULAR RESPONSE TO PEPTIDE,0.00095906,0.14489,0.12674,1,1
3,GO DNA CATABOLIC PROCESS,0.00041602,0.14484,0.13751,1,1
3,GO ORGANIC ACID TRANSPORT,0.00055855,0.14471,0.1826,1,1
3,GO MEMBRANE ORGANIZATION,0.0067808,0.14444,0.096234,1,1
3,GO REGULATION OF PROTEIN BINDING,0.0069616,0.1438,0.12157,1,1
3,GO ALCOHOL CATABOLIC PROCESS,0.0026572,0.14355,0.16184,1,1
3,GO POSITIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION,0.009256,0.14343,0.14644,1,1
3,GO PHOTOTRANSDUCTION,0.0081404,0.14334,0.097881,1,1
3,GO NEGATIVE REGULATION OF TOR SIGNALING,0.027803,0.14289,0.099521,1,1
3,GO GLUCOSE IMPORT,0.0056288,0.14246,0.15952,1,1
3,GO NEGATIVE REGULATION OF PROTEIN BINDING,0.00072223,0.14183,0.15495,1,1
3,GO POSITIVE REGULATION OF SMALL MOLECULE METABOLIC PROCESS,0.004408,0.1417,0.14392,1,1
3,GO RESPONSE TO PEPTIDE HORMONE,0.00038934,0.14169,0.13554,1,1
3,GO ACTIVATION OF MAPK ACTIVITY,0.0021689,0.14155,0.12045,1,1
3,GO POSITIVE REGULATION OF LEUKOCYTE CHEMOTAXIS,0.015953,0.14148,0.10286,1,1
3,GO POSITIVE REGULATION OF CELL AGING,0.021165,0.14145,0.18253,1,1
3,GO REGULATION OF MYELOID CELL DIFFERENTIATION,0.00042998,0.14143,0.14393,1,1
3,GO REGULATION OF MAPK CASCADE,0.0085714,0.14108,0.11069,1,1
3,GO PHOSPHATIDYLINOSITOL METABOLIC PROCESS,0.0017123,0.14075,0.1245,1,1
3,GO RETINA HOMEOSTASIS,0.0037331,0.14057,0.099368,1,1
3,GO RESPONSE TO TOXIC SUBSTANCE,0.0017641,0.14034,0.18138,1,1
3,GO NEGATIVE REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,0.00049035,0.13993,0.13026,1,1
3,GO OVARIAN FOLLICLE DEVELOPMENT,0.023205,0.13966,0.11367,1,1
3,GO POSITIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,0.00045924,0.13962,0.12972,1,1
3,GO CELLULAR ION HOMEOSTASIS,0.0010206,0.13958,0.12439,1,1
3,GO CELLULAR RESPONSE TO OXYGEN CONTAINING COMPOUND,0.0017123,0.13952,0.11475,1,1
3,GO RESPONSE TO ETHANOL,0.0083534,0.13943,0.11912,1,1
3,GO NEGATIVE REGULATION OF CELL POPULATION PROLIFERATION,0.0034322,0.13934,0.11488,1,1
3,GO TISSUE MIGRATION,0.0094949,0.13913,0.13727,1,1
3,GO SMALL MOLECULE BIOSYNTHETIC PROCESS,0.001872,0.13887,0.15284,1,1
3,GO CELLULAR RESPONSE TO HORMONE STIMULUS,0.0013457,0.13879,0.12769,1,1
3,GO TRANSMEMBRANE TRANSPORT,0.00059588,0.13802,0.13532,1,1
3,GO ORGANIC ACID METABOLIC PROCESS,0.0027346,0.1377,0.15711,1,1
3,GO MAMMARY GLAND DEVELOPMENT,0.024846,0.13759,0.10532,1,1
3,GO FEEDING BEHAVIOR,0.02068,0.13754,0.11872,1,1
3,GO PROTEIN AUTOUBIQUITINATION,0.00019753,0.13753,0.12538,1,1
3,GO ERBB SIGNALING PATHWAY,0.024846,0.13749,0.11284,1,1
3,GO REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.0046564,0.13658,0.12941,1,1
3,GO NUCLEOSIDE BISPHOSPHATE BIOSYNTHETIC PROCESS,0.0057817,0.13632,0.1724,1,1
3,GO REGULATION OF RAS PROTEIN SIGNAL TRANSDUCTION,0.019283,0.13627,0.10043,1,1
3,GO SENSORY PERCEPTION OF CHEMICAL STIMULUS,0.00045924,0.13624,0.13926,1,1
3,GO NEGATIVE REGULATION OF FATTY ACID METABOLIC PROCESS,0.035393,0.13597,0.15191,1,1
3,GO CELLULAR RESPONSE TO CARBOHYDRATE STIMULUS,0.00045924,0.13592,0.15552,1,1
3,GO RESPONSE TO NITROGEN COMPOUND,0.00090094,0.13562,0.11191,1,1
3,GO ION TRANSPORT,0.00055855,0.13539,0.13944,1,1
3,GO EXOCYTIC PROCESS,0.012203,0.13513,0.15488,1,1
3,GO REPRODUCTIVE SYSTEM DEVELOPMENT,0.037747,0.13399,0.085239,1,1
3,GO POSITIVE REGULATION OF PEPTIDASE ACTIVITY,0.00069957,0.13392,0.17091,1,1
3,GO REGULATION OF HYDROLASE ACTIVITY,0.0029794,0.1336,0.10774,1,1
3,GO LIPID MODIFICATION,0.0007696,0.13355,0.15197,1,1
3,GO EXCRETION,0.016339,0.13355,0.11073,1,1
3,GO POSITIVE REGULATION OF PROTEIN POLYMERIZATION,0.0094949,0.13332,0.10628,1,1
3,GO MONOSACCHARIDE BIOSYNTHETIC PROCESS,0.004408,0.13285,0.16494,1,1
3,GO PROTEIN K11 LINKED UBIQUITINATION,0.015953,0.13252,0.14004,1,1
3,GO POSITIVE REGULATION OF MAP KINASE ACTIVITY,0.0071468,0.13197,0.1089,1,1
3,GO MONOCARBOXYLIC ACID METABOLIC PROCESS,0.0024367,0.13193,0.14674,1,1
3,GO REGULATION OF GENERATION OF PRECURSOR METABOLITES AND ENERGY,0.017549,0.13183,0.10271,1,1
3,GO RESPONSE TO ESTRADIOL,0.04854,0.13157,0.075075,1,1
3,GO ACTIN FILAMENT BUNDLE ORGANIZATION,0.041967,0.1314,0.08592,1,1
3,GO NEGATIVE REGULATION OF MOLECULAR FUNCTION,0.0032441,0.13121,0.10641,1,1
3,GO ERYTHROCYTE HOMEOSTASIS,0.0021062,0.13104,0.12857,1,1
3,GO SECOND MESSENGER MEDIATED SIGNALING,0.0024367,0.13079,0.11272,1,1
3,GO SIGNAL TRANSDUCTION BY PROTEIN PHOSPHORYLATION,0.004408,0.13062,0.11429,1,1
3,GO DRUG CATABOLIC PROCESS,0.0064317,0.13028,0.2252,1,1
3,GO RESPONSE TO OXYGEN LEVELS,0.0051916,0.13023,0.11824,1,1
3,GO IMPORT ACROSS PLASMA MEMBRANE,0.02166,0.13017,0.12369,1,1
3,GO POTASSIUM ION IMPORT ACROSS PLASMA MEMBRANE,0.019739,0.12975,0.15222,1,1
3,GO POSITIVE REGULATION OF MAPK CASCADE,0.0075304,0.12942,0.11221,1,1
3,GO POSITIVE REGULATION OF CELLULAR COMPONENT MOVEMENT,0.026586,0.12917,0.095864,1,1
3,GO T CELL HOMEOSTASIS,0.02843,0.12911,0.12048,1,1
3,GO REGULATION OF CELLULAR COMPONENT MOVEMENT,0.022165,0.12908,0.087029,1,1
3,GO PHOSPHATE ION TRANSMEMBRANE TRANSPORT,0.025994,0.12878,0.14027,1,1
3,GO RESPONSE TO PEPTIDE,0.0015189,0.12876,0.11853,1,1
3,GO TRANSITION METAL ION TRANSPORT,0.00026003,0.12873,0.20556,1,1
3,GO REGULATION OF TRANSPORT,0.0023671,0.12863,0.09751,1,1
3,GO RESPONSE TO ACTIVITY,0.0099891,0.12851,0.14795,1,1
3,GO INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS,0.0026572,0.12839,0.13127,1,1
3,GO NEPHRON DEVELOPMENT,0.045624,0.12782,0.086589,1,1
3,GO CELLULAR MODIFIED AMINO ACID METABOLIC PROCESS,0.02843,0.12756,0.14526,1,1
3,GO REGULATION OF PROTEIN LOCALIZATION,0.0015189,0.12745,0.10232,1,1
3,GO REGULATION OF CELL DEATH,0.0017641,0.12694,0.10856,1,1
3,GO ENERGY DERIVATION BY OXIDATION OF ORGANIC COMPOUNDS,0.0079323,0.1269,0.12969,1,1
3,GO POSITIVE REGULATION OF MONOOXYGENASE ACTIVITY,0.029068,0.12688,0.126,1,1
3,GO GOLGI ORGANIZATION,0.00026003,0.12648,0.15889,1,1
3,GO SINGLE FERTILIZATION,0.0085714,0.12646,0.094661,1,1
3,GO POSITIVE REGULATION OF SIGNALING,0.00079435,0.12628,0.11647,1,1
3,GO ORGANIC ACID TRANSMEMBRANE TRANSPORT,0.021165,0.12623,0.13786,1,1
3,GO POLYOL METABOLIC PROCESS,0.0054795,0.12612,0.12626,1,1
3,GO POSITIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.0060989,0.126,0.13175,1,1
3,GO UROGENITAL SYSTEM DEVELOPMENT,0.05161,0.12597,0.079052,1,1
3,GO CELLULAR RESPONSE TO NITROGEN COMPOUND,0.0027346,0.12596,0.10191,1,1
3,GO HOMEOSTASIS OF NUMBER OF CELLS,0.0097392,0.1258,0.10034,1,1
3,GO SENSORY PERCEPTION OF MECHANICAL STIMULUS,0.0087944,0.12523,0.11282,1,1
3,GO THYMIC T CELL SELECTION,0.050569,0.12519,0.076334,1,1
3,GO POSITIVE REGULATION OF NITRIC OXIDE SYNTHASE ACTIVITY,0.05161,0.12496,0.14341,1,1
3,GO MESONEPHROS DEVELOPMENT,0.020205,0.12443,0.11024,1,1
3,GO MEGAKARYOCYTE DIFFERENTIATION,0.0020453,0.12397,0.11708,1,1
3,GO CELLULAR RESPONSE TO STEROID HORMONE STIMULUS,0.0094949,0.12395,0.11021,1,1
3,GO REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,0.0030654,0.12391,0.10048,1,1
3,GO DNA SYNTHESIS INVOLVED IN DNA REPAIR,0.00092958,0.12374,0.12392,1,1
3,GO PHOSPHATIDYLGLYCEROL METABOLIC PROCESS,0.0027346,0.12361,0.13996,1,1
3,GO SOMITOGENESIS,0.0075304,0.12298,0.11065,1,1
3,GO REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,0.0051916,0.12226,0.12252,1,1
3,GO REGULATION OF OXIDOREDUCTASE ACTIVITY,0.017549,0.122,0.1236,1,1
3,GO RESPONSE TO ENDOGENOUS STIMULUS,0.0014299,0.12195,0.11275,1,1
3,GO REGULATION OF TOR SIGNALING,0.00014418,0.12162,0.12346,1,1
3,GO ORGANONITROGEN COMPOUND BIOSYNTHETIC PROCESS,0.0099891,0.12096,0.09958,1,1
3,GO POSITIVE REGULATION OF PROTEIN MODIFICATION PROCESS,0.001872,0.12069,0.10651,1,1
3,GO CELLULAR RESPONSE TO ACID CHEMICAL,0.02843,0.12041,0.10955,1,1
3,GO REGULATION OF DNA CATABOLIC PROCESS,0.011904,0.12031,0.1286,1,1
3,GO SMALL MOLECULE CATABOLIC PROCESS,0.0029794,0.12013,0.16704,1,1
3,GO CALCIUM ION TRANSMEMBRANE TRANSPORT,0.03939,0.11995,0.074557,1,1
3,GO REGULATION OF OXIDATIVE STRESS INDUCED CELL DEATH,0.0038387,0.11988,0.11314,1,1
3,GO PEPTIDYL TYROSINE MODIFICATION,0.0099891,0.11954,0.10916,1,1
3,GO NEURON DEATH IN RESPONSE TO OXIDATIVE STRESS,0.010506,0.11944,0.12645,1,1
3,GO POSITIVE REGULATION OF CELL DEATH,0.0075304,0.11934,0.09971,1,1
3,GO ACTIVATION OF GTPASE ACTIVITY,0.0069616,0.11927,0.097033,1,1
3,GO ADENYLATE CYCLASE ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.024288,0.11859,0.10853,1,1
3,GO CELLULAR GLUCOSE HOMEOSTASIS,0.0039469,0.11856,0.12659,1,1
3,GO OOGENESIS,0.029068,0.11829,0.083935,1,1
3,GO REGULATION OF MITOTIC SPINDLE ASSEMBLY,0.047551,0.1177,0.12461,1,1
3,GO REGULATION OF MITOCHONDRION ORGANIZATION,0.0020453,0.11731,0.11067,1,1
3,GO POSITIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS,0.0054795,0.1171,0.095334,1,1
3,GO FC RECEPTOR MEDIATED STIMULATORY SIGNALING PATHWAY,0.0069616,0.11709,0.13457,1,1
3,GO INTRA S DNA DAMAGE CHECKPOINT,0.0046564,0.11704,0.11737,1,1
3,GO NEGATIVE REGULATION OF SECRETION,0.011612,0.11689,0.087758,1,1
3,GO HORMONE MEDIATED SIGNALING PATHWAY,0.02166,0.11678,0.076581,1,1
3,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION,0.00019753,0.11666,0.13006,1,1
3,GO TOR SIGNALING,4.4878e-05,0.11657,0.11111,1,1
3,GO REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,0.0056288,0.11614,0.12165,1,1
3,GO DETECTION OF STIMULUS INVOLVED IN SENSORY PERCEPTION,0.0022332,0.11581,0.13244,1,1
3,GO VIRAL BUDDING,0.0032441,0.11537,0.1501,1,1
3,GO LYMPH NODE DEVELOPMENT,0.02843,0.11534,0.1533,1,1
3,GO RESPONSE TO SALT,0.02166,0.1153,0.11703,1,1
3,GO FATTY ACYL COA METABOLIC PROCESS,0.015203,0.11528,0.16745,1,1
3,GO NEGATIVE REGULATION OF OSTEOCLAST DIFFERENTIATION,0.043763,0.11505,0.11297,1,1
3,GO SEROTONIN RECEPTOR SIGNALING PATHWAY,0.012203,0.11428,0.11547,1,1
3,GO ACTIVATION OF PROTEIN KINASE ACTIVITY,0.00047456,0.11425,0.13088,1,1
3,GO ANATOMICAL STRUCTURE MATURATION,0.0053338,0.11408,0.10172,1,1
3,GO APOPTOTIC PROCESS,0.0013457,0.11407,0.11118,1,1
3,GO PROTEIN LOCALIZATION TO CELL PERIPHERY,0.052669,0.11373,0.076961,1,1
3,GO REGULATION OF REPRODUCTIVE PROCESS,0.0087944,0.11341,0.099344,1,1
3,GO RESPONSE TO ABIOTIC STIMULUS,0.001986,0.11296,0.099434,1,1
3,GO ORGANOPHOSPHATE METABOLIC PROCESS,0.0040578,0.11278,0.11439,1,1
3,GO NEGATIVE REGULATION OF CELL DEATH,0.0046564,0.11234,0.10379,1,1
3,GO POSITIVE REGULATION OF PROTEIN METABOLIC PROCESS,0.0049174,0.1121,0.095623,1,1
3,GO REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.015203,0.11186,0.10071,1,1
3,GO RUFFLE ASSEMBLY,0.050569,0.11175,0.1094,1,1
3,GO INOSITOL PHOSPHATE CATABOLIC PROCESS,0.012203,0.11165,0.17069,1,1
3,GO KIDNEY EPITHELIUM DEVELOPMENT,0.025994,0.11142,0.10261,1,1
3,GO POSITIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,0.018398,0.11117,0.085774,1,1
3,GO NEGATIVE REGULATION OF ERAD PATHWAY,0.029719,0.1106,0.11873,1,1
3,GO NEGATIVE REGULATION OF ANIMAL ORGAN MORPHOGENESIS,0.019283,0.1103,0.12188,1,1
3,GO NEGATIVE REGULATION OF PROTEIN METABOLIC PROCESS,0.0083534,0.10983,0.092377,1,1
3,GO POSITIVE REGULATION OF TRANSPORT,0.0021689,0.10978,0.10654,1,1
3,GO POSITIVE REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.044685,0.10925,0.12129,1,1
3,GO REGULATION OF ATP METABOLIC PROCESS,0.025414,0.1091,0.097324,1,1
3,GO REGULATION OF MEGAKARYOCYTE DIFFERENTIATION,0.011904,0.1084,0.10469,1,1
3,GO FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.018398,0.10754,0.081408,1,1
3,GO CELLULAR HOMEOSTASIS,0.0022992,0.10737,0.11169,1,1
3,GO BODY FLUID SECRETION,0.030383,0.10641,0.087398,1,1
3,GO DIVALENT INORGANIC CATION TRANSPORT,0.017137,0.10609,0.092323,1,1
3,GO PROCESS UTILIZING AUTOPHAGIC MECHANISM,0.00044439,0.10565,0.12904,1,1
3,GO ORGANOPHOSPHATE CATABOLIC PROCESS,0.00045924,0.10491,0.14944,1,1
3,GO POSITIVE REGULATION OF MITOTIC NUCLEAR DIVISION,0.0069616,0.10469,0.097781,1,1
3,GO CELLULAR RESPONSE TO ENDOGENOUS STIMULUS,0.0053338,0.10449,0.091579,1,1
3,GO LEUKOCYTE TETHERING OR ROLLING,0.018836,0.10447,0.097305,1,1
3,GO NEGATIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS,0.016734,0.10425,0.083415,1,1
3,GO POSITIVE REGULATION OF PROTEIN KINASE ACTIVITY,0.0025817,0.10374,0.11005,1,1
3,GO MULTI ORGANISM PROCESS,0.02268,0.10252,0.068445,1,1
3,GO REGULATION OF PROTEIN KINASE ACTIVITY,0.0062634,0.10176,0.097566,1,1
3,GO CYCLIC NUCLEOTIDE MEDIATED SIGNALING,0.044685,0.10115,0.081777,1,1
3,GO REGULATION OF OSTEOCLAST DIFFERENTIATION,0.027803,0.099952,0.093385,1,1
3,GO POSITIVE REGULATION OF NEURON DEATH,0.0075304,0.099901,0.12582,1,1
3,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO OXIDATIVE STRESS,0.015574,0.099547,0.1108,1,1
3,GO COENZYME A BIOSYNTHETIC PROCESS,0.020205,0.099346,0.17499,1,1
3,GO NEGATIVE REGULATION OF PHOSPHORYLATION,0.015203,0.09916,0.093914,1,1
3,GO JNK CASCADE,0.013798,0.098803,0.10266,1,1
3,GO REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.021165,0.098234,0.0806,1,1
3,GO ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,0.02166,0.098003,0.11549,1,1
3,GO REGULATION OF PROTEIN STABILITY,0.0030654,0.097367,0.10446,1,1
3,GO POSITIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS,0.018398,0.097021,0.07864,1,1
3,GO ACTIN FILAMENT ORGANIZATION,0.047551,0.096972,0.069518,1,1
3,GO FERTILIZATION,0.015953,0.096811,0.078782,1,1
3,GO NEGATIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS,0.01282,0.09659,0.084872,1,1
3,GO NEGATIVE REGULATION OF INTRACELLULAR TRANSPORT,0.029719,0.096461,0.086809,1,1
3,GO PHOSPHATIDYLINOSITOL PHOSPHORYLATION,0.013798,0.094521,0.12516,1,1
3,GO REGULATION OF PHOSPHORYLATION,0.0062634,0.093668,0.088926,1,1
3,GO PROTEIN AUTOPHOSPHORYLATION,0.019739,0.093621,0.079344,1,1
3,GO BLASTOCYST DEVELOPMENT,0.0010206,0.091934,0.10786,1,1
3,GO REGULATION OF PHOSPHORUS METABOLIC PROCESS,0.013139,0.091238,0.079177,1,1
3,GO REPRODUCTION,0.0094949,0.091163,0.079481,1,1
3,GO NEGATIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,0.0067808,0.089947,0.10395,1,1
3,GO REGULATION OF AUTOPHAGY,0.0017641,0.089513,0.11498,1,1
3,GO DEVELOPMENTAL PROCESS INVOLVED IN REPRODUCTION,0.011904,0.089413,0.07827,1,1
3,GO COBALAMIN METABOLIC PROCESS,0.020205,0.088844,0.22056,1,1
3,GO POSITIVE REGULATION OF MOLECULAR FUNCTION,0.0038387,0.088291,0.09015,1,1
3,GO POSITIVE REGULATION OF CYTOSKELETON ORGANIZATION,0.015203,0.088287,0.090424,1,1
3,GO ESTABLISHMENT OF ORGANELLE LOCALIZATION,0.010773,0.088254,0.078366,1,1
3,GO REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,0.012203,0.087474,0.07671,1,1
3,GO REGULATION OF PROTEIN MODIFICATION PROCESS,0.007729,0.087366,0.083463,1,1
3,GO RESPONSE TO PURINE CONTAINING COMPOUND,0.047551,0.087265,0.0745,1,1
3,GO POSITIVE REGULATION OF BINDING,0.04854,0.087128,0.068513,1,1
3,GO REGULATION OF EXOCYTOSIS,0.020205,0.086981,0.10693,1,1
3,GO TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE SIGNALING PATHWAY,0.012203,0.086719,0.099805,1,1
3,GO ANATOMICAL STRUCTURE HOMEOSTASIS,0.0034322,0.086554,0.095057,1,1
3,GO POSITIVE REGULATION OF CELLULAR CARBOHYDRATE METABOLIC PROCESS,0.024288,0.086479,0.13321,1,1
3,GO NEGATIVE REGULATION OF TRANSFERASE ACTIVITY,0.013139,0.085515,0.099149,1,1
3,GO CELL DEATH IN RESPONSE TO OXIDATIVE STRESS,0.0036303,0.085158,0.1107,1,1
3,GO REGULATION OF OSSIFICATION,0.036164,0.084586,0.090831,1,1
3,GO NEGATIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION,0.036164,0.084275,0.065206,1,1
3,GO CYTOSOLIC TRANSPORT,0.01282,0.083011,0.087034,1,1
3,GO MALE SEX DIFFERENTIATION,0.05161,0.082424,0.087856,1,1
3,GO TUBE DEVELOPMENT,0.052669,0.082063,0.07018,1,1
3,GO NEGATIVE REGULATION OF TRANSPORT,0.04854,0.079597,0.066755,1,1
3,GO REGULATION OF TRANSFERASE ACTIVITY,0.013798,0.079462,0.078101,1,1
3,GO POSITIVE REGULATION OF CARBOHYDRATE METABOLIC PROCESS,0.04854,0.078901,0.11083,1,1
3,GO POSITIVE REGULATION OF CATALYTIC ACTIVITY,0.0054795,0.078131,0.089991,1,1
3,GO VESICLE LOCALIZATION,0.02268,0.077178,0.09118,1,1
3,GO DNA MODIFICATION,0.042857,0.074619,0.05439,1,1
3,GO POSITIVE REGULATION OF TRANSFERASE ACTIVITY,0.011326,0.073097,0.0845,1,1
3,GO NEURON DEATH,0.05161,0.072877,0.054786,1,1
3,GO RESPONSE TO TEMPERATURE STIMULUS,0.0051916,0.072863,0.10532,1,1
3,GO POSITIVE REGULATION OF ORGANELLE ORGANIZATION,0.015574,0.071852,0.064108,1,1
3,GO MULTICELLULAR ORGANISM REPRODUCTION,0.040234,0.071169,0.057666,1,1
3,GO POSITIVE REGULATION OF HYDROLASE ACTIVITY,0.014841,0.070833,0.082227,1,1
3,GO POSITIVE REGULATION OF CALCIUM MEDIATED SIGNALING,0.041093,0.070567,0.12879,1,1
3,GO REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,0.011904,0.070548,0.063561,1,1
3,GO ANTIMICROBIAL HUMORAL IMMUNE RESPONSE MEDIATED BY ANTIMICROBIAL PEPTIDE,0.024288,0.070072,0.070492,1,1
3,GO DNA METHYLATION OR DEMETHYLATION,0.05161,0.069713,0.066724,1,1
3,GO GERM CELL DEVELOPMENT,0.05161,0.068916,0.057818,1,1
3,GO INTRACELLULAR TRANSPORT,0.016734,0.068648,0.061097,1,1
3,GO POSITIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION,0.03939,0.0685,0.065484,1,1
3,GO POSITIVE REGULATION OF CELL CYCLE,0.025994,0.067266,0.057089,1,1
3,GO MITOCHONDRIAL TRANSPORT,0.023205,0.065633,0.072125,1,1
3,GO PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION,0.0054795,0.062657,0.064778,1,1
3,GO CELLULAR MACROMOLECULE LOCALIZATION,0.049546,0.062551,0.046632,1,1
3,GO SEXUAL REPRODUCTION,0.027803,0.061944,0.059534,1,1
3,GO REGULATION OF CIRCADIAN RHYTHM,0.041093,0.061863,0.086973,1,1
3,GO GAMETE GENERATION,0.044685,0.058099,0.05447,1,1
3,GO POSITIVE REGULATION OF CELLULAR BIOSYNTHETIC PROCESS,0.031748,0.056636,0.048077,1,1
3,GO HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION,0.0059384,0.051948,0.083655,1,1
3,GO CELLULAR COMPONENT DISASSEMBLY INVOLVED IN EXECUTION PHASE OF APOPTOSIS,0.018836,0.05034,0.06502,1,1
3,GO PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.012203,0.049143,0.055688,1,1
4,GO FOREBRAIN NEURON FATE COMMITMENT,6.5149e-05,0.73192,0.83554,1,1
4,GO TRIGEMINAL NERVE DEVELOPMENT,0.0012662,0.54552,0.40372,1,1
4,GO REGULATION OF LONG TERM SYNAPTIC DEPRESSION,0.0057817,0.52017,0.41061,1,1
4,GO CEREBELLAR GRANULAR LAYER DEVELOPMENT,0.0034322,0.51584,0.38169,1,1
4,GO POSITIVE REGULATION OF INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.004408,0.48262,0.48711,1,1
4,GO POSITIVE REGULATION OF GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR PRODUCTION,2.4346e-05,0.4627,0.47053,1,1
4,GO GANGLION DEVELOPMENT,0.0020453,0.40488,0.39085,1,1
4,GO PERIPHERAL NERVOUS SYSTEM NEURON DIFFERENTIATION,0.0024367,0.40189,0.42301,1,1
4,GO NEGATIVE REGULATION OF INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY,0.00057693,0.37051,0.35265,1,1
4,GO NOSE DEVELOPMENT,0.00012074,0.35766,0.53896,1,1
4,GO POSITIVE REGULATION OF CIRCADIAN RHYTHM,0.00059588,0.35455,0.37652,1,1
4,GO GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR PRODUCTION,3.0689e-05,0.35264,0.39851,1,1
4,GO REGULATION OF POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR ACTIVITY,0.010773,0.33388,0.36385,1,1
4,GO SEMINIFEROUS TUBULE DEVELOPMENT,0.0031536,0.32926,0.2864,1,1
4,GO ENDOSOME TO PLASMA MEMBRANE PROTEIN TRANSPORT,7.547e-05,0.30278,0.46125,1,1
4,GO SPONTANEOUS SYNAPTIC TRANSMISSION,0.010506,0.29878,0.31093,1,1
4,GO REGULATION OF GROWTH HORMONE SECRETION,0.0041716,0.29631,0.33167,1,1
4,GO THALAMUS DEVELOPMENT,0.014486,0.29575,0.25277,1,1
4,GO NETRIN ACTIVATED SIGNALING PATHWAY,0.019739,0.27628,0.25116,1,1
4,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO POSTSYNAPTIC MEMBRANE,0.0022992,0.27087,0.34953,1,1
4,GO POSITIVE REGULATION OF OLIGODENDROCYTE DIFFERENTIATION,0.0090226,0.26035,0.22564,1,1
4,GO LENS MORPHOGENESIS IN CAMERA TYPE EYE,0.0049174,0.25445,0.2194,1,1
4,GO KINETOCHORE ORGANIZATION,0.00047456,0.25256,0.2283,1,1
4,GO NEGATIVE REGULATION OF NERVOUS SYSTEM PROCESS,0.0014299,0.23977,0.22012,1,1
4,GO MRNA SPLICE SITE SELECTION,0.00017796,0.23498,0.24923,1,1
4,GO VIRAL LATENCY,0.0085714,0.22431,0.17658,1,1
4,GO REGULATION OF SISTER CHROMATID COHESION,0.00059588,0.22176,0.18529,1,1
4,GO REGULATION OF INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY,0.004408,0.2162,0.15676,1,1
4,GO POSITIVE REGULATION OF MULTICELLULAR ORGANISM GROWTH,0.0033369,0.21256,0.20385,1,1
4,GO KINETOCHORE ASSEMBLY,0.0025083,0.21244,0.19026,1,1
4,GO HISTONE H4 K16 ACETYLATION,0.00010092,0.20893,0.20782,1,1
4,GO MAMMARY GLAND EPITHELIAL CELL DIFFERENTIATION,0.025414,0.20268,0.14571,1,1
4,GO CHROMATIN REMODELING AT CENTROMERE,0.00087311,0.20199,0.19563,1,1
4,GO HISTONE H2A MONOUBIQUITINATION,2.0833e-05,0.19936,0.23382,1,1
4,GO PARENTAL BEHAVIOR,0.033894,0.19777,0.2891,1,1
4,GO CARDIOBLAST DIFFERENTIATION,0.030383,0.19668,0.17282,1,1
4,GO HISTONE H3 K9 TRIMETHYLATION,0.00037661,0.19526,0.17953,1,1
4,GO PROTEIN INSERTION INTO MITOCHONDRIAL MEMBRANE INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.0085714,0.19285,0.18205,1,1
4,GO APICAL PROTEIN LOCALIZATION,0.004408,0.18962,0.18031,1,1
4,GO SINGLE STRAND BREAK REPAIR,0.0056288,0.18818,0.16033,1,1
4,GO CENTROMERE COMPLEX ASSEMBLY,0.0012662,0.1826,0.183,1,1
4,GO DENDRITIC TRANSPORT,0.033166,0.1809,0.16839,1,1
4,GO NEGATIVE REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION,0.031059,0.17925,0.14976,1,1
4,GO PROTECTION FROM NON HOMOLOGOUS END JOINING AT TELOMERE,9.0551e-05,0.17735,0.19836,1,1
4,GO POSITIVE REGULATION OF CILIUM ASSEMBLY,0.0032441,0.17643,0.19938,1,1
4,GO MICROTUBULE ORGANIZING CENTER LOCALIZATION,0.0042883,0.17501,0.15487,1,1
4,GO GENETIC IMPRINTING,0.001986,0.17474,0.1918,1,1
4,GO EMBRYONIC DIGESTIVE TRACT MORPHOGENESIS,0.025994,0.16964,0.14179,1,1
4,GO ALTERNATIVE MRNA SPLICING VIA SPLICEOSOME,0.0010528,0.16926,0.15522,1,1
4,GO REGULATION OF TRANSCRIPTION INVOLVED IN G1 S TRANSITION OF MITOTIC CELL CYCLE,0.0062634,0.16873,0.1475,1,1
4,GO HISTONE H3 K9 METHYLATION,0.0015189,0.16495,0.15333,1,1
4,GO NEGATIVE REGULATION OF MRNA SPLICING VIA SPLICEOSOME,0.001228,0.16197,0.15866,1,1
4,GO REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION,0.0066042,0.16126,0.13324,1,1
4,GO PROTEIN LOCALIZATION TO MICROTUBULE ORGANIZING CENTER,0.00059588,0.16114,0.1529,1,1
4,GO PROTEIN LOCALIZATION TO CHROMOSOME CENTROMERIC REGION,0.0066042,0.16109,0.15344,1,1
4,GO RESPONSE TO PLATELET DERIVED GROWTH FACTOR,0.023205,0.15991,0.13764,1,1
4,GO T HELPER 17 CELL LINEAGE COMMITMENT,0.017969,0.15752,0.12124,1,1
4,GO MITOTIC SISTER CHROMATID COHESION,0.001191,0.15708,0.19539,1,1
4,GO DOUBLE STRAND BREAK REPAIR VIA BREAK INDUCED REPLICATION,0.0069616,0.15629,0.14054,1,1
4,GO HEMATOPOIETIC STEM CELL PROLIFERATION,0.015953,0.15067,0.14098,1,1
4,GO CILIARY BASAL BODY PLASMA MEMBRANE DOCKING,8.1192e-05,0.14761,0.15361,1,1
4,GO COPULATION,0.046579,0.14744,0.13528,1,1
4,GO CAMERA TYPE EYE PHOTORECEPTOR CELL DIFFERENTIATION,0.02068,0.14734,0.1475,1,1
4,GO CENTROSOME DUPLICATION,0.0010859,0.14612,0.13878,1,1
4,GO POSITIVE REGULATION OF CENTROSOME CYCLE,0.004408,0.14572,0.16357,1,1
4,GO MAINTENANCE OF ORGANELLE LOCATION,0.021165,0.14457,0.092121,1,1
4,GO NERVE GROWTH FACTOR SIGNALING PATHWAY,0.014841,0.14431,0.17856,1,1
4,GO INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY,0.015953,0.14333,0.092095,1,1
4,GO REGULATION OF DNA DAMAGE CHECKPOINT,0.0067808,0.14327,0.11995,1,1
4,GO TELOMERE MAINTENANCE IN RESPONSE TO DNA DAMAGE,0.001872,0.14262,0.14307,1,1
4,GO REGULATION OF MRNA SPLICING VIA SPLICEOSOME,0.0075304,0.14194,0.10835,1,1
4,GO HISTONE H2A UBIQUITINATION,0.0022332,0.14116,0.14206,1,1
4,GO MITOTIC CHROMOSOME CONDENSATION,0.0013054,0.1411,0.18113,1,1
4,GO NEGATIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,0.024846,0.13966,0.1203,1,1
4,GO DOSAGE COMPENSATION,0.0028141,0.13802,0.12387,1,1
4,GO CENTRIOLE ASSEMBLY,0.0062634,0.13652,0.11065,1,1
4,GO POSITIVE REGULATION OF HISTONE H3 K4 METHYLATION,0.031748,0.13621,0.15014,1,1
4,GO DNA DEMETHYLATION,0.041093,0.12979,0.10298,1,1
4,GO POSITIVE REGULATION OF PEPTIDYL LYSINE ACETYLATION,0.02843,0.12766,0.098878,1,1
4,GO POST ANAL TAIL MORPHOGENESIS,0.031059,0.12724,0.11676,1,1
4,GO RAB PROTEIN SIGNAL TRANSDUCTION,0.0047853,0.12632,0.24321,1,1
4,GO CENTRIOLE CENTRIOLE COHESION,0.045624,0.12593,0.1252,1,1
4,GO SPLICEOSOMAL TRI SNRNP COMPLEX ASSEMBLY,0.026586,0.12424,0.10963,1,1
4,GO HISTONE H3 K9 MODIFICATION,0.0013457,0.12246,0.13179,1,1
4,GO POSITIVE REGULATION OF GLIAL CELL DIFFERENTIATION,0.017549,0.12059,0.13672,1,1
4,GO ATP DEPENDENT CHROMATIN REMODELING,0.00095906,0.11954,0.13302,1,1
4,GO HISTONE H2A ACETYLATION,0.0069616,0.11909,0.14549,1,1
4,GO MICROTUBULE NUCLEATION BY MICROTUBULE ORGANIZING CENTER,0.027188,0.11613,0.13691,1,1
4,GO POSITIVE REGULATION OF DNA DEPENDENT DNA REPLICATION,0.034637,0.11335,0.11178,1,1
4,GO PEPTIDYL LYSINE TRIMETHYLATION,0.0083534,0.11291,0.096996,1,1
4,GO REGULATION OF CILIUM ASSEMBLY,0.0066042,0.112,0.1111,1,1
4,GO HISTONE MONOUBIQUITINATION,0.00042998,0.11174,0.132,1,1
4,GO DNA REPLICATION INDEPENDENT NUCLEOSOME ORGANIZATION,0.0079323,0.11063,0.13786,1,1
4,GO G0 TO G1 TRANSITION,0.0022332,0.10972,0.13708,1,1
4,GO SPLICEOSOMAL COMPLEX ASSEMBLY,0.0059384,0.10927,0.12731,1,1
4,GO NEGATIVE REGULATION OF RNA SPLICING,0.0099891,0.10913,0.11065,1,1
4,GO REGULATION OF HISTONE H3 K9 ACETYLATION,0.017969,0.10741,0.13352,1,1
4,GO PROTEIN LOCALIZATION TO KINETOCHORE,0.02268,0.10711,0.14448,1,1
4,GO NUCLEOSOME ASSEMBLY,0.007729,0.10641,0.1306,1,1
4,GO MRNA CIS SPLICING VIA SPLICEOSOME,0.007729,0.1054,0.10199,1,1
4,GO REGULATION OF CELL CYCLE CHECKPOINT,0.0041716,0.10436,0.089469,1,1
4,GO HISTONE UBIQUITINATION,0.0075304,0.1027,0.08436,1,1
4,GO DNA METHYLATION DEPENDENT HETEROCHROMATIN ASSEMBLY,0.015203,0.10152,0.14485,1,1
4,GO POSITIVE REGULATION OF PROTEIN ACETYLATION,0.0085714,0.10112,0.098933,1,1
4,GO REGULATION OF CENTRIOLE REPLICATION,0.034637,0.10095,0.086272,1,1
4,GO SISTER CHROMATID COHESION,0.0040578,0.095238,0.1236,1,1
4,GO CHROMATIN SILENCING,0.014138,0.094697,0.094194,1,1
4,GO SIGNAL TRANSDUCTION INVOLVED IN CELL CYCLE CHECKPOINT,0.009256,0.093737,0.093567,1,1
4,GO PEPTIDYL LYSINE ACETYLATION,0.0022332,0.08858,0.081499,1,1
4,GO REGULATION OF HISTONE H3 K4 METHYLATION,0.044685,0.088149,0.10667,1,1
4,GO NEGATIVE REGULATION OF DNA RECOMBINATION,0.009256,0.086238,0.11253,1,1
4,GO NUCLEOSOME ORGANIZATION,0.02068,0.085869,0.088084,1,1
4,GO PROTEIN ACETYLATION,0.0085714,0.085217,0.060142,1,1
4,GO POSITIVE REGULATION OF DNA REPAIR,0.0071468,0.084598,0.097344,1,1
4,GO POSITIVE REGULATION OF CELL CYCLE ARREST,0.0042883,0.083858,0.1008,1,1
4,GO RECOMBINATIONAL REPAIR,0.033894,0.077691,0.058192,1,1
4,GO CHROMOSOME SEGREGATION,0.021165,0.07699,0.056893,1,1
4,GO CHROMATIN ASSEMBLY OR DISASSEMBLY,0.0069616,0.07494,0.096738,1,1
4,GO HISTONE EXCHANGE,0.02268,0.074262,0.10068,1,1
4,GO MICROTUBULE ORGANIZING CENTER ORGANIZATION,0.0075304,0.073894,0.074685,1,1
4,GO SISTER CHROMATID SEGREGATION,0.012203,0.069227,0.073967,1,1
4,GO MITOTIC SISTER CHROMATID SEGREGATION,0.029719,0.067949,0.072144,1,1
4,GO HETEROCHROMATIN ORGANIZATION,0.0090226,0.064468,0.091426,1,1
4,GO REGULATION OF HISTONE METHYLATION,0.052669,0.062353,0.076376,1,1
4,GO NUCLEAR CHROMOSOME SEGREGATION,0.025414,0.056554,0.052015,1,1
4,GO MITOTIC DNA INTEGRITY CHECKPOINT,0.036948,0.055987,0.049316,1,1
4,GO DNA INTEGRITY CHECKPOINT,0.037747,0.055462,0.045768,1,1
4,GO PROTEIN MONOUBIQUITINATION,0.042857,0.055354,0.055484,1,1
4,GO CELL CYCLE CHECKPOINT,0.017549,0.053169,0.053872,1,1
4,GO CHROMATIN ORGANIZATION,0.012203,0.052844,0.0523,1,1
4,GO DNA PACKAGING,0.0075304,0.051835,0.088078,1,1
4,GO REGULATION OF RNA SPLICING,0.041093,0.048391,0.052706,1,1
